cell_line_id,drug_id,response
GSS,9926054,1.4316065343869406
CAL-54,9927531,5.326263652959217
SNU-1076,6505803,0.872724284931209
YKG-1,54618771,1.607640245193468
SW1783,10385095,3.137926014779676
Aska-SS,11396600,4.186494523446212
Karpas-299,4705,2.3837874770371816
TE-11,135411,0.502393128637252
SK-MES-1,9926054,1.7676300515090215
NCI-N87,11455910,1.6652699053284308
NCI-H1666,9926054,1.8501166706396857
HCC1395,10385095,1.414977783873619
TALL-1 [Human adult T-ALL],11167602,2.991652645826846
NCI-H1915,9887053,6.299480289507978
NCI-H146,12001922,1.0892970499924846
LMSU,42642645,1.4355208101232508
TE-11,3825829,3.5720700994834065
COLO 684,135411,0.5955197764940872
HPAF-II,12001922,2.5154532011185453
GMS-10,49836020,0.0918808601925
QGP-1,54618771,1.891890541476157
LNCaP clone FGC,42642645,0.6379836145749267
RCH-ACV,9926054,1.6841422831368045
BT 145,6505803,-1.6156517406127768
PE/CA-PJ34 (clone C12),12001922,2.3473594689504687
HSC-3,3825829,3.2177804213288757
MOR/CPR,136227924,3.350851412370925
KP-2,2746,4.5923372847517765
HOP-92,11455910,1.423553791437778
RPMI-6666,42642645,-0.1813442323026931
JHUEM-3,6505803,0.6198707712073951
MIA PaCa-2,136227924,2.1731844460154743
RVH-421,136227331,4.595276173623148
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
CCK-81,4705,0.3214356139711527
KP-3,135411,0.6280074036773945
Detroit 562,54649381,3.692436567903405
KE-39,11455910,-0.1151631297895284
BT 498,54618771,3.343910197755889
Daudi,42642645,-0.8700738631175318
Panc 04.03,24753719,4.39873379823384
HCC2108,9926054,2.5765466804926445
TE-8,12001922,2.2229767626504033
PK-59,2746,3.5698867833367585
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
Sq-1,100016,4.274424361552861
Hs 944.T,15953870,3.200922643689585
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
AU565,42642645,1.544546710659079
Hs 839.T,9926054,1.9387188117771836
SK-N-SH,2746,2.865356656524813
Rh41,12001922,1.8310366018380897
KNS-60,10385095,0.8805216107898952
HCC1195,11455910,0.2918122154241095
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
CAL-78,54649381,4.392304657608324
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
U-118MG,2746,3.48796975848492
LAMA-84,selumetinib-GDC-0941 (4-1 mol-mol),-0.0298835136014615
SUP-HD1,135411,-0.3028303477944072
TE-6,9927531,3.995869764794834
JHH-5,11396600,2.359739892843467
Granta-519,24753719,3.151565571990212
KMS-21-BM,15953870,1.9146916461850392
SNU-449,6505803,1.2866498789511422
SU.86.86,42642645,1.126847321592776
OE21,9926054,1.7334869398194368
BT 333,12001922,1.156738111129213
LUDLU-1,136227924,3.2639698653649254
HT-29,selumetinib-GDC-0941 (4-1 mol-mol),2.4520768151927976
A-172,15953870,4.193482845980262
KCL-22,9926054,1.5140986246434818
Lu-65,10385095,0.4710137676717799
HuP-T4,4705,0.794216535307181
Hep-G2,3825829,5.065822708326793
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
EBC-1,54649381,4.088093961784369
2004,136227331,4.391518238587266
VCaP,100016,6.449384825808392
RL,135411,0.5861751179014983
NCI-H1581,12001922,1.607289643662706
CAL-120,42642645,1.510413497688765
EoL-1,9926054,1.828019217783983
SNU-398,54618771,-4.947778172038554
COLO 320,11455910,0.88882946750677
SNU-423,11396600,4.403909661334611
YD-8,387447,-3.9759575932823377
HH [Human lymphoma],15953870,1.8767067040809713
BT 147,135423438,1.671229902583041
KYM-1,54649381,3.730762835815669
BT 216,6505803,-2.2402570422569905
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
Hep 3B2.1-7,12001922,1.6092774927634723
BT 112,10385095,0.9487594139156588
Raji,100016,6.465762715187829
SK-MM-2,11396600,-5.924315206412897
SK-BR-3,135411,0.1528289927830416
NCI-H508,54649381,4.093009449452267
KE-97,15953870,2.7852134555454113
PaTu 8988t,3825829,4.270364787448243
CAS-1,15953870,3.65049630749974
PK-45H,136227924,2.93841309707887
JHUEM-3,135411,-0.5185169275916
SK-MM-2,11455910,-0.2856161246837256
THP-1,135423438,1.568931663958045
BT 147,4705,1.580019140366276
Daudi,12001922,0.8334324910861088
CMK,9887053,4.193696191476208
Karpas-422,246676,4.416007405024325
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
SEM,6505803,-1.7011482867291614
OVCAR-5,11455910,0.5140465150742446
COR-L95,9926054,2.0133423062539726
NCI-H2009,135928012,4.098076343567735
Karpas-422,2746,1.689970111701259
KMRC-3,54618771,0.1504826951638593
P3HR-1,136227924,2.9304577514896466
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
NCI-H1975,387447,-4.175912833480318
SW1990,3825829,4.305269855808273
AU565,2746,2.9112036552039737
LOX-IMVI,12001922,1.75616119917211
HEC-1-A,54649381,3.7591987856888056
HH [Human lymphoma],10385095,0.7495240150076384
OUMS-23,49836020,3.7624735721332736
DU145,24753719,4.348475848084312
Mino,135928012,3.1712921803995164
CAS-1,135423438,2.545447966463113
Calu-3,6505803,0.3203856441914136
NCI-H2286,selumetinib-GDC-0941 (4-1 mol-mol),2.0876737367962495
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
NCI-H1666,9927531,4.532813040549954
NCI-H1105,2746,0.8615179559982858
A2058,15953870,4.042942989918645
NB4,9926054,1.6278742802322663
CAL-78,11396600,3.713466274420595
A3/Kawakami,6505803,-0.1184666814431136
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
DK-MG,3825829,4.3807090093483145
L-428,6505803,0.937044713122246
Hs 888.Lu,100016,7.863224005148367
HCC15,9927531,3.758901572486559
LS513,selumetinib-GDC-0941 (4-1 mol-mol),-1.1553983681711826
WM983B,10385095,1.4622249945753911
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
CML-T1,73707440,4.384977554594534
THP-1,4705,2.9352513647716836
NCI-H358,selumetinib-GDC-0941 (4-1 mol-mol),-1.5970203411339507
SK-N-FI,135928012,3.2718960822387477
COR-L279,42642645,-0.755067780920211
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
42-MG-BA,42642645,-0.4532056424627484
H-STS,9887053,3.8773696813734246
BT 187,387447,-4.484418910630628
A-375,4705,2.938448414109293
SYO-1,2746,1.3641867767791351
Rh18,387447,-4.838990663773022
CL-11,15953870,2.924387128340288
T3M-10,11167602,2.9337684641616404
Hs 940.T,42642645,0.6803316850662994
RCC10RGB,72199289,4.762339751475906
GMS-10,3825829,4.3106978990557785
NCI-H1573,9926054,1.726764013189345
GOS-3,42642645,0.8540004409462456
KE-97,387447,-5.076031706583081
Ki-JK,42642645,-0.4297643746928631
KNS-42,15953870,4.27273957362212
TYK-nu,42642645,1.951584067029853
NCI-H23,49836020,3.049554437236292
NCI-H838,24753719,4.505890543607651
MOLT-16,42642645,-0.3198167115760065
CL-11,135423438,1.6097510193323543
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
SK-MEL-24,54618771,0.9964231192757652
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
SEM,11167602,1.6764895293096356
MOTN-1,10385095,0.7679120233788934
TYK-nu,15953870,4.306996584578628
RPMI-7951,387447,-4.73850592434981
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
SEM,100016,5.238818929389881
NU-DUL-1,3825829,3.5613626051620324
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 216,11455910,0.3541622799052987
SNB-75,selumetinib-GDC-0941 (4-1 mol-mol),0.9916175958844948
KNS-81,10385095,2.623724927445881
MHH-NB-11,387447,-4.6204646094324575
NCI-H661,15953870,2.9876041506010003
MDA-MB-231,387447,-4.230750295993303
MPP 89,54618771,3.5839559613282916
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
NCI-H28,selumetinib-GDC-0941 (4-1 mol-mol),0.00452428337889
NH-6,11396600,3.28881859897494
CA46,9926054,1.6892727173627182
RT-4,10385095,2.2650869360881742
M059K,selumetinib-GDC-0941 (4-1 mol-mol),1.9371226079768809
253J,9926054,1.3748639406347178
BT 271,selumetinib-GDC-0941 (4-1 mol-mol),1.6032684287566925
SK-MEL-28,4705,3.074639735007158
IPC-298,387447,-3.033501118023336
RL,24753719,3.794775355260619
PK-45H,selumetinib-GDC-0941 (4-1 mol-mol),0.6996398674072702
Hs 683,10385095,1.154404132181591
Hs 746.T,15953870,3.143153585235011
VMRC-LCD,3825829,3.794583756543404
TE-5,11167602,1.4006524913204792
HCC95,6505803,-0.8812410115134491
Rh18,9926054,2.105597282648335
TE 617.T,9926054,1.7506239081922086
BT 112,11396600,2.640188999201151
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
SK-BR-3,246676,6.129452787407131
NCI-H23,9926054,1.8354921761885392
TCCSUP,135423438,2.289740320598626
HCC38,10385095,1.2215690544753306
HEC-151,135423438,1.588330635557561
NCI-H1869,387447,-5.59099149502925
JVM-2,73707440,4.245846854009652
KG-1-C,10385095,2.1458285557943
NCI-H889,10385095,1.4076394224078
MCF-7,3825829,4.318732310499928
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
TE-6,2746,2.631645333531432
SNG-M,24753719,4.6329108840502755
HCC2279,9926054,2.352300509177514
TCCSUP,54649381,3.810492846864681
SW1271,136227924,3.2074421772411372
KP-3,100016,6.07483479536675
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
THP-1,73707440,3.8767846220301254
PE/CA-PJ15,100016,6.230779358531284
PC-14,9927531,4.079128694018213
JMSU-1,49836020,6.465700185404903
647V,136227924,2.038450233147295
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
AsPC-1,9926054,1.8957621767397328
BICR 56,54618771,-1.9015282957289323
HOS,9927531,4.717123870748892
SK-MM-2,6505803,0.930978545894494
Granta-519,49836020,3.8229564713378057
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
SNU-61,24753719,3.71513491278392
JeKo-1,9887053,3.7322509372114014
JM-1,136227924,1.2038413750130548
JURL-MK1,24753719,4.043686822156311
Peer,10385095,1.0208585172172266
PK-45H,3825829,5.080641597339373
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
SNU-1105,387447,-4.485614226958937
BT 359,selumetinib-GDC-0941 (4-1 mol-mol),2.125695165959512
HEC-151,10385095,0.96058203758897
NCI-H1299,9926054,1.7323284970245385
BT 271,136227924,1.335352033885486
NCI-H2228,387447,-4.579190591408471
WM88,136227924,2.639448330236639
Hs 683,136227924,2.524769704566026
KMH-2,12001922,1.6434388157498154
COLO 678,100016,6.808142270815235
CCK-81,387447,-5.058904253649345
FaDu,135423438,3.89304152437962
TUHR10TKB,49836020,-1.137446729131538
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
EKVX,9926054,2.0075425899751513
SK-HEP-1,136227924,3.6301481247272287
OS-RC-2,12001922,2.486780505206833
HCC4006,4705,-0.7694526877641281
Hs 611.T,136227331,5.417316134562269
EB1,3825829,2.349268822943128
TE 617.T,2746,2.7076097617545276
NCI-H1105,49836020,4.351413850540497
Malme-3M,selumetinib-GDC-0941 (4-1 mol-mol),-2.272222861013609
KNS-60,49836020,-2.408070727278554
OAW28,10385095,1.310156197215646
NCI-H1703,136227924,2.979921585365296
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685
42-MG-BA,387447,-3.738086352736779
CAL-51,9887053,4.486783389261201
ACHN,2746,3.5458826569709587
NCI-H1703,4705,3.628855745395659
NCI-H520,11167602,5.235788711953261
PE/CA-PJ41 (clone D2),9887053,5.327755452479389
SK-MEL-1,10385095,0.7361766454760428
OVCAR-4,11396600,4.545943819655395
FU-OV-1,136227924,3.2834953568281597
EHEB,387447,-4.8695156526166175
HCC1195,15953870,3.89221598126291
SW620,42642645,0.3116858019196081
TE-5,42642645,1.5612345498377809
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
VM-CUB-1,6505803,-3.0574642511129833
EKVX,11396600,3.2965982260380136
MEC-1,387447,-5.625408544081315
NCI-H522,3825829,3.960912701697082
OCI-Ly3,9887053,0.9864220486962928
NCI-H2286,3825829,3.866263629958525
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
HEC-108,54618771,2.78064765565191
KMS-21-BM,9927531,3.894276575541364
HCC366,100016,6.086233690393214
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
EFO-21,10385095,2.378784787122908
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
NCI-H1341,135411,-0.4161952243135416
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
FaDu,49836020,4.381495172511739
HuH-6,11455910,0.6602078622110275
REC-1,3825829,3.4040065823648877
NCI-H69,246676,0.9229049002680756
SK-MEL-3,2746,3.317338205228237
NU-DHL-1,387447,-5.01713614563577
SKM-1,11396600,2.556560537938587
DMS 454,54649381,2.937210132953357
EJM,6505803,0.0546883993617254
COLO 678,4705,2.6344609779467603
BICR 22,42642645,1.569820729256039
BT 216,135411,3.4499066316795757
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
NALM-6,24753719,2.2035307503634782
SU-DHL-8,387447,-5.4530627854789895
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
Hs 729.T,3825829,4.437772247197977
SNU-626,12001922,2.047071853515294
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
LS411N,15953870,3.79326986504028
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
KP-4,100016,6.84348879863886
G-361,9926054,2.5235638278884687
Rh30,246676,4.974323438581708
DMS 53,15953870,2.9823135915769825
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
NCI-H292,136227924,3.1886204590132654
SNU-869,11396600,4.186989660644326
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
NCI-H358,3825829,3.341708794533524
RT-112,9926054,1.990332375678948
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
Ri-1,42642645,-0.2308158770997515
NCI-H1339,11455910,0.5713481488212533
Jurkat,11455910,1.124658813154621
HCC95,9926054,2.566209783667777
NCI-H520,135423438,3.6436020684370463
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919
PE/CA-PJ15,2746,3.741230111498992
BT 444,10385095,2.291363159248322
SNU-1079,10385095,2.438291597532159
SF268,24753719,4.152631547377157
NCI-H2452,136227924,3.4253193575490695
HEL 92.1.7,135928012,5.6864206311390895
SUP-M2,2746,1.4359324283751405
KP-3,6505803,-1.05905255098836
NCI-H889,4705,2.395490274803622
NCI-H2087,4705,3.3747422843456185
MOLM-6,135411,-0.1146730086772346
SF539,11455910,0.0331728686867912
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
AsPC-1,10385095,2.76496705920137
NCI-N87,42642645,0.5523493290598761
HGC-27,9926054,1.079439551544522
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
HT-1376,10385095,2.277565827704352
SK-MEL-2,9926054,1.8796163413954976
A-549,10385095,1.3823205412091923
Karpas-422,11455910,0.7211757450052372
SW1271,9926054,1.9992649208496855
COR-L105,12001922,2.476912212032941
PF-382,136227924,2.0859082008018084
SNU-C1,24753719,4.251341478623143
JHOS-2,100016,8.119351788295337
Hs 294T,9887053,6.47824344544203
SK-N-AS,11167602,1.8912366678699168
CAL-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.559817490656083
PF-382,387447,-5.996282081470132
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
TM-31,6505803,1.056244562382091
JeKo-1,9927531,3.3417502019075473
RD,9926054,1.756104923287422
BT 498,11455910,2.7063920015971084
RL,387447,-5.732393658509671
AU565,136227924,2.2371309282915184
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
HuP-T3,387447,-4.787053098216054
TUHR4TKB,54618771,1.114218379650299
HCC1438,24753719,4.380159840100211
JHOM-1,387447,-5.058279885089814
SK-N-MC,54618771,0.9306599486262166
SW1710,selumetinib-GDC-0941 (4-1 mol-mol),2.8555583802472277
SUP-HD1,9926054,1.7829346209502994
HT-1080,2746,2.8042774445835397
CAL-54,11167602,2.099432821181125
GDM-1,9926054,1.958570414824769
BT 286,387447,-4.984845769910886
TE-8,24753719,4.333493803280939
RERF-LC-A1,11167602,2.3879562150409788
SW1990,136227924,4.2742525725591864
BT 271,10385095,1.1814538061663578
SNU-503,135411,1.7129526348419049
SK-N-AS,9926054,1.80921327911472
SNU-5,387447,-4.881105633655803
KE-39,54649381,3.8116402123721578
RD,49836020,4.595069513532316
M059K,10385095,0.9414832034202614
FU-OV-1,9926054,2.079351745951841
UO-31,9927531,3.0316635123485693
HT-1376,3825829,4.798908151638593
RCC10RGB,12001922,2.277970650057297
RERF-LC-MS,100016,6.56071523320666
SK-MEL-3,387447,-4.20138117116068
SNU-182,11455910,3.5316691934445372
HT-144,12001922,1.18330458650956
UO-31,11455910,0.6340600347677866
SNU-410,9926054,3.256884508245376
NCI-H2196,136227924,2.7386742576768643
EoL-1,11455910,-0.8638634709362212
AN3-CA,12001922,1.6874605479132982
NCI-H661,12001922,2.629031416850278
NB1,387447,-4.486126826484062
KMS-18,136227924,4.439422503928272
PK-59,54618771,0.2590305123117813
SNU-738,15953870,3.846452227266911
KO52,3825829,1.880917675310284
HEC-59,15953870,2.7298961378439497
NCI-H660,135411,1.3272330845070606
SW1783,136227924,2.7676121780420364
MG-63,4705,3.9801982101515825
M-07e,3825829,3.009769948939105
EoL-1,24753719,1.9160330711500224
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
KMS-20,4705,2.611307391977677
HuP-T4,9926054,2.1001790007483843
SHP-77,6505803,-0.6748725536499449
HSC-2,9926054,1.7452128350759892
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
SUP-M2,4705,3.1560884673066765
SNU-503,11455910,1.6883627644278838
HSC-4,54618771,2.9865797342969564
MDA-MB-361,54649381,4.112801745055837
BT 416,387447,-4.305201856785441
T-47D,136227924,3.374798567013006
NCI-H2030,12001922,2.618392132225964
SCC-25,10385095,1.5155908276599988
HCC78,6505803,3.403944957250862
UM-UC-1,135423438,1.3266275240072287
NCI-H1155,54649381,3.742773113011414
HCC1143,11396600,3.529486359294858
JHH-1,3825829,4.384644777268597
KP-N-SI9s,54618771,1.0229229118908414
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
Hs 611.T,9887053,1.7338078284968432
IGR-39,selumetinib-GDC-0941 (4-1 mol-mol),2.3690668734503415
BT 248,12001922,0.9128950259060647
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
NCI-H1651,136227924,3.2782738852919966
MDA-MB-157,11396600,3.7386973485738424
G-402,24753719,4.198758939409353
EC-GI-10,9926054,1.9054317321627203
Hs 934.T,135423438,1.6511410830672884
UM-UC-3,15953870,4.67065166945441
NCI-H1385,12001922,1.2518788218711565
SNU-308,54618771,1.0411941789938453
NCI-H2081,11455910,0.9023670010212674
SK-N-DZ,9926054,1.7056763451018535
Ri-1,387447,-5.205370002845584
COLO 678,selumetinib-GDC-0941 (4-1 mol-mol),0.6470701140991139
SW1353,54618771,0.8265365902772687
UM-UC-3,24753719,3.867864319815473
NCI-H211,10385095,1.0017780744512903
SCC-4,135411,0.2370019716570117
BT 216,selumetinib-GDC-0941 (4-1 mol-mol),3.6929291774805177
SK-MEL-1,54618771,1.3594910944295866
Caki-1,42642645,1.7325433847206684
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
LN-18,10385095,1.390416786921598
Capan-2,42642645,0.3636475203499639
HMCB,100016,6.123582467992384
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
SNU-685,3825829,4.771762841763475
Kuramochi,54618771,2.421317406339968
SNU-387,387447,-4.4919086410640165
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
Ki-JK,100016,3.514869011895543
SNU-1066,135411,0.5424409485372343
Hs 888.Lu,3825829,4.745896718470508
IGROV-1,3825829,4.144093606877803
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
ESS-1,12001922,2.286773298620945
Daudi,136227924,1.3476403322374937
HT-55,42642645,0.8650986556369931
BT 131,136227924,1.4796003986288269
JeKo-1,42642645,-0.0384862855340998
A101D,135411,1.0100718015817742
J82,12001922,2.40674550471966
DU145,11455910,2.077410590950561
Hs 944.T,9887053,4.35534571936394
Hs 766T,2746,3.89842644202364
DEL,9927531,3.262771629290843
TYK-nu,11396600,3.490673589764442
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
KYSE-510,9927531,4.748041591600806
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
CAL-27,54618771,1.1214145254285035
Kasumi-1,2746,0.7375663953189775
PE/CA-PJ34 (clone C12),135411,0.6306768615973338
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
SR,136227924,2.657612515566446
CGTH-W-1,selumetinib-GDC-0941 (4-1 mol-mol),1.204610504332706
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
JHH-4,3825829,3.8204260503654783
OV56,12001922,2.3940987556028603
SNU-840,3825829,4.4905928388032486
BT 216,11167602,3.059440616592098
ZR-75-1,54649381,5.397898776516143
L-363,49836020,4.471751893617592
Pfeiffer,selumetinib-GDC-0941 (4-1 mol-mol),-0.3312571594037772
SUP-M2,42642645,-1.0637242009857042
WSU-DLCL2,9887053,3.184091563459313
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
RERF-LC-A1,9927531,4.243256542635893
HCC38,24753719,4.142998608855599
IGR-37,135423438,1.6806022412705843
RPMI-8226,15953870,3.016476625298254
CML-T1,9927531,3.1672020542525674
GaMG,selumetinib-GDC-0941 (4-1 mol-mol),2.5044066808337644
PaTu 8988s,12001922,1.9011418575580596
EKVX,136227924,3.396888883126824
CCK-81,selumetinib-GDC-0941 (4-1 mol-mol),1.1249387686067662
TE-5,44197249,4.569530404182259
OAW28,2746,2.637952220594215
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
HDLM-2,10385095,1.1751737013594648
SaOS-2,135411,0.7043200334589346
KYSE-30,9927531,4.7729245028370055
NCI-H1299,3825829,3.823746918774883
SNU-245,42642645,1.2507631801507788
BHT-101,136227924,2.4401355841785173
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
YD-10B,3825829,4.000592717007246
U-CH1,12001922,2.974889748905739
Caov-3,135411,0.2837776081420471
DV-90,24753719,3.9838843577401057
BT 359,135411,3.2777439739390517
CJM [Human melanoma],selumetinib-GDC-0941 (4-1 mol-mol),2.04616975422909
JHUEM-3,15953870,4.03589819233106
BT 231,10385095,0.727650114829806
JHOM-1,4705,3.029937408009012
IST-Mes1,10385095,2.3784865098232255
BT 320,11455910,4.86644863423661
A-549,9926054,1.8971220341716168
8305C,54649381,3.0536862018763458
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
BT-12,15953870,4.180045501680736
Jurkat,135411,-0.3691928576830424
NCI-H1944,135928012,4.419665731378367
IM95,11455910,0.766351703140193
HEC-151,136227924,2.850288220591168
SW948,135411,1.551236240082995
LAMA-84,136227924,2.847754951874779
CW-2,4705,1.5406950136134017
HCC1143,12001922,1.8011931254041345
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
EHEB,12001922,1.634649199110844
HDQ-P1,387447,-3.607985305197666
NCI-H2081,9927531,2.933726437844289
BT 239,9887053,2.078731857230059
CHP-126,24753719,3.177202687001685
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
Mono-Mac-1,387447,-4.177588984938143
COLO 201,387447,-3.84352744544922
AGS,100016,6.525427767108566
COR-L51,54618771,1.1553419440915085
SNU-16,11167602,-0.1178640924914608
COR-L105,6505803,1.059348129706536
B-CPAP,9926054,2.1103473685311043
RL95-2,100016,4.898266673475204
EFM-192A,136227924,3.313769329286525
NCI-H1299,12001922,3.316312201562729
SNU-182,54618771,-1.075104843594332
TE-6,selumetinib-GDC-0941 (4-1 mol-mol),3.56930262529698
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
U-251MG,4705,3.583212540247193
MDA-MB-157,135411,-1.5273896245850724
HT115,387447,-4.095898798922125
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
BT 159,12001922,1.1251798598398994
HEC-108,12001922,1.836445664605824
ACHN,9926054,1.8123369817060109
Namalwa,11396600,2.5581294543218616
NCI-H2085,42642645,-0.6152765019079011
HCC-56,24753719,4.191949755437233
Hs 578Bst,3825829,4.351434379327266
MOLT-3,42642645,-1.0169381656861618
HDLM-2,54649381,3.58174421093447
WM1799,11396600,3.8068565686639273
NCI-H520,4705,3.58444135118044
HCC1143,9926054,1.808099247882512
COR-L105,10385095,2.1444085139831643
COLO 684,54649381,2.9373028216168175
HCC78,387447,-4.596579028182117
SEM,15953870,2.946140214563167
Hep 3B2.1-7,42642645,-0.3061550717373256
NCI-H747,11167602,2.3003371875721323
U-CH1,6505803,-2.0509718148007408
PE/CA-PJ15,11455910,0.2163871462693647
SU-DHL-8,9887053,3.500664478815664
JL-1,12001922,3.16743841150469
SK-N-SH,11455910,2.5268556232530868
MHH-CALL-3,2746,2.3163095915542224
SIG-M5,387447,-4.808050086142086
Karpas-299,49836020,-1.2149928929897504
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
Pfeiffer,54618771,-1.2193011849050512
NCI-H1184,10385095,0.4197461741705012
HD-MY-Z,54618771,0.9859939173589182
SNU-C4,54649381,4.0637067586691895
CAL-51,54649381,3.902782783768603
HOP-92,42642645,4.076812094577793
CML-T1,10385095,0.9719029483379856
A2780,24753719,3.5545225878481745
NCI-H2087,54618771,-0.2190788311634532
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188
NCI-H1339,11396600,3.0711399080961934
BICR 56,54649381,4.405790270307774
WM983B,136227924,4.383113443662036
YH-13,136227924,2.93381240838723
NCI-H2106,135423438,0.968781117866004
Granta-519,9926054,1.8135939424605243
FU-OV-1,135411,0.8541212220651947
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SEM,136227924,1.2424830449991908
SNU-423,4705,3.684586446624816
OE19,136227924,3.1692952710595557
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
ECC10,10385095,1.0735709305574426
KYSE-450,10385095,1.1558983027763154
PF-382,100016,3.957595275699552
HT-144,24753719,4.5313758383114875
769-P,12001922,2.0584521566205853
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
BL-70,9927531,3.241092589782463
OAW28,15953870,5.078636607909671
NCI-H2452,11167602,2.565240148317103
MES-SA,387447,-5.07165900883666
OCI-Ly3,10385095,0.3067517365379972
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
NCI-H1793,135411,2.8610430580212647
SNB-75,135423438,1.7474486526711988
HCT 8,54649381,3.984075414572073
MOLP-8,136227924,1.5113872866650588
SNU-407,selumetinib-GDC-0941 (4-1 mol-mol),0.3272948267945177
CML-T1,3825829,3.084807192466588
SK-ES-1,9926054,1.5618900800676432
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
SNU-1077,10385095,2.8092985891088444
OCI-Ly19,54618771,-1.0348518015701054
SNU-C1,9926054,1.821636344159182
BT 422,135411,3.587558651892253
BT 216,2746,3.994166924580774
Panc 04.03,9887053,4.247469701197239
RERF-LC-MS,10385095,0.7812016081678173
PE/CA-PJ34 (clone C12),10385095,0.6586777190246488
U-251MG,3825829,4.324198339525675
Caov-3,135928012,5.73348436832311
BT 498,12001922,1.1592789388500984
NCI-H358,42642645,0.4773131225748792
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
HCC2108,6505803,-0.7557590797286265
SH-4,10385095,1.3963711964007446
BT 444,136227924,3.5279486847576886
NCI-H1563,135411,3.1882737086349526
ACC-MESO-1,42642645,1.530706527419768
SNU-423,10385095,0.9709432237153084
NCI-H2286,24753719,4.826815158403235
SU.86.86,2746,2.8574990792137234
NCI-H28,54649381,4.171657872205153
Karpas-422,15953870,3.6595418641007895
PK-59,12001922,1.7937436025082794
Aska-SS,54649381,3.801699572591553
SNU-C1,4705,2.5587329567228414
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
HSC-4,11455910,0.337268703123225
SW1990,387447,-5.224232089189946
SNU-1076,11396600,4.278437683696295
MFE-319,3825829,3.994579969985173
CHP-212,12001922,1.5548125354784377
SK-MEL-24,9927531,5.248971858061216
NCI-H2023,6505803,-0.0935545329611447
OVCAR-5,11167602,2.4899386017639302
DMS 454,9926054,2.735237319148254
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
SK-MEL-1,387447,-2.6389063498741225
BT-549,10385095,1.777553004720717
SW579,42642645,-2.112171270637768
COV434,11396600,2.8403888234500663
SNU-410,9887053,4.621800309440906
PaTu 8988s,6505803,-2.1809975101024417
HCC1500,9926054,1.7367797854287812
Hs 683,136227331,4.5546400151434066
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
RPMI-6666,135411,0.4048942382641434
Hs 944.T,2746,3.0349004525827583
HuP-T4,54618771,-0.0993332629416019
HGC-27,15953870,2.2715241692137007
NCI-H810,3825829,3.871867138460076
G-402,11167602,-0.1731760245539544
MOLT-13,136227924,1.9107910741830303
KYM-1,42642645,0.3232590242582667
CAL-148,24753719,5.136890260522855
SNU-1214,135411,0.9910284163381392
PK-45H,6505803,-1.06717257205605
HuH-1,136227924,2.959438331398248
OAW28,42642645,0.9360886571737812
COLO 678,387447,-0.8230962334401238
SR,49836020,-3.5786730229489603
TE-8,10385095,0.7440006584278842
P12-Ichikawa,246676,5.130179134655631
TC-71,100016,6.681443396825605
HEC-1-B,54618771,2.2656883390933342
BT 131,54649381,3.736211613029731
Hs 683,11167602,3.3707679458067195
HMC-1-8,387447,-4.620795945977579
NCI-H1694,9927531,4.024250624925043
OV-90,9926054,2.051582159797273
KMRC-20,10385095,2.891783125869015
T84,15953870,2.47809665421024
DB,11167602,0.5461148982527376
CA46,135423438,1.6657304721140649
A-673,4705,3.2416788332737454
Daoy,135411,0.3720572374857977
MDA-MB-435S,15953870,5.087475189137702
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
Hs 729.T,12001922,1.942480426190768
GA-10,9926054,1.7130115486469382
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
AU565,10385095,1.377392665812461
LMSU,2746,4.6094970791668315
SiMa,9887053,1.477649240654772
GCT,387447,-3.572707888873446
RPMI-8402,9927531,3.4344708783390856
SNU-466,3825829,3.853445476336988
NCI-H1703,135423438,-3.3255405313096733
MSTO-211H,136227924,2.717505566177341
Li-7,11167602,2.0459258123097968
SNU-407,11455910,0.0868474536937429
TF-1,387447,-4.909535596913282
HMCB,136227924,3.0347930044007643
SUP-HD1,387447,-5.795886755753075
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
HMCB,2746,4.319833835287885
MES-SA,4705,2.820968448326189
BT 187,6505803,-2.6159963341734613
JJN-3,2746,1.639686724346065
HL-60,136227924,2.3594265520512447
NCI-H2342,11396600,5.770432473059626
Hs 888.T,4705,3.9900399475264887
SNU-213,42642645,1.3935899873683228
DU145,4705,5.59514886378127
LUDLU-1,11455910,1.2851880169886276
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
NCI-H2087,11396600,3.1581134421925
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
MDA-MB-468,3825829,3.701721569325122
OCI-Ly3,11167602,4.156606603429628
MKN74,10385095,1.1692289790304908
JHUEM-2,100016,5.904304927611702
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
SNU-899,9877608,7.308498444418231
Calu-1,42642645,1.6117131337640775
PL-21,3825829,3.2055348919547013
SNU-1,246676,4.276260560619348
BDCM,42642645,-0.0643833873100858
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
LK-2,selumetinib-GDC-0941 (4-1 mol-mol),2.476952398707666
RKN,44197249,3.9607888926275217
KNS-81,selumetinib-GDC-0941 (4-1 mol-mol),3.534657473122144
SK-LMS-1,42642645,1.473121102676234
HEC-59,12001922,2.684343539817944
PSN1,9926054,1.7845816919346065
KP-N-YN,136227924,3.0572578369433376
SK-N-DZ,9887053,3.116578322277313
Hep 3B2.1-7,10385095,2.639944911413333
HCC2935,6505803,-3.078757042045483
NCI-H647,11167602,1.715536193581494
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
TCCSUP,11455910,2.681471740921846
SK-MM-2,54649381,3.3796887468679637
NCI-H211,11396600,3.088009676720855
MDA-MB-415,42642645,1.537763888858758
Aska-SS,135411,1.2728425883633323
OAW28,24753719,4.434201172795376
Hs 578T,9926054,1.6885826482167057
NCI-H2023,387447,-2.82603871216759
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
BT 232,11396600,3.2918989092466813
HCC1428,3825829,4.476590621730654
EFO-27,9887053,4.025142225668377
NCI-H2106,10385095,2.0087546591640413
NCI-H2106,54649381,3.7148001205838144
EFO-21,9926054,1.8086504581736744
Panc 08.13,6505803,-2.482053644474571
OV-90,15953870,5.938090482155434
RPMI-6666,100016,5.822007631719843
LoVo,24753719,4.853832341629896
NCI-H1563,136227924,3.549094897051017
SK-LMS-1,9887053,6.082946871961119
SK-LU-1,42642645,0.8775390823653701
CML-T1,9926054,1.696565612874625
HuP-T3,9887053,4.07990532641299
LS180,135411,0.2951252953722391
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
COLO 205,100016,5.963233409359241
J82,24753719,4.250519286572852
SNU-489,42642645,1.446131989151047
ZR-75-30,11455910,1.1218208272028805
GSS,136227924,2.0459518542117983
ChaGo-K-1,135411,1.2465105696898682
HuH-1,12001922,2.276808008127668
A-673,9926054,1.7717409858597033
HCC1438,3825829,3.528469083772071
OCI-AML-5,3825829,3.816123541795588
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
DMS 273,4705,3.496116762813734
CJM [Human melanoma],54618771,1.1195989916695683
Raji,6505803,2.919386850087895
SNU-840,6505803,4.055722811765136
SW620,6505803,-2.457729118039499
MDA-MB-453,11455910,-0.0078824359576409
BICR 6,4705,4.392083823551742
Lu-99,9926054,1.653362823410905
NCI-H2405,135928012,4.490410902674299
KMS-28BM,54649381,1.3646043418960458
697,12001922,1.178934780109417
LCLC-103H,136227924,3.302464114309801
Karpas-299,9927531,5.423795277339213
ECC12,54618771,2.554935234255265
JIMT-1,42642645,1.596095812784991
SK-MES-1,10385095,1.1316059221084596
KYSE-70,9887053,4.5630363901990565
HCC827,54618771,-0.2286942378672794
OV56,9887053,4.443134296906958
SNU-182,49836020,5.156218287298631
Rh41,136227924,2.134040377876842
HCC2218,9887053,4.291749578436511
647V,135411,0.4502173490424586
KALS-1,387447,-4.425335240007256
NCI-H1693,49836020,4.720041053935088
OCI-Ly3,49836020,4.868556688555981
BT 333,11455910,0.8481846232713552
NCI-H1155,11455910,-0.6780769977748015
HCT 15,54618771,1.4400117592771968
NCI-H2126,11167602,4.336967628548722
VMRC-LCD,15953870,4.086184190839628
TF-1,3825829,3.269338648524401
CCK-81,54618771,1.3252136057849369
HCC2935,9926054,1.9348902152341665
KMS-34,15953870,1.4832320437991018
AU565,4705,1.275846161151896
NCI-H841,10385095,0.5087858353581881
KYSE-30,387447,-5.111361944966211
WM88,24753719,4.471197406675096
HCC-56,42642645,0.9479180632890486
NCI-H1623,9926054,1.7409203229588674
FTC-133,42642645,4.559192948180462
EB1,100016,6.112181525197604
NH-6,387447,-4.4618094432555395
RPMI-6666,9887053,1.3759490121659068
HT,135928012,3.391675154453864
CFPAC-1,54649381,3.7423940406665728
MDA-MB-157,136227924,3.402219650297347
2004,44197249,4.85678870205773
KMS-12-BM,4705,2.431122737655679
MeWo,11455910,-0.0610908401405663
NCI-H2342,9926054,1.8673615783954545
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
HGC-27,42642645,-0.9522403053623212
P12-Ichikawa,11455910,-0.4653341655184377
HCT 8,15953870,3.901942062297189
CHP-212,4705,3.1318410503879717
OV-90,42642645,1.3445598155452378
BICR 6,135411,0.9026012646007944
TUHR14TKB,135423438,1.0375302517653642
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
PK-1,136227924,2.8943441164421633
M-07e,11455910,0.9135610826931194
TE 617.T,3825829,3.961501634657472
EN,24753719,4.333025335337193
L3.3,11455910,1.84757483649511
KNS-60,135423438,1.647918923583617
COR-L51,11455910,-0.1708653149441187
PF-382,54618771,-0.2642287573533248
Calu-1,15953870,5.3238181569878655
HMC-1-8,100016,5.583587343649554
SET-2,4705,3.0557910229077554
HuT 78,2746,0.9832751477780014
NCI-H23,15953870,3.389217436283598
KNS-60,54618771,0.379873149864298
NCI-H2106,136227924,2.8262070038466955
KMS-21-BM,54649381,2.8597103971231053
JHH-5,54618771,-0.2658300379563106
LS411N,12001922,2.0246848718715604
BT 444,selumetinib-GDC-0941 (4-1 mol-mol),1.0784151115799612
HuP-T3,24753719,4.122061219367772
NCO2,15953870,2.09569549914886
NCI-H929,387447,-6.464991803110621
SUP-M2,100016,3.7473632933772394
FTC-238,100016,6.441740826290021
RERF-LC-Ad1,12001922,2.2096549629967424
SW579,9926054,1.761228342294705
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
BC-3C,4705,2.713954554956948
SNU-C4,12001922,2.464393367213334
CAL-148,11396600,3.115756586832573
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
BT 422,54649381,3.977413737986301
LOU-NH91,136227331,3.865245001267085
NCI-H2030,387447,-2.9646513764291726
SNU-C1,387447,-5.135741423380568
YKG-1,2746,3.802533592415727
MDA-MB-453,44197249,5.538441394278097
KYSE-180,24753719,4.5603328664886815
BL-70,3825829,2.842311799056166
Kelly,6505803,1.0108033674457453
KO52,387447,-5.494795804144642
OV56,10385095,1.4769772001806318
SNU-1076,9887053,5.990453322652331
NCI-H2342,6505803,3.6269686653214497
Sq-1,12001922,1.894605943805168
Hs 611.T,6505803,0.4096396664447451
MOLT-16,4705,2.727533313346627
KP-4,11455910,-0.3156101411278702
BT 428,42642645,2.2161145652022465
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
PLC/PRF/5,10385095,1.1350857797892653
CL-11,11455910,1.292205129341028
SF126,387447,-4.690809327980121
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
F-36P,54649381,2.918510203679049
VMRC-RCZ,2746,3.717022138974909
HCC1833,135411,4.072451811658786
42-MG-BA,2746,3.593124420605687
YH-13,6505803,-0.6394660445903715
BT 131,10385095,0.8018228032587859
BxPC-3,387447,-4.571753731996322
HLF,9926054,1.9113272674317217
SW1783,54618771,3.657201070811366
SNU-466,387447,-5.749674593795746
COLO 800,9887053,4.3423056909775495
DU4475,11167602,1.0956541119687018
TYK-nu,selumetinib-GDC-0941 (4-1 mol-mol),1.6731134624767203
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
NCI-H2286,11396600,3.697851476409739
NCI-H747,3825829,3.836494951629734
Karpas-422,12001922,1.302445651758517
MOTN-1,9926054,1.7711575511093696
NCI-H1581,9926054,1.914442948452832
LAMA-84,3825829,2.644350972197575
OCI-AML-3,136227331,4.0355343672890935
SK-MM-2,15953870,3.144090957646678
GMS-10,2746,4.267808418736884
NCI-H2405,11455910,1.6640905380907716
SNU-1214,15953870,3.760154168645951
Panc 08.13,2746,3.457516363442077
GMS-10,9887053,4.423386867558436
Hs 888.Lu,9927531,5.408720252144841
NCI-H211,15953870,2.2321535025048473
T3M-10,24753719,4.5173650451398375
NCI-H1573,54618771,0.5890663299030774
VMRC-RCZ,9926054,3.085597836740958
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
A2780,11167602,1.1290528312474395
LCLC-97TM1,387447,-4.752686001320434
HuP-T3,2746,4.662800576379415
JHUEM-2,11455910,0.0999331855360444
KNS-62,6505803,0.1679251813007588
LK-2,54618771,0.9625218695691432
NCI-H1666,54618771,-1.5571959335462928
AsPC-1,11396600,3.3240147605355506
CAS-1,136227924,2.284810237581045
A-549,6505803,-0.295425809550202
JHUEM-2,54649381,2.2170818577793416
VMRC-LCD,12001922,1.4293091709925143
HOS,selumetinib-GDC-0941 (4-1 mol-mol),2.6717134852728264
HCC1500,9887053,4.8738692747205175
Caki-1,9927531,5.587911994434885
DB,9926054,1.795775748692003
PC-14,24753719,5.07098831205633
Rh41,9926054,1.5140566326622644
NH-6,9887053,4.189380428879396
TC-71,3825829,4.097679921403836
HuCC-T1,6505803,-2.738852814934829
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
CAL-78,6505803,-0.7223654000652794
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
COLO 320,136227331,6.064515235330745
HeLa,135411,1.4034383621508255
Yamato-SS,6505803,-0.8903036807486634
SNU-626,54618771,3.903853524129119
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
T24,11396600,3.350791028009117
SW1271,15953870,2.918493523161381
NCI-H2171,6505803,-0.0596794204500112
MDST8,54649381,4.2434412709491385
GP2d,387447,-3.5089212813908555
TE-1,15953870,6.162944204210377
MDA-MB-435S,11396600,4.912452343589747
CAL-54,9887053,2.330605082797834
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
TE-14,11455910,0.8853432614856256
A-549,100016,7.181380121169662
KHM-1B,54618771,-0.6219515555388266
DMS 114,12001922,1.4189684985551902
HT115,54649381,1.603749615511734
EoL-1,100016,3.3783759894754795
LNCaP clone FGC,9927531,4.548275216558741
TE 441.T,246676,4.366193760638462
Detroit 562,42642645,-0.2748468333370469
Detroit 562,10385095,0.9539498650756362
BT 179,11396600,2.8965915614229036
THP-1,42642645,1.4949313287554449
HT-1080,135423438,3.624839631641402
MOLT-13,73707440,5.68984628441443
GB-1,42642645,1.1082458991208304
SNU-1196,12001922,1.9094751070316105
HCC366,9926054,2.0580421664352513
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
NCI-H2171,3825829,3.727904622873516
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
Hs 888.Lu,54618771,0.7485520203089981
MEC-1,6505803,0.1083566885748684
NCI-H2291,10385095,3.0052020950396803
BxPC-3,42642645,0.6313588777440967
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
U-118MG,42642645,0.9116200662177444
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
SNU-16,54618771,0.522197701958757
Calu-3,selumetinib-GDC-0941 (4-1 mol-mol),0.8119052170432226
HT-55,387447,-2.9652468787769117
Kasumi-1,9887053,2.407055654937695
BV-173,49836020,4.1850611213091105
A4/Fukuda,3825829,2.918538307685252
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
NCI-H810,12001922,0.7441638611552192
QGP-1,246676,4.4119150603625785
CHP-126,136227924,2.2251507312000576
NCI-H1915,11396600,3.355120861633073
VMRC-RCZ,135423438,3.1126992087806427
JHUEM-2,9887053,1.6256778729362749
SF539,3825829,3.026626259970261
HOS,3825829,4.179715442111216
IGR-1,15953870,3.783071657079609
KMS-20,135411,-0.1800034953276003
HCC95,246676,5.0629416583220594
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
HDQ-P1,3825829,3.7192102671489025
MHH-CALL-4,10385095,1.014467804729014
NCI-H28,42642645,-0.7063570196132356
BFTC-905,9926054,1.624797844745876
KE-37,54649381,3.200374692422198
NCI-H1563,387447,-1.0299503832040529
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
MEC-1,100016,3.995806762220144
PLC/PRF/5,11396600,2.8035721911913645
DEL,24753719,4.131064863651074
SK-N-FI,2746,2.6055222437505248
NCI-H2291,136227924,3.7471032532575457
CAL-51,3825829,3.9510679995615257
Ri-1,15953870,1.4105014554932769
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
SNU-719,10385095,1.1651309868833004
U-118MG,4705,3.313386331825358
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
Panc 10.05,136227924,2.25248962667623
HEY A8,11396600,3.7173618063092246
Daoy,100016,6.878604021612681
NCI-H1975,11396600,3.468451084221391
HT-144,135928012,4.592385888315641
Panc 03.27,387447,-4.361669860899462
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
HH [Human lymphoma],24753719,3.74360908946732
RERF-LC-MS,9926054,1.8051014319834384
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
Mel Ho,135411,1.058536239321601
SNU-620,42642645,-4.665294155605358
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
SNU-738,135411,0.9070326584939036
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
SNU-119,3825829,3.624299392396196
A-549,54649381,4.103112658972653
A-549,10385095,1.3823205412091923
KMRC-1,2746,4.901784458568857
RPMI-8226,6505803,-1.0247105512133972
U-BLC1,24753719,4.182183061493439
NCI-H1693,2746,3.264827301273958
SHP-77,24753719,2.943112918593436
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
OV7,10385095,1.1258332285506143
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
SNU-308,6505803,-0.8731800664163156
Ki-JK,11396600,1.9069544068718032
WM983B,54618771,1.7213296960323683
NCI-H1734,136227924,2.5893506458509634
H-STS,100016,5.985929376611731
KMS-11,135423438,-0.4348123575852698
KG-1-C,136227924,2.6958486075351944
GMS-10,387447,-4.108668356974444
BICR 22,11455910,2.0554057071158303
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
WM115,9927531,5.125567810288171
SNU-719,135411,-1.2607769967563354
Calu-1,136227924,3.5665542391568774
C2BBe1,11167602,1.733240679037377
Hep 3B2.1-7,15953870,2.3473696237911175
L-363,135411,0.8060542256206319
Aska-SS,2746,3.0488180575917463
HCC1954,136227924,3.208934620428715
HLF,3825829,4.06854125402289
BT 179,24753719,4.0957950149587825
HSC-2,12001922,2.13206397118556
MFE-319,11396600,2.9869741461400956
MOLT-16,2746,1.4936688600740762
SK-OV-3,49836020,-5.2191550029019025
U-118MG,12001922,1.823491723273408
HT,387447,-5.331330775189022
OVCAR-5,3825829,4.414914037420697
RL,9887053,3.797069854176534
SW1783,2746,4.238030101530504
HCC2218,9926054,1.6047846197702569
MOLT-16,49836020,4.026167262908274
CAL-120,54649381,4.148294107007869
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
TE-9,24753719,4.526239655009243
HT-1080,135411,0.873350403613355
IGR-39,9926054,2.0144252699344176
SUP-HD1,42642645,0.8958349562614806
GI-1,100016,6.475829804009189
K-562,15953870,3.5143251027161613
KMS-11,11455910,-0.6344101562888161
NCI-H526,9887053,3.513561317344273
CAL-12T,15953870,2.7173643693522203
HOP-92,135411,1.4111014193013556
P-STS,9887053,1.5892564436631793
SNU-1077,100016,6.64200464659652
BT 232,12001922,1.1651494969808018
ONCO-DG-1,54649381,3.410732959433385
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
SK-MEL-1,44197249,3.702910884570759
Pfeiffer,9887053,1.2270614066262502
A-204,15953870,2.518500939569863
YD-15,24753719,4.654665275696266
HEC-151,54618771,1.151174886462992
KATO III,3825829,4.3106060651966205
DMS 273,3825829,3.788583241717048
CAS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.9599714674157864
U2OS,100016,5.485609538675787
Daudi,11167602,1.0022899570414256
HEY A8,9926054,2.010020919181283
HeLa,100016,5.8653655502295
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
TC-71,42642645,0.3664127835845306
HCC1954,54649381,3.6805683308891006
KMS-21-BM,11167602,0.9421858410696404
NCI-H1734,11455910,0.8885636438539928
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
IGROV-1,246676,4.485924799339535
DLD-1,135411,0.4984403552284953
SNG-M,3825829,3.923028715096589
SW982,135411,0.789315860577339
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
Caov-3,54618771,0.7751702842643667
BT 164,42642645,1.0091349522016777
GB-1,135411,-0.0393119040424056
BT 232,387447,-4.759475598097268
NCI-H2342,12001922,1.9622996452701171
KO52,15953870,3.5562610214324653
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
NCI-H1581,9927531,4.312096995742435
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
HCC1588,6505803,-1.104009998130938
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
OCI-Ly10,54618771,1.2684517844951826
OCI-Ly10,100016,6.418038918193145
WM266-4,6505803,-3.5137777685434384
HeLa,12001922,2.6860406183593284
HuH-6,3825829,4.141582300184341
NCI-H226,11167602,2.8727400053308054
BHT-101,54618771,-0.9032414416493152
CAL-27,6505803,-0.9389361210216336
Hs 729.T,9926054,1.9199617191316192
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
KMS-27,11455910,0.2864489394234576
CAL-62,387447,-3.991779746748149
TOV-112D,4705,3.678495004677763
DB,9887053,1.6577511862784755
KE-97,selumetinib-GDC-0941 (4-1 mol-mol),2.3217302036143295
NCI-H838,selumetinib-GDC-0941 (4-1 mol-mol),1.9940738428957552
NCI-H446,3825829,2.631896077384849
JHUEM-2,3825829,2.0785445935498372
DMS 114,387447,-3.781568547943584
HEL,6505803,1.212867497705534
AGS,6505803,-2.0321610426726364
DMS 114,6505803,0.1700974971727873
COLO 792,10385095,1.0234389393888734
SNU-16,136227924,1.93853165721534
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
SNU-5,3825829,4.029679526206597
RPMI-8402,24753719,3.36311083579876
HCC1588,44498493,4.322492032224609
SK-MES-1,100016,6.467052003541006
NCI-H1650,54649381,4.059826493369658
HT-55,11455910,0.5022530474255873
GCT,135423438,1.822480313844277
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
U-BLC1,54649381,3.6511376697877806
NCI-H322,selumetinib-GDC-0941 (4-1 mol-mol),1.023926311645034
A-673,24753719,3.397650756866718
SNU-16,42642645,-2.2644667457719723
TE-14,54618771,0.7402705360744307
OPM-2,135411,1.0006691045824918
SaOS-2,9927531,5.410264314347966
CAL-62,9887053,3.97950601110499
RL95-2,9887053,5.768648117414598
KMRC-1,100016,6.458679548763862
HEC-151,11455910,-0.546024976491568
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
BT 428,135411,-0.3033533624025099
RERF-LC-MS,4705,3.292681011259135
HCT 8,11455910,0.923477323038918
OVSAHO,selumetinib-GDC-0941 (4-1 mol-mol),2.882517977180431
SW1417,24753719,4.352651557823784
Lu-99,11167602,1.8840831812456384
KYSE-520,100016,6.554858217735662
TUHR14TKB,136227924,3.4575547117836836
KYSE-180,136227924,3.113518519432139
Li-7,54618771,0.3416557888944573
Ku812,42642645,-2.294133807161646
NCI-H2029,136227924,2.308767464525173
SNU-423,6505803,0.7785757061169877
NCI-H2110,100016,6.079052375839209
JHH-6,387447,-3.149306823183498
SUP-T11,136227924,2.659905722722051
KNS-60,11455910,1.2653119972070106
HCC44,24753719,4.095734182241044
IA-LM,10385095,1.8174613436578264
COLO 205,10385095,2.547390594330649
TC-71,2746,3.085188483378043
IGR-1,54618771,0.8622245008505476
MDA-MB-157,10385095,0.7848337329764868
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
EM-2,136227924,2.1746228564853864
Hs 852.T,49836020,3.510211812103559
HEC-265,9926054,2.077081644507314
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JHUEM-1,2746,3.5357921784869775
G-361,54618771,0.3816147000987149
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
LN-18,selumetinib-GDC-0941 (4-1 mol-mol),2.471662791203074
NCI-H520,135411,0.8483952582503486
CAL-51,42642645,0.4324607401831485
MDA-MB-361,11396600,3.700077553751832
EoL-1,387447,-5.86187072163508
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
NCI-H810,42642645,0.068308459982717
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
HCT 15,42642645,0.9487337080218844
A-375,2746,3.0738136393469393
CAL-27,387447,-5.151734149672665
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
A-549,136227924,3.1395144761786486
CML-T1,54618771,0.285641515878807
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
KYSE-510,100016,5.186546688011686
KP-N-YN,135928012,3.4778289270548233
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
SYO-1,136227924,1.0009147925604558
UACC-62,6505803,1.051812418083976
SNU-C4,2746,3.564383627090603
KMRC-1,10385095,1.0697515150450725
BT-12,10385095,1.681177963714551
BT 440,12001922,1.1865564955535637
CAL-33,12001922,2.290965152697736
NCI-H508,4705,1.5778147513769882
SU-DHL-1,11455910,0.1271925880707346
TE-11,246676,4.370161981630627
FaDu,selumetinib-GDC-0941 (4-1 mol-mol),1.0128048472171496
HuNS1,136227924,1.7771734051898846
OVCAR-5,136227924,3.2070295394145782
BT 271,54649381,3.6171528578741152
COV434,3825829,3.70631735810159
SUP-T11,15953870,0.8580958185661772
HCC78,54618771,0.9247891976251188
KMS-27,49836020,5.305149991763679
MeWo,9887053,3.3798182463049153
RCH-ACV,49836020,-2.2684832321475774
UM-UC-1,24753719,4.148551390379188
SBC-5,54618771,0.9612938071948806
SNU-503,42642645,0.5012196317175169
NCI-H1651,24753719,4.9084535596395025
NCI-H1339,9926054,1.7994324687191725
SK-MEL-3,3825829,4.277239969217916
SW1990,12001922,2.3012891946870866
SNU-407,6505803,0.2782297431267146
COV644,136227924,2.3380958896938147
SU-DHL-8,2746,1.0938758310486527
ACHN,10385095,1.2392970016125753
OUMS-23,12001922,1.49023198743415
OVSAHO,387447,-4.458105935950033
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
HEC-151,9887053,2.104759905960382
SNU-869,136227924,3.0372027283613505
NCI-H1666,selumetinib-GDC-0941 (4-1 mol-mol),-1.4234011879049815
TE-4,135411,0.3465098697705454
OCI-M1,4705,3.4843889260435215
Hs 944.T,136227924,3.55320847384718
HL-60,15953870,4.13027916589304
PK-45H,2746,3.885970840485544
RVH-421,12001922,1.7440008087742485
KNS-81,11167602,2.9643139944480517
EFM-192A,387447,-4.369337270783392
NCI-H1341,387447,-4.86829794539116
EBC-1,135411,0.2465956949348399
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
OCI-M1,6505803,0.7665872263269772
VMRC-RCZ,11396600,4.06764978038785
22Rv1,24753719,4.182881339762408
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
EC-GI-10,135411,0.5990482011384969
NCI-H1651,11396600,5.109965211899371
BT 147,11396600,2.435185258634128
BT 112,42642645,0.6970367427086502
786-O,3825829,4.505714689849562
MV4-11,24753719,3.2063608225430618
TUHR10TKB,9926054,2.161946529406516
PL-21,387447,-4.452583454516552
RERF-LC-MS,12001922,2.43602915295576
GB-1,selumetinib-GDC-0941 (4-1 mol-mol),1.0997063493321384
U-251MG,9927531,5.06166571476347
OAW42,135411,0.7410867506657871
TE-15,12001922,2.3177412223130496
BICR 16,100016,8.634217681257812
SJSA-1,42642645,0.9449774068990856
YD-10B,11396600,-4.483822340213775
SW579,11167602,0.0492455153665494
SNU-1,6505803,-3.5096009035536593
Hs 611.T,24753719,2.639825501985761
THP-1,11455910,-0.1573617764654806
LNCaP clone FGC,11455910,0.1396389722474823
MM1.S,135928012,3.410124861289675
PC-3,11167602,2.0015823323074264
SCC-25,24753719,4.468812461486699
SNU-C4,136227924,2.9928621999202467
MOTN-1,49836020,2.722382817781131
ALL-SIL,100016,4.099229681419155
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
EN,387447,-4.245639569058789
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
BT 286,11455910,-0.3413435906946745
HuNS1,9887053,3.2166937440729897
NCI-H2009,54649381,3.659944396907473
HMCB,387447,-4.760692258076148
CAL-29,42642645,1.401027727701586
SNU-620,135928012,3.889135229419255
SW620,10385095,-0.3354769525576651
SF126,selumetinib-GDC-0941 (4-1 mol-mol),2.749668996319385
AML-193,54618771,0.4173774880605814
KMBC-2,11167602,2.9141077523233587
BT 286,2746,4.414216796759687
IGR-1,4705,3.3965723543512647
TE-10,11396600,3.9393585387483334
SU-DHL-10,12001922,2.416254444448666
BxPC-3,15953870,2.831569416015373
BT 498,11396600,3.4855943403203704
SNU-668,24753719,4.518564993175217
Rh30,11455910,-0.173986116803538
SF268,9927531,3.0957828421568396
KYO-1,54618771,-0.1196374796023553
LP-1,135411,1.3083387665888602
U-BLC1,11167602,2.1562651935387636
NCI-H2228,11455910,0.4514463057977056
SW1417,135411,0.7696226489141811
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
OPM-2,11167602,1.1745103577473592
Calu-6,54618771,1.0169937306444143
NCI-H460,3825829,4.446795399525052
SK-HEP-1,24753719,4.401042857593667
JVM-3,selumetinib-GDC-0941 (4-1 mol-mol),1.8327445847214063
JeKo-1,12001922,1.5537981384141524
HCC38,135411,0.5496750692519626
KCL-22,135411,-0.2737399752852757
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
DND-41,135928012,3.181027691938762
HuT 78,11167602,1.7844027861507523
GP2d,11455910,0.6533370320075141
KNS-60,11167602,0.3409321951638689
SNU-449,24753719,4.452712705797618
KNS-81,49836020,5.788020143086265
BFTC-905,387447,-4.660262995674083
NCI-H2196,6505803,0.6828723886008686
TE-5,10385095,1.0844383451266395
PLC/PRF/5,42642645,1.69070755210191
NCI-H1581,136227924,2.9082899651974734
ST486,100016,6.384120256869386
A-549,54618771,0.0374822867627876
MDA-MB-415,54618771,1.363110492584667
KYSE-510,12001922,2.4168763157889597
L-428,54618771,0.5974116891557107
A4/Fukuda,9926054,1.7963505717751411
Panc 10.05,11455910,2.05873127969748
SNU-61,3825829,4.102120147241808
HCC-56,15953870,3.831801374344366
Toledo,9927531,3.803347409887559
TYK-nu,2746,4.272425827953672
NCI-H1944,100016,8.062523558454052
JHOM-1,100016,6.419236010839144
KMS-26,10385095,0.2941309941627629
NCI-H209,135411,0.7970408532487251
NCI-H1355,4705,2.565459964061863
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
Pfeiffer,2746,2.517649488872207
YKG-1,9887053,4.276479175493701
TE-8,11455910,0.8822945282493246
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
YD-10B,12001922,1.8882455182500395
BICR 16,11167602,3.879250924421472
HEC-59,135411,0.9538108728911344
SUP-M2,9887053,0.3495582222663632
PC-3,387447,-4.22389592606635
DLD-1,9927531,4.358823264887286
T84,11455910,1.5017947925367456
WM115,42642645,1.5932691238490415
LN-229,54649381,3.67762537887386
MDA-MB-231,9927531,7.115369189993137
HCC2935,9927531,5.26637836845999
NCI-H889,54618771,1.1876594721233993
BL-70,136227924,2.857298369944604
NCI-H1581,54649381,3.479452840348651
22Rv1,54618771,1.0786787609274302
BT 145,11396600,1.7169241977244534
DBTRG-05MG,387447,-3.344150933312496
HD-MY-Z,10385095,0.804290449533917
8305C,12001922,1.7650020233075272
SW1271,387447,-4.431171658059158
FTC-133,11167602,2.051836472120041
NCI-H1869,136227924,3.4575085361719955
Capan-2,24753719,4.630444613431859
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
BICR 6,6505803,-0.317492661903071
NCI-H2087,6505803,-0.9340345564408612
Detroit 562,6505803,-1.754599489690224
2004,135411,0.3678490019477489
SK-ES-1,100016,7.4795645853927475
EPLC-272H,11396600,3.8096472633651106
SK-N-FI,54618771,1.4169008036751305
HSC-4,6505803,0.688410933428746
PaTu 8988s,387447,-4.143715999712614
TE-6,12001922,1.7987294897266162
HCC38,3825829,4.30429369181038
U-CH1,42642645,1.6115373623669207
TE-15,9887053,4.0849522615234735
GMS-10,9926054,1.955397909013321
K-562,387447,-4.172741798582805
TM-31,12001922,2.306399953971235
SK-MEL-2,387447,-4.977672858008192
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
HPAC,12001922,1.477818112094615
PANC-1,4705,3.930019058376023
NCI-H522,136227331,5.948504593030567
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
MFE-296,54618771,1.0202577840468772
OPM-2,387447,-6.258797979541162
HPAC,42642645,0.7543377157238116
BCP-1,11396600,3.181201903061476
HCC1438,11167602,2.937384581285184
Sq-1,11396600,4.017113697276402
VMRC-LCD,24753719,4.020316071517673
Pfeiffer,136227924,1.7936916860357504
NCI-H1568,15953870,3.42403550557497
SNU-C1,136227924,2.406947195401098
NCI-H929,6505803,-1.240454682973536
OE33,12001922,2.146874521539325
NH-6,4705,3.0039103568475674
ST486,387447,-5.600747003706374
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
FTC-133,4705,5.547028107549284
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
697,42642645,-1.0763054209922995
HOP-62,135423438,1.5837123025968611
Peer,9926054,0.3844122788400798
A4/Fukuda,54618771,0.259551202975953
THP-1,54618771,0.1282958307593316
SK-N-DZ,4705,3.245242705626778
NCI-N87,135411,0.0487965919912929
Kasumi-2,135423438,1.5853456579896534
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
TE-14,136227924,3.1216716097465365
NCI-H1299,100016,6.953805951258825
Mono-Mac-6,100016,3.84240036835353
M-07e,9887053,4.2278025595712805
HT-1376,387447,-2.8643924716279905
EBC-1,10385095,0.7726573405677492
P31/FUJ,11396600,3.188193103342261
DV-90,selumetinib-GDC-0941 (4-1 mol-mol),-0.7506307924929138
SW1710,387447,-5.007662835498346
Tm87-16,6505803,-2.793426888899639
647V,100016,6.109475002217934
OCUM-1,4705,2.5400266776319067
Hs 839.T,42642645,0.4646091383833484
HOS,2746,3.590009491278375
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
MHH-ES-1,100016,6.165620846351705
BT 498,9927531,5.612738328284819
BICR 6,9927531,3.2709369283144674
U2OS,387447,-3.7334582338473536
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
SNG-M,49836020,6.278284295689695
LK-2,135411,0.9233967394229105
KMM-1,44498493,4.304498595072859
KYSE-30,12001922,1.8673769959819408
L3.3,3825829,3.356100526361819
Hs 683,6505803,-1.9207933299910505
Daoy,42642645,1.6398366536366578
Pfeiffer,9927531,3.43317918273791
RL95-2,3825829,2.9806096879089927
NCI-H1734,135411,-1.1623304634405327
MOLP-2,135423438,1.6947558908608933
SUP-M2,11167602,1.4540339199549586
MCF-7,54618771,-0.7262011969078179
SNU-1033,11455910,1.238389627301748
NCI-H1755,3825829,4.404071414228659
HMCB,3825829,4.05483266037916
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
DV-90,9926054,1.8346982871797115
OCI-Ly10,24753719,4.462719317862582
KNS-60,4705,3.2659251845873425
Karpas-299,selumetinib-GDC-0941 (4-1 mol-mol),2.273668184734746
RERF-LC-Ad2,2746,5.029161088145208
MOTN-1,3825829,3.768049052511154
639V,42642645,1.6869758922484823
RERF-LC-A1,246676,4.379402832179336
HCC78,42642645,1.5281518484144585
LoVo,4705,1.5085236639058903
BT 164,24753719,3.8785353041176265
OCI-AML-3,12001922,1.0955211063319066
MES-SA,9926054,1.7710161106499946
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
OV7,135928012,4.341145686378131
KP-N-YN,12001922,2.2461644398319303
RKO,9926054,1.883626680074333
HD-MY-Z,1474550,4.47836514924332
HuP-T3,15953870,4.533958601099395
SNU-C1,42642645,1.2006005211142348
G-361,54649381,3.7878870070761264
OCI-Ly10,15953870,3.7214241877317
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
HuNS1,15953870,3.4393359169701845
BT 187,2746,4.1078549912417355
SW1271,10385095,1.244878723840673
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
JM-1,49836020,4.6064946369246025
SK-LU-1,12001922,1.7357890036098025
BT-474,136227924,2.4914554847870187
HEC-59,3825829,4.170328417295255
HCC827,12001922,2.4034932793383708
697,246676,4.276106546265392
BICR 22,387447,-3.632542993789297
OCUM-1,9926054,1.1512095062885492
NCI-H2196,100016,7.101599749729703
NCI-H446,24753719,4.670302039262769
MKN1,42642645,1.3849471116012968
SW48,15953870,2.1672009909649415
SNU-1079,11396600,3.205631918167514
LOX-IMVI,9887053,4.363573973806746
Kasumi-1,135411,0.9188413287042528
TE 441.T,10385095,0.7638238428487356
HT-144,387447,-4.995484571496653
SK-CO-1,246676,3.87632071272349
8305C,387447,-4.500899735651715
LXF 289,54649381,3.6309892426510406
NOMO-1,54649381,4.1030759428324455
JeKo-1,135928012,3.8687150177410783
UM-UC-1,9927531,4.732850009488004
NCI-H2106,11167602,1.6194300633388694
NCI-H226,9927531,4.418189277296578
SNG-M,15953870,3.3752690175514632
RVH-421,3825829,4.543247180098805
Panc 04.03,54618771,1.7180394725494992
AM-38,9887053,5.766592020557762
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
SNG-M,9926054,2.579798992981947
ECC10,4705,2.6842412149864012
NALM-6,selumetinib-GDC-0941 (4-1 mol-mol),-0.5223211713783823
EM-2,54649381,2.8073338680672646
ECC10,9887053,3.130226708389206
CHP-212,9887053,1.8136622207304371
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
COLO 320,4705,2.552881427676556
IM95,15953870,3.373945481394273
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
MOTN-1,2746,1.1076991402099114
BT 330,387447,-5.2185859135267405
NCI-H1755,387447,-2.9360463075069414
BT 245,4705,2.436380122563236
OVCAR-5,54618771,0.5295799029989672
SUP-M2,9927531,2.443296482682693
RS4;11,9927531,3.90062082158746
Hs 729.T,135411,0.9381464169553372
TUHR10TKB,42642645,1.733702344994975
Panc 10.05,100016,7.2735240015579645
OV-90,100016,6.511633470460193
TOV-21G,6505803,-2.649430601885361
CAL-148,10385095,1.1693047418499267
Hs 822.T,11396600,4.268177594859087
LMSU,9926054,1.9493229998791417
SNU-8,136227924,2.992589463119238
JHH-5,387447,-4.253458969818264
BL-70,42642645,0.4499383926542911
LP-1,54618771,-0.0349126371834358
MIA PaCa-2,135411,0.8482732025592005
DV-90,12001922,1.5026816273536598
Hs 944.T,9927531,3.41915171718772
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
NCI-H146,6505803,-0.3489025917214021
COLO 668,2746,3.082307436589746
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
IGR-37,136227331,4.32939216676153
HuG1-N,15953870,4.201966851714453
NCI-H358,54649381,5.590807367296295
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
JHOS-2,3825829,4.2893765124737255
NCI-H1838,42642645,1.5460674274292951
SNU-175,9887053,3.375312386151919
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
OAW28,15953870,5.078636607909671
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459
DAN-G,6505803,-1.4113382946218047
NCI-H2087,9926054,1.8666936138192145
Li-7,12001922,1.900546605766219
HSC-2,54618771,1.8867567266847771
Kuramochi,42642645,1.5705539291509247
NCI-H661,10385095,0.8549868667974337
KP-4,9926054,2.5953636784587877
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
KYM-1,135928012,5.160711805692309
H-STS,15953870,3.89259126645257
SK-N-FI,4705,2.5887830768874993
KYO-1,11396600,3.3836130470467736
DU145,3825829,4.09288773137039
BT-549,387447,-4.9509675804959
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
CAL-120,11167602,2.9935141150710085
BT 330,10385095,1.0976852552783771
PaTu 8902,10385095,2.391345219233966
T98G,54618771,1.1759260656480666
BT 248,42642645,1.464081071598135
OVK18,387447,-3.0214202428408496
L-540,24753719,2.8573995264136256
Hs 746.T,135423438,3.2102823304550463
SNU-738,12001922,2.5274053930067093
Hs 895.T,11396600,3.5595368141538297
WM793,387447,-3.0647343941704603
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784
SK-N-MC,2746,2.1914120575245373
NOMO-1,11455910,0.2303469505827257
LS123,2746,2.8702857681070064
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
YD-8,135423438,0.9954856602627224
MOTN-1,15953870,3.5056455850107255
OE33,3825829,6.240341971286144
KYSE-510,10385095,1.814777248632933
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
IGROV-1,11455910,-0.2792640061206097
KNS-81,15953870,3.65114697794392
B-CPAP,10385095,0.9210921841581224
NCI-H2029,2746,2.486824956560061
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
A-204,135411,0.2587270978260984
SNU-213,10385095,2.7554812107877065
Namalwa,100016,3.934978584241161
SNU-478,10385095,0.9475992892849324
SUP-B15,100016,6.907261874504965
YH-13,24753719,4.493928762122736
SK-MEL-3,9926054,1.7891311822278144
SK-HEP-1,387447,-3.995016034956776
BT-16,136227924,2.1772162484418924
MV4-11,11455910,0.2618062537213718
NCI-H522,387447,-5.403881314975521
L-428,387447,-4.651207393676816
SF268,54618771,0.7113827759626075
SaOS-2,9887053,4.468769125876902
RPMI-8226,3825829,3.1291570476333153
NCI-H460,54618771,1.6853262233131374
UACC-257,selumetinib-GDC-0941 (4-1 mol-mol),-0.8117172075049729
BT 330,246676,6.180038418715505
SK-N-SH,24753719,3.5601626189030746
SU-DHL-1,24753719,3.670729792524347
TE-4,15953870,2.6693338311046295
Mino,15953870,2.630005403588916
UM-UC-1,135411,-0.607345035408787
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
DMS 114,4705,3.4227674177619187
GSU,387447,-4.229472700316046
BHY,44197249,3.808858397047082
HEY A8,selumetinib-GDC-0941 (4-1 mol-mol),1.3817126396854498
NCI-H2081,15953870,2.893627667573686
TE-10,54649381,3.705734267692881
Mono-Mac-6,135411,-0.384377643391869
SNU-761,selumetinib-GDC-0941 (4-1 mol-mol),3.4718208794514167
CAL-33,42642645,0.1092185761999633
JHH-6,10385095,3.92462202352124
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
CAL-27,15953870,4.2113853407980795
NCI-H1944,3825829,3.684755943429072
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
SF295,10385095,1.9844654960624617
SW1088,9926054,2.0788174328581515
LS411N,10385095,1.4098978051841675
SW1088,24753719,4.9947563556598285
KE-97,9887053,2.144563312813172
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
Kasumi-2,6505803,-2.445084849944434
KLE,11455910,3.332048563725763
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
Mino,100016,3.8828597807205023
BT 139,42642645,1.0499068063196206
WT2-iPS,10385095,0.7837031813281792
NCI-H2110,9926054,1.839297705521365
MCAS,49836020,4.94613909678053
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
SBC-5,11396600,3.6683316442381617
SNU-685,10385095,1.2325598072827673
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
LCLC-97TM1,9926054,1.7367616025320842
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
GSS,246676,4.2642843593675765
SNU-466,selumetinib-GDC-0941 (4-1 mol-mol),2.355398867195719
TE-1,12001922,1.7576157202697524
NCI-H2172,54618771,2.767787208774524
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
IST-Mes1,135411,1.0362911335756892
BT 228,24753719,4.472096298736932
EFO-21,6505803,0.6098596142059811
C2BBe1,6505803,1.1561047092337646
JHUEM-2,387447,-5.581309296156035
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
SNU-449,135411,1.1071215925884743
TYK-nu,135411,0.1131200627063575
A-549,4705,3.61311120139633
NCI-H2170,9926054,1.935868452223027
NCI-H1105,9927531,4.896971855718655
TE-4,11396600,3.940884116586543
PE/CA-PJ15,3825829,4.163765164448535
G-402,136227924,2.8538202085088185
UM-UC-3,135411,0.279650670815757
MOLT-3,9887053,-0.0169003049486202
KMS-18,9927531,3.9141727382936624
Hs 578T,136227924,2.600789152961688
OC 314,3825829,2.8934826485773817
BT 216,42642645,1.5818855101681288
NCI-H2444,9926054,0.9505376631945008
BL-70,10385095,0.3917305885216868
KHM-1B,3825829,3.6551708099406
CAL-148,136227924,1.0972662327382037
SK-MEL-30,12001922,1.777601925017025
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
KPL-1,11167602,3.344088823698267
U-118MG,100016,6.712569444944465
DU4475,54618771,1.1300821286191531
SK-CO-1,9887053,2.665990529661509
KE-39,387447,-3.456484721663708
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
COLO 320,12001922,1.3503920764033814
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
SK-N-MC,selumetinib-GDC-0941 (4-1 mol-mol),1.42335889342789
SW982,3825829,4.67729538884365
HCC1500,15953870,3.698430879415157
SK-N-MC,246676,4.732478125097426
NU-DHL-1,136227924,1.2519389073848997
JK-1,387447,-5.482180524443791
KYSE-30,9926054,2.699990284064641
SR,54618771,1.0757630585056626
COR-L95,12001922,1.5177554079359803
DND-41,9887053,3.342047494083637
U-BLC1,9887053,5.166701097686756
RMG-I,11455910,3.4870876000849704
SW620,15953870,4.9044658405000465
769-P,9887053,4.395798617132143
JVM-3,387447,-4.69475989920384
C2BBe1,42642645,0.5291716641909177
KMS-26,136227924,1.9705002365993127
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
CAL-85-1,24753719,4.0831645287035325
BT 231,42642645,0.5530706708925721
SUP-M2,135411,-2.329512125323606
DU145,2746,3.3697589984535528
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
SNU-601,54618771,0.1352260287728254
HuCC-T1,135411,0.6762339733573818
COLO 684,9887053,2.5500209248028245
L-428,11167602,1.8021338177269608
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
AsPC-1,6505803,-1.959385905579291
Yamato-SS,10385095,1.6025498107671532
HEC-1-A,6505803,-1.1464384293678307
TF-1,9887053,3.752269621216284
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
Sq-1,2746,3.2736389846426532
KYSE-140,387447,-3.3359687565935534
Mono-Mac-1,6505803,-1.0735015571845192
SUP-T1,387447,-4.745337935816621
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
PaTu 8988s,9926054,1.8956430403525124
NCI-H2172,24753719,5.109863925049923
ALL-SIL,6505803,0.7073572306495796
RPMI-6666,9926054,1.733679521146624
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
KYSE-510,11167602,2.041208237103879
U-BLC1,135411,1.129772715841648
Mino,42642645,-0.9713328397694244
IGROV-1,49836020,5.658436828096057
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
DMS 273,136227924,2.538513279360657
WT2-iPS,44197249,3.726242225493656
MOLM-16,387447,-5.0833306463146135
639V,selumetinib-GDC-0941 (4-1 mol-mol),4.596668684568556
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
SNU-119,9877608,5.864690809801913
SNU-1272,9926054,2.4790221898932283
NCI-H520,54618771,1.0653077757718592
HCC1419,15953870,4.452457759022411
Daudi,10385095,0.347773175212431
KMS-28BM,selumetinib-GDC-0941 (4-1 mol-mol),1.2761888843371896
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
BFTC-909,10385095,0.9839595624316404
DU145,15953870,4.361451151024508
SW1271,136227331,4.376300443457216
MCF-7,12001922,1.7200036674392143
TALL-1 [Human adult T-ALL],49836020,4.412561834618748
Peer,136227924,2.1160969435978303
NCI-H460,100016,5.855223104671776
NCI-H1355,2746,3.638121411384877
U-937,100016,4.26159584690163
Hs 683,4705,2.6530339386806476
BICR 6,42642645,1.0275005034154885
JHUEM-2,6505803,-3.169169021996555
T84,42642645,0.3072828791348135
Hep-G2,136227924,2.2133800896817304
NCI-H1184,6505803,-0.2982079096547607
CCF-STTG1,12001922,1.64779237690147
SNU-478,42642645,0.5875365780640257
Fu97,54618771,-4.808914794700833
JHUEM-7,12001922,1.974346294613864
ACC-MESO-1,9926054,4.037988480167424
LS411N,42642645,1.4293896003043414
Mono-Mac-6,387447,-2.1739497963852186
BT 340,387447,-4.456579269050091
IGR-1,24753719,4.2023901433737425
SR,9926054,1.591402599592269
HEC-6,135411,0.3752143630739118
NCI-H520,10385095,1.0283003388284149
NCI-H28,9927531,4.6016482528028515
HCC2279,42642645,0.9878718074268956
NCI-H1650,387447,-5.007985584658555
KMS-20,11167602,1.9500667412435135
NCI-H1355,42642645,1.5720739417052991
GA-10,135928012,0.2112396318699025
NCI-H1435,6505803,-2.6053022646715207
HCC-56,10385095,2.391265735319104
NCI-H838,246676,4.96378057345008
SNU-449,12001922,2.031450773900583
ONCO-DG-1,49836020,4.455184005808947
TE-1,135411,1.0964573767777424
A-549,100016,7.181380121169662
Hs 888.T,9927531,5.625894406785977
HDQ-P1,54649381,4.160382500104933
KG-1-C,selumetinib-GDC-0941 (4-1 mol-mol),0.970562535367186
A-673,9887053,2.3565868011684956
HCC2108,100016,5.291323338255078
KP-3,24753719,4.638034647169119
UACC-257,15953870,3.378203800048497
COR-L105,54618771,2.0419110046350135
A2780,246676,4.314588687253318
BFTC-909,135411,0.8518885281649031
SaOS-2,2746,3.4161371679978436
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
SW1710,9926054,2.792354936189826
BT 147,54618771,0.8857496125783197
BT 145,12001922,1.5979935834051522
SW948,9926054,1.8406028662949705
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
SNU-1077,42642645,1.1218523174966224
NCI-H226,54618771,1.8675416009470285
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
Hs 888.T,42642645,0.5877529045222073
F-36P,11167602,2.0610720557550755
GOS-3,10385095,1.261141423395055
2004,6505803,1.2288982510543929
BICR 56,15953870,5.950945836523494
Panc 10.05,9927531,5.445272240057394
OC 314,9887053,3.91921943415716
MDA-MB-453,6505803,-3.8322805026755806
VMRC-RCZ,42642645,1.2752496599296788
MeWo,246676,0.2399157367161025
DMS 273,387447,-5.016212668564022
SNU-738,9927531,4.827507825762818
BT 172,136227924,2.3975770198101545
AN3-CA,11455910,0.3745394880525272
MFE-296,12001922,1.6700543167480952
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
DMS 79,6505803,3.896341959956276
GB-1,9926054,2.832614445271179
CW-2,2746,2.3288495510322087
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
HLF,135411,0.5085725199405622
EN,selumetinib-GDC-0941 (4-1 mol-mol),3.4742194134426168
KYSE-510,11455910,0.588334409452975
253J,12001922,1.793542001419408
OCI-Ly10,9927531,5.366378866921267
Rh18,10385095,0.8210854840293843
DMS 273,24753719,4.257561408038297
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
BT 428,24753719,4.392925021958881
5637,100016,5.253062593048346
NCI-H1623,4705,0.0935418442786881
SNG-M,54649381,4.595450861098138
NU-DUL-1,4705,2.4106173006018268
EB1,9926054,1.6799735914328415
OAW28,3825829,4.635564939734502
COLO 684,100016,6.373471933627605
JK-1,42642645,-3.176584856831934
KYM-1,11167602,2.068998786913783
P31/FUJ,135411,-0.6620772647112111
COV434,6505803,-0.6125824697560679
TT2609-C02,10385095,1.344780053059808
COV644,9926054,1.7976744262803612
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
CHP-212,10385095,0.0488360201020664
BV-173,2746,1.3543374496057554
HEL 92.1.7,selumetinib-GDC-0941 (4-1 mol-mol),3.657513004741347
HCC1588,11455910,1.225245370216729
HCC1171,11455910,2.1800393678946395
OC 314,135423438,1.699134190233343
OCI-Ly3,136227924,2.2750950031645885
LNCaP clone FGC,11167602,1.6735547882241617
WSU-DLCL2,54649381,3.811032881245604
KMS-34,24753719,2.278848453246231
JK-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404611397538406
HDLM-2,3825829,2.899481570882313
MPP 89,selumetinib-GDC-0941 (4-1 mol-mol),2.3167615576876734
KYSE-150,387447,-4.502560163754148
NCI-H1581,135411,1.4585971798048771
SW48,387447,-4.885505238560258
A-253,11396600,3.687595077759593
JM-1,135411,-1.048960589681706
SNU-81,3825829,3.873341985908314
KMS-27,9926054,0.4648817543416692
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
HPB-ALL,24753719,3.680358106970135
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948
NCI-H1694,6505803,0.2523164939163045
KP-4,136227924,3.1314573836961235
NCI-H1581,135423438,0.6953694326358761
LoVo,42642645,0.0146125142547242
NOMO-1,100016,4.546215242968586
U266B1,11455910,1.3573355580969808
DU145,387447,-4.445676725008602
HOP-62,11167602,2.5582425778829356
VMRC-LCD,136227924,2.9641387298533868
CW-2,24753719,3.5794357651557407
BV-173,11167602,1.519259403160705
Karpas-620,42642645,1.9321882783533009
MIA PaCa-2,12001922,1.5564360891917508
LMSU,100016,7.332455698517509
D283 Med,15953870,2.787040507745561
KYO-1,11167602,1.4429278451618828
MOLT-16,44197249,4.172878647705966
KYSE-30,15953870,3.608839098975031
NU-DUL-1,2746,1.0800469209102068
OCI-AML-3,100016,6.665392900980702
Hs 578Bst,12001922,1.1284146459958757
MFE-319,2746,3.158531328998989
UACC-257,11455910,0.2602701775607313
KE-39,24753719,4.8851025960405074
Caki-1,11455910,2.5342429467421144
F-36P,2746,1.451851668810028
NMC-G1,6505803,2.4700924205747827
KMRC-1,6505803,1.455434702084088
SW1088,15953870,4.981163108910373
BT 172,100016,6.450201924949107
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
LXF 289,54618771,-0.5375230222620658
OCI-AML-5,9926054,1.291118063021603
HEY A8,11455910,0.7579063331214974
COLO 699,54618771,0.7648431477044199
KYSE-510,11396600,3.570057014705878
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
KYSE-140,10385095,1.6004896195430536
NOMO-1,9927531,5.049638663441057
TT2609-C02,136227331,4.484463069653878
KMS-11,10385095,1.0740998272588806
SK-MES-1,135411,0.4726928284800262
U2OS,42642645,-0.4799474120670963
JHOC-5,11167602,4.441059570207515
HCC827,10385095,1.4458528410781517
NUGC-3,3825829,3.787352426707947
MHH-ES-1,3825829,3.024649062845587
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
HDQ-P1,selumetinib-GDC-0941 (4-1 mol-mol),1.336429644847675
JHH-2,54618771,-0.1274840314711515
8505C,135423438,2.0572853298066036
KALS-1,135411,2.3952428324891355
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
Ki-JK,136227924,2.2053195341815424
MHH-CALL-3,15953870,3.0908384888962988
KMS-12-BM,3825829,2.160644220643388
HT-55,6505803,-1.0332246956791955
LC-1/sq-SF,42642645,1.491788883302931
DMS 114,54618771,0.497932875253643
NCI-H1355,9927531,4.199887735428921
HSC-2,10385095,1.233116039516603
YD-38,3825829,3.4785077609672057
TALL-1 [Human adult T-ALL],3825829,4.0355439020412005
VM-CUB-1,9926054,1.9231906197166304
COV434,44197249,4.844663942040957
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
A-549,42642645,0.883993697279782
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
NCI-H1693,9926054,2.0729608249560436
SNU-387,4705,3.526786738032827
HT-1080,11167602,1.7548131113833343
SNU-449,11455910,0.8938620280411973
IST-Mes1,6505803,0.837907313306775
Ci-1,42642645,1.0777407011168454
YD-38,9926054,1.970357209117647
COLO 205,54618771,0.9873734762739949
IGR-37,387447,-4.39014205040547
Karpas-422,49836020,3.572840137931533
Hs 683,9927531,5.316569157291169
BL-70,6505803,0.7841621895069785
NCI-H508,44498493,4.417033186640656
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
FTC-238,4705,3.281251392763017
MKN74,2746,3.2220393473660973
Kuramochi,136227924,3.2782581577037964
WM88,4705,3.410375599390418
OCI-Ly19,387447,-4.367545425629013
SNU-466,135411,2.078168875611288
CGTH-W-1,11455910,1.5970205272466635
KE-39,10385095,1.3052459079941114
HSC-3,100016,6.558832951826536
SK-N-SH,135928012,5.794138033449565
ONS-76,11396600,3.887590392789339
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
DU4475,11455910,-0.5137096491730787
A-253,9926054,1.90575113373639
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
UACC-62,10385095,1.0513221751606243
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
NCI-H1694,11455910,0.2193513858726209
HCT 15,11396600,4.026693260912133
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
TOV-21G,selumetinib-GDC-0941 (4-1 mol-mol),3.592857274356158
TE 441.T,49836020,3.964912597269393
Hs 766T,135411,3.02898708226595
VMRC-RCW,387447,-4.094085420764261
NCI-H2110,135411,0.5672279219720924
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
UM-UC-1,6505803,-2.248189153857155
HuH-28,387447,-4.5886015489859435
RD,42642645,0.9791940036196682
NCI-H1373,10385095,1.3516674750323112
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
NCI-H1435,24753719,4.622788209855311
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
MHH-ES-1,11455910,0.3888631975426587
LCLC-97TM1,44197249,3.7483906325702545
NUGC-3,54618771,-0.8642995608201182
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
MPP 89,42642645,0.822299313543259
OC 314,2746,3.4168775378472893
SNU-668,136227924,2.8591825047695925
HCC1833,9926054,1.8132192248663452
U266B1,54618771,0.5848544182666181
Fu97,2746,1.9781372466422251
OCI-Ly3,selumetinib-GDC-0941 (4-1 mol-mol),1.725768146081181
RPMI-6666,2746,2.3385323995154033
OCI-Ly3,15953870,3.3607399240404177
PSN1,10385095,0.8827094939681907
PC-3,10385095,1.1414412954098598
HSC-4,135423438,1.814117839489682
NMC-G1,12001922,1.7140481956648972
SNU-761,10385095,2.457168715913424
SNU-1076,9926054,2.0143618167190493
JMSU-1,10385095,0.0262593871982068
TT,136227924,2.992692937715844
SCC-4,6505803,-0.4511168499672106
EJM,9926054,1.7534790705740089
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
MHH-ES-1,136227924,2.293763722118734
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
BT 231,6505803,0.1418659460842767
NCI-H1355,135928012,3.9455574894340097
HCC95,selumetinib-GDC-0941 (4-1 mol-mol),2.25370960012268
DBTRG-05MG,9887053,5.08363420896019
Reh,135928012,5.673029038671632
HOP-62,9926054,1.899267170249981
JVM-3,9926054,1.6493371537606276
QGP-1,135411,0.8462998609635609
NCI-H520,11396600,3.7776798770198594
NCI-H2444,135411,1.8366332857146552
BT 328,4705,3.594890989297502
JHOM-1,15953870,3.5712461049748137
NCI-H2405,6505803,-2.525065037693204
Hs 729.T,11396600,3.2923365887008966
L-428,54649381,3.825783954120757
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
Hs 888.Lu,24753719,4.75417176582107
Kasumi-2,10385095,0.5473944457717855
COV434,136227924,1.351853150285656
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
CMK,136227924,3.317343215770968
OCI-AML-5,15953870,3.896531488259219
Mel JuSo,9926054,2.008818568190823
Calu-3,44197249,5.437860538886515
NCI-H69,12001922,1.4659882472435273
MOLM-13,3825829,3.189823245525434
NCI-H1703,selumetinib-GDC-0941 (4-1 mol-mol),1.0120925414359212
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
KP-3,136227924,3.03068470875373
BT-20,100016,6.680150665921765
CCF-STTG1,387447,-3.430424241609023
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
A4/Fukuda,4705,2.104501352907832
NCI-H2444,12001922,2.4309890811674344
HCC1833,12001922,1.7724795128114657
KMS-28BM,387447,-4.698484727253072
Pfeiffer,387447,-6.030484053949509
IGR-39,24753719,4.202195809310512
Hs 940.T,54618771,0.7106983337265675
SR,10385095,0.7110611878101281
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
NCI-H1184,49836020,5.907287846852096
PE/CA-PJ34 (clone C12),135928012,3.818108144360031
CAL-51,15953870,3.220977372988981
MPP 89,4705,3.4869840360057855
RPMI-8402,9887053,2.689325905031518
G-292 clone A141B1,9887053,4.478043019460206
NCI-H1105,6505803,1.9416219535122128
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
NU-DUL-1,54649381,3.738011086181328
JHUEM-1,6505803,-0.0330531463180682
CAL-85-1,387447,-4.375269692131687
ME-1 [Human leukemia],15953870,4.05849032013588
NCI-H1299,387447,-3.841089512214304
Hs 766T,72199289,4.423272467575485
NCI-H2228,135411,-1.26469554290231
NUGC-3,9926054,1.9670154065403471
SK-N-BE(2),135411,-1.6029790975990694
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
NCI-H1755,54618771,-0.2834105943747247
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
TT2609-C02,12001922,2.958311362365458
SNU-878,42642645,0.7359757577909016
NCI-N87,54618771,0.8863121899707505
IGR-37,11167602,3.226073746517762
HEC-108,100016,6.393272881400893
BT 172,11396600,2.88874233952659
TE-4,selumetinib-GDC-0941 (4-1 mol-mol),0.9436267923396215
HuP-T4,selumetinib-GDC-0941 (4-1 mol-mol),-0.95779192570868
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
CAL-51,42642645,0.4324607401831485
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
A3/Kawakami,9927531,2.786138883968946
SU.86.86,selumetinib-GDC-0941 (4-1 mol-mol),2.756391846899265
Sq-1,15953870,1.4474413341048356
KMS-34,9927531,3.5487000216351277
TE-9,3825829,3.646134442790622
DBTRG-05MG,3825829,4.693695440502582
CAL-85-1,42642645,0.8020654430054682
JIMT-1,12001922,2.0583785152306247
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
SNG-M,2746,3.2265366784113914
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
HD-MY-Z,42642645,0.9582143168219108
MOLP-8,42642645,0.4027543307161444
RPMI-7951,135411,0.7923410936868759
BT 224,12001922,1.6144119939642625
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
OVISE,387447,-4.037756707187744
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
PaTu 8902,136227331,5.567107594748722
DK-MG,387447,-5.64321062598625
ST486,136227924,1.8715049257554837
A3/Kawakami,11455910,-1.104878748608077
NCI-H460,54649381,4.173104904963283
SW1990,6505803,-2.4928933936476048
KYSE-30,54649381,3.8376199137118223
Ku812,135423438,-2.2335088833738146
MOLT-3,135423438,2.3622071216207594
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
KMS-27,10385095,0.2784313447424752
LUDLU-1,11396600,3.511011158799078
RS4;11,73707440,6.471067447631978
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
NCI-H1703,387447,-5.110948907883488
NCI-H2087,2746,2.6080456190013632
DMS 114,11167602,2.9651501039197385
HEC-265,135411,0.6888454782846094
Hs 888.T,selumetinib-GDC-0941 (4-1 mol-mol),2.8983060042425484
COR-L51,42642645,-0.3198751299974817
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
G-361,100016,5.501390716782531
HEC-6,9926054,1.6312694597986903
LS180,24753719,4.21554861148433
SW1417,387447,-5.343159426353255
MIA PaCa-2,100016,4.223400842588871
OVTOKO,42642645,1.6221118816670084
BT 422,54618771,0.9695029183446764
KP-4,3825829,3.2044690277521592
HCC2935,24753719,4.859796375591352
A-549,4705,3.61311120139633
Rh18,54618771,1.0178435523811953
SNU-1076,3825829,3.8516030239462538
ECC12,15953870,4.377791113762721
NCI-H1563,12001922,1.2867809989852097
SW620,12001922,2.2997921929026277
CAL-51,54649381,3.902782783768603
NCI-H23,3825829,3.2793635538739787
BHY,135411,0.2787136199586732
HeLa,15953870,4.982907578745
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
SNU-8,3825829,4.279062116005913
OCI-Ly19,9887053,1.1638970784630067
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
HEC-151,135411,-0.0260657506821276
WM793,3825829,4.563508127916012
NCI-H23,selumetinib-GDC-0941 (4-1 mol-mol),-0.1629435385383226
KMS-26,11455910,-0.0860099305648322
VCaP,3825829,4.405995154773428
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
HCC-56,selumetinib-GDC-0941 (4-1 mol-mol),-0.1385009392783674
KO52,54618771,1.4631554759036511
SHP-77,42642645,1.4396929010125237
NCI-H2087,49836020,4.38375865979883
BT 248,54649381,3.7327878949357394
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
UM-UC-3,54618771,3.8430059461326658
NB4,11396600,3.2499354212792646
HEC-1-A,selumetinib-GDC-0941 (4-1 mol-mol),0.8454811422727944
HCC1806,54649381,3.81240317499671
COR-L95,135928012,3.4969711227856397
SNU-761,9926054,1.7039655374796845
NCI-H508,387447,-4.882445919105301
EM-2,10385095,1.5140639606504105
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
YD-10B,selumetinib-GDC-0941 (4-1 mol-mol),-2.4124074693543887
P12-Ichikawa,100016,6.391056060940552
KYSE-410,42642645,0.880387648201634
AGS,11455910,2.3599070102743274
8505C,49836020,5.7227071797800235
TT2609-C02,9927531,6.514577910597335
MDA-MB-453,135928012,3.1518499848728534
SNU-398,15953870,2.938908926570635
HCC1588,135411,0.2992295908671926
RMG-I,4705,2.197778207097114
Kuramochi,9926054,1.9908985756300632
NCI-H1373,100016,4.430083600999957
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
Yamato-SS,selumetinib-GDC-0941 (4-1 mol-mol),-1.5672740621691217
SNU-119,136227924,3.0573258202750253
SK-MEL-30,9926054,2.6578574468285434
NCI-H2009,136227924,2.9896301065010933
HCC1588,100016,6.591658390404969
SNU-61,9887053,4.377899885829067
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
HEL 92.1.7,11396600,3.6147449573871735
A-549,15953870,4.749569227898693
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
SW620,24753719,3.88955545054986
BT 239,15953870,4.70138897711737
Yamato-SS,12001922,1.7751519903008417
JHH-5,3825829,3.4775370756717012
SNU-423,11167602,4.222331627049854
NCI-H2291,11396600,4.122894095421017
T-47D,54618771,0.7815754342030017
BV-173,3825829,3.2403404878944535
U-118MG,11455910,0.7446076183130194
SUP-B15,2746,1.2299523793541935
LS123,12001922,2.1621506959030623
TE-10,24753719,4.768956775579738
DLD-1,10385095,2.044160408314856
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
GOS-3,24753719,4.687766883023854
JJN-3,15953870,3.4925873743805846
HCC1195,24753719,6.180231383527519
Kasumi-1,10385095,0.9710021907970404
697,selumetinib-GDC-0941 (4-1 mol-mol),0.5718014976116145
BICR 18,selumetinib-GDC-0941 (4-1 mol-mol),2.10893562893339
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
OV56,54649381,3.155777358535006
LK-2,10385095,0.7985519747751707
LCLC-97TM1,2746,2.92478275020961
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
Hs 683,15953870,3.706668121424788
TE-6,6505803,-2.104083305056956
SKM-1,54649381,3.9349803004412496
NCI-H747,9927531,5.010482166224782
GCT,136227331,4.154263248782668
BICR 18,387447,-3.3607708298023304
COV362,11396600,3.1783397213372293
JHUEM-7,10385095,0.8646007643870881
OCI-AML-3,9887053,0.3982822517551575
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
BT 112,15953870,4.403390528576976
L-428,12001922,1.439728988302904
OE21,387447,-4.65456656277309
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
SNU-387,12001922,2.18397039319762
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
NCI-H1694,9887053,1.826144640374545
Pfeiffer,135423438,1.688577361264551
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
COLO 684,6505803,-1.3840458684273105
KYM-1,136227924,2.3887987595454594
U-251MG,136227331,3.886496175618068
Mino,10385095,0.494040271373144
COR-L95,42642645,0.7279572059378924
A-204,4705,2.732319737517574
RPMI-8226,387447,-5.730762424967482
NCI-H810,11396600,2.3533971168912036
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
A-204,54649381,3.6539777610747946
L3.3,54618771,1.1558037208399272
CMK,12001922,2.528896889662982
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
HuH-28,9887053,6.189895466467789
HCC366,12001922,2.335783180589688
NCI-H1666,135411,0.7630528171238863
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
DMS 454,4705,3.5434056229110498
PE/CA-PJ41 (clone D2),387447,-3.919842712569756
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
SNU-398,9887053,4.392129112459129
UACC-62,54618771,1.116169218616572
NMC-G1,3825829,5.0747615717694154
ME-1 [Human leukemia],100016,5.540349228215307
HGC-27,6505803,-2.0578617298265787
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
ECC12,135423438,4.440785881559049
JJN-3,selumetinib-GDC-0941 (4-1 mol-mol),1.20099577342293
HEC-1-B,selumetinib-GDC-0941 (4-1 mol-mol),1.120792302253412
KATO III,54618771,1.8555498660455492
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
U2OS,135411,0.2862290386581381
CAL-78,54618771,1.2758318023633108
BV-173,4705,2.8039060927559505
HCC1833,24753719,5.582495333758276
ZR-75-30,selumetinib-GDC-0941 (4-1 mol-mol),2.2960611598253178
HT-1197,135423438,4.472256481601468
NCI-H2171,42642645,-0.8345775302937554
IA-LM,9926054,3.212619063516659
NCI-H841,9926054,1.733938420008062
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
Hs 940.T,136227924,0.9830608526546036
KP-4,9927531,4.133132471869078
BT 147,selumetinib-GDC-0941 (4-1 mol-mol),1.4700877243858868
UM-UC-1,387447,-5.016221725702392
ALL-SIL,15953870,2.429039509996585
OAW42,12001922,2.4464310473843667
HuCC-T1,12001922,1.9544481882669544
TE-9,selumetinib-GDC-0941 (4-1 mol-mol),2.552175387754049
NCI-H1155,11167602,1.6039885275526522
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
DV-90,135928012,4.881681995143342
MHH-CALL-4,6505803,0.4342437692072871
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
OAW28,135411,2.218427323792269
T98G,24753719,3.9354730231291186
ONCO-DG-1,54618771,2.377307525963503
CA46,24753719,4.040239779097469
WSU-DLCL2,42642645,0.2304951394475088
SEM,24753719,1.9867479465315392
BxPC-3,54618771,0.182098153600537
HEC-1-A,100016,7.347183870003149
CAL-33,136227924,2.366373998099427
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
NCI-H1092,135411,1.4198261476430412
JHUEM-7,100016,7.782886537779513
NCI-H1755,12001922,1.9923447027601
SNU-1077,9926054,3.1436307505327123
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
G-361,10385095,0.8073927778155511
CAL-148,15953870,3.637183399383744
JHUEM-1,10385095,0.0269931721526632
TE-1,3825829,4.443596935858325
A3/Kawakami,15953870,3.5307965463933315
Hs 895.T,9926054,3.037300507007888
Capan-1,135411,1.1920717014747266
U266B1,10385095,0.7447923341287666
EJM,3825829,3.923583211439946
KYM-1,6505803,-2.3943028473817005
ALL-SIL,12001922,1.676377280214729
KYM-1,15953870,2.4855448430766653
BT-549,54618771,1.4883156908959423
KMS-11,54618771,1.142705350534528
Namalwa,4705,3.621778373883038
HEC-265,12001922,1.9111125629541512
KMS-12-BM,135928012,2.4606603364640995
Becker,3825829,4.088732787660409
SU.86.86,15953870,3.3388737453334243
RPMI-6666,3825829,3.972819269306284
BT 359,42642645,1.7600288593942324
KMRC-20,6505803,2.060614018584274
ACHN,12001922,3.012749471746897
253J-BV,136227924,2.6085874458601066
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
NCI-H716,6505803,-2.390779236038046
NCI-H1975,49836020,-1.0893813245468835
BT 340,9926054,4.031759543162761
A-673,135928012,2.926877088120134
EBC-1,4705,2.4186429670201153
SF268,135423438,1.590927583342323
BT-474,42642645,1.6083573501039448
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
KE-37,135411,-2.0489803246501657
SCC-25,3825829,3.937484757880054
HGC-27,11167602,1.8077063625690304
HCC4006,9927531,5.0093588349321125
BT-474,10385095,2.724644688135605
SK-MEL-5,387447,-4.830533625987401
J82,4705,3.746320789135998
WM793,10385095,0.6081370186912695
SNU-8,135411,1.0950293066595111
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
SK-LU-1,11455910,1.7364253174007704
HCC44,10385095,1.1962803833979956
JVM-3,136227924,1.9937281150641608
Daoy,9887053,3.186388090513817
HPB-ALL,9887053,3.0740159366835975
HCC2218,24753719,4.203747077764167
PaTu 8988s,9887053,3.932226470782735
TM-31,135411,1.038502637627495
MES-SA,24753719,4.32411267678538
JURL-MK1,3825829,3.348877576523759
BHY,73707440,3.8308297989049143
MOLT-13,6505803,0.7492781623920575
OVSAHO,54649381,3.5592959125115726
MOR/CPR,11455910,1.2367157670420523
KNS-60,42642645,-0.6617499172774441
8-MG-BA,24753719,4.263352567955377
KMRC-2,54618771,2.1629104463678335
MHH-CALL-3,3825829,5.0306479136340245
BT 187,42642645,1.5524088863182646
SK-ES-1,135928012,4.904082217354868
HEL,135411,-2.1892340188273836
BT 248,387447,-5.028656036950466
PE/CA-PJ41 (clone D2),11396600,3.63156445822279
IGR-37,136227924,2.9944260233382667
CAL-29,11167602,3.3383566807946288
NCI-H1373,3825829,4.17363026916489
OCI-Ly10,10385095,2.1916577267775006
NCI-H727,9926054,2.0492739470784445
SNB-75,136227924,3.131186635449868
PaTu 8988s,54618771,-1.1165982816182902
NCI-H1944,387447,-3.465546845658231
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
M059K,12001922,1.7626117010087567
HCC1588,11167602,2.5321103891623755
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
SNU-C4,54618771,0.9535591955957128
SNU-119,387447,-4.116955767451351
JMSU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3740828564312233
ACC-MESO-1,54618771,0.8381740730227087
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
A3/Kawakami,11396600,1.9424572968751193
SW1088,11167602,3.230115211313107
NCI-H28,3825829,2.8421371351018117
SNU-5,135411,-1.2917678026520507
U-937,10385095,1.0203935809420186
DMS 273,9926054,1.8030373867492464
Caov-3,100016,5.7781449283056645
BT 172,136227331,3.9802920608276886
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
T3M-10,6505803,-2.029388568048509
JVM-3,100016,3.63486720200834
COLO 678,24753719,4.6560213294731865
EHEB,136227924,2.586993854279513
U-87MG ATCC,387447,-4.315541516944791
P-STS,12001922,1.2184731977849366
ONS-76,73707440,4.1934861569389845
A-375,9926054,2.393426871996004
GP2d,6505803,-3.22314968715238
BT 231,2746,2.74381286555369
SW1417,42642645,0.6995844964446892
Calu-3,54618771,0.5501561277635466
KMS-34,selumetinib-GDC-0941 (4-1 mol-mol),0.0635053645557878
BT 330,6505803,-1.6088860696930485
DMS 79,42642645,1.5108783619853128
BT 216,12001922,1.2347948099394384
SUP-B15,6505803,0.8159138339473696
NCI-H1666,135423438,1.706411429493964
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
Hs 578Bst,10385095,2.557953315757008
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
SaOS-2,136227924,4.496792726095474
COLO 678,15953870,4.259364652264935
LOX-IMVI,11455910,0.9161498134653596
EBC-1,12001922,1.7084500464855945
Daudi,49836020,3.49644839546437
NCI-H69,54649381,3.676678139095967
Sq-1,11455910,0.8534874445635723
SCC-4,12001922,1.7845274211446436
TTC-709,6505803,0.8575358462555939
NCI-H2087,10385095,1.015430791106066
TE-1,49836020,4.425156685624386
NCI-H716,10385095,0.9651730847529224
NCI-H1703,49836020,-2.068142260286603
A2780,9927531,3.2712332494904226
TE-8,6505803,-0.116387849534283
SNU-685,100016,6.855109756647912
SNU-16,49836020,4.5096990404507125
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115
BT 224,100016,6.546386559669457
WSU-DLCL2,11396600,2.507675324045039
OCI-Ly3,2746,1.9886775425138576
SCaBER,10385095,0.9747050381713424
OCI-AML-3,24753719,3.7261949702489496
KCL-22,24753719,3.821125268566526
KYSE-30,10385095,1.4963223193065267
SCC-25,42642645,0.655225205153659
2004,9887053,1.933284293403171
FTC-133,15953870,4.441911294632587
KLE,387447,-3.4483101569970804
EM-2,73707440,3.768751115811406
SUP-T11,11167602,2.323687506743599
HEC-59,9887053,4.859779160998265
OAW28,24753719,4.434201172795376
LN-18,11396600,4.155710167267898
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
T84,2746,3.6506002682923926
U266B1,15953870,2.9244025083114047
SNU-407,11396600,4.026955307306754
LCLC-103H,24753719,4.521159399126971
CW-2,136227924,3.283467391951437
ST486,9887053,3.404821135742608
REC-1,10385095,3.1459726814165205
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
FTC-238,9927531,3.762159625160711
OCI-Ly3,9926054,1.7075624586647575
SUP-B15,9887053,1.6058669564982466
BT 179,selumetinib-GDC-0941 (4-1 mol-mol),2.518966795971957
TE 441.T,9887053,1.638763624659808
BC-3C,12001922,2.342706988586835
Kelly,9926054,1.469291049176786
CHP-212,11396600,2.9941835804811507
SNU-423,3825829,4.083312388937309
HGC-27,54649381,3.670670285859323
NCI-H522,11396600,3.374818989992459
RVH-421,24753719,4.348289476497124
SUP-B15,136227924,1.2725004934322246
Ci-1,11167602,4.192862947655439
MDA-MB-415,selumetinib-GDC-0941 (4-1 mol-mol),-0.0962287719038293
SU-DHL-4,15953870,2.5809053774245205
SCC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.2085595072680022
GOS-3,6505803,2.171469842265414
Panc 08.13,10385095,1.049834622484976
Toledo,11167602,3.4106313498630305
HL-60,3825829,3.866573357252148
CAL-51,9926054,2.2227862000004577
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
RERF-LC-MS,6505803,-0.6931241555509828
Lu-99,136227924,2.52697800854745
NCI-H1341,11167602,1.3962971674420526
HCC2279,11396600,5.494062372014229
UO-31,135423438,1.1750437401104377
MeWo,136227331,4.002976901142853
NCI-H526,387447,-4.198953334444907
SNU-601,2746,3.467999192841188
TF-1,4705,3.093952009928188
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
PK-1,12001922,2.4372916011863146
NCI-H647,9927531,5.004225610104877
KCL-22,12001922,1.604902572796732
D283 Med,11396600,2.9109671183024983
697,4705,2.278672622564821
Kasumi-2,9887053,0.7760357688642865
NCI-H196,387447,-3.86918133998242
Rh41,10385095,-0.194443175425209
Lu-99,135423438,2.1448370442307865
HT,10385095,0.5448968972509004
BT 147,246676,3.6303996753868466
SNU-489,3825829,4.236567995838523
647V,9887053,4.428311174199906
KNS-81,9926054,3.3411524859237196
NCI-H1915,4705,3.3172772088085307
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
ONS-76,24753719,3.8801096922841656
RPMI-7951,42642645,1.1114872828283802
HCC1395,9927531,6.948950349672662
ECC12,6505803,-3.012781394546517
SET-2,24753719,3.747338164648229
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
NCI-H747,11455910,-0.1344323307423927
NCI-H810,135411,0.8127680392622941
HEL 92.1.7,10385095,0.8888746409107244
DLD-1,387447,-4.577066335044948
NCI-H1703,11396600,3.3181128171686254
GA-10,54618771,-2.458628793316373
SK-MES-1,11396600,3.1861183641425823
CGTH-W-1,15953870,4.029905258966992
BT 231,135411,2.441426423284162
BT 164,100016,6.2228733531949505
SR,6505803,-2.233743184339516
KPL-1,12001922,1.6797775385183875
JHUEM-7,6505803,0.2461537124409258
SNU-1076,selumetinib-GDC-0941 (4-1 mol-mol),-0.5128697942190128
T24,12001922,2.3629401243985524
SNU-5,24753719,4.11741377949036
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
MG-63,42642645,1.5055761317097798
ALL-SIL,54618771,-0.3818526805852408
Detroit 562,387447,-4.6714218611010185
HCC15,6505803,-2.813846830430111
NU-DHL-1,15953870,2.3700996174311095
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
HPB-ALL,387447,-4.495383841008534
NCI-N87,6505803,-6.101345662019038
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
IGROV-1,4705,3.3098412390054603
A-549,11455910,0.2975953497649719
KMS-12-BM,6505803,-0.6027320108546551
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
PE/CA-PJ49,9927531,5.215467759359
Hs 944.T,6505803,-0.4446247220242906
LMSU,387447,-4.878284727647071
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
RPMI-8402,11396600,3.4463493734861186
SNU-201,54649381,3.8467571339725097
MOLT-3,6505803,0.4924044650744431
FTC-133,387447,-3.6414317999651336
IGR-1,11455910,1.3265797692921302
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
LS180,49836020,0.6204023867713871
SKM-1,54618771,0.6725959366795358
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
GA-10,135423438,1.5263864558122735
KE-97,100016,5.841816758085698
MCAS,24753719,3.982586102388834
PK-1,42642645,1.5487015676648606
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
NCI-H2110,1474550,4.464144178106605
P12-Ichikawa,12001922,1.6503145096786451
ONCO-DG-1,3825829,4.644117610573569
RVH-421,387447,-4.920988474499805
NCI-H1734,42642645,0.0222189962272223
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
AsPC-1,42642645,1.2436203489585118
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
SUP-M2,9926054,1.703022301763295
HGC-27,9927531,3.8749849093672744
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
SW1417,12001922,2.008835145968964
HCC202,42642645,1.8127145273304064
HEC-265,6505803,-2.0773679998805346
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
KMM-1,54649381,4.178393145644004
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
SNU-1214,387447,-4.544627243417016
A-253,15953870,3.748232857439042
RCC10RGB,136227924,3.611686331312014
PF-382,6505803,0.1218702134100329
YKG-1,4705,3.5798209595137247
DU4475,9927531,3.2558531780718507
AU565,15953870,2.093538779145719
HT-1376,54649381,4.652232038250366
OS-RC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8729257102095325
A-549,54649381,4.103112658972653
BT 164,54618771,1.1636109320756167
HCC1806,387447,-3.955420136885432
SNU-899,24753719,4.419339048792099
SK-N-SH,6505803,1.028408820078618
SW948,10385095,1.3660359707166476
SNU-620,136227924,2.4539673197881444
FaDu,10385095,0.7962717218730669
HEL,15953870,2.2428109686656295
Kasumi-2,24753719,3.2877720740856815
OCI-AML-5,9887053,1.7365351572910726
MHH-CALL-4,246676,1.7310022839692016
SNU-869,24753719,4.492105093022048
OCI-AML-2,10385095,1.002219409748186
DU4475,387447,-5.548765838523413
SYO-1,49836020,4.445841076102608
SUP-HD1,10385095,0.5343363886609982
BT 187,selumetinib-GDC-0941 (4-1 mol-mol),2.194213096235158
A-172,24753719,4.737896512470815
SH-10-TC,9926054,2.8749564288273604
TE 617.T,9927531,4.756324122053051
OCUM-1,42642645,0.3488855018664854
RKN,9887053,4.324470541002337
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
BT 179,6505803,-3.5400824860100224
SK-MEL-1,42642645,1.4415647495242137
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
SNU-1066,42642645,1.5367034555801566
Kelly,11455910,-0.435640272884412
TE 441.T,11455910,0.1965703482136005
LS411N,387447,-3.952629374311597
OV56,42642645,1.6702785912966691
HCC-56,11455910,0.944400073561266
BT 216,11396600,1.9603911758569217
T3M-10,4705,2.7923170944145643
NB4,136227924,2.0986844076590616
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
Daoy,11455910,0.1226016368388986
AGS,24753719,4.906480809834557
SNU-1,100016,5.685360721271126
VMRC-RCW,10385095,2.320143164196655
WM793,9926054,1.9861694749243135
A4/Fukuda,387447,-5.631039688913266
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
HSC-2,9927531,4.076262005833891
BICR 31,9926054,1.721382648019371
HCC4006,11396600,3.4330968627911425
EFO-27,135423438,3.7049046399150134
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
PF-382,10385095,1.1317259097020056
NH-6,2746,1.9017163102404129
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
GaMG,3825829,4.479190041487972
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776
TCCSUP,10385095,1.359914637472657
SHP-77,54649381,3.594572668811144
KMRC-1,24753719,4.192591897270876
GaMG,12001922,2.016001378963053
SU-DHL-4,9887053,2.9236028491312327
HT-55,54649381,4.169716949085753
BT 231,44197249,1.909514175256433
NCI-H2023,2746,4.105485199258473
RL,54618771,1.0204483724933282
JVM-3,11396600,3.007140156358036
UACC-257,4705,3.5446001139477197
MEC-1,4705,3.2350662901156264
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
HCC1195,4705,3.3009207230647952
SNU-5,11396600,3.811291488960962
BT 498,136227331,4.544114350665722
Granta-519,11167602,4.36712443545526
WM983B,9926054,1.9818225106954688
COV644,54618771,0.8361295238713768
SNU-16,44197249,3.7186110689268648
UM-UC-3,3825829,3.8459417894183465
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
LS513,24753719,2.61980978763879
BT 428,11396600,2.03305192481219
L-428,9927531,4.649182566177492
BT 112,3825829,4.160828844250468
OAW28,135411,2.218427323792269
RT-112,selumetinib-GDC-0941 (4-1 mol-mol),2.1504291571764287
Detroit 562,135411,0.5019761155900848
LS513,135411,0.3578202419683822
MM1.S,135411,0.4705097492243096
SK-BR-3,10385095,0.7592595065406185
MHH-CALL-4,9926054,1.817922343737897
MKN1,11396600,3.1092750639740903
NCI-H69,10385095,1.3596271471395216
WM115,11396600,2.8854117577089378
TOV-21G,2746,4.617945270091336
BICR 56,2746,2.65605235072967
VCaP,6505803,0.850097300385562
CMK,387447,-5.5646510060591705
U-118MG,10385095,1.6981951861544773
42-MG-BA,24753719,4.475529386283597
SNU-1079,3825829,2.842759975194076
NCI-H2122,6505803,-2.4477843500675207
MOLM-13,73707440,5.976327057082507
KNS-62,11396600,3.6666207328470217
SF295,100016,6.949657377166824
SW1088,12001922,1.7246636441691086
HeLa,2746,3.522514487554161
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
BxPC-3,10385095,1.8732992891777025
MDA-MB-453,3825829,3.844348445708714
NCI-H1105,54618771,0.6246243373087411
MDA-MB-453,135411,0.2962177293375728
BT 271,4705,1.1408708850439713
NCI-H460,387447,-2.436463262555682
VCaP,4705,2.864443182344748
Raji,24753719,3.12822311930087
OAW28,3825829,4.635564939734502
JURL-MK1,selumetinib-GDC-0941 (4-1 mol-mol),-1.4981298966453434
Daoy,136227924,3.329647267316264
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
LS1034,11396600,3.6253356993405266
AML-193,11455910,0.2037712262055268
BT 172,135411,0.6468572338874367
BT 422,9926054,2.139061359959833
COR-L51,3825829,3.9116417824181218
NCI-H929,9927531,5.740923779315927
KNS-60,9926054,1.3283551370415152
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
Ki-JK,3825829,3.114870559361067
PE/CA-PJ15,6505803,-4.077813218319251
SNU-878,12001922,1.6650811053991978
Hs 895.T,4705,4.1293689798575794
RD,3825829,4.309341020179526
MSTO-211H,24753719,3.2448003358152286
CAL-78,9926054,2.780134265811309
NCI-H1693,9927531,4.77981113730065
Jurkat,54618771,-0.5483098658584711
AM-38,11455910,0.8170455923888418
NCI-H2081,135411,-0.7766989256852646
JHUEM-2,135411,-0.9973417905819366
EFO-21,54618771,1.150184773372703
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
Hs 852.T,11455910,5.310115560593476
CHP-212,42642645,-1.0126611214322565
TALL-1 [Human adult T-ALL],2746,0.9231868013667444
PaTu 8988s,4705,3.38811272412219
Mel Ho,9926054,2.124486503190193
NU-DUL-1,387447,-5.732732132971775
RPMI-8402,100016,6.7779334067701145
NCI-H460,11455910,1.4134750909778395
SW1116,11167602,2.496759203352098
OV56,54618771,2.692220458386417
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
TE-10,54618771,1.2495537185307453
PL-21,24753719,3.7602550214129047
LN-229,9927531,7.375456166440614
Panc 05.04,6505803,-2.723455605097511
Kelly,135411,0.3917448689765906
COR-L88,2746,1.355169672755057
GSS,12001922,1.6250350563630838
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
647V,135928012,5.45168670171733
Lu-65,11455910,0.1308260352372195
BT 145,49836020,5.352704973250576
WM983B,42642645,1.301241234400086
HSC-4,2746,3.845189406581069
KYSE-450,42642645,1.660330797131617
AsPC-1,11396600,3.3240147605355506
DK-MG,24753719,4.624606885184868
MV4-11,9926054,1.3518163817603386
Karpas-620,100016,5.312019885835398
SNU-5,12001922,1.6021137090499598
Mel JuSo,3825829,4.236025723966311
SK-MEL-2,15953870,4.259716832213739
OCI-Ly19,selumetinib-GDC-0941 (4-1 mol-mol),-1.7363769217481064
NCO2,12001922,1.2398854630234812
TCCSUP,11396600,4.109332889227832
NALM-6,12001922,1.4292018321805873
HCC2218,6505803,-2.0723621071637788
K029AX,9926054,1.886633217948548
DB,6505803,0.2792419606143702
KNS-81,11396600,3.683177466862877
Hs 294T,2746,2.985563453462856
F-36P,135423438,1.517615115973094
SW1710,10385095,1.3769987294121624
SW982,12001922,2.117338501617987
LNCaP clone FGC,4705,3.099970805518314
THP-1,9926054,1.7604592205221938
OPM-2,12001922,1.1641343868089369
KYSE-450,3825829,4.738351974491715
SW1573,9926054,3.1618263718643513
OAW28,10385095,1.310156197215646
SK-ES-1,387447,-4.404865359615053
P31/FUJ,11455910,0.7543092217738059
KYO-1,selumetinib-GDC-0941 (4-1 mol-mol),1.8614571416094257
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
PE/CA-PJ15,136227331,4.888188791536357
SW1990,11455910,1.2583427289615488
Mono-Mac-1,54649381,3.5140339031114705
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
RVH-421,selumetinib-GDC-0941 (4-1 mol-mol),0.2332916793846582
KM12,11455910,1.6759446540932372
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
ALL-SIL,49836020,-3.56746653346715
CMK,24753719,4.095257030332969
MHH-ES-1,6505803,-0.7832039030153297
BV-173,387447,-4.784897587760684
L3.3,135411,0.9568641453583406
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
ST486,42642645,-0.9245149010192216
COR-L51,2746,1.8698991434806345
MDA-MB-231,2746,3.4899061229386965
NCI-H2444,54649381,4.5893706898472795
NCI-H2196,10385095,0.8172347164501069
TUHR10TKB,2746,4.350875917891638
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
CA46,2746,0.9501634288999758
SNU-449,42642645,1.3579889941817174
HLF,49836020,3.6461336560985087
NCI-H28,24753719,3.964656611316639
CAL-51,10385095,1.0305027810027567
OE33,2746,2.7393344543249443
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
BT 271,12001922,1.0730079220507094
KMBC-2,24753719,5.4446471977662245
AGS,42642645,4.654845178834479
OUMS-23,9926054,1.8521308155808696
BL-70,9926054,1.763509439822291
NCI-H1568,9926054,1.8156743035592564
Caki-1,selumetinib-GDC-0941 (4-1 mol-mol),2.159609795753867
OVCAR-5,2746,2.6087959831645433
MDA-MB-468,10385095,1.6609124988223734
SK-UT-1,11455910,0.1513173468225572
JHUEM-1,136227331,3.9088223702445526
FTC-133,12001922,3.1425787892022656
NCI-H23,2746,2.7818216168279526
Ki-JK,387447,-5.190871812566441
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
L-540,9926054,1.766103135672326
NCI-H838,12001922,2.3401720278038294
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
KHM-1B,73707440,5.196065246508486
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
BT 145,9926054,1.693307076625488
Hs 683,11396600,3.438921740314131
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
COV362,11167602,2.1491075464188816
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
PE/CA-PJ34 (clone C12),3825829,4.057915478742878
LOX-IMVI,54649381,4.093748298589484
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
SNU-308,54649381,3.890823095113657
NCI-H838,387447,-3.9496960571448154
8305C,selumetinib-GDC-0941 (4-1 mol-mol),-0.5953379888353332
Mel Ho,selumetinib-GDC-0941 (4-1 mol-mol),-1.3923525506877812
DMS 79,9926054,1.7240828255931135
EJM,4705,3.167336091742425
VMRC-RCW,42642645,1.3384268533982144
NCI-H1869,9927531,5.985290716685452
SK-UT-1,100016,6.311695779547894
BFTC-905,6505803,1.2859108596962958
EKVX,24753719,4.757500855044641
2004,54618771,0.1677615799091476
BICR 56,100016,6.239283130221144
YD-8,10385095,1.4410870728115226
SNU-449,15953870,3.8419288275174326
IM95,42642645,-2.5830586148477153
BICR 31,12001922,2.662375748901725
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
NCI-H1915,387447,-5.174706106426464
BT 340,9887053,3.811817093427324
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
TE-11,6505803,-1.6927698953047237
CJM [Human melanoma],24753719,4.233213241561211
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
HCC1395,12001922,1.575765193583952
KE-39,11396600,3.848773124810753
HGC-27,54618771,0.7122849148463839
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
PaTu 8988s,11455910,0.872430488696118
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
Mel Ho,11396600,5.196544531499117
HSC-2,135411,0.7446020195387469
YD-38,136227924,2.6123275605059075
ES-2,3825829,4.313229749640832
HCC202,12001922,1.585997390388739
LOX-IMVI,100016,4.319089113839007
Ku812,9927531,3.686533687467188
JHH-6,12001922,2.541576950919736
COV644,2746,2.991747419191786
Panc 08.13,135928012,3.876292243456592
SK-N-DZ,49836020,4.282357500475809
MM1.S,54649381,2.997921024059072
SF126,11455910,2.6986445536104138
UO-31,4705,2.423149562470716
TE-4,9926054,1.7320967547040995
OE19,2746,3.0430549573559036
NCI-H2085,10385095,0.9549878752429372
TE 617.T,10385095,0.7381710373926665
BxPC-3,136227924,2.62858882862477
BT 228,11396600,1.874591390979962
LN-18,100016,6.511039950794577
LK-2,15953870,4.02216442259968
697,10385095,0.7645414684782499
Hs 294T,24753719,4.268891526182451
SNU-119,135423438,2.0179604003543288
OCI-AML-5,136227924,1.61818972770755
COLO 205,6505803,-3.0495951977326774
HCC2218,246676,3.234854854561146
HCC44,11455910,-0.4907181791415154
LNCaP clone FGC,15953870,2.830210193885845
SNU-398,24753719,4.047798166557335
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
KALS-1,54649381,4.765920507871789
Caki-2,3825829,5.083297569740858
KYSE-140,44487330,3.7235857458146104
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
SK-MEL-31,9926054,3.613636907383419
Becker,2746,3.675450807498904
KYSE-180,9926054,1.7654325832877988
MOLT-13,24753719,2.239197881715532
BL-41,9887053,3.0943084345903342
TE-5,24753719,4.174035669818234
OCI-AML-3,9926054,1.7279388216590237
HEL,24753719,3.7144242054355985
HCC1833,136227924,3.0159379881399895
OVCAR-5,136227331,3.878676395565833
SH-10-TC,2746,4.061240756381498
SUIT-2,136227924,3.4861054974924133
NCI-H838,4705,3.3276720699815563
CAS-1,3825829,6.446494170744513
SNU-C1,11167602,4.838873863189907
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
MOTN-1,11396600,3.137567702451298
BT 231,246676,5.655367787950382
KMS-26,100016,3.884140356330727
SNU-5,100016,6.769356825304223
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
TALL-1 [Human adult T-ALL],24753719,3.125963092877027
SW620,selumetinib-GDC-0941 (4-1 mol-mol),-0.6864895325025141
PE/CA-PJ41 (clone D2),11455910,-0.0174306689930347
RCH-ACV,136227924,2.5365542828193957
HCC1806,6505803,-1.844009581745865
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
DMS 53,387447,-3.8710370033388544
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
TE-11,54618771,1.216683446725779
VMRC-RCZ,12001922,1.612629814086355
MOLT-3,135411,-1.7457892815927607
BICR 16,42642645,1.3694023365654742
JMSU-1,54618771,0.1163446167769653
SU-DHL-10,selumetinib-GDC-0941 (4-1 mol-mol),2.1131040208605576
NCI-H23,136227924,2.7523480468192254
SK-N-DZ,135423438,2.1379059476501023
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904
Panc 02.03,42642645,1.4849485241267697
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
CAL-78,3825829,4.625429730768832
KNS-60,2746,2.742254085521436
HOP-62,12001922,2.1949882095207225
253J-BV,135411,0.8444762507617795
OV-90,135411,1.0641514662146805
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
ChaGo-K-1,42642645,1.188286091204559
G-402,9927531,4.821419019473558
T84,10385095,1.394973696850744
SNU-449,44197249,4.950419501644914
ST486,11167602,3.831852392866298
SK-HEP-1,54618771,0.9570801540222316
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
KYSE-30,2746,4.052809859815596
JVM-2,10385095,0.5822709341989288
HEC-108,10385095,1.228149017066595
JIMT-1,10385095,3.3257762843711913
NCI-H209,9927531,3.5477571143466156
Hs 729.T,9927531,5.3265551472820425
IGR-1,12001922,1.0833942045481628
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
SR,selumetinib-GDC-0941 (4-1 mol-mol),2.945554798995567
NCI-H889,54649381,3.759170454584202
Mel JuSo,11455910,0.951920968650534
G-361,12001922,1.6043447466769785
NCI-H211,9927531,3.644928626875117
SNU-449,100016,6.350050439021361
SF295,15953870,3.68553477527874
ME-1 [Human leukemia],10385095,2.9677233185394094
HuH-28,15953870,3.0591550960119127
Hs 688(A).T,12001922,2.1329884543839537
HDLM-2,11396600,2.3384367351946604
MCAS,11455910,0.7655577193657753
NB1,selumetinib-GDC-0941 (4-1 mol-mol),2.4185204185307527
CGTH-W-1,135411,0.5665990172382324
DMS 454,6505803,3.432232665344106
H-STS,2746,2.861217997075228
SiMa,136227924,1.9858625956320377
NCI-H1299,135411,1.0826020500388394
TUHR4TKB,9926054,1.808622022375876
NCI-H1339,15953870,3.9739600190387128
OCI-AML-2,136227331,6.356124272356354
P3HR-1,24753719,4.729434793185607
BT 187,4705,4.226067351518777
PC-14,15953870,2.774112835405703
SNU-8,11455910,1.7503640063904615
JHOM-1,12001922,2.3318411865934303
LC-1/sq-SF,136227924,3.5583860131764835
IST-Mes1,3825829,6.080187468224706
NCI-H196,10385095,1.1966476706382554
VCaP,24753719,3.942596689247525
SNU-C2A,54618771,1.0947392287826
BL-70,11396600,2.443517551582617
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
DEL,6505803,-2.9749849917390763
BFTC-905,10385095,2.0978900554642275
BT 147,3825829,4.48036860572395
Mino,11455910,-0.3204403040643599
MFE-296,10385095,1.184383964247713
HMC-1-8,24753719,4.642702183611676
MKN7,9926054,2.9968312406373574
A2780,100016,4.757543521992015
HT-55,54618771,1.7226930749216656
DU4475,3825829,3.81988693977628
NCI-H929,9926054,0.4409605375156073
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
KYO-1,42642645,-1.982320991772033
MKN7,135411,1.3551050000322211
SNU-C4,135411,0.5973873272039923
A-375,135411,0.6366609875542943
SW48,10385095,0.7767009249070084
SJSA-1,15953870,3.696319719980623
SET-2,10385095,0.921007815514528
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
COR-L88,24753719,4.4645681423957715
WM115,24753719,4.6734048968266775
B-CPAP,3825829,3.169966347621692
SR,42642645,1.5750560379508187
A101D,49836020,-1.073011415975237
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
HOS,44197249,5.4193218173548745
GCT,12001922,1.1920114018656918
COV644,42642645,1.3297039880308927
KP-N-SI9s,11396600,4.554176657358924
Hs 839.T,12001922,3.093450826873914
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
COLO 201,selumetinib-GDC-0941 (4-1 mol-mol),0.0601925657233566
SNU-398,3825829,3.4888745171385547
TF-1,11455910,-0.5944245496950694
KMS-18,4705,2.900796291419513
TOV-112D,10385095,0.7671064543335444
A4/Fukuda,6505803,0.0348674492980193
SCC-25,9926054,1.6689856093207305
G-361,42642645,1.1839596906279637
HCC1588,12001922,1.5954691809355774
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
NCI-H1563,selumetinib-GDC-0941 (4-1 mol-mol),0.8971079477843085
ESS-1,9927531,5.52249907084491
697,54618771,-1.411266128730911
OS-RC-2,10385095,2.54718391477598
BT 482,387447,-4.785640292909403
SNU-475,100016,7.606290519099935
Hs 940.T,49836020,0.3433567165193816
Hs 944.T,selumetinib-GDC-0941 (4-1 mol-mol),0.0800181936999451
BT 112,100016,6.504213631006025
Ishikawa (Heraklio) 02 ER-,10385095,1.7165210430114106
JHH-4,2746,2.8564345574200685
BICR 22,12001922,2.2523981699696165
HEC-151,9926054,1.821769205783168
BT 147,12001922,0.9264859441879948
23132/87,10385095,1.3644671590937965
SK-ES-1,11396600,3.1511462884170656
NCI-H747,12001922,1.331352091405127
COR-L95,6505803,0.0712785503404296
OVCAR-5,15953870,3.764921216050492
ESS-1,10385095,0.0154495368261296
UACC-812,6505803,-4.59801553223132
SNU-16,135411,0.6130883321533732
KP-N-SI9s,10385095,0.9567135101145878
Lu-65,135411,0.4933451720371167
Panc 02.03,100016,6.582809568040202
TE-10,42642645,1.6798457461811331
COR-L105,9926054,1.7310748902984938
DOV13,42642645,1.7336561355349642
SBC-5,12001922,2.404615034975172
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
AN3-CA,246676,4.36497705352595
OCI-Ly10,3825829,4.8842666495763725
Caki-2,42642645,1.6595172050412297
G-361,387447,-2.9995152368132314
CAL-54,2746,3.3346441526791306
NCI-H1869,136227924,3.4575085361719955
DK-MG,100016,7.056187444773538
KNS-60,387447,-3.487902654116386
GMS-10,10385095,2.1230156170889756
HCC44,15953870,1.6077175502190424
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
NCI-H1184,387447,-3.0553961035252093
HuG1-N,3825829,4.137452773960458
C2BBe1,135423438,2.0550808175205755
Panc 02.03,12001922,2.5444953584324193
MOLM-16,15953870,2.0029332282884895
Capan-1,12001922,2.315520056823488
KMS-12-BM,11455910,-0.5978210432128618
KYSE-520,42642645,1.6519390059848047
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
MSTO-211H,10385095,1.0224754227931234
Li-7,10385095,2.245762871379806
Panc 10.05,135411,0.7416863739096307
Karpas-422,11396600,4.033756538148708
SNU-601,136227924,3.114119824082727
NCI-H1944,9926054,1.887577830316648
Daoy,54618771,2.692188489844714
ACC-MESO-1,387447,-3.5837310917006384
KHM-1B,135411,-0.0530336141709349
COV644,11455910,3.873776923883242
NCI-H1299,24753719,4.197116792706203
SNU-869,4705,4.285651078954769
Hs 578T,15953870,4.173543051659192
KE-39,54618771,0.8543301924142261
Rh30,54618771,1.1038289315266856
COR-L95,100016,6.620829555802918
NCI-H446,10385095,-0.4257133247784896
SNU-C2A,100016,6.499335908465164
NB1,135411,-0.3225067569612446
SNU-1,42642645,-0.0891259703255789
NCI-H358,11167602,2.5925137081670293
OV7,3825829,3.5830442787086363
KLE,54618771,1.0287660425791825
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
QGP-1,54649381,3.912586928645863
MOLT-3,12001922,1.155195335537139
BT 286,10385095,0.5786279467469033
HCC1588,15953870,3.423854603853334
RS4;11,100016,4.815282587104974
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
A3/Kawakami,2746,0.9859280265710952
SCaBER,4705,0.4436742600385659
A-549,12001922,2.28641691667768
42-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),0.6620658581773345
A3/Kawakami,3825829,3.643525487380167
KYSE-520,2746,5.1336312613599295
IGR-1,387447,-4.065061012203796
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
NCI-H460,100016,5.855223104671776
JURL-MK1,10385095,1.017024501660633
GB-1,54618771,2.0040836599793077
MHH-CALL-4,136227924,1.8406000029443903
Becker,9926054,2.0290907819284283
NCI-H522,24753719,5.009376195679754
IA-LM,387447,-4.406032561698067
KP-2,15953870,4.046063987032253
NCI-H2009,9926054,2.181635437582939
GOS-3,9926054,2.0544356724695776
WM88,246676,-1.5613699028719277
DU4475,selumetinib-GDC-0941 (4-1 mol-mol),-4.053577940845995
BT 228,135411,2.59709347329382
NOMO-1,9926054,1.6113291347040215
NUGC-4,12001922,1.7013116164726718
BT-20,4705,3.454921322809781
Mono-Mac-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3199178680358683
SW579,135411,0.5527090362124778
NCI-H647,6505803,-1.8408777306089303
HLF,100016,6.001250521147636
JMSU-1,135411,0.1393074162540354
TALL-1 [Human adult T-ALL],9887053,2.691986629664257
NCI-H211,135411,0.1396072527544301
SW948,387447,-4.931777613053621
SU-DHL-1,11396600,2.533401176626175
MOLT-3,135928012,3.8138816362107546
SNU-685,9926054,1.8961816645578051
SNU-1,387447,-4.091974021303754
BT 216,387447,-5.161294904158778
JHH-4,12001922,1.817008254991594
SCC-4,2746,2.994805038812276
NCI-H2170,135423438,3.656006227697759
Aska-SS,100016,5.454856815374324
ALL-SIL,387447,-4.904935645240703
KMBC-2,11396600,3.805651469243142
MM1.S,10385095,0.5772741744912003
OCI-AML-2,11396600,1.0789992022533794
MOLM-6,136227924,2.6719988051227386
Mel JuSo,15953870,4.667296610993139
KMS-27,11396600,3.3340163467465573
NCI-N87,9926054,1.7069639615174013
HT115,100016,5.804685245268015
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
QGP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3136510607151746
JHOM-1,24753719,4.3491159440390925
ECC12,100016,5.969737428755433
BT 333,136227924,4.6219554593863075
PE/CA-PJ34 (clone C12),2746,3.651379195242312
KMS-28BM,12001922,0.9171185388908628
GaMG,6505803,-1.4041196242536171
EFO-21,24753719,4.305542391555895
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
NCI-H889,9926054,1.840125789909785
HuT 78,135928012,5.03508248735035
NCI-H2170,54618771,1.1991545038550235
DAN-G,3825829,4.25868911237416
OVCAR-4,49836020,-3.3998329005368833
JeKo-1,54618771,0.9651230591785864
TALL-1 [Human adult T-ALL],11455910,0.0661503545953694
COLO 800,15953870,4.375155296248563
AGS,10385095,1.3436642130251
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
BT 340,selumetinib-GDC-0941 (4-1 mol-mol),2.751381864792414
TT,387447,-4.143641256754616
BT-474,3825829,4.608965089399906
NUGC-4,9887053,1.8010310380365988
NCI-H661,11396600,4.301216087095742
NCI-H889,selumetinib-GDC-0941 (4-1 mol-mol),5.471466100727687
COLO 792,3825829,4.076573980332456
TE-6,135411,1.1786200606916124
SNU-16,9927531,3.2030544942563317
BT 422,10385095,2.26397401850802
NCI-H1623,2746,3.1722069840164533
NCI-H1184,42642645,-0.543529619331064
Hs 688(A).T,135423438,1.627421563855232
WM1799,54618771,2.4607401092815677
TCCSUP,9927531,4.77726983491798
YKG-1,12001922,2.2090036010272533
MDA-MB-361,42642645,1.4471470117056768
SCaBER,6505803,-1.4253513809076774
KCL-22,selumetinib-GDC-0941 (4-1 mol-mol),1.6879768271667388
SJSA-1,9927531,4.886165341408575
Panc 08.13,136227924,2.4171431229910265
NCI-N87,100016,7.118039999797619
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
HCC4006,11167602,3.2569091350722363
SW48,11396600,3.829401994456863
HCC-56,387447,-4.913611947679653
OVCAR-4,136227924,3.1468518699477097
JJN-3,9887053,4.154983524121206
BT 248,10385095,1.1706577035646757
SYO-1,135411,0.7492266024460972
HCC1428,11396600,5.584589218980949
NCI-H1694,10385095,-0.2584704723374293
MES-SA,3825829,4.099028869680393
HuT 78,15953870,2.5576152772998832
Calu-6,49836020,4.336137767537177
BT-20,387447,-3.8237379342261018
NCI-H28,10385095,0.5737685165722669
BT 159,10385095,0.5382854517142396
A2780,11396600,2.9320615716687564
A2058,6505803,-1.8574702030952697
CAL-33,135928012,3.742985271193067
BICR 22,72199289,4.441607504718354
MIA PaCa-2,136227331,4.243512473772355
LCLC-103H,12001922,1.920474262728411
AU565,11455910,2.266336610800082
BT 232,10385095,0.8696563866685341
2004,9926054,1.8081714609693849
BT 172,54618771,0.7743085294895093
Calu-6,selumetinib-GDC-0941 (4-1 mol-mol),1.8439594255895029
SF539,100016,5.965471494853995
BT 224,2746,4.512164577407842
COR-L105,3825829,4.424164708702568
Hs 895.T,12001922,2.3318448901614484
EPLC-272H,11455910,1.2178341739631082
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
OCI-Ly3,11455910,-0.0789783968306418
OC 314,selumetinib-GDC-0941 (4-1 mol-mol),0.5636308108859065
A-172,136227924,1.9508876589720905
HLF,6505803,-1.0701085003041886
YD-8,42642645,0.5447742050526033
TE 617.T,54618771,-2.3163435045847436
CAL-33,11167602,3.101269278162525
Hs 578Bst,11455910,1.5492426268686
HCC1937,10385095,1.7835531106095328
NUGC-4,54618771,0.2838784179231751
Daoy,3825829,3.72270414906679
HEC-1-A,4705,4.084299527202415
NCI-H2452,54618771,2.226699645078912
OVISE,54618771,1.319775250733869
QGP-1,10385095,1.9081018172996016
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
TE-9,54649381,3.590702501630868
RERF-LC-Ad2,136227924,3.207411157267862
PE/CA-PJ15,11396600,3.3444318017760986
HSC-3,10385095,1.3564065222448
BT 147,387447,-4.289669419984606
KMM-1,selumetinib-GDC-0941 (4-1 mol-mol),3.455450229836309
D283 Med,4705,3.1008912872866325
NCI-H1568,42642645,1.4281976900349445
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
HCC1438,135411,0.4166590423277641
SK-N-MC,136227924,2.70298794492574
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
GI-1,2746,3.841206202688264
BC-3C,42642645,1.452807214560988
MOLT-16,54649381,2.829674321404976
NU-DHL-1,3825829,3.145887822053552
SW1271,2746,3.8382249001906814
NCI-H2110,42642645,1.3057236795101204
LN-229,9926054,2.0012507920531206
NCI-H322,10385095,1.0506033340780307
Karpas-299,9926054,1.611454190499719
A101D,selumetinib-GDC-0941 (4-1 mol-mol),0.5924729203046659
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
SIG-M5,42642645,0.5495592688599952
KMS-20,49836020,5.970121389426133
U-937,3825829,2.2902720574284783
BT 271,11396600,2.12554769286952
SNU-C5,387447,-3.8138293545311983
BT 131,387447,-5.63155482132915
Hs 852.T,10385095,0.7954814716288584
KYSE-410,9927531,5.048506934315496
BT 416,2746,4.178903855653317
BT 359,11396600,2.03647677274721
GSS,11396600,2.8148513524153005
ACC-MESO-1,6505803,0.753585399472996
NCI-H2444,15953870,3.4675637250743803
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
Li-7,100016,6.9157107863456915
SK-MEL-1,135423438,4.488053456325811
Hs 888.Lu,4705,3.630552951351385
UO-31,15953870,2.854530619868244
HCC827,selumetinib-GDC-0941 (4-1 mol-mol),0.5704009597174646
NCI-H460,135411,0.3374737909082799
PaTu 8988s,11396600,3.1820503715354276
KYSE-140,9926054,1.9800704230635255
OCI-AML-5,387447,-3.8231326026403223
SIG-M5,4705,3.652896158282669
WM793,11396600,4.503186389543736
TE-14,100016,6.976624848230786
NCI-H747,136227331,4.187158203356049
BC-3C,6505803,1.2910533343434352
KNS-42,11167602,1.769656279065476
JIMT-1,11396600,4.3251237501633675
BT 320,9887053,4.397401387197895
SNU-46,10385095,2.8766156258526565
TE 617.T,15953870,3.1067145457473906
SW579,9927531,5.20286248500357
COLO 320,9926054,1.5350415050718291
KM12,3825829,3.731717784271544
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
BT 482,54618771,0.8626033669866102
MHH-ES-1,42642645,-1.0578856293193435
SNU-1033,387447,-4.464166548944418
TE 441.T,3825829,4.967629977359632
COLO 668,selumetinib-GDC-0941 (4-1 mol-mol),1.3136339769423369
KYSE-70,54649381,4.140433754758901
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
BT 248,24753719,4.394714770526552
A2058,9926054,1.7529225868456957
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
COLO 668,11167602,1.730642767212305
HSC-3,246676,5.897694948115853
LN-229,135411,0.2309092656461875
U-BLC1,54618771,-0.2094086487307373
SF268,135411,-0.0879605486011991
NCI-H1703,135411,0.9613807936305684
SNU-475,387447,-3.88273907811747
SK-N-AS,11396600,3.143624411786837
Raji,54649381,3.576842683556631
MDA-MB-453,11167602,2.244240898320102
KO52,12001922,1.5749423624462988
BT-12,49836020,2.972579306483729
NCI-H2170,6505803,-0.4260199985432408
TE-6,3825829,2.1359819955637747
SNU-738,11455910,-0.0360600662579626
KP-N-YN,42642645,1.6698991874885412
HEL,9926054,1.596813412273358
NCI-H747,42642645,0.0681422149861399
NCI-H1568,11167602,1.5259281753697294
647V,15953870,3.4390114905121054
8-MG-BA,12001922,2.9882672695429005
KMS-18,135411,1.0708492049550828
NCI-H1703,2746,3.536107682516814
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
NCI-H1869,100016,6.8338343579730285
SK-MEL-30,6505803,3.705919925101854
PE/CA-PJ49,136227924,2.4190721025981987
SK-N-AS,6505803,0.8631817321203803
Kasumi-2,2746,1.0036072682129122
JK-1,9887053,1.5727378599868107
NCI-H2405,54618771,0.0947860267625534
KYSE-450,100016,6.589468110151047
D283 Med,246676,4.416806480399498
UACC-257,3825829,4.864840363124495
JHUEM-7,42642645,-0.2590687534288647
SNU-387,42642645,1.5519703214489633
Hep-G2,54618771,-1.2901934533941846
MDA-MB-453,387447,-4.667010811634082
A-204,6505803,-3.259421100625582
MSTO-211H,9926054,1.9546831701161536
SYO-1,54649381,4.05071020492894
SW1573,135411,2.599466343128946
PaTu 8902,12001922,1.8953174279693872
OUMS-23,100016,6.512546818056364
KMS-11,2746,1.943011072949534
697,24753719,1.7067732585289954
EBC-1,3825829,3.4831949511424667
KE-37,selumetinib-GDC-0941 (4-1 mol-mol),2.002060120469268
LCLC-103H,135411,1.3970817088756593
NCI-H810,387447,-5.012321585269143
HCC2108,135411,0.8115668550852202
MKN1,387447,-4.833530002955664
SNU-C4,3825829,4.2974880631738
CGTH-W-1,9926054,2.1439424725815814
BT 328,11167602,4.034112762840579
SJSA-1,9926054,1.739207886020936
SNU-1041,9926054,2.2828270152060623
CFPAC-1,136227924,3.3404294087361883
YH-13,3825829,4.007616735103447
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
REC-1,136227924,3.1866861789415855
TE-11,136227924,3.028335758763499
NCI-H1105,136227924,3.5995085606393955
HT-1197,54618771,2.611053325854013
BHY,136227924,2.366046867351899
KMS-12-BM,9927531,3.2870919606414963
KLE,49836020,-2.0520357560351714
TE-8,4705,2.806711792876773
CJM [Human melanoma],387447,-4.140568438345911
BT 145,387447,-5.837702505197111
U-937,9887053,2.6687840394517823
SU-DHL-10,15953870,2.576972793053673
CAL-120,9926054,3.430797555245233
NCI-H2196,135411,1.1857241282325688
MOLT-13,100016,6.122983577816604
U-87MG ATCC,24753719,6.032602189167671
HOP-62,54618771,0.1660184306238314
HCT 8,11396600,3.8842790603170023
SNU-869,selumetinib-GDC-0941 (4-1 mol-mol),1.3245686314727811
JHH-4,246676,4.666331816889099
SW1990,9926054,1.8053433824091036
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
LN-18,54649381,3.749493605335194
Mino,2746,0.8044795617412364
Calu-1,11396600,3.740782908411944
8505C,44197249,4.653526022240332
HeLa,3825829,3.5823199274172457
SBC-5,9927531,4.452264212548339
HCC1195,54618771,3.4499455256162475
TUHR10TKB,12001922,1.9838467040361976
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
769-P,11396600,4.3298717315530935
VMRC-RCZ,9927531,5.06353509308392
KMS-21-BM,10385095,1.1305886144467554
DU145,136227924,5.593457102459236
LS513,15953870,3.424888989312981
Panc 08.13,54618771,0.3340259245614503
SET-2,135423438,1.6244153608303664
647V,6505803,0.3251392573539524
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
MOLT-16,135928012,3.5431079212099523
MKN1,54618771,0.4952124443033494
CHP-212,2746,0.548553476305332
MOLP-2,136227924,2.531478892468582
SNU-308,387447,-4.108149171712701
LOX-IMVI,15953870,3.5036673786727683
OVCAR-5,100016,6.797399029850292
BT 145,2746,2.646861409473543
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
SNB-75,9926054,1.9842991929062104
DU145,6505803,2.9308640693327126
HT,9926054,1.610418759813605
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
NCI-H2023,3825829,3.8442541203812546
WM1799,selumetinib-GDC-0941 (4-1 mol-mol),0.0731579232599876
HEC-108,136227924,3.134071919213167
JMSU-1,6505803,-3.090216312025297
BT 428,54618771,1.9125909448822425
BT 286,136227331,4.205096233968031
MDA-MB-157,136227331,3.870321503168366
Karpas-299,136227924,2.4546473500331576
MEC-1,9927531,3.3122365402427816
COLO 680N,9926054,2.740733080202674
SUP-T11,9926054,1.9086268061731997
BFTC-905,135411,0.6848188644938399
CA46,11167602,1.6890466560929325
SIG-M5,9927531,4.880658167161108
22Rv1,135411,0.4857801669744458
EFO-21,selumetinib-GDC-0941 (4-1 mol-mol),2.070102563498296
BICR 56,11455910,1.513170236314074
639V,12001922,1.7294019537220402
SU.86.86,9927531,4.197811757313418
RL95-2,11396600,6.018951630956894
SNU-449,54618771,0.9697829427454708
NCI-H1105,3825829,4.132324128680646
JHUEM-7,11396600,4.730722840017514
NCI-H647,135411,0.7702839137009989
A-549,9926054,1.8971220341716168
SNU-61,12001922,2.043150446887516
KYM-1,11396600,3.5240556474022737
IA-LM,12001922,1.9531449792239188
SF268,136227924,2.8034077121566967
KMS-34,11396600,-3.5704564556839227
L-363,24753719,4.154726318334622
NCI-H226,135411,3.097357579098039
BT 139,11455910,0.9756266505311688
KYSE-30,136227924,3.298083829392356
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
HH [Human lymphoma],11396600,2.7706503807111575
SK-N-BE(2),9927531,3.511797224243287
NCI-H2110,11455910,0.8455410267883708
HCC1588,10385095,1.6204955784292203
NU-DHL-1,42642645,1.3661891975131202
COLO 205,387447,-3.444737053037922
NCI-H1373,387447,-3.648314511279975
BT 224,11455910,0.6330255553599808
KYO-1,11455910,-0.2516095405982875
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
COLO 792,54618771,0.4942463473126465
SNU-899,136227924,3.189426259363562
Panc 03.27,11455910,0.4781856768651555
ES-2,54618771,2.1434167327207954
BT 330,9887053,2.636361390531868
MeWo,100016,6.619977613887792
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
CCF-STTG1,136227924,3.7108552267199504
YD-8,15953870,3.5713699030166186
NCI-H2087,24753719,4.17997265759222
WM88,11396600,2.133090606668807
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
MCF-7,selumetinib-GDC-0941 (4-1 mol-mol),1.646510277694018
KP-3,3825829,4.167375675761747
HEC-265,49836020,-5.012817345393805
CAL-54,135411,0.8303289589920061
LCLC-97TM1,135423438,1.8911988038183152
LK-2,4705,3.2443649801870382
HT,11167602,5.369824507711039
SYO-1,12001922,1.74504955263497
BT-16,387447,-2.6678404938143614
WT2-iPS,135423438,3.753455715800744
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
MKN7,9887053,4.349351963721361
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
HCC1438,9926054,1.860816529304143
F-36P,135928012,3.654174626785145
NCI-H1623,15953870,1.9962949386047493
DB,11396600,2.484814775765491
NCI-H1581,100016,6.5572943300427795
SK-N-MC,10385095,0.8357656726976791
COLO 800,24753719,4.203367346938301
NCI-H2110,6505803,-2.3425437188382587
IMR-32,11455910,-0.0063621760742968
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
23132/87,12001922,1.761404950464383
Lu-99,42642645,0.8443356487328937
NUGC-4,11455910,2.097041344071872
Tm87-16,387447,-3.843934916128936
A-253,4705,3.938906906816397
SNU-478,54618771,0.1182109485114638
YH-13,135411,1.4167541971469908
HH [Human lymphoma],135423438,1.7493298511702722
CADO-ES1,11167602,2.670854143653412
KMS-20,6505803,-0.2025622916563878
HD-MY-Z,6505803,-1.982363986131319
2004,136227924,1.8982400348113204
HuH-28,54618771,1.3880976899184387
SUP-T1,11455910,0.2462561508535602
TE-10,387447,-4.412625040403518
HPB-ALL,4705,3.3035953851942548
OCI-AML-5,12001922,1.601315163188935
LN-18,387447,-3.3897712256994423
NUGC-3,11396600,3.780901195469807
KE-37,135928012,3.673479484423186
Sq-1,135411,0.3075018613661032
OCI-Ly19,136227924,2.004549918496879
KMS-27,24753719,3.911687472760716
NCI-H2009,6505803,-0.1719772058921901
769-P,136227924,4.180099818093012
HSC-4,3825829,4.330540788358233
LC-1/sq-SF,387447,-4.86370220627557
EFO-27,9927531,5.387402639259967
OCI-AML-3,10385095,0.7580975177780899
U-937,11396600,2.847104167418143
CHP-212,54618771,1.2694957147058317
P3HR-1,136227924,2.9304577514896466
WSU-DLCL2,387447,-5.074845470822875
GA-10,4705,2.180825520695711
RCC10RGB,2746,4.042085650474663
NCI-H1869,11455910,2.924449694106302
Jurkat,24753719,2.875512939853453
5637,387447,-4.648099554825834
EoL-1,135411,-1.9769058733801703
RD,100016,6.5954800872388155
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
NCI-H647,11396600,2.927909062901915
Capan-1,15953870,4.132273739370711
NCI-H1869,387447,-5.59099149502925
ES-2,136227924,4.099714373678264
YD-15,246676,4.797554441862922
SNU-C4,6505803,0.4157286441200272
BT 482,11167602,2.215432858582155
RVH-421,9927531,5.089842816937553
HCC1500,42642645,1.451455976812008
BFTC-905,12001922,1.8770650389586967
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
NCI-H1944,9927531,4.180597511578871
HuT 78,135411,-0.1860381511558323
BT 112,11455910,0.2027348347828513
Lu-99,3825829,3.5256416756654367
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
G-292 clone A141B1,10385095,0.9697207611364824
SH-4,24753719,4.294817471843681
SNU-216,54649381,4.402747428048603
KMS-26,15953870,2.1274684282642387
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
CAS-1,12001922,1.798376664922692
BV-173,246676,5.29399575682718
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
TE-11,11167602,1.8271765665442756
PC-3,135423438,4.806220333593262
BT-12,54649381,4.284222029295221
PSN1,11455910,0.0826195354078685
KMRC-20,15953870,3.781161229519325
NCI-H460,11455910,1.4134750909778395
SIG-M5,136227924,2.112174988724855
PF-382,73707440,6.113676619987129
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
DMS 53,9887053,2.0574198723536052
GCT,3825829,3.3867780854753535
VMRC-RCZ,387447,-4.554238845248696
TE-15,135928012,3.6935983275775537
RPMI-7951,54649381,3.585382450251425
COLO 680N,selumetinib-GDC-0941 (4-1 mol-mol),2.523373252620712
BT 179,4705,3.3464119205412697
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
BT 286,12001922,0.9308288717182952
COV644,3825829,4.316695889828485
Yamato-SS,54649381,3.7947631823444454
SU-DHL-8,135411,0.2390013238215946
Tm87-16,10385095,1.868855301750613
JHH-5,135411,0.4760925780645566
HCC78,135928012,4.488247833354647
TYK-nu,9887053,3.2670178267716783
HMCB,54618771,0.8772324111806863
MG-63,15953870,4.424502832603743
RT-112,54618771,0.4568083672151968
A-498,6505803,4.020571046679738
BT 440,15953870,4.656274496952199
IGR-1,9926054,1.7421331192656782
HGC-27,135411,-0.7526174751077652
BT 131,9926054,2.1358376599970397
JHH-5,9926054,1.852888607063122
DOV13,135411,0.9747494657071124
EPLC-272H,3825829,5.133223283552697
Capan-2,4705,4.948104259721338
IGROV-1,4705,3.3098412390054603
NU-DUL-1,15953870,0.0488377520565827
Panc 04.03,11396600,3.73844061007523
HCC1833,10385095,1.4425301929083445
JJN-3,12001922,1.6120006774773203
5637,11455910,0.64521724418638
COV434,100016,6.159872289007743
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
FTC-238,10385095,1.0815791008824205
HCC1438,42642645,0.7212422194182266
NCI-H661,6505803,-0.5859050253944337
HCC366,3825829,3.5921088541682615
P-STS,15953870,3.743014451957387
UM-UC-1,11396600,1.80390855748595
L-428,42642645,1.572958286567082
SNU-16,136227331,3.664519264936635
NCI-H1869,135411,3.671136614310566
A-253,11455910,0.0705993826212342
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
HSC-2,4705,1.5590916600613702
K-562,135411,0.731253239019591
Mono-Mac-1,3825829,3.369538014411621
NCI-H2444,11167602,2.3165888125394796
VMRC-LCD,10385095,1.1989116175151169
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
OCI-AML-3,136227924,1.3599145322416812
COLO 792,2746,4.014850740160219
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
RPMI-6666,12001922,1.75785023080333
JHH-1,24753719,3.7906138687565343
NCI-H226,135423438,1.8109443416998463
BT 187,10385095,1.3711588262291492
SNU-685,selumetinib-GDC-0941 (4-1 mol-mol),4.064777169332982
NCI-H292,11455910,1.285235050416197
DEL,54649381,3.784399167987178
NCI-H889,136227924,2.7199111384597447
SNU-886,54618771,-0.5899639628082597
BT 147,136227331,3.829920256470893
HT-29,11455910,2.35614963734945
JK-1,136227924,1.8733417156502243
RL,4705,3.6746067243503857
HCC2279,54618771,-0.3569311345677481
GSS,9877608,3.923769598981982
NH-6,135928012,4.567427968162051
Hs 936.T,10385095,1.5324384752571614
BT 232,54649381,4.617404703214
KMS-20,387447,-4.754784447636382
M-07e,49836020,-3.7990494796960337
JM-1,3825829,3.3725964609251005
L-540,11396600,2.910168116055403
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
COV644,6505803,4.248640118534715
IGROV-1,2746,2.8413672686351212
BT 482,11455910,0.8854890707649536
BT 216,49836020,1.982286397666987
B-CPAP,136227924,3.258845757188781
NCI-H661,42642645,1.2812432760018797
PaTu 8988s,15953870,3.81421509052964
HCC1419,4705,1.9049721189242583
SNU-16,2746,1.5955901549759912
IM95,136227924,1.5571875137371276
BT 179,12001922,1.738906631233252
NCI-H520,15953870,3.2948576647285797
Daudi,24753719,1.7041863717102288
OV-90,49836020,4.456425733691278
NCI-H2141,387447,-5.685665154489107
Hs 839.T,9927531,5.8565553238540655
OS-RC-2,387447,-3.825106116333215
BICR 6,100016,5.983099357165641
A-375,24753719,4.237865986535525
L-1236,54618771,1.349542879439561
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
HCC1143,10385095,1.0799280769088206
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
BL-70,11455910,0.0297014164053517
SK-HEP-1,12001922,2.448252559355595
NCI-H211,11167602,1.4659047290410885
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
SNU-1077,3825829,4.049018603201765
SK-HEP-1,2746,4.04921422913523
OCI-M1,54618771,0.2801133336374899
MKN74,24753719,4.72692215200023
HL-60,54618771,-0.823810735668653
Karpas-620,136227331,4.429067996401553
BxPC-3,12001922,2.0478076671218317
DND-41,9926054,1.3861019613196697
COLO 680N,42642645,1.7110596080486196
NCO2,9887053,2.509790456363511
HSC-4,11396600,3.0766488056466104
NCI-H1703,42642645,-2.8901170785380255
HCC38,42642645,1.0705938044979555
BICR 18,135411,0.8889297750482907
HCC15,3825829,3.261310602619802
PLC/PRF/5,3825829,3.651094243261873
Calu-3,11396600,4.335639453655832
CAL-78,42642645,0.6133615461906909
NCI-H520,selumetinib-GDC-0941 (4-1 mol-mol),1.617810838341725
SK-CO-1,387447,-5.86001644251988
NCI-H1792,54649381,4.656235411439999
GA-10,24753719,1.5492278869101457
ONS-76,9926054,2.5108803232151304
JHUEM-2,11396600,2.4680372971734372
TALL-1 [Human adult T-ALL],135928012,3.608420591531505
SNU-1196,54618771,1.539198282600217
SK-N-BE(2),15953870,1.9801295323043675
Panc 03.27,24753719,4.289669652814175
MDA-MB-453,9926054,1.6596725660557576
SNU-5,54618771,-0.9797108545959382
OUMS-23,6505803,0.855156690272806
EHEB,135411,-0.07398268976703
NCI-H526,selumetinib-GDC-0941 (4-1 mol-mol),3.379534287031186
NCI-H2286,136227331,5.6980309243628
RCH-ACV,6505803,0.7886152170301014
Panc 10.05,387447,-4.7993552621110105
BxPC-3,49836020,-2.380895293574403
NCI-H526,54649381,3.4891689121132448
YAPC,135411,0.9254838530178896
SU-DHL-1,49836020,5.336381428124731
DU4475,6505803,-2.3168305657918156
BT 330,9926054,2.1336209959126253
PaTu 8988t,10385095,1.1295524511895831
BL-70,2746,1.4659724026992842
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
HuCC-T1,15953870,3.338570200088189
H-STS,11396600,3.334455384541719
MIA PaCa-2,11167602,2.3171919978995636
VM-CUB-1,10385095,1.1194240757711134
CAL-12T,12001922,1.8295391939935424
HT-55,12001922,2.012487187005666
YH-13,11455910,2.765771134789071
LXF 289,11396600,4.152956454399736
JK-1,24753719,4.0136408647796165
CL-11,135411,0.9492306180370104
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
KMS-34,42642645,-0.0002773838861193
SW579,24753719,4.045318345169703
Fu97,3825829,4.00033260812453
2004,selumetinib-GDC-0941 (4-1 mol-mol),4.378845407517423
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
DU145,12001922,2.62580913406857
SU-DHL-1,135411,-2.10627226052293
L-363,42642645,0.7519589523961394
MOLM-13,100016,3.967621300341963
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
NCI-H441,selumetinib-GDC-0941 (4-1 mol-mol),1.6335298040025916
786-O,10385095,1.074274496181899
CCF-STTG1,10385095,1.287783842967002
RKO,54649381,4.449908747747005
Calu-1,100016,7.639038839177244
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525
BT 245,135411,1.173620525211862
TOV-112D,2746,3.3421101516838445
Mono-Mac-6,11396600,3.7802987218854898
HCC-56,11396600,3.807461388056502
UO-31,136227331,3.2031973353809833
SNU-119,11167602,2.3286246928254335
KALS-1,54618771,1.5195853448840246
CAL-85-1,9927531,5.462917800107974
SK-OV-3,15953870,4.452396287203901
FaDu,9927531,4.819445610620238
DU145,135411,0.7312573110789992
JHH-1,12001922,1.7454788119163624
NCI-H446,2746,2.3498670428559807
SK-LU-1,54618771,0.3237862890103595
WM88,2746,2.5770363002684555
8305C,15953870,2.5336153259169176
GDM-1,3825829,3.088592770806933
KMS-26,11396600,-5.248360616459154
BT 328,12001922,1.7973322325176817
NCI-H1092,135928012,3.192957596716536
HT-144,44197249,4.845658178062306
8305C,54618771,0.5083809192665402
CAS-1,11167602,3.00714266116136
Rh41,15953870,2.317355614199239
BFTC-909,136227924,2.3418993883842134
CW-2,9926054,2.0798492458785978
HEY A8,49836020,5.6501572313244885
SU.86.86,135411,0.6045897954598343
CAL-12T,54649381,3.416368413227002
L-428,11455910,-0.1426546871205822
MDA-MB-435S,54618771,0.9964394209064932
COR-L88,11396600,3.064115551453064
A101D,136227924,2.7929516463081123
JL-1,42642645,1.449211418694902
Hs 729.T,15953870,3.6218732353289
BT 286,42642645,0.4820370250639494
HDQ-P1,12001922,2.4546609866891775
RMG-I,2746,2.7034933006437023
SUIT-2,11396600,4.33113824085374
BT 498,387447,-2.1725153128348547
KP-2,9926054,2.0579312242664645
RKN,387447,-2.9807645129134066
SK-MEL-1,11396600,3.732963338182352
SNU-503,selumetinib-GDC-0941 (4-1 mol-mol),1.4877260570474324
P-STS,135411,0.2620868727557398
KYSE-180,135411,0.6343145122787996
Mono-Mac-1,135411,-1.165468414197589
NCI-H889,42642645,1.7045704248641913
EM-2,54618771,-0.9805043805831684
DEL,135411,-0.7781965900847985
PF-382,9927531,5.462558018035092
OV56,387447,-4.974398279067266
BT 328,11396600,3.7528560222461858
BT 172,10385095,1.1313035697005236
Namalwa,10385095,0.4710651537039255
NCI-H146,54618771,0.1782763900918093
U-251MG,136227924,4.317491880233533
NCI-H1435,11396600,4.531231464370408
Aska-SS,54618771,0.6758112733038071
ST486,12001922,0.9282775976329514
KMS-21-BM,54618771,-0.9009155156599936
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
BxPC-3,3825829,3.4267099071969738
OAW28,54649381,3.786658613217657
NCI-H810,15953870,2.9273740419027434
CAL-12T,387447,-2.54798811202932
KMS-26,54618771,-0.1721472849955331
BT 482,9926054,2.2206643781764184
KMRC-20,44197249,3.899612901236983
NCI-H322,135411,0.3121054372239065
KCL-22,3825829,3.061689811765635
EBC-1,24753719,4.292125104938372
HCT 15,135928012,3.705140560958693
GI-1,6505803,0.8519906132881799
NCI-H838,2746,3.438518103958065
SNU-840,54649381,4.841797234333967
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
ZR-75-30,2746,3.4802316913865563
A-549,54618771,0.0374822867627876
G-361,246676,0.6670896942083654
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
Rh18,2746,2.848745725372627
Hs 578T,387447,-4.966638212642196
A-549,12001922,2.28641691667768
SK-MM-2,10385095,1.5805301391709368
SW1271,49836020,-1.4027167140646708
UM-UC-3,11455910,-0.2189764508549214
MSTO-211H,42642645,-0.4763575861779333
COLO 680N,24753719,4.633194138255632
PE/CA-PJ49,9887053,4.12500650202634
BICR 31,9927531,5.661036072082279
SW982,42642645,-0.2734994229240252
BT 239,11167602,1.6889728447058876
NCI-H716,387447,-5.314010938930765
SNU-620,9887053,3.4104464673778883
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
A-549,100016,7.181380121169662
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974
CL-11,2746,2.4152572914027366
NCI-H146,135423438,2.8528911509997137
ZR-75-1,6505803,-2.5048653445309297
NCI-H1573,11167602,1.820662844195984
A2058,24753719,4.097483540961699
U-937,135411,0.4657286963513147
UM-UC-3,136227331,3.94021080809034
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
HOP-62,100016,6.313498249886369
RPMI-7951,6505803,-3.4302306957343434
LOU-NH91,135411,2.1671070624345674
KMS-21-BM,9926054,0.3453207317075127
BICR 22,3825829,4.259881935728516
CW-2,9927531,5.678325078717316
Lu-99,387447,-4.011331298811201
NCI-H322,3825829,4.238142837604242
Caov-3,42642645,0.1182455680385969
CML-T1,11167602,0.5863351465273275
Li-7,387447,-4.165186760469194
BT 328,387447,-3.18043057197166
COLO 680N,15953870,4.063578485018074
ChaGo-K-1,136227924,2.8574479872364247
MFE-319,42642645,1.7414638697140636
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
CCF-STTG1,9926054,1.9394922490252933
Rh18,selumetinib-GDC-0941 (4-1 mol-mol),2.126634875194983
NCI-H810,10385095,0.4764692150659226
GCT,9926054,1.6553855879894792
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
Panc 04.03,10385095,1.3607276101908192
L-428,24753719,2.0145740660886045
MKN1,135423438,3.025317436009671
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323
Aska-SS,6505803,-1.3133371843623132
KHM-1B,136227924,1.9174951940989704
NCI-H727,10385095,1.3903964913374658
NCI-H2452,6505803,0.3706171048891257
VCaP,136227924,2.2790218879563255
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
ECC12,11455910,2.320558491794217
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
BT 482,135423438,1.5025223732344029
OCI-Ly10,2746,1.6714722565073843
GSU,42642645,1.4932743887837436
HGC-27,9887053,1.0468629495159063
COLO 680N,10385095,1.9656390133911903
Panc 05.04,42642645,0.9642603836116296
KP-N-SI9s,54649381,4.055686735415603
G-361,2746,2.496090432084752
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
NCI-H226,11396600,3.8487542891861697
Li-7,9927531,4.31523724383209
SNU-C4,10385095,2.739530321811718
TCCSUP,387447,-4.825347113965475
KMRC-1,54618771,0.2036698487849761
PL-21,136227924,2.3397761554923413
U-BLC1,6505803,-1.6216028529729
KE-37,11455910,-0.4991335198758184
KYM-1,135411,-1.7132383053162352
PaTu 8988t,136227924,2.49705731140334
IMR-32,11396600,2.686072598374917
SH-10-TC,54618771,0.3960881038412169
RVH-421,6505803,-0.8379256184936457
KMS-12-BM,42642645,-0.399689528391991
A-375,54618771,0.2489032260565352
SK-MES-1,4705,1.78363684998227
PaTu 8902,54649381,5.340946431274584
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
ESS-1,3825829,4.02803833382595
JHOC-5,135411,0.5193328179752612
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
OCUM-1,49836020,-0.6781383792077297
JHOS-2,12001922,2.4863036118532493
LP-1,24753719,3.6405716630369014
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
SU-DHL-1,6505803,-0.92520479323989
Hep 3B2.1-7,24753719,3.3025122123493573
SK-MES-1,15953870,3.5806199424860115
BICR 6,9926054,1.8719413430769756
8505C,11167602,1.7953198802479176
RKO,3825829,4.017808531984142
KNS-42,12001922,1.7934883834799902
SNU-738,387447,-3.86580266089946
UACC-62,135423438,3.882587391697005
NCI-H196,6505803,-2.584709085122825
KYSE-150,12001922,2.2916926558482973
697,11455910,-1.5843121483230655
IGROV-1,15953870,2.712793598656007
SNU-601,11167602,2.836035120173089
F-36P,9926054,1.445748070072179
NCI-H2081,44197249,1.2499480792075393
SNU-C5,11455910,0.7223735264442241
ONS-76,54618771,0.5276024038238057
BT 139,4705,1.2736947517063846
BT-16,54618771,-1.2134331946377312
LXF 289,12001922,1.5738020993239468
COR-L105,9927531,5.197941564874311
SNU-8,54618771,-0.2346938322915562
Raji,11455910,3.338513112420112
SK-MES-1,136227924,2.193847007439744
KALS-1,11167602,3.631671875961461
MV4-11,3825829,3.040085708530912
DAN-G,11396600,4.828113333823666
RS4;11,9926054,1.3996833727357625
NCI-H1755,6505803,-1.1693878768610966
SR,100016,4.130694890660373
SNU-601,15953870,2.989838911938568
Toledo,11396600,3.3426369304139825
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
NCI-H1793,11396600,3.5619281448280233
HCC1395,387447,-3.83768171987275
MOTN-1,54618771,0.6090768126034483
CL-11,100016,6.945803371228119
BT 482,246676,4.047789712479496
L-363,3825829,3.9527426660546223
EJM,100016,6.634092198961092
769-P,54618771,0.1291484559700657
COV434,9926054,1.0674163383843658
DEL,246676,4.437673993378433
KP-N-SI9s,3825829,3.77861999639184
Hs 936.T,387447,-2.8293562515845303
HCT 15,3825829,3.876699051536366
GDM-1,11455910,2.236688406286894
42-MG-BA,9926054,1.7568260355296932
Ri-1,246676,4.619716207885173
NCI-H1155,6505803,-2.994970974649892
COR-L51,10385095,0.6951794902881232
NCI-H929,136227924,1.899057841083653
RL,100016,6.4335673885856135
U266B1,12001922,1.0730896290289216
NCI-H520,387447,-5.005937359447702
SNU-61,6505803,-0.8091898598550518
A-549,2746,4.106748757541722
Peer,100016,3.808596484759728
NU-DUL-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.5711505169578749
SK-MES-1,54618771,-0.0773843626642112
MHH-NB-11,3825829,3.098223701993546
THP-1,387447,-3.5138185957721197
ESS-1,135411,0.5252983253091638
HCC1806,12001922,2.003540382154338
Karpas-299,54649381,3.598409895266759
LS123,9887053,3.6466724654961977
LOX-IMVI,9887053,4.363573973806746
NCI-H810,135423438,2.2822714598344764
MOLM-6,4705,2.310096856528744
P12-Ichikawa,136227924,2.6176590952299477
HCC1588,49836020,4.436779912961811
GOS-3,100016,7.242262816552233
SF126,9927531,4.99089280929888
COLO 684,4705,3.605341252393416
BHT-101,6505803,-0.1519656140432062
NCI-H2081,4705,3.121794828383862
NCI-H2405,136227924,3.1304062683146747
BT 286,136227924,1.3356746395497436
NCI-H2171,15953870,3.344319567560605
WM1799,15953870,5.538260791542412
COR-L47,12001922,1.7829962669033108
KYSE-520,136227924,3.1208401396418592
Hep 3B2.1-7,54649381,3.772857705678292
PF-382,135423438,0.1628237790601052
KE-37,11396600,2.928108153981295
KATO III,4705,2.4067147037992696
MOLM-6,3825829,2.8579760504550915
FaDu,24753719,4.130411465313579
KP-4,54618771,2.957585816818264
SNU-878,3825829,1.72780472157954
NH-6,10385095,0.738045984427429
LS411N,9887053,4.348393626170801
NCI-H1568,12001922,1.1909466973303815
EFE-184,10385095,1.4083515460753824
HL-60,10385095,1.2256262065084265
KE-97,24753719,3.3445945063938676
SU-DHL-10,24753719,3.959524589589147
NCI-H1915,135411,1.7244736886965215
COLO 800,135411,1.873061539966024
KE-37,3825829,3.396228686518362
HT-144,42642645,1.1321798282633526
U-937,11455910,-0.571974283584222
KMS-12-BM,11396600,1.1666466615999174
MDA-MB-435S,9887053,5.779780766032965
SU-DHL-1,3825829,2.249840075454991
A-172,49836020,6.443724072404216
BHT-101,9926054,1.1931762912946844
BT 416,136227924,3.4255307271180726
SK-MEL-5,4705,2.45435106083484
LN-18,24753719,3.9269044306428262
Ki-JK,9887053,2.7128536562728693
SK-N-DZ,42642645,0.1554208834123088
NCI-H358,9926054,2.488331292072961
BT 112,135411,-0.6618805280288009
MKN7,9927531,4.538796074024755
Daudi,3825829,3.2006002080342544
JHOS-2,4705,4.289779797821904
Pfeiffer,42642645,-0.842471316588586
HCC1833,54618771,1.9776792637653005
GSU,54649381,3.926926162610623
HT-1080,4705,3.343447730900498
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
TOV-21G,11455910,0.2385703250097463
BT-16,11455910,0.4164616318960097
Mino,24753719,3.6621526674985416
SNU-216,15953870,2.862027857822619
C2BBe1,10385095,1.7021974015652714
DMS 273,42642645,-0.2214891751848421
RKO,11396600,3.504834935214814
HCC1500,4705,3.1720127097688073
CAS-1,9927531,5.442580925984542
SNU-489,54649381,4.350183464151375
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
23132/87,24753719,4.2798195859801575
OV-90,selumetinib-GDC-0941 (4-1 mol-mol),0.0279948147357564
Calu-3,15953870,2.8031660002155503
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
KYSE-410,11167602,2.662008040827567
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
GCT,136227924,3.024645180957839
HT-144,49836020,4.351286347642034
WM1799,10385095,1.0402810693524889
NCI-H1793,11455910,0.5323419140009732
ZR-75-30,136227924,3.5756469644058613
NU-DHL-1,11167602,2.239253055046329
KMBC-2,10385095,2.342587870752789
BHY,42642645,1.2774922205893602
HT-1197,11396600,2.8973650572318213
MeWo,54618771,2.702523015833562
A-172,10385095,2.860957773873438
TUHR14TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.1009270469043897
OVCAR-8,135928012,5.170916330488166
SU-DHL-10,3825829,3.9428977929088673
SF126,73707440,4.55142805783094
JHH-1,387447,-5.003007504910175
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
UM-UC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.321826526721954
IM95,2746,2.7432811533123247
Yamato-SS,42642645,-3.900481117283226
NCI-H841,15953870,4.289460769129973
SET-2,387447,-5.133141904857513
SET-2,54618771,0.9858111819135928
SUP-HD1,12001922,1.762640198359478
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
NB1,54618771,1.1360692536684358
SK-MEL-30,2746,2.9636242403288344
SNU-16,135423438,0.927911457885393
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
SNU-761,9927531,4.19360542314586
NCI-H2122,15953870,4.425905668313166
SNU-410,15953870,3.0110821873040607
SU.86.86,10385095,1.2045752824309466
HT-1197,9927531,4.678863685283018
NCI-H2023,11396600,4.497397906995783
NCI-H2170,11167602,3.042196123088182
BICR 6,24753719,4.141296069645995
HCC1438,12001922,2.3392861524529933
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
KMH-2,73707440,5.915660341573708
NCI-H2029,12001922,1.4883517554557018
Panc 04.03,12001922,2.0215480430072588
NU-DHL-1,54618771,-0.7819429035186433
SK-UT-1,12001922,1.8761579048113184
YD-15,136227924,2.6934840054154834
DB,49836020,4.238014398783195
HT-1376,11455910,0.3601219062444335
SUP-T11,11396600,2.6585567591139245
KO52,11167602,0.9021081553845208
SR,24753719,3.424862135799519
OCI-M1,15953870,3.52877399844703
KMRC-3,135411,1.0423275908984542
SK-ES-1,6505803,0.0582919065380463
Ci-1,6505803,1.2287490885597057
HOP-62,136227331,3.5608481617611165
VMRC-RCZ,24753719,4.580216363961944
Hs 940.T,387447,-3.434681901384252
IPC-298,15953870,4.648641890884126
SW48,100016,6.031440310304127
L-363,4705,4.264725490975614
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
CA46,15953870,3.0438117584706164
Tm87-16,54618771,0.1838114986679219
HCC2935,11396600,3.842906803447669
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
NCI-H460,10385095,2.2920897819597896
HCC1395,9926054,1.865398038154908
NCI-H1651,11455910,1.357904809543347
GI-1,12001922,1.7081345379458135
OE21,4705,-2.1528136210817324
BHY,selumetinib-GDC-0941 (4-1 mol-mol),0.2537821037586068
Daoy,6505803,0.5477852544594343
NB1,2746,2.341012333124764
LOX-IMVI,1474550,4.500366479302131
RD,54618771,0.0144347314731342
SUP-T1,24753719,2.6929520515821515
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
OE19,10385095,1.3050426260801358
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
CAMA-1,12001922,1.7144452504587175
NCI-H1869,11396600,4.813854369313605
PL-21,6505803,-0.5329499578695445
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
RT-4,135411,2.3178037837243166
COLO 320,10385095,0.1624567480450137
BFTC-905,42642645,1.4700970475154644
SYO-1,10385095,1.1678960163185943
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
42-MG-BA,246676,4.8928589872752335
WM266-4,135928012,4.470932738377761
CGTH-W-1,42642645,-1.8172361681938831
BT 416,10385095,0.9416016414331604
EBC-1,42642645,4.109091528916688
COLO 699,11396600,3.859625290158775
SNU-1066,selumetinib-GDC-0941 (4-1 mol-mol),1.622393970628324
TF-1,11396600,2.862627725963247
Mono-Mac-1,135928012,3.3963935861333816
A-673,387447,-4.940230504934896
CAL-78,2746,3.5103539544732745
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
KMS-11,100016,4.183673123455152
GaMG,136227924,2.741790754216058
T84,100016,6.649554415164183
BT 232,136227924,3.5495643934514223
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
HCC44,9927531,3.2754168004895328
SK-CO-1,54618771,-0.118181134306818
BT 172,246676,2.57801593089919
JURL-MK1,136227924,2.4264924164691135
MPP 89,9887053,5.889967557916615
DND-41,24753719,3.046875575777515
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
JHOM-1,11167602,4.155766274688487
GMS-10,6505803,0.344915295589296
BL-70,11167602,1.611057170206316
HCC15,11396600,3.725702968544969
OE21,15953870,1.724082394316485
Hs 944.T,387447,-3.848854411083538
PSN1,3825829,4.264065609006961
Kasumi-1,387447,-4.894380224163889
SNU-1076,100016,6.986031941643801
KP-N-YN,11455910,2.456468445716411
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
DV-90,10385095,0.6570221400102684
UACC-62,11455910,0.399778260959969
Pfeiffer,135928012,2.7795934005677516
ChaGo-K-1,9927531,4.39504142130407
NCI-H1355,11167602,2.0680047351334254
Sq-1,135423438,3.0560767843125793
PE/CA-PJ49,54618771,0.7503164660158113
OCI-AML-2,6505803,-2.2709004607894583
JHOS-2,15953870,5.073130096765707
SF268,12001922,1.2204154008989687
BT 239,54649381,3.7055214741556752
L-540,54649381,3.7224269331936206
SH-4,12001922,1.169897949605615
KMBC-2,6505803,0.8249091565927539
MDA-MB-231,6505803,0.6630652134402967
HCC1419,387447,-4.686318611145254
SUP-B15,9927531,5.1368052730530955
MKN1,136227924,3.2741698595271025
HOP-62,54649381,3.909621773040776
Panc 03.27,3825829,3.951952247459651
HEC-108,54649381,3.8371593577221255
TE 441.T,15953870,3.627702948690547
LAMA-84,15953870,2.7342242191693154
Rh18,6505803,-0.099361262112988
DU4475,135928012,4.362003464185386
JMSU-1,15953870,2.566017426774328
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
BT 145,44197249,3.86655282398804
A-549,3825829,4.248968416167453
NCI-H1341,49836020,4.324192381476246
NCI-H1092,54618771,1.961811722948082
CMK,2746,1.105123942963827
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
MDA-MB-453,54618771,-0.4179555738274852
TE-14,11396600,4.264622215416366
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
2004,42642645,-3.0109401003978147
SK-BR-3,42642645,1.641863587303232
NCI-H2444,42642645,1.6399981136373118
GCT,10385095,0.729711936953439
SBC-5,9926054,3.0567796435466628
DU145,136227331,5.067250261949365
KMRC-2,9927531,6.175340087469203
JHUEM-7,387447,-4.291919985887575
PK-1,9926054,1.83429012816666
NCI-H1355,selumetinib-GDC-0941 (4-1 mol-mol),2.7709082983519564
HuT 78,9927531,5.1568522769540674
Panc 02.03,9926054,1.881153725115377
Hs 888.Lu,10385095,1.093902628388718
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
HCC2279,15953870,3.94742460395944
A2780,387447,-4.368237522415053
AM-38,9926054,1.7644212109272557
PaTu 8988t,387447,-4.215036300164339
TUHR10TKB,15953870,3.5246669540253155
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
NCI-H647,100016,4.3873613110575045
SEM,42642645,-5.09846827798555
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
Mino,9926054,1.8004792382140618
KYSE-510,2746,3.665067942472177
HT-1197,15953870,3.885327712470257
G-401,9926054,1.744192331951833
ME-1 [Human leukemia],135411,0.1977011007868252
639V,9926054,0.5445384370060099
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
NCI-H1792,42642645,1.546584780699499
Ishikawa (Heraklio) 02 ER-,135423438,4.463987581910629
HEC-1-A,135411,0.6369779822563821
KE-97,3825829,2.578612905632661
OCI-AML-3,54618771,-1.4994430738546511
KMRC-1,3825829,4.43742858244417
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
HCC15,135411,0.5020362424433897
Granta-519,15953870,3.078322892664931
PC-14,100016,6.551425062945198
NCI-H1105,9926054,1.86457745322678
SNU-216,42642645,0.8137216939792844
COV644,selumetinib-GDC-0941 (4-1 mol-mol),0.580143851486064
L-540,15953870,2.0916487999348155
KP-3,387447,-4.22311088168715
SF268,100016,6.377468220379779
GOS-3,54618771,2.751038853336045
CA46,6505803,0.7805822725654986
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
IM95,selumetinib-GDC-0941 (4-1 mol-mol),-0.8100536248662729
SNU-1196,3825829,4.562279369348024
MHH-CALL-4,3825829,4.255364052517795
Panc 10.05,10385095,1.5878322903216917
SNU-899,42642645,1.8856316626403191
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
COLO 699,54649381,4.008524988140669
SNU-119,10385095,1.2447707748514782
MKN7,3825829,4.738497336590758
NCI-H2052,10385095,2.956469806402845
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289
SNU-C5,9926054,1.8417265889744416
CFPAC-1,3825829,4.805499515472961
ES-2,54649381,4.212438503442145
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
NCI-H1869,135411,3.671136614310566
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
BT 248,4705,2.6318547262793386
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
UM-UC-3,10385095,1.4265186510957917
GOS-3,12001922,1.73057519179838
DMS 53,selumetinib-GDC-0941 (4-1 mol-mol),1.3170486781657051
Detroit 562,24753719,4.8099067031484894
WM983B,3825829,4.481974226562025
NUGC-3,135411,0.6658905713792896
MDA-MB-468,12001922,1.39875185506382
NCI-H1915,10385095,0.8614949927187568
MeWo,6505803,3.0730315194784947
PaTu 8902,135423438,1.708930423466824
DLD-1,3825829,3.8736500372976943
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
Ku812,54618771,-0.0049031848150657
SK-MM-2,9927531,3.423086236737343
RERF-LC-Ad2,9927531,7.758899930646885
LK-2,2746,3.266884411488981
U-87MG ATCC,12001922,1.8057528898700492
42-MG-BA,135411,0.3674889037919356
SW1710,15953870,3.6161614177049057
LoVo,9887053,2.8676927346989265
CAL-148,54618771,-0.772242663626429
EB1,6505803,0.7002035239944829
NCI-H1581,selumetinib-GDC-0941 (4-1 mol-mol),1.7228993365162983
LUDLU-1,4705,2.2241864664767013
NCI-H522,10385095,0.7404415633977295
NCI-H1155,9887053,2.234247798855995
FaDu,11396600,3.202627424323668
LS180,11455910,2.088798844266998
CAL-27,42642645,0.9503416388368572
KYSE-450,6505803,0.925446652115482
EM-2,42642645,-2.0665859943713207
KMRC-2,9926054,2.0216271093968263
Hs 683,100016,6.526692615081327
GMS-10,135411,1.0987259107867149
L-540,387447,-5.906751085072673
RMG-I,54618771,1.320928613305781
PC-3,11455910,0.8033042289278307
NCI-H1581,11455910,-0.5870511913964108
LOU-NH91,4705,2.8449970854381945
BICR 18,9926054,1.7755527669372533
NCI-H196,54649381,4.303776340582988
JHH-5,9927531,4.499670785521202
NCI-H1838,12001922,1.7536043221918316
KO52,9927531,4.721929704585103
KYSE-150,15953870,3.8855163555924626
T84,11396600,3.8176066701556097
GSU,136227924,3.064976264970486
HT,11455910,-0.2280059787426213
TCCSUP,24753719,4.825833368668945
OPM-2,9926054,1.8132463747821628
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
D283 Med,136227924,2.613464686393682
EKVX,4705,1.6368061530799292
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
ST486,11455910,-0.3463533308218484
P12-Ichikawa,selumetinib-GDC-0941 (4-1 mol-mol),1.616010765024319
MOLP-2,10385095,1.1784058949266252
M-07e,54618771,0.3587170705521248
Reh,selumetinib-GDC-0941 (4-1 mol-mol),2.2162895945823093
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
JHUEM-3,11167602,2.7925879803312386
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
TUHR4TKB,6505803,0.1183916105816245
LS513,6505803,-2.1765779470092332
Caki-1,135411,3.519344707650215
NCI-H2228,9927531,4.856676083567804
MOLP-2,42642645,2.430213649735383
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
L-540,6505803,-0.3168506234020811
LXF 289,2746,3.190299829163617
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
NCI-H1651,3825829,3.522872193486989
COLO 829,54618771,1.3486725115535303
KU-19-19,6505803,0.0199416611110358
HCC44,9887053,3.529003644163673
HCC366,9887053,5.465228651595439
SJSA-1,10385095,1.3301881302452143
MDA-MB-468,6505803,0.9541010396346138
Fu97,387447,-4.696019716888308
EHEB,9926054,1.8810570858595552
WM793,15953870,5.050143340220593
MDA-MB-361,100016,6.5281042722822145
MOR/CPR,24753719,4.642511920808052
SNU-1079,54649381,2.4249067376910487
Daudi,4705,2.565440722309658
OVCAR-8,9926054,3.028637084123283
COR-L51,12001922,2.3799283821407693
CAL-54,3825829,4.452720712593216
HCC44,12001922,1.6331909521858985
HSC-2,100016,6.282703144403752
BT 159,selumetinib-GDC-0941 (4-1 mol-mol),1.265249520396083
SU.86.86,54618771,0.7552640390383902
NCI-H747,387447,-4.932873964507138
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
GCT,15953870,2.9129460513464065
MV4-11,selumetinib-GDC-0941 (4-1 mol-mol),-2.1623049126826372
Yamato-SS,135411,1.7337352244001774
ME-1 [Human leukemia],54618771,1.2979456738996673
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
SK-UT-1,24753719,3.8954683516034194
HT-1197,3825829,4.6685347101076395
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
SK-MEL-28,9926054,3.4888277398466765
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
SCC-25,135411,1.9524899256814177
SBC-5,11167602,1.6319389998554443
T24,54618771,1.5069365622547568
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
SW48,54649381,3.6753624817280706
HT,24753719,3.8914471596117655
JHH-5,2746,3.1730265714990047
Hs 852.T,9926054,1.891936574698373
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
HCC1195,2746,3.3067232318452895
WT2-iPS,42642645,1.002722157106249
M-07e,42642645,0.4654557328978623
KM12,54649381,4.282905365665102
ES-2,387447,-4.281981218202758
PC-3,54618771,1.1708182294918184
BCP-1,387447,-5.804214417300883
CAL-78,15953870,3.4858548290636553
VMRC-RCZ,11455910,2.4109500553955487
CAL-33,54649381,3.817080797439293
DU145,11455910,2.077410590950561
NCI-H1693,3825829,4.219251789246142
MKN45,10385095,2.790688226275196
PK-59,54649381,3.782815852131327
KYSE-150,10385095,2.102532274232982
KMH-2,9926054,1.558336314725876
23132/87,135423438,4.4665628389477305
BC-3C,10385095,2.7598083039620764
KHM-1B,11167602,5.170482443949449
Ki-JK,15953870,2.35721426290404
NCI-N87,24753719,4.36387060101307
TCC-Pan2,selumetinib-GDC-0941 (4-1 mol-mol),0.1470991216405226
SW1783,3825829,4.196997387332537
ECC10,3825829,3.3631877901745626
PF-382,11396600,2.839145334831077
ESS-1,9887053,4.577592103187429
SK-ES-1,12001922,1.480047432032178
BT 482,selumetinib-GDC-0941 (4-1 mol-mol),-0.4370874918517858
K029AX,136227924,2.929460109593454
HuCC-T1,54618771,0.1107160240770854
T84,9887053,2.925651375717051
BHT-101,12001922,2.1577365221916613
QGP-1,3825829,3.518938606213147
PC-14,135411,0.053480983141028
MKN7,15953870,4.938608456268053
SNU-175,6505803,-3.2820452967658778
A2780,10385095,0.5603604864283975
Hs 746.T,42642645,-4.287124320079624
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
SNU-449,2746,3.928036011173348
MV4-11,135423438,-3.04560179632734
TE-1,6505803,-1.9402426230347345
SK-MM-2,100016,6.381158442456996
HSC-2,15953870,3.6429680450117408
SNU-398,246676,5.025344941549461
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
BT 245,6505803,1.0921416598826974
HEC-1-A,3825829,3.8272182541889785
NCI-H2444,11396600,3.7702875929264312
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
Kelly,10385095,0.4242417641374412
NCI-H2110,387447,-4.13995118678638
KMS-11,11396600,1.6057835101589155
MV4-11,12001922,1.2602127995241734
RCH-ACV,54649381,3.745504594626648
SNU-1,135423438,1.6465849203291467
HeLa,10385095,1.105005903985203
NCI-H1355,9926054,1.8192914468713284
BT-16,12001922,1.9603730979247904
T3M-10,2746,5.219719103110665
TE-11,12001922,1.6964539977258914
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
MeWo,2746,2.380002507942182
HCC44,49836020,-1.9143926504163185
KYSE-30,42642645,1.5481968016239538
YH-13,10385095,0.585484965582367
LOX-IMVI,6505803,-1.7860593354464098
MFE-319,9926054,1.8492827713698956
JURL-MK1,54649381,4.032161492368704
HCC15,136227924,3.0147456858017923
Hs 294T,42642645,0.9699194140175204
SK-MEL-3,54618771,0.906293998556286
LP-1,11396600,4.222971690174634
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
SNU-626,15953870,3.7664057202558534
CA46,11396600,2.515122226404857
GDM-1,54618771,1.3683939355818997
VCaP,42642645,0.1672421767914478
SH-4,42642645,1.4929428090423946
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
BT 286,54618771,0.8427122634128117
BT 271,9926054,1.6411198648288656
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
EM-2,15953870,2.1302046604776246
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Lu-65,12001922,1.746900064695359
IMR-32,246676,3.267106458420984
HD-MY-Z,9927531,4.2813620085195625
BT-20,9887053,4.223418717862435
BHT-101,10385095,1.3780896504603424
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
NCI-H211,6505803,-2.3118945325693216
NCI-H522,136227924,2.2034936459857506
KMS-18,100016,3.3973864073508864
GI-1,4705,3.0771619650951214
KE-37,42642645,-1.2780991032953624
AU565,387447,-4.131425766006191
NCI-H1693,54618771,1.322684232768969
Panc 10.05,12001922,1.664149887088702
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
SNU-1041,136227924,4.256354114890169
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
A101D,42642645,1.597329636929403
NCI-H2085,387447,-3.875462690750846
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
JHUEM-7,9926054,1.641999407547345
HCC95,54649381,4.004941290048799
SEM,10385095,0.8510184643991832
NCI-H1299,6505803,-0.2534280947368875
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
DMS 114,135411,0.7761254050205509
ESS-1,4705,3.449305158476875
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
IGROV-1,54618771,1.2456991772210466
KG-1-C,4705,4.10841801715904
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
DOV13,246676,4.3974836150314145
DV-90,9887053,-0.8356629628703925
OVCAR-5,11396600,3.059623725203541
CAL-29,246676,4.336236168449078
Capan-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.340534390124913
NCI-H1666,12001922,1.6387287745593944
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
SNU-5,136227924,2.8950932658181876
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
A-498,42642645,1.5845020846141176
DMS 273,135411,0.7219297948054574
OCI-Ly19,4705,3.3718260967656715
NUGC-3,11455910,1.6597314376827883
SNU-886,10385095,1.1038149480439057
HeLa,387447,-3.452898150134073
JVM-3,3825829,2.7890752549224307
SET-2,11396600,3.171295781716927
MES-SA,2746,3.3783826340616243
BT 172,11167602,1.9084752133750955
NCI-H1339,12001922,2.434231494820422
NCI-H1339,6505803,-2.1203038529931857
NCI-H1339,9927531,5.416434112117517
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
A3/Kawakami,54618771,0.7801439877237109
SNU-8,10385095,1.1888093081137228
K-562,24753719,4.107201496626299
MSTO-211H,15953870,2.3250629767102273
SIG-M5,6505803,-0.1487060693646739
SUP-HD1,3825829,3.734358098945598
Hs 746.T,2746,3.181547233706405
HCC15,12001922,1.9087360775911748
K029AX,387447,-5.333288540951922
NU-DHL-1,9927531,5.134600574788464
SNU-407,10385095,1.195722316637187
SW620,387447,-6.368263113836077
NU-DUL-1,9887053,0.6250279437432532
T24,9927531,4.8353414036700615
NCI-H1755,135423438,4.382002312871588
Granta-519,11455910,0.302072347623865
LCLC-103H,10385095,1.2650204488740564
HEC-59,54649381,3.861109001326165
OVTOKO,135411,0.4380165674523987
JVM-2,3825829,3.667071447409651
KMS-12-BM,54618771,-0.8802136937205215
SK-MEL-24,12001922,0.9811279957036384
KMS-34,11455910,-1.0188772923185183
SCC-9,15953870,4.1491811794097995
A-549,42642645,0.883993697279782
TOV-112D,9887053,2.1727255041557223
DU145,12001922,2.62580913406857
SiMa,11167602,1.9833509975334416
SK-MES-1,6505803,-1.6452904236752195
PE/CA-PJ49,246676,4.881777870317724
SNU-475,9926054,2.638013601993947
HuG1-N,136227924,2.3836679865505332
Jurkat,11167602,4.314009231868755
DMS 53,11396600,2.5093833662364107
NB1,136227924,2.7984479768491335
RKN,12001922,2.582060834791438
HEC-1-B,12001922,1.7614780035136628
COLO 668,24753719,3.586871518456208
SK-ES-1,135411,-0.3352461254710313
KM12,100016,6.486077549174115
SNU-16,10385095,0.9288452386070228
SW1990,135411,0.6325357507232034
Hs 852.T,54649381,3.5176554581485533
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
NU-DHL-1,135928012,0.9972695617711916
SNU-899,54649381,3.8019934686670296
GSS,100016,3.718199006522657
SW579,2746,2.8077894693149017
SNU-503,2746,2.787173124084262
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
NCI-H1339,24753719,4.233509766860094
NUGC-3,2746,2.5957810637319625
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
SK-MEL-24,15953870,4.011443634430626
JHUEM-1,12001922,1.684058505832667
JVM-2,selumetinib-GDC-0941 (4-1 mol-mol),-4.259839678662807
OPM-2,4705,3.10353547990691
A2780,9926054,1.5482217772077662
HCC38,9926054,1.7712684565891563
PaTu 8902,136227924,3.2072125986231117
Hs 852.T,2746,1.815262794144644
NCI-H2444,136227924,3.2293818919988153
SUP-HD1,15953870,4.016157078943499
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
SK-LU-1,49836020,-1.7403396635124715
BT 147,6505803,-5.108349885338799
Hs 611.T,12001922,0.9714328775162276
Calu-6,387447,-3.025554321131701
AML-193,136227331,3.928096776967208
LOU-NH91,100016,8.416108067142021
Hs 683,54618771,0.8006472003548896
HT-1197,4705,3.093520040309316
BFTC-909,54649381,4.487285574329416
Capan-2,12001922,2.324988045090678
Caki-2,10385095,4.329135402221186
SR,3825829,3.762519597646996
JHOS-2,9926054,1.95390752128008
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
MDA-MB-157,100016,3.517936084480814
CAL-51,15953870,3.220977372988981
H-STS,10385095,1.1550393753572457
HEC-59,136227924,4.443118393205084
NCI-H1385,135423438,1.627035115180022
NCI-H1693,11455910,0.7254587825692573
DU4475,136227924,1.4993153773488237
HT-1080,selumetinib-GDC-0941 (4-1 mol-mol),1.1211488481166476
Panc 03.27,136227924,3.110606575361216
TE-15,2746,3.020954904357082
DMS 114,15953870,3.8301924596606582
NCI-H838,11167602,1.8804093923167309
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
HEC-1-A,387447,-3.9278073424840274
OVSAHO,3825829,4.33503580639277
KMS-18,387447,-4.868104896908412
VMRC-RCW,selumetinib-GDC-0941 (4-1 mol-mol),3.3415688059991537
HCC78,selumetinib-GDC-0941 (4-1 mol-mol),2.9308548857555303
TALL-1 [Human adult T-ALL],4705,3.508136996580395
A-204,10385095,-0.0930629845983446
AU565,12001922,1.255153902569356
SW948,24753719,4.222068008445673
KYSE-150,42642645,0.5805353641361395
HEC-1-B,9926054,2.0295913011539173
253J-BV,387447,-4.3092279124433865
SNU-466,15953870,3.5192248528991215
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
CMK,selumetinib-GDC-0941 (4-1 mol-mol),2.84334284857712
SCC-9,6505803,-0.8932206272709824
Hs 729.T,4705,3.584127080125275
Panc 03.27,11396600,3.3574447393288547
HuG1-N,387447,-5.779372940824672
DEL,selumetinib-GDC-0941 (4-1 mol-mol),2.6612594732504475
RMG-I,selumetinib-GDC-0941 (4-1 mol-mol),3.743143666757181
SUP-B15,9926054,1.7233676505424833
KM12,54618771,2.3555448487565247
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
KO52,10385095,0.862604455305029
YD-15,9887053,6.205576358236465
ES-2,42642645,1.9481348104306395
A-375,135411,0.6366609875542943
Panc 02.03,6505803,-1.93196111296706
OVCAR-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.7048742493039822
LS180,100016,6.005443229591697
Calu-3,11455910,0.8473272312384381
NH-6,15953870,3.93195788486603
BICR 56,387447,-3.586463092237337
RPMI-8402,15953870,2.1946861333823677
SW579,11396600,3.356641244231253
SK-CO-1,42642645,0.466262192383588
NCI-H146,42642645,1.3339409860624971
SNU-620,11396600,4.54842563346304
Hs 746.T,135411,1.2994424668692373
DOV13,12001922,2.3038736291038857
SCaBER,3825829,3.8081578463772496
LOU-NH91,387447,-3.4249375140388247
NCI-H460,6505803,-0.4074860596498978
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
BT 232,4705,3.775264883664604
SNU-886,42642645,0.8705530909872051
BT 224,136227924,4.003699925469014
LS123,135411,0.2583261289474444
BT 504,387447,-4.821883327941117
PK-1,387447,-3.905660984584684
NCI-H1792,10385095,1.4616161754759327
SNG-M,246676,4.426055935007725
JHUEM-1,15953870,3.7236524190335007
HCT 116,3825829,4.252279133905312
PaTu 8988s,42642645,0.9870759100571196
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
SK-CO-1,12001922,1.782153173177779
Hs 944.T,100016,5.802201252997301
LOX-IMVI,54618771,-0.8031507578309087
DAN-G,9927531,4.82875872277198
Namalwa,9927531,3.1365070733929663
BT 440,11167602,1.2625640094474482
UO-31,9926054,1.6709527378064972
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
OVCAR-8,3825829,4.040953856189254
HPB-ALL,9927531,5.02886546731598
HOP-62,15953870,3.4456314683727154
Peer,11396600,1.9228051784431397
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
CL-11,selumetinib-GDC-0941 (4-1 mol-mol),-0.9577137132947868
SIG-M5,24753719,3.8499837054147656
NCI-H1355,136227331,3.624687432922337
OCI-Ly3,54618771,0.9426860423184806
JMSU-1,3825829,3.614347342697906
NCI-H1184,3825829,4.026961757949262
SNU-1105,11167602,4.397999517431836
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
KO52,100016,6.24417827042609
MOLM-13,9927531,3.44947203831576
Panc 10.05,4705,4.9433650756166685
SNU-886,387447,-3.9367278767128617
SNU-407,100016,6.489561303898527
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
NCO2,387447,-5.467195701538589
BT-20,9926054,1.9620105743223175
JHOS-2,2746,4.554227628602608
SET-2,12001922,1.3771697775776517
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
P12-Ichikawa,15953870,2.4394502057996417
SUP-HD1,100016,7.0046366432620735
SNU-719,387447,-3.508056175019648
T98G,3825829,3.773056601629321
COLO 829,selumetinib-GDC-0941 (4-1 mol-mol),-1.0343545456738177
TOV-112D,387447,-4.742704707237927
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
Hs 936.T,24753719,4.451311160426746
HEL,12001922,1.658840092002429
NCI-H716,15953870,4.3589430553409185
HEL,10385095,1.0320529067741009
SiMa,24753719,1.4793957520378191
ME-1 [Human leukemia],54649381,3.0215738019742173
NCI-H2106,11396600,2.567316038119924
NU-DUL-1,11396600,2.3602642092623753
RKN,9926054,2.8101544562472056
NCI-H1395,9926054,1.836702615994444
NCI-H1666,11455910,-0.2695956952552506
Ri-1,3825829,3.218260810941893
EC-GI-10,12001922,2.379133274281777
OVCAR-8,100016,5.760214455598188
NUGC-4,9926054,2.05156938319837
COR-L105,4705,0.5312031062005766
JHH-6,9927531,5.6306250844291075
Jurkat,6505803,0.70436685648012
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
NCI-H520,3825829,4.101892879518108
KG-1-C,9926054,3.438726286073136
BT 239,135928012,3.5752215268119003
NCI-H2085,54649381,4.0095467972527965
Hs 578T,49836020,0.6847429303234678
MFE-296,246676,4.375622879184601
BT 330,54618771,1.126600316617638
RPMI-8226,135411,0.5567590566750303
NCI-H1703,12001922,2.2411034990553427
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
Raji,11396600,3.2888358336472496
HeLa,54618771,0.9271666044907572
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
SNU-503,54618771,1.215393479173298
HT,135411,0.2620483590690934
SNU-387,100016,7.682207014450764
PE/CA-PJ41 (clone D2),24753719,4.254731595705647
8305C,135411,0.7414640099029057
NCI-H2228,15953870,3.293528464415493
SNU-620,9926054,1.6234040218368857
HEC-251,9926054,2.414490090670839
BT 444,54649381,4.528641444672739
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
Capan-1,10385095,2.965633532815102
SCC-9,24753719,4.411411644196846
QGP-1,9926054,1.84722301836143
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
HCC1438,100016,5.852637802531623
MIA PaCa-2,135423438,2.2894715060157553
ESS-1,49836020,-4.193111027878734
RPMI-8402,3825829,2.8272382949394053
BT 330,42642645,0.9623973470262224
KMS-11,selumetinib-GDC-0941 (4-1 mol-mol),1.0292581351367205
Yamato-SS,2746,2.81924703396879
SW1353,136227924,3.029116785491403
Panc 03.27,4705,3.85101081283364
MOR/CPR,44197249,3.8890673109188874
KO52,135411,0.3217608625451301
BT-549,9926054,1.9687680834705423
KMS-20,54618771,0.3177440488164709
NCI-H2052,12001922,1.4030856163019476
IST-Mes1,24753719,4.106786270688489
NCI-H211,44197249,1.1030149791648227
Caki-1,10385095,2.9849389864820473
OV-90,12001922,2.30498457428582
DAN-G,24753719,4.221870013489763
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
M-07e,11396600,2.6873765044270463
SW1088,54618771,1.1113850453219438
NCI-H2126,9926054,2.0707718665056456
TE-15,9926054,1.8189889434505215
CW-2,3825829,4.020764983058887
A2780,11455910,-0.8495199814745813
HD-MY-Z,387447,-5.134052723603236
ST486,10385095,0.6554259467266613
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
KE-97,11167602,2.214438718590508
JJN-3,9926054,1.1995633611794354
ONS-76,387447,-4.115404850127739
SNU-308,100016,6.582722131637771
SH-10-TC,24753719,4.195244142324667
NCI-H522,100016,6.692385014202011
YH-13,2746,3.803826628530811
SNU-C4,42642645,1.6040710853877287
RL95-2,54649381,3.667477044937513
KP-3,54618771,0.4281141975114925
MDA-MB-435S,42642645,1.0001985862598834
NCI-H1299,100016,6.953805951258825
SK-LMS-1,136227924,4.704854352606181
PaTu 8902,387447,-3.44390255134181
JIMT-1,3825829,5.589584621729448
J82,387447,-5.163817583067923
SNU-61,100016,6.106397388471953
Hs 888.T,11167602,2.912486877165088
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
HuH-1,6505803,-0.939416670904982
BICR 16,54618771,0.7733031407883998
MCAS,11396600,3.718076439368648
LAMA-84,10385095,1.2024516707569957
MDA-MB-435S,selumetinib-GDC-0941 (4-1 mol-mol),0.7675119040231712
CAL-12T,9926054,1.6569209752811729
ONCO-DG-1,12001922,1.8431474934853176
SW620,11455910,-0.2228085222725968
A4/Fukuda,12001922,1.2276815023009988
SK-MEL-2,42642645,1.9027852819088145
NCI-H1915,136227924,2.449863082820113
HEC-265,136227924,3.2525592636436405
OC 314,9926054,1.7783261777640869
SNU-1196,24753719,5.368207599086299
MOTN-1,4705,3.315167180619075
KMH-2,387447,-5.191236757244743
PF-382,9887053,3.994345366087283
Hs 888.Lu,12001922,3.1108523340401995
A-253,9887053,4.22695596945182
COR-L95,387447,-4.370301659619954
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
SEM,387447,-5.877720306537758
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
5637,24753719,4.154782017420858
GDM-1,136227924,3.363011715884638
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
OVK18,24753719,3.9291794932307336
VM-CUB-1,136227924,2.7643713240945016
BV-173,100016,4.070459829867503
NCI-H1299,9887053,5.800538449025383
UACC-62,136227331,3.8337503750077175
MM1.S,49836020,3.8296017324588942
SNU-685,42642645,1.256997957714878
SCC-9,10385095,1.4052834583911455
F-36P,24753719,4.27265638786198
IGROV-1,49836020,5.658436828096057
MKN7,54618771,2.9720813941878577
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
BT 428,4705,1.6502431761366996
MOLP-2,11455910,1.1959894171141363
A-204,24753719,4.486389218856005
M059K,136227924,2.883059674155944
B-CPAP,387447,-4.237504830751881
DMS 114,136227924,2.8316140416519664
HT115,10385095,2.886361535276013
SNU-46,12001922,2.3071175817410476
DLD-1,54649381,3.965811040267792
MFE-296,selumetinib-GDC-0941 (4-1 mol-mol),2.628937371578258
L-540,11455910,-0.1938391362250027
CAL-85-1,11396600,3.0340075631394248
WM793,6505803,-1.695252066312567
MOLT-13,15953870,3.025033790462738
23132/87,136227924,2.929197271565677
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
SK-MEL-30,15953870,4.7000153731719205
REC-1,9887053,4.003103851529854
G-361,24753719,4.309851667537251
HCC1419,24753719,4.227307108666
HCC366,135411,0.8187090497406451
WM88,3825829,4.299563751491245
CW-2,15953870,2.735162072951353
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
TE-15,11396600,3.8567248680954056
Ri-1,9887053,2.359250902526285
MeWo,11396600,3.146503563655223
NCI-H647,135423438,3.3344215247990507
T24,42642645,1.542467754528259
NCI-H2023,100016,7.201065180404722
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
Lu-99,100016,4.341210602126273
VMRC-RCZ,3825829,4.6512942183149875
RCH-ACV,387447,-4.01100204029626
DOV13,24753719,4.184041404375166
HCC1438,10385095,0.8016310732930643
HCC1937,136227924,3.58866664774513
Jurkat,selumetinib-GDC-0941 (4-1 mol-mol),2.512422287113006
JL-1,387447,-1.945068321590859
WM983B,12001922,1.1321510020540164
SNU-410,42642645,1.7213694286184011
TE-1,54618771,1.3906017960660586
HSC-3,49836020,-1.9036219787804456
CAL-12T,11455910,1.8992809146905865
CHP-212,9927531,5.318398541001747
Hs 746.T,9927531,5.239357337613853
NCI-H2126,12001922,1.9300208973781172
HOP-92,9926054,1.661169949591577
RVH-421,2746,3.1689695044320056
TT,11455910,1.6357775292121417
EKVX,49836020,5.428301745137177
NCI-H1755,135411,2.478221415571617
NCI-H747,54618771,0.1335600477139397
Panc 10.05,42642645,1.2891752371687342
DU145,136227924,5.593457102459236
HEC-1-B,387447,-4.842588513106762
VCaP,selumetinib-GDC-0941 (4-1 mol-mol),1.6951262679306962
Detroit 562,54618771,-0.8917291521267056
NCI-H1373,15953870,3.2978476143523525
SNU-1079,9926054,1.5049009904469195
YD-8,9926054,2.068126295394322
NALM-6,11396600,2.9362643003919975
NCI-H1734,387447,-5.055307677294442
SNU-1214,9926054,3.9057313084396656
LMSU,4705,3.840410851100799
PK-59,24753719,4.213783257625297
RPMI-8402,10385095,1.0671050599141887
ONCO-DG-1,11396600,3.950887665043145
NCI-H322,100016,6.362238943247445
DB,11455910,-0.1853401051603744
JM-1,12001922,1.1772658700026328
MEC-1,11396600,2.4763898883602384
OE21,2746,3.2562317048816363
H-STS,12001922,1.5454673867103017
SUP-HD1,2746,2.2026290919231055
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827
KYSE-70,11396600,3.829938839575827
BT 428,9887053,4.346878495583028
MV4-11,42642645,-6.378298022112773
LS513,136227924,2.4637797835127793
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
SNU-738,selumetinib-GDC-0941 (4-1 mol-mol),2.490499311064832
SNU-886,9926054,2.2284003182480774
OCUM-1,387447,-4.779129042713062
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
SK-LU-1,6505803,-1.477995420791017
Hs 578Bst,54618771,0.4145984361233129
COV434,135411,0.3745930362298973
CCK-81,135411,0.0123304355029261
COLO 800,3825829,4.80054389265544
ESS-1,9926054,1.828443058535804
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
HPB-ALL,10385095,1.4399710108120187
SNG-M,selumetinib-GDC-0941 (4-1 mol-mol),2.713078980516464
SNU-C1,100016,6.347812039507436
HEL 92.1.7,387447,-5.259004877493087
BL-41,135411,-0.2231470735650762
786-O,9887053,4.158928075536059
Panc 04.03,3825829,5.002168928220905
NCI-H1563,9926054,1.9605295654487136
CAL-51,2746,3.539110169106334
JURL-MK1,100016,3.373338788856286
COLO 205,12001922,1.6804101936598892
Hs 683,135423438,3.058302675128977
BT 504,54649381,3.6811603299344418
NCI-H1734,15953870,1.790378231343731
NCI-H2126,54649381,4.398704825252912
COLO 684,136227924,2.900562305918871
WM266-4,24753719,4.092945854895752
Karpas-299,6505803,-1.557594922161658
Tm87-16,42642645,-2.0474609052342143
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
WM1799,2746,3.8578156417169542
NCI-H1563,10385095,2.0577358054307453
HL-60,9927531,5.393037826630499
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
P3HR-1,9926054,1.7849212389607798
QGP-1,24753719,4.344903542576564
SNU-216,24753719,4.261315806086272
HCC1143,42642645,1.0566197638440329
RKO,42642645,1.3055497818976145
HEL,54618771,0.7283869495698151
TE-5,387447,-5.57753998135032
GA-10,12001922,1.1091305368788935
U-CH1,selumetinib-GDC-0941 (4-1 mol-mol),2.4998386609630834
BT-20,54618771,4.093139907883374
BT 231,24753719,4.299852690221636
Capan-2,15953870,3.933825207926273
KE-37,15953870,2.357955819665911
P12-Ichikawa,9926054,1.82657661814102
BT 504,136227331,4.427068433279088
NCI-H1105,42642645,1.037258992079275
CMK,100016,5.771362707779288
BICR 18,1474550,4.416198374840753
EBC-1,387447,-3.627191847891748
HEC-151,2746,2.893075641123897
K-562,136227924,2.737847329779252
Malme-3M,49836020,-0.4276181558524726
RPMI-6666,6505803,-0.9166803455399566
HCC827,54649381,4.076273765230762
NCI-H1666,10385095,1.243907749807907
HL-60,100016,6.415560767920564
BL-70,387447,-4.876140012040821
Hs 766T,54618771,0.4813536193297115
HuT 78,135423438,1.6811720044411254
MEC-1,9887053,3.202673389446896
THP-1,9887053,1.364204769397395
T24,100016,6.183675550900896
J82,100016,6.509431143115434
BT 320,387447,-3.873135040539017
BT 224,42642645,1.5634098488486985
RPMI-8226,9926054,1.537898782638624
WM266-4,2746,2.9939940640061495
TTC-709,12001922,1.509100510592997
JM-1,135928012,4.176764785732949
KMS-12-BM,15953870,2.0453814346354577
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
KYSE-450,54618771,1.2705031609145587
SNU-620,24753719,4.282331882564318
253J,11455910,0.0349890570981946
Ri-1,6505803,0.1421500129584279
CHP-126,12001922,2.8434081460004874
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
SNU-213,9926054,2.110529432598139
BT 239,2746,2.5478715326116252
WM266-4,42642645,0.900181295737673
SU-DHL-8,100016,4.106875584244309
HT-1080,10385095,0.6979966425129256
42-MG-BA,136227924,3.1509029182486845
TE-9,12001922,2.0918020418336587
TTC-709,9887053,2.1821926159541136
SNU-C5,54649381,3.869629520470492
RL95-2,12001922,1.6461154689091368
NCI-H2444,9927531,4.993346804303282
SUP-T1,11396600,2.9540043474610287
SKM-1,11455910,-0.0252675410510007
KYSE-520,72199289,5.964996237473484
HCC2935,15953870,3.112421404920631
HCC78,15953870,4.187942278955075
RS4;11,136227924,1.742872720779967
AU565,54618771,1.1954147839624212
BT 428,6505803,-2.216718160472342
SNU-423,11455910,2.439649543978504
SNU-C5,136227924,3.8791329718590264
NCI-H520,42642645,0.4863260579261142
BT 179,387447,-4.909903523722291
Ku812,136227924,2.6493599225721742
MDA-MB-468,49836020,3.927183487044253
COR-L95,3825829,4.2210058836960265
HT-1376,100016,4.270787672820572
Rh18,11167602,3.1947375247166976
NCI-H1651,54618771,4.521553313874046
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
MES-SA,6505803,-3.213195974579349
UACC-257,24753719,4.721002106837754
FaDu,9926054,1.9668207116492555
RL95-2,54618771,0.9471315050617304
5637,9927531,3.46604374571058
CAL-85-1,135411,0.7703450767243978
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
NALM-6,135928012,3.565883061202426
CAL-29,49836020,4.434653881531219
BT-16,11396600,4.325514003074736
EFO-27,24753719,4.6250624916483405
TCC-Pan2,11455910,2.002854110835051
LXF 289,4705,5.10311909598278
Karpas-422,54618771,1.0964695949683176
JHOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.3752490539264866
CAL-85-1,49836020,1.7789600466695898
DU145,10385095,0.949692238641196
LS123,54649381,5.33335531678428
HuCC-T1,10385095,1.350448743277585
NCI-H1975,10385095,1.0404282110785523
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
T3M-10,11455910,0.8263435212921274
SK-BR-3,135928012,3.7159994767081352
SU-DHL-8,selumetinib-GDC-0941 (4-1 mol-mol),1.9311696765253152
SK-N-DZ,12001922,0.9238274843608734
AMO1,387447,-5.892458225811164
Hs 940.T,12001922,1.391657000103385
MIA PaCa-2,135928012,3.7841811685806337
SK-MM-2,4705,2.736644708232148
NCI-H28,9887053,4.161280950055318
NCI-H2087,9887053,4.243910340069795
SNU-16,15953870,2.3040141918998103
YD-8,11455910,2.3608003231552717
TUHR10TKB,54618771,-1.4225066809641267
KMS-34,54618771,-0.7533215739464646
HuP-T4,49836020,4.250504685299003
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642
COR-L95,9927531,5.207677506691081
Hs 729.T,10385095,0.8500631053471632
OC 314,11167602,2.889183254159994
JVM-3,135411,-2.070544403003672
HEC-1-B,54649381,3.688923551546755
TM-31,2746,3.629695868471985
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
FaDu,42642645,1.5338973230627893
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
SNU-601,135928012,5.790515994086994
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
LCLC-97TM1,49836020,1.9924259842665932
K029AX,246676,5.307982399914677
Ku812,11455910,-0.1088527514294285
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
HDLM-2,12001922,1.6187966717064417
HEL 92.1.7,2746,1.730022792287867
BICR 18,6505803,0.1715229764566586
EC-GI-10,11455910,2.357666913009647
HEC-1-A,11396600,3.204796240985317
YD-15,11396600,3.950136388858035
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
TE 617.T,4705,0.0619159999462867
WSU-DLCL2,135411,0.4415582339426167
NCI-H2286,135411,-0.841499566250141
EFE-184,42642645,1.9325086849429032
Panc 10.05,selumetinib-GDC-0941 (4-1 mol-mol),-0.0838909853180393
OV-90,24753719,4.229565281891426
A-549,135411,0.6793431682717198
UACC-257,11167602,2.6462198424244465
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
SIG-M5,9887053,1.921907892618564
HCC4006,3825829,4.487732431711326
BT 428,11167602,1.02406203093047
NCI-H2009,24753719,4.192950544032197
MDA-MB-468,2746,3.461391528245753
Panc 08.13,12001922,1.7433700834462942
JHOM-1,selumetinib-GDC-0941 (4-1 mol-mol),2.18755430310554
8505C,11455910,-0.1403664208341097
YAPC,11455910,1.8317787914833017
NH-6,54618771,1.535066774557613
JHH-4,100016,6.356907567320683
OVK18,selumetinib-GDC-0941 (4-1 mol-mol),1.2512103740452307
OVTOKO,100016,8.078720974707625
NB1,9926054,1.7584183979270531
SK-MEL-1,100016,6.470813601542051
EJM,24753719,3.944145631978448
U-BLC1,4705,-2.296462105953433
WSU-DLCL2,246676,4.362117975883253
WM115,4705,2.3860154683324897
NCI-H1869,3825829,5.0249554409349875
COR-L88,54618771,0.6942100062595253
Peer,11167602,0.4701356469892311
NH-6,136227331,4.3480381735805365
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
KMS-20,42642645,0.7493716009663114
U-937,selumetinib-GDC-0941 (4-1 mol-mol),2.5351871004530713
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
ZR-75-1,10385095,1.3245901682852046
COLO 680N,135411,0.8302154922889711
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
MJ,11455910,1.0370030045754386
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
SK-BR-3,11396600,4.1222338228644695
MG-63,100016,6.791496028485962
A101D,387447,-5.179338881938456
Hs 746.T,12001922,2.1881603173512936
A-375,387447,-3.5908810872536066
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
EBC-1,49836020,4.041761576127936
JL-1,100016,8.572446789328106
SK-BR-3,4705,1.1013734177792738
SW1417,9926054,1.9097255829508144
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
SNU-398,2746,3.3199250937792866
ME-1 [Human leukemia],136227924,3.8385097232305103
CAL-62,12001922,2.1383279245882747
OV7,54618771,3.08705703189789
C2BBe1,387447,-4.815000038755363
TE-6,387447,-3.2101916315240873
JHOS-2,136227924,2.6850771580880783
SNU-761,136227924,3.0890701215325085
KPL-1,15953870,4.274810061267122
NCI-H1869,15953870,3.614398642782243
OVCAR-8,24753719,4.601270085518873
NCI-H23,4705,3.013128646573162
COV362,100016,7.994124175315401
CAL-54,9926054,1.984720179187459
HEY A8,54618771,0.8975201265586629
Panc 04.03,246676,4.5210437514033615
KYM-1,12001922,1.495322615929134
SK-OV-3,135411,1.6318689765112546
KE-97,11455910,0.2852885194409614
COLO 205,3825829,3.776979482332574
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
769-P,3825829,4.3805602076793075
LXF 289,42642645,0.485507292149712
KMS-18,9926054,1.804034237605838
SNU-1079,136227924,2.5648904820695693
COV362,135423438,3.2580935345525672
COLO 668,12001922,1.504534355585137
SK-N-DZ,54618771,1.6513533063720298
COLO 320,3825829,3.838237093759711
MOLM-13,136227924,1.704251401840426
TE-15,4705,1.329912019407035
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
MOLP-2,2746,2.18726921703514
ESS-1,11455910,0.1046831634026344
U2OS,136227924,2.232158663555595
HeLa,100016,5.8653655502295
A-172,42642645,0.4952207954303959
SW1088,42642645,0.5386820566769255
KCL-22,100016,3.971728515649248
NCI-H889,11396600,3.5135706355172016
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
KPL-1,9927531,4.948797048783531
HOP-92,136227924,3.2563886907656725
GCT,11167602,2.068911089346331
KMRC-2,10385095,2.7581688365802917
BT 428,2746,2.3155764073240177
NCI-H446,11455910,-0.4036414129969405
Karpas-422,11167602,5.140993072754682
HH [Human lymphoma],100016,3.957825935624259
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
SW948,2746,1.2183078272507333
NCI-H2087,15953870,3.2507904502912743
BT 286,6505803,-2.395900359039176
CCK-81,11455910,1.1979404959065163
NCI-H226,9926054,2.2620908490117526
UM-UC-1,4705,3.153349109118703
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
HCC1500,6505803,-1.3038553273576796
Hs 852.T,387447,-2.852402833566069
JHOM-1,11455910,0.6774290111714439
LP-1,6505803,0.6581900547283019
NCI-H1666,135928012,5.287847480706352
SNU-C5,135411,0.0907365810157003
NCI-H1395,54649381,3.0165140825256884
MM1.S,3825829,4.169189674904385
JM-1,24753719,1.6485500810507543
647V,387447,-4.902578453861827
HCC1419,3825829,4.344028613262655
COLO 792,12001922,0.9942941289918464
PANC-1,135411,5.06554614706648
HCC1588,54649381,3.837378950831829
SNU-213,100016,6.954868306659309
COLO 668,3825829,4.015753695019376
LS1034,387447,-4.102694249904828
NCI-H747,135411,2.912270314051426
BT 333,387447,-4.583252572492687
JMSU-1,387447,-4.7843170709495295
KMS-26,3825829,2.5270100411904264
NCI-H2196,3825829,4.206354506385182
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
PaTu 8988t,54618771,0.599962301527202
SW1417,9927531,5.165268920139929
NCI-H1155,11396600,2.7094100495435165
OVCAR-4,3825829,5.195458986122372
NCI-H226,selumetinib-GDC-0941 (4-1 mol-mol),3.612309653965627
Hs 294T,100016,6.337209257885702
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
CAL-85-1,3825829,4.0461732785581885
NCI-H1666,9887053,5.868411051573696
HT115,9877608,5.791889645309291
NCI-H1385,24753719,1.900238363016148
NCI-H2110,11167602,4.9824234878437395
SW1417,11455910,2.2970669346586168
MPP 89,9926054,1.8831902537321672
2004,135928012,3.7459619106467854
NCI-H1105,135423438,2.0106385414009025
DK-MG,6505803,1.1282501869631134
SUP-M2,6505803,-1.2925324333028148
HCC38,100016,6.688694515924342
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
COR-L105,11167602,4.878993593502554
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
JHH-6,42642645,1.8324509286670403
EJM,10385095,0.7131434808495797
RVH-421,4705,3.3547577531124175
COR-L279,135423438,1.6988524729087828
NCI-H650,9926054,2.0416939641657175
BT 416,12001922,1.667963405341588
VMRC-RCW,54649381,4.560016313743058
BT 179,11455910,0.244595682570849
BICR 16,387447,-2.966842975174554
HeLa,135411,1.4034383621508255
HuCC-T1,42642645,1.759871158066272
NCI-H1395,100016,6.569605836811141
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
Jurkat,100016,5.920987823967134
EFE-184,selumetinib-GDC-0941 (4-1 mol-mol),4.957759622991816
KPL-1,135423438,2.328481946215466
8-MG-BA,3825829,4.017566415867284
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
RERF-LC-A1,11396600,3.681688949161253
GB-1,6505803,1.9427567614251149
SNU-119,11396600,3.5657342992920547
DB,135928012,3.223982508994008
Daudi,11455910,-1.173613913103254
MHH-NB-11,136227924,1.3020282745517038
NCI-H747,2746,2.5698832282909665
MDA-MB-157,9926054,2.0716850398098368
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
TTC-709,11396600,2.7906512267667325
Kasumi-2,135411,-1.6102115279025644
JURL-MK1,9926054,0.5883612269898851
NCI-H2228,42642645,-0.082274231799226
SNU-685,15953870,4.652036294968
HT-55,2746,2.9467453757111848
Karpas-422,387447,-5.164381252871863
AU565,6505803,-0.7592801042803803
SUP-M2,54618771,0.2858718534698647
BICR 56,136227924,3.153782585129781
WM88,42642645,0.6445252364672451
SK-N-BE(2),11167602,1.930499183272272
DLD-1,24753719,4.894891523802126
C2BBe1,12001922,1.656470935488987
NB1,11396600,3.5328020412692376
TUHR14TKB,136227331,4.279193413134127
MOLM-6,selumetinib-GDC-0941 (4-1 mol-mol),0.1291930510848496
A-673,136227924,1.815433973878695
SU-DHL-1,54649381,3.644517842316546
SCC-9,100016,6.423023301160456
NCI-H2141,3825829,4.046208623846932
KYM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.885650004060589
NCI-H2196,387447,-3.892291433138439
BT 504,4705,3.101925484309532
JHUEM-7,15953870,4.009699489789049
Karpas-422,10385095,1.106745644266175
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
LC-1/sq-SF,10385095,1.4235715068677564
HCC38,54618771,2.492060866479401
BT 112,387447,-5.550366096650992
SNU-1,3825829,3.558466268148627
JHOM-1,10385095,2.4213386194216007
SK-MEL-3,42642645,1.5354776601943807
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
SUIT-2,44197249,3.8764143883383224
NCI-H23,9887053,5.166693268278415
Hs 683,2746,3.210764654839646
NCI-H2228,9926054,2.036678685605589
DOV13,54618771,0.905613637796649
BICR 18,54618771,1.6226277377850309
JK-1,44498493,6.05542248479131
HCC1171,24753719,4.346022619119034
SK-N-SH,10385095,0.0454755158879893
BT 231,11396600,2.44608853396947
PL-21,10385095,1.1291915165256132
NCI-H520,11396600,3.7776798770198594
NCI-H522,9927531,4.749051096908956
U-251MG,24753719,5.108579480796019
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
KNS-81,135411,3.740981069141683
TE 441.T,42642645,-0.7295119160835342
Calu-1,11167602,2.6874692075040816
HCC1954,387447,-4.682580475299967
SK-MES-1,136227331,4.390258592428933
NCI-H661,9926054,1.7811448977738318
Hs 294T,15953870,3.8963441435419703
SJSA-1,135423438,1.6287779060663292
SNU-C1,3825829,3.980716473267423
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
CFPAC-1,24753719,4.623602158880275
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
NCI-H747,24753719,4.371264768005184
SK-MEL-2,10385095,1.309860426299206
253J,9927531,4.121406347708415
BV-173,11455910,0.1396519641049683
Hs 888.T,6505803,-0.3251966852868098
SK-MEL-24,24753719,3.524117271265627
SH-10-TC,9927531,5.280985634466932
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
NCI-H2171,135411,0.036573209368321
BT 359,12001922,1.1389821806423004
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
NCI-H358,135423438,2.3856947945666587
VM-CUB-1,15953870,3.353826832507298
A2058,387447,-3.663773169306
NALM-6,6505803,0.3598749037472731
DU145,15953870,4.361451151024508
YD-8,73707440,4.452607469919264
KMS-27,42642645,1.0749697510061529
Tm87-16,136227924,1.7990989939748585
DMS 273,10385095,0.5027476993233067
Hs 683,42642645,-0.321926076165572
TUHR4TKB,10385095,1.8119484720686647
HCC366,387447,-4.096407519322278
OVISE,42642645,1.7980918591344808
SNU-1076,135423438,4.345092573001933
NCI-H520,9926054,1.793691213544428
23132/87,135411,0.1577913323823315
SNU-308,12001922,2.139310360120992
EFE-184,2746,3.7272239224015697
NALM-6,135411,-2.127207991469936
NB1,54649381,4.242784419676278
NCI-H727,387447,-3.6268426938273457
HDLM-2,15953870,2.508458665439202
TYK-nu,387447,-4.931959218422222
KYSE-450,387447,-4.1038253742642725
OV7,135411,0.5071551006740256
HT-1080,15953870,3.650960703297201
COV434,9887053,3.480860318299462
NCI-H727,3825829,4.725008182252989
BHT-101,100016,6.007811941047966
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
G-402,135928012,5.126397260544081
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
GCT,42642645,0.9770055866451108
BT 112,24753719,4.155930680700891
BFTC-909,12001922,1.803559970478093
SNU-899,3825829,4.094939389165457
HEC-108,24753719,4.945792887212488
T98G,1474550,5.862074316554119
NCI-H322,9926054,1.834077312686318
COLO 800,54618771,0.8952139014407665
SUP-T11,54649381,3.55477207532117
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
MCAS,135411,0.3992258142971907
HCC95,135411,0.9114756545199342
JHUEM-1,11455910,-0.2565923916493475
NCI-H1792,24753719,5.861700790005554
NCI-H520,10385095,1.0283003388284149
TE-9,135411,0.4649210560490445
LOX-IMVI,135411,0.7340032834996221
JHH-5,24753719,3.9547152551319567
CAMA-1,10385095,1.2422213124573045
OCI-AML-5,135423438,1.842047430976123
8505C,387447,-5.398947944109461
HOS,6505803,0.7785174414799726
BT 504,136227924,2.4961671253802957
CAMA-1,387447,-4.5861768245202015
Ci-1,9926054,1.7408061846273166
BT 444,11455910,1.1196809594429316
HCC1395,11396600,4.211353464920311
EKVX,387447,-2.291182872299631
SNU-C1,54618771,0.8389876741679191
BT 359,4705,3.8493251509059
DMS 454,15953870,2.350173283726864
BxPC-3,6505803,-3.0514917868960767
BT 359,15953870,4.1713351072613305
MPP 89,15953870,3.961072638438732
SNU-761,387447,-3.603410290917655
MHH-ES-1,44197249,3.70244207851584
NCI-H2110,135928012,4.809338380726518
NCI-H1581,42642645,-0.3810166111745459
NCI-H2029,4705,3.1961427877566173
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
NCI-H1755,2746,2.93988031593663
SK-MES-1,24753719,3.7681083522004464
KP-4,135411,0.2840057840675377
Hep 3B2.1-7,54618771,-0.219926675598239
KP-N-SI9s,135411,0.1313762004540259
OVISE,12001922,2.261742632923514
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
Hs 888.Lu,6505803,0.1464853570019931
HCT 15,11455910,-0.2039943057976136
KYSE-180,9887053,4.517108897198139
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
HCC15,54618771,1.6567762934530044
SNU-16,9926054,1.81351744877406
BT 245,15953870,3.843140095574177
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
Kasumi-2,4705,3.579279614719375
YD-15,387447,-4.197267666691031
SF268,11167602,2.138708916654699
CAL-12T,24753719,4.611079410668424
Hep-G2,44498493,5.1826431923254335
OAW42,387447,-3.273094128668254
BT 216,10385095,1.421919147273648
U-BLC1,10385095,1.1292120884131938
NCI-H747,135423438,1.6378864766896262
JHUEM-1,9887053,0.0424366322654341
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
KYSE-180,3825829,3.0319007091325267
BT 359,6505803,3.620605516662926
UO-31,54618771,0.667805712786254
SF295,49836020,5.953375339581455
WM88,11455910,0.2100258474381383
HuP-T3,54618771,0.8132197250487964
COLO 668,135423438,2.664391389217799
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
SH-4,135423438,4.390344914590639
SNU-216,10385095,1.0317587818104637
8505C,9927531,4.3206227244137745
TYK-nu,11167602,1.6438072622140507
Rh30,136227924,4.165333500464175
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
Hs 729.T,100016,6.726636381823557
ZR-75-1,11396600,4.04408078338515
EM-2,11455910,-0.237589126916505
NCI-H1869,11396600,4.813854369313605
MKN1,10385095,1.5634257957183793
NCI-H28,44494015,-5.3692657980463965
HCC1395,54618771,2.360286103240852
SNU-61,15953870,3.2687219409332657
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
RPMI-6666,11455910,2.3485395047161783
BT 330,11396600,1.7759393171748088
KE-39,100016,6.665188081944046
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
SW948,3825829,4.076553662425885
SK-MEL-2,2746,3.33396317139844
NCI-H1373,136227331,6.256455591315265
Panc 05.04,387447,-2.80170329149952
LCLC-97TM1,10385095,1.2595894653665305
U-251MG,15953870,3.759122667587819
CAL-120,9877608,5.792965508852075
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
Becker,6505803,-1.1443258225494983
LOX-IMVI,42642645,1.0245315252626934
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
PaTu 8988t,9926054,1.9241127892750265
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
WM266-4,12001922,1.3397104538799205
JK-1,4705,2.217809938793497
NOMO-1,6505803,0.1224616163714439
SNU-387,11455910,4.584937750024463
A-673,11396600,2.723776149104898
SK-N-MC,72199289,4.349528374595986
HCC2935,135423438,1.9147959056392905
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
Hs 940.T,4705,3.481010414742296
LN-18,9926054,0.598983976680667
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
TE-8,2746,1.7722164747559497
NCI-H508,15953870,3.350350094923197
MV4-11,10385095,0.4660551916464017
HCC1395,24753719,4.820074852548623
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
COLO 668,11396600,3.0895910074964856
MCAS,10385095,0.5712472701663329
MEC-1,9926054,1.8123305243841612
KMM-1,135411,1.4640935602572651
NCI-H526,100016,5.298819017471169
A-549,24753719,4.621771717936227
NCI-H292,9927531,4.942242070848643
SNU-489,387447,-4.172406042946091
SNU-601,10385095,1.2470698415779116
TF-1,54618771,1.249031073864191
HT-144,6505803,-0.5901763284760635
BT 228,9926054,2.418157139092261
MEC-1,135411,0.3255583108120364
HuT 78,9887053,1.4751024014992844
NCI-H810,100016,4.22640705156995
DOV13,11396600,3.62542872436994
HMC-1-8,11455910,0.6557155975266148
KCL-22,54649381,3.624544621774499
NCI-H1341,136227924,2.213362476241057
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
ME-1 [Human leukemia],24753719,3.9162148348734385
TT,11396600,4.947180830424627
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
COLO 792,387447,-5.258695621768076
HuH-6,135423438,1.011063885151324
SBC-5,24753719,5.823724927288436
Capan-1,11455910,2.2189515930780312
MDA-MB-468,54618771,2.476122879099443
KO52,4705,3.2027960620979576
MKN1,3825829,4.385928470075506
SK-ES-1,136227924,2.7143313352480143
TALL-1 [Human adult T-ALL],387447,-5.5724048281359195
697,2746,0.8778149651277364
KNS-62,11167602,2.252686967098562
CAL-27,2746,3.342989034660484
AN3-CA,24753719,4.3754867797298544
KMM-1,11455910,2.3238855811198262
SK-ES-1,9887053,1.6661666698426836
GaMG,387447,-3.8071849018357016
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
RCC10RGB,3825829,4.92777419243283
BHT-101,15953870,3.3900603048359628
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
KMS-11,24753719,4.269419300798277
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
Hs 611.T,9926054,1.8280926290746755
RERF-LC-Ad2,11167602,5.947765325830758
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
HuG1-N,12001922,1.3963118443317126
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
TC-71,6505803,0.7879550085796516
NB4,selumetinib-GDC-0941 (4-1 mol-mol),-0.8849476640562556
JK-1,3825829,3.583742829916569
NCI-H520,24753719,4.403096106170392
DU4475,24753719,3.9456883650846266
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
CW-2,54618771,-1.320149123720888
HEC-1-A,136227331,4.058497716463453
MDA-MB-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.5607130395634891
SNU-1105,135928012,3.770168563335305
COLO 800,100016,6.663651406564157
SW1088,11455910,0.1121601149091921
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
JHH-4,11455910,0.4294886649556081
Hs 766T,24753719,5.233332005240799
Panc 03.27,54618771,0.0634128871766815
Reh,6505803,1.7551372132350431
SNU-1079,15953870,2.2216848714755644
SNU-1,54618771,0.7827346323778329
SK-ES-1,9927531,4.061932878113416
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
SNB-75,15953870,3.534658652359115
CL-11,24753719,3.552982050369589
KP-N-YN,9927531,3.406811023385209
SNU-407,12001922,2.2443670057545724
SNU-1033,24753719,4.01001604133428
HT,12001922,1.2978364764397456
DMS 114,2746,3.518384680762127
KYO-1,6505803,0.8445463549156219
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
ALL-SIL,136227924,2.439460537978413
PL-21,2746,1.912238920638634
VCaP,11396600,5.246887519153865
KYSE-150,4705,4.321978699991397
BHT-101,387447,-4.024280990459913
SK-MEL-24,3825829,4.459279909559526
NCI-H1869,54618771,2.934235316942264
ALL-SIL,9887053,2.3955838154567703
PSN1,100016,3.987578982943132
SCC-25,15953870,3.436709615565111
NCI-H322,135423438,4.4893674583899505
ALL-SIL,9927531,4.600523700119875
Kelly,2746,1.4763853988158775
Panc 04.03,2746,3.3610494767062513
MOTN-1,100016,6.2802968176710445
BT 159,54618771,0.7710223588064036
WM88,12001922,1.5033741634608095
KMS-12-BM,54649381,3.2424778032361186
NCI-H2126,135423438,4.586735604556358
IST-Mes1,42642645,0.3467837133172653
KMS-27,6505803,-0.687237988201334
COLO 800,136227924,2.9949932078985437
HEL 92.1.7,6505803,1.0440378201694858
SNU-1033,12001922,1.3471825847750112
Hs 611.T,15953870,4.69578906059893
SH-10-TC,12001922,3.0373903088359673
Kasumi-2,42642645,-0.9002721123779656
KNS-60,136227924,2.463930704521007
WM115,54618771,0.9043395114740442
Karpas-422,9926054,1.7787061620357676
BT-20,11396600,3.3625164921440884
A-673,42642645,-0.8052568071576633
NB4,49836020,-4.1463475414292
HT-1080,12001922,1.6844004164203288
LNCaP clone FGC,100016,6.505127339133147
MOLP-2,9887053,3.683836865014703
HCC44,54649381,3.4331046862978214
KNS-81,54618771,0.6221036403024617
BT 271,9927531,5.398706995408204
NCI-H1623,42642645,0.9313727170286358
G-402,135423438,-0.2175800815480045
OVTOKO,9887053,6.132057443095758
NCI-H1341,24753719,4.054742398972124
A4/Fukuda,135928012,2.23734461349398
COLO 201,6505803,-2.3014705342843365
Ci-1,10385095,0.9596805208950844
KYM-1,3825829,3.681102948390849
JK-1,9926054,1.218283183105194
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
P31/FUJ,135928012,4.893710575363991
UM-UC-3,11167602,1.6394154211216836
RPMI-8402,11455910,1.2135317922717286
CAL-85-1,135423438,4.043372499873488
UM-UC-3,246676,5.7049600513092456
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
Panc 08.13,135411,0.6242343529937433
NCI-H226,54649381,4.639442174818557
HCC202,2746,3.341807216301485
GSS,3825829,2.772967132966308
EFO-27,135411,0.9008731550993504
COLO 829,12001922,2.2494559999764325
ZR-75-30,54618771,0.9428020193636316
KMS-27,135411,0.1575765990656979
T-47D,100016,6.980531714745858
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
HuCC-T1,9926054,1.7884670483643574
ONS-76,54649381,4.0197495944656465
DLD-1,136227924,3.626313463652563
HOS,54618771,1.216646065025966
JHUEM-1,4705,3.281034175975557
SK-UT-1,10385095,1.6809894125740852
NCI-H1666,42642645,1.1867635900224789
HCC202,44498493,4.349026498274847
T98G,135411,0.5395204002071603
EFE-184,3825829,4.518103838762878
RVH-421,135423438,4.562658125390885
SF539,4705,3.4621418210440296
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
KM12,9926054,1.9213576714139085
LoVo,10385095,1.3603816893768768
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
CCK-81,9926054,1.6277365454540644
MOLM-13,42642645,-6.876168570605093
MOLM-13,6505803,-3.0527041000310255
PE/CA-PJ49,15953870,3.8672773648321015
SCC-9,9927531,5.254709651648818
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
BT-20,44498493,4.427046206906442
KP-2,387447,-4.012668991222254
TCC-Pan2,12001922,2.8722002566643843
TE-11,selumetinib-GDC-0941 (4-1 mol-mol),0.8389295990054343
ChaGo-K-1,135423438,3.972168514727344
COLO 829,9927531,5.213552390265391
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
NCI-H727,54618771,2.7901712320729333
NCI-H838,54618771,3.458197236352402
WM88,100016,6.2407728308576
HCC2279,3825829,3.745796690412588
SUIT-2,15953870,4.979127052854588
Kasumi-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1995459699844852
K029AX,42642645,1.5654112836378848
Hs 936.T,12001922,1.824804134649663
JHOS-2,42642645,1.5308234748873637
BT 422,42642645,1.5945612640536957
SW1417,11396600,4.42518333755826
VM-CUB-1,42642645,1.2937052816555008
HuH-6,135411,1.7993653644444905
MDA-MB-435S,10385095,1.8862945201752297
SW620,135411,0.7000850616121314
KE-39,100016,6.665188081944046
MOLM-13,54649381,3.864277780400009
HCC1954,6505803,-2.3098961788546655
BT 231,387447,-4.897581630448022
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
Sq-1,10385095,1.2921547265885305
SK-MEL-5,11455910,0.3432757840716531
HEC-6,136227924,2.983713037764577
SNU-1196,100016,6.169672174830197
U266B1,3825829,3.552038550307413
HEL,136227924,2.725456875957553
BT 245,10385095,1.400283775793094
RL,9926054,1.8760180722442283
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
L-540,9887053,3.729332880825345
A4/Fukuda,9887053,3.945623871756388
RCH-ACV,2746,0.9590882361015028
PC-3,15953870,4.209894588480111
NCI-H1734,selumetinib-GDC-0941 (4-1 mol-mol),-0.5700124177299448
Daoy,9926054,2.457854765834399
MIA PaCa-2,49836020,4.16350045307359
NCI-H1299,12001922,3.316312201562729
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
NCI-H1869,12001922,2.1512424663065692
SNG-M,54618771,1.0542976852091588
SUP-T11,6505803,1.7392273117289616
UACC-257,42642645,1.3634594926124557
NCI-H1793,42642645,0.7025453760481193
253J,54649381,3.89739771977921
SK-ES-1,246676,6.206745799744681
Toledo,135411,3.0531564845523804
5637,11396600,4.421550522360851
OCI-Ly3,9927531,4.54855652960748
Mel JuSo,54649381,4.181896317344574
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
CHP-126,9926054,1.6835442403825218
KMS-26,135411,0.6977602532774166
DU4475,136227331,3.920684597845916
DMS 454,42642645,-0.0329800851632565
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
SUP-T11,100016,5.673603064365157
RL,11396600,2.7344364548427413
NH-6,42642645,-0.7396750696986364
KYSE-510,3825829,3.4984079576895843
LXF 289,10385095,0.5776298837700374
HD-MY-Z,15953870,3.40341843750169
Hs 688(A).T,6505803,2.8960604198469206
TUHR10TKB,387447,-3.2938610949928067
JHOC-5,100016,4.009706795291197
NCI-H446,15953870,3.1278755328705965
HCC1438,136227924,3.0530124683265725
PK-45H,11396600,6.037310564900793
MOLM-6,2746,1.449988915639522
NCI-H522,4705,3.8595388748644375
U266B1,135411,0.4522647304717376
Hs 822.T,12001922,1.6272893429277095
GCT,54618771,1.7991225479555093
Hs 766T,42642645,0.6344870023566558
NCI-H460,135411,0.3374737909082799
MHH-CALL-4,12001922,2.60292711517169
SK-MEL-2,11455910,1.0662653811839238
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
SK-OV-3,54618771,2.5849230632376923
BT 232,135411,3.0273187561105757
CA46,4705,3.1649236354970154
BT 328,10385095,1.6482003129933624
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
LS1034,54618771,0.9023023463820332
NCI-H1869,2746,3.565752906078767
NB4,135411,-0.6814349798632195
BT 333,54618771,1.0971803659169013
SH-4,selumetinib-GDC-0941 (4-1 mol-mol),-0.2287581368829222
SNU-886,135928012,0.9415972865486992
KE-39,12001922,1.538248730222034
MOLM-13,135423438,-5.2048777869707035
ZR-75-1,9926054,2.043336248210882
TOV-21G,387447,-5.609056442506682
PE/CA-PJ15,136227924,2.633948596133963
KMH-2,24753719,2.762394243468006
HEL 92.1.7,54618771,1.044267286847691
NH-6,11167602,2.105969587149216
KYSE-140,15953870,3.2653213178091725
T84,54618771,0.5762306711501146
KYSE-410,10385095,1.3109396001615272
TE-1,387447,-2.863693371559293
SCC-4,15953870,2.5035492123667424
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
SNU-478,9927531,5.143977185818116
RL,selumetinib-GDC-0941 (4-1 mol-mol),2.248792439261428
NCI-H211,selumetinib-GDC-0941 (4-1 mol-mol),1.1345350253302544
NALM-6,73707440,6.057800002109687
NCI-H810,9927531,3.2474997445381693
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
42-MG-BA,6505803,-4.6954878984778885
HCT 116,54649381,3.7342869837095742
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
HOP-92,6505803,0.7885009521193799
SUP-M2,11396600,1.284411602276366
COLO 800,12001922,1.4603831505730631
HT-55,selumetinib-GDC-0941 (4-1 mol-mol),0.6831799344698409
SNU-1214,11396600,3.7056462791365847
DU4475,15953870,3.572841650803797
TF-1,100016,6.442708110888471
ECC12,54649381,3.7795573949918713
MIA PaCa-2,6505803,-3.969520749405985
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
Ri-1,10385095,0.3591008967084118
SNU-503,11167602,5.027457454632991
PE/CA-PJ49,9926054,1.8069972619127008
NB1,9887053,3.718695243203221
SK-N-FI,135411,0.686707507501241
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
OCI-Ly3,11396600,1.20620750211381
EJM,11455910,0.7170091081693915
CAL-62,135411,0.6768974596088725
SK-N-AS,100016,6.379811774246359
KG-1-C,6505803,-0.4264272439200833
SW1990,1474550,4.493069593499753
DU145,54618771,3.337458824494602
NCI-H1838,11455910,2.7014431026549386
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
DND-41,10385095,0.8865843835874836
HCC4006,246676,6.339514931848246
Namalwa,54618771,0.6847017954935718
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
KMS-34,54649381,1.472512019347838
NCI-H520,135411,0.8483952582503486
Hs 294T,11167602,6.170800692067223
A-498,135411,0.9450284346401692
Hs 578Bst,42642645,1.2916875916052444
KLE,9927531,4.8057879583658405
T3M-10,3825829,4.259261222418987
RCH-ACV,9927531,3.1896486071629724
SBC-5,15953870,3.487984127844562
NCI-H520,24753719,4.403096106170392
KE-37,10385095,0.7123817404194451
GSS,387447,-5.1490583646059855
LC-1/sq-SF,selumetinib-GDC-0941 (4-1 mol-mol),2.9597977830319935
BT 440,3825829,4.790902919975163
G-401,9927531,4.9703255494446035
AU565,9887053,5.902090445564702
KMRC-1,12001922,2.9414276180440884
SNU-216,387447,-4.222955466200769
Lu-99,54649381,3.687539209670329
L3.3,54649381,4.658116253691046
LUDLU-1,3825829,5.496165236830282
SNU-475,54618771,1.821628813352334
RD,10385095,1.2570153977648164
BT 139,54649381,3.76760719227815
JMSU-1,100016,3.921608363156487
NUGC-3,6505803,-1.151304908691564
IA-LM,3825829,4.571991496451351
BT 340,10385095,1.3886421901194472
MOTN-1,135928012,3.1814831552217737
Jurkat,9926054,1.8890918367446592
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
TE-9,10385095,1.1890447645443694
WM88,6505803,-1.994136504003607
JK-1,15953870,2.331955325474776
KMBC-2,4705,2.3520992205272395
AML-193,54649381,3.6703519441302097
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
Caki-1,12001922,3.0696080211273187
JHOC-5,387447,-3.937440126680621
Kelly,15953870,2.846393978870574
L-540,selumetinib-GDC-0941 (4-1 mol-mol),4.246283194196457
NCI-H727,15953870,3.6175866373148713
LOX-IMVI,12001922,1.75616119917211
PC-14,11455910,0.0459407670906722
NCI-H1355,11396600,3.5209515786022156
BV-173,11396600,2.9579324152439224
OVCAR-8,11455910,1.074074633675783
COV362,136227331,5.836047268415018
TE-14,387447,-3.5543881689563483
SF539,11396600,2.4945499602014487
JHH-1,selumetinib-GDC-0941 (4-1 mol-mol),2.043129184310282
MM1.S,6505803,-0.1841114080814497
A-253,9927531,5.71272933596785
KYSE-30,24753719,4.589617632068179
KLE,12001922,1.8770805284945848
Karpas-620,selumetinib-GDC-0941 (4-1 mol-mol),4.598341067647778
MDST8,24753719,4.799692184779076
DAN-G,15953870,4.101414487482255
BICR 22,54618771,-1.5156377594303725
NCI-H1339,135411,0.7339446872015564
MDA-MB-157,9927531,5.35009923211275
EFO-21,387447,-3.3575648447894735
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
SK-CO-1,11396600,4.255124433433546
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
C2BBe1,selumetinib-GDC-0941 (4-1 mol-mol),0.2357334763777015
MG-63,136227924,3.2795436313273685
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
253J,135411,1.0372170192585162
Jurkat,9887053,3.6191492419005393
CAL-29,54618771,1.1722146209139084
SNU-489,10385095,2.294114675628452
NCI-H211,387447,-3.505498556718565
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
SBC-5,11455910,0.8715920005264659
UO-31,136227924,2.530889708332206
BT 482,15953870,4.379793325035303
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
COLO 320,selumetinib-GDC-0941 (4-1 mol-mol),1.1921670353492264
NCI-H2141,2746,2.383841945459931
HCC1428,1474550,4.462214245855356
Karpas-620,15953870,2.834468937620933
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
U-251MG,12001922,1.7731516260923752
OVISE,135411,0.7729741022965545
COLO 201,136227924,3.2878786819809105
BT 131,11455910,0.493476636285018
SNU-8,9887053,4.177655211283038
KALS-1,10385095,1.3956260866944918
FTC-238,3825829,3.8227779639407657
Panc 10.05,9926054,2.010421160581402
JHH-1,4705,3.6727549882245634
MKN74,54649381,4.134428711266374
MES-SA,10385095,1.0508846247548498
BT 239,44197249,1.3567645545283795
CCK-81,54649381,3.9694085189365578
SK-N-MC,49836020,5.673841333096494
SNU-C5,42642645,0.9113779638180028
SK-N-DZ,11455910,0.8503332996504234
HSC-4,9887053,4.087399127765092
BDCM,6505803,-1.085958720489184
KU-19-19,54618771,0.4920305765445359
Kelly,54618771,0.9246671147478912
UACC-62,9926054,3.2338645061682914
SK-UT-1,9926054,1.807396230777958
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
HSC-4,136227924,4.2199200707906845
HGC-27,11455910,-0.7196123988614116
KYO-1,387447,-5.270632314944693
LS123,10385095,1.1165638509540754
BT 286,24753719,5.642521821790082
NCI-H460,12001922,2.3574763109101253
SUP-T11,135411,0.1630530414261487
JeKo-1,387447,-5.188650578129272
B-CPAP,11396600,0.7084279408075309
MHH-CALL-3,42642645,1.450580331373367
KMS-20,15953870,2.7543869132459378
SU-DHL-10,44197249,4.622496966162441
MKN1,135411,2.680389546140594
L-428,100016,6.045371287660442
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
Jurkat,73707440,5.030996622710699
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
RS4;11,11167602,0.3393907697934239
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
OCI-AML-3,15953870,2.1290082500420833
SNU-81,49836020,-3.195484765979539
HH [Human lymphoma],12001922,0.9834360002534656
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
IM95,9926054,1.717853214717972
LK-2,387447,-4.358451355170903
SW48,42642645,-1.378549292450493
KMRC-1,11167602,5.704956856257104
JK-1,54649381,1.6932721246898548
BT 159,11396600,2.8148026318928054
M059K,135411,1.0469019990186696
RERF-LC-A1,3825829,3.3687382314808265
PLC/PRF/5,246676,4.431557533323378
NCI-H2087,3825829,3.626836228263037
SF268,4705,3.336245866912317
JK-1,100016,6.141145240463154
EBC-1,54618771,0.4501558342724816
KMS-21-BM,387447,-6.5544559619500955
CAL-29,9887053,3.8321660832212654
SW948,42642645,-0.386998084672917
BT 231,136227924,3.1954768658582378
SNU-478,12001922,1.6955259949857977
GDM-1,100016,5.649529454604957
KYSE-410,9926054,2.1669765108653483
DMS 53,54649381,1.9903431446362323
ONCO-DG-1,135411,1.068209946017225
NCI-H2141,9887053,1.2732501453263714
CAL-62,42642645,1.5537568953281695
SF539,9927531,4.183842431586729
HCC38,12001922,1.9391245494676863
MKN7,10385095,2.2658881450110604
OVTOKO,12001922,1.951401286035266
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
LUDLU-1,135411,-0.5034652044269404
SK-N-MC,135411,0.3246591190152385
SaOS-2,11455910,0.8777485884783317
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
NCC-StC-K140,6505803,1.225711680594439
RT-4,54649381,5.182810489152522
TTC-709,9926054,1.3747627831999318
JHOC-5,12001922,1.99453296159482
BT 172,selumetinib-GDC-0941 (4-1 mol-mol),1.268434466812915
KE-37,136227924,2.0912429237758796
SNU-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.1592396564326592
NCI-H2170,11396600,3.579707270807188
EFE-184,12001922,2.361488137914465
NCI-H1581,387447,-4.849206230239017
CCK-81,11396600,4.135348832339609
Hs 578T,3825829,4.12008492864824
NCI-H2170,15953870,3.266345993576973
NCI-H1341,54618771,1.0375359960566886
KYSE-410,54618771,1.043731623373752
PE/CA-PJ15,387447,-4.5457624697994
NCI-H446,selumetinib-GDC-0941 (4-1 mol-mol),2.0638797586373263
Panc 05.04,12001922,1.713192738695624
NCI-H838,42642645,1.1725175672218051
CAL-54,12001922,2.321581035942916
NCI-H446,387447,-5.306627499261033
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
MOR/CPR,54649381,3.911921961982227
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
HT,42642645,1.6796971919487842
PK-59,9887053,5.458657189600831
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
HuH-28,136227924,3.512267666844948
MV4-11,15953870,2.1146216389677295
YD-10B,387447,-4.063776509527343
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
NCI-H2405,12001922,1.885500732937501
SK-CO-1,54649381,3.727346200170898
VMRC-RCZ,4705,5.276450440378561
KMS-18,11396600,2.8169219147606066
BT 440,6505803,-2.620705612839711
MEC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4728620848599026
OVCAR-5,135411,1.8788449592084264
HCT 8,11167602,3.4597414266317443
KMH-2,6505803,-1.1271558599433815
D283 Med,12001922,1.043249882837814
TE-5,11455910,0.4645654676747968
697,11396600,1.1442486142510078
PaTu 8988t,42642645,1.5127014290808742
A-172,6505803,0.7314329706083597
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
NCI-H2405,15953870,3.7135382148998546
AN3-CA,11396600,4.58709626361668
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
Raji,136227924,2.5188827267380116
SH-10-TC,387447,-4.92778108245121
CHP-212,3825829,2.095967212695281
UM-UC-1,15953870,3.625164373429232
SNU-423,12001922,2.3385317619154353
Ku812,12001922,1.5776657122495092
NCI-H69,9926054,1.6669613133383836
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
BT 428,136227331,3.9646009077151456
Daudi,2746,0.9195319579001202
Daoy,15953870,3.2165706741674316
Mel Ho,136227924,2.792099034627563
Calu-1,4705,3.5470871536142563
Hs 611.T,11396600,2.963461604358696
LS123,42642645,1.3766242781191698
CHP-212,135411,-1.4236413711587437
NCI-H2342,135411,4.311220908548416
HCC2279,387447,-4.255230349468773
NCI-H2029,387447,-4.305848508820894
BT-16,selumetinib-GDC-0941 (4-1 mol-mol),1.0815618001864344
MOR/CPR,15953870,2.443454604679901
COV434,24753719,3.694828401712744
TUHR14TKB,10385095,1.3771420408488644
HEC-6,24753719,4.021686089972085
SK-LMS-1,11455910,0.8292842204783425
HeLa,12001922,2.6860406183593284
KYO-1,100016,4.086276175586104
HCC1806,54618771,-0.2864222176978986
ME-1 [Human leukemia],2746,2.1142830069466467
NCI-H929,11396600,-1.497885086375298
HCC1428,9927531,5.49162668491902
ChaGo-K-1,11396600,3.1968353669128637
Kuramochi,3825829,4.837522317092888
KP-3,42642645,1.348436123185398
LoVo,100016,6.001395250082881
HEL 92.1.7,100016,4.201358504841771
C2BBe1,9926054,1.888966029374552
KE-97,10385095,1.0750509177193088
SNU-201,135411,5.421260593446126
NCI-H2196,42642645,0.9699299185054828
NCI-H660,10385095,0.7862786947444187
NCI-H2023,42642645,0.9583585122801802
ECC12,24753719,4.634678850895111
SNU-C2A,54649381,3.695698896689231
SK-MEL-1,54649381,4.230171165309088
Reh,246676,2.3151108839907213
HCC1195,100016,5.060252338886612
MHH-NB-11,15953870,3.2602806905438233
BHY,9887053,5.348150036241129
SNU-407,9887053,4.090838838618247
5637,136227924,2.876940542257041
MIA PaCa-2,15953870,2.730980253379173
WM115,2746,3.2273654457979957
BT 145,100016,5.857999875396141
CAL-12T,49836020,4.6523718910669745
Caki-1,3825829,6.100536396708196
EJM,387447,-5.475320927013608
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
MKN1,9926054,3.700935468951971
Yamato-SS,136227924,3.1022512927874444
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
AML-193,11396600,2.463856517722703
MIA PaCa-2,9926054,1.823118001934022
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
WM983B,4705,3.3375940959152244
MES-SA,135423438,4.43653608071916
HPAF-II,42642645,1.2803458474574565
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
SNU-81,9926054,1.3093723678717843
A2058,10385095,1.1585362440671565
TE-9,9926054,2.1843594630677674
MPP 89,11167602,2.1738819968252607
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
LS180,9887053,3.1718141126704618
BT 139,15953870,4.456672182655599
A2780,54618771,-0.248592168161829
RPMI-6666,136227924,2.5880592922669097
NB4,54649381,3.907161904420691
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
Reh,135411,0.0124245128710199
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
SUP-B15,11455910,0.511116887846229
PE/CA-PJ15,54618771,-1.2856394778285385
SNU-1076,136227924,3.042119222699605
CAL-33,24753719,4.340545120601804
MM1.S,54618771,0.954891721558104
647V,24753719,3.7750625934618864
DMS 53,24753719,3.748235801374395
22Rv1,selumetinib-GDC-0941 (4-1 mol-mol),-0.8202887961023889
SK-BR-3,3825829,3.842512996646099
NCI-H520,9926054,1.793691213544428
OVK18,6505803,-0.991074322239109
OCI-AML-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.789265040727208
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
RERF-LC-MS,2746,3.2731211053052647
NH-6,136227924,2.082013315983653
KYSE-520,6505803,-2.015031116266543
SNU-899,6505803,-0.0802623134971481
CCF-STTG1,387447,-3.430424241609023
TE-11,2746,3.705466590750396
647V,54618771,-0.1034366562319205
PSN1,12001922,2.1769127452815766
OCI-Ly19,15953870,2.9658869430670483
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
BHY,100016,6.773898116669002
FaDu,12001922,2.015415997740503
KCL-22,11396600,5.105155728417937
DV-90,4705,1.8434366903908024
CAL-62,100016,6.567555445612565
NCI-H716,9926054,1.9023068554939984
SNU-182,6505803,1.4884406130314256
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
2004,387447,-4.874809052459365
SK-N-BE(2),100016,5.117046374692038
WM266-4,54618771,1.3867437118908044
IGR-1,selumetinib-GDC-0941 (4-1 mol-mol),0.2767905376035742
253J,100016,6.267948749211356
BT 216,136227924,4.751796234635162
RKO,387447,-4.452540898932811
MKN74,387447,-3.1334283259497067
SNU-1041,42642645,1.227574933871924
ONCO-DG-1,135928012,3.7594281307234345
SET-2,11455910,-0.0425011411311434
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
CAL-27,9926054,1.784787570446616
CCK-81,10385095,1.2197432593182902
NOMO-1,11396600,3.3888037624860674
JHH-4,135411,1.1840261360156377
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
CAL-85-1,15953870,3.63081800708328
DU145,10385095,0.949692238641196
U-118MG,11167602,5.665581577338733
TE-15,54618771,1.8265153099983404
REC-1,54618771,4.304155025574206
IPC-298,42642645,1.710993555969076
AGS,9926054,2.4402585627733844
SNU-466,54618771,0.431904700089911
TUHR14TKB,42642645,-0.5177374025961153
WM983B,135411,0.5869655766066777
HEL 92.1.7,9927531,3.309303309112431
NCI-H1703,6505803,-4.731386050574026
NCI-H2106,9887053,3.5957481463045644
Panc 03.27,135411,0.8057922501185131
G-402,11396600,2.964823639578594
HuP-T4,3825829,4.662199879109773
SU.86.86,4705,2.6337462408918846
OE33,387447,-5.027649776547387
HH [Human lymphoma],selumetinib-GDC-0941 (4-1 mol-mol),-1.1427111457994747
MHH-ES-1,11396600,3.76498087597508
A-204,9887053,2.25644890687753
SET-2,9927531,4.801393694643548
SW1710,54618771,1.2075824947863512
MOLT-16,11396600,2.170033155162838
GaMG,135423438,1.57749164646486
SNU-738,10385095,0.1021175037849084
COV362,12001922,1.666050118025863
SNU-407,135411,0.2039769906623827
SK-LU-1,135411,1.1287152034241594
KMRC-2,135928012,3.7345117496586937
HEC-1-B,100016,7.817681002018073
Karpas-299,10385095,0.9106183768206608
Caki-1,54618771,1.6306245872023055
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
SNB-75,6505803,-1.615420165549335
HCC95,42642645,1.1736766700486458
647V,selumetinib-GDC-0941 (4-1 mol-mol),1.2881187017164255
SW1990,11396600,4.084870548965884
ONCO-DG-1,136227924,3.186548860778023
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
PSN1,9887053,2.1695040110520445
TTC-709,10385095,1.138092247834034
NCI-H1838,9927531,5.140983076545055
RERF-LC-A1,15953870,3.4479949128076592
KYSE-180,387447,-4.108861459218713
KATO III,selumetinib-GDC-0941 (4-1 mol-mol),2.4282234364089863
LCLC-97TM1,9927531,5.703886109604247
SK-CO-1,3825829,3.015639513793665
A-204,11396600,3.09168738174324
TOV-21G,54618771,2.0367745651121867
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302
SU-DHL-6,9887053,3.723065049771557
JHH-1,11455910,0.6944106748858588
Rh41,100016,7.167579216403683
L-363,15953870,3.108220211148021
KMBC-2,11455910,1.9151529363040984
SJSA-1,4705,2.8709767105947974
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
ZR-75-30,9926054,1.848847204207402
REC-1,15953870,2.7067445833073407
SUP-HD1,selumetinib-GDC-0941 (4-1 mol-mol),2.188403523917611
NCI-H1793,387447,-2.120651747469511
KU-19-19,24753719,4.40371401160258
MV4-11,73707440,5.432484386170161
HT-29,42642645,4.213543122656591
MOLP-8,9887053,1.3364969406129874
BT 440,11455910,0.0350443808128442
SK-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4310498502666769
HGC-27,12001922,1.011658387648396
BT 504,11396600,2.364157912442885
SR,2746,2.1071904113131392
CAL-51,9887053,4.486783389261201
SNU-1214,12001922,1.6320434938041075
BT 232,42642645,1.569258938157716
NCI-H2342,24753719,5.01821313413428
OAW42,9927531,5.261343543721406
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
IGROV-1,42642645,0.3750175292659389
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
SUP-B15,54618771,-0.7938935218437335
TE-1,selumetinib-GDC-0941 (4-1 mol-mol),3.018112465414828
NB4,3825829,1.723952097913668
JHUEM-1,24753719,3.9307242908195272
RD,387447,-4.515049515965848
Aska-SS,9926054,1.7306138768842658
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
NCI-H810,136227331,3.856341284870196
NCI-H1105,11455910,0.5219957952901316
HCC1428,11167602,2.130823244043548
JVM-2,9926054,1.9901106639385144
KYM-1,54618771,0.695388101268428
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
WSU-DLCL2,136227924,1.92257757824623
RL95-2,387447,-4.211661588148395
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
Calu-6,136227924,5.658776934081175
LS513,54618771,0.3815245482334266
NU-DUL-1,42642645,0.5631757316610277
HCC44,11167602,1.0616844624356492
SW1710,6505803,1.2425561690078113
HCC95,135928012,4.377690896237646
HuH-6,6505803,-0.5786152978547117
SNU-489,54618771,1.3505446494743896
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
Lu-99,12001922,1.824341843197012
HDQ-P1,9927531,5.7159143296477115
BICR 16,15953870,4.397063198266117
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
SF126,6505803,1.4927738710676783
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
SNU-C1,selumetinib-GDC-0941 (4-1 mol-mol),-7.034120569721028
HCT 8,4705,3.304717107003546
KMS-21-BM,6505803,-3.224254978227179
IGROV-1,6505803,-0.2382223795960626
MKN45,136227924,3.646033724215572
697,9927531,2.816043229727806
HSC-4,9926054,2.0278633205902468
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
SNU-1076,54618771,0.3413327758331145
BT 164,9926054,1.7569954478000085
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
YD-15,3825829,3.492354939220674
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
KYSE-510,6505803,-1.66043256037682
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
G-401,3825829,3.962498358217521
HEL 92.1.7,3825829,3.8531411399826943
RCH-ACV,4705,2.8616908433941495
CCF-STTG1,100016,6.985278157575169
JHUEM-3,136227924,3.0400208358424243
SU-DHL-6,15953870,2.4587311871536315
Lu-99,54618771,-0.746886748911533
GB-1,136227924,3.951727784027331
NCI-H929,3825829,4.289333234926349
SUP-M2,49836020,-3.0340639982218898
RKO,136227924,3.256787131627037
TT2609-C02,15953870,4.383418207760618
KMS-27,12001922,1.6667680080633047
786-O,100016,5.342252836782742
Kelly,9927531,6.376471657693257
CAL-78,11455910,2.8056640629270766
MKN1,12001922,2.1601219462493235
HCC1428,44197249,4.46361740533094
HEC-50B,15953870,3.3922030681305437
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
SNU-C1,11455910,1.0435411312145502
BICR 22,9926054,1.8271931211135617
OVCAR-8,387447,-3.679431477796991
BT 428,12001922,1.1406957911423092
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
LS513,10385095,1.5532641665833944
OE33,100016,6.493432597771833
LUDLU-1,2746,3.195399638512964
B-CPAP,12001922,1.695452056973735
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
SUP-B15,10385095,1.069894879797162
BT 286,135423438,1.7051552017965996
NCI-H1385,54649381,2.0407943939496502
253J,9887053,4.443771808250968
Hs 822.T,54618771,1.097463284906687
IGR-37,54649381,3.787553488532969
NCI-H2342,3825829,4.386120436320443
SF268,54649381,3.723694059500435
Mono-Mac-1,9927531,4.461355065468675
Kasumi-1,42642645,-5.7921821950831
NCI-H1838,6505803,1.6268298993788928
NCI-H522,12001922,1.5621076115514363
ALL-SIL,24753719,3.3195109491118635
OCI-Ly19,10385095,0.8757541357960408
DB,136227924,2.1225886217744376
MOR/CPR,9926054,1.7872025764961004
JHH-5,15953870,3.5862787893013293
Pfeiffer,12001922,0.9135896884368476
HOP-92,387447,-4.191692232449402
NCI-H2196,49836020,4.894055204627393
LMSU,12001922,2.4559246423075707
PE/CA-PJ15,15953870,3.815080099518923
BT 340,6505803,0.8782913115261707
Malme-3M,136227331,3.99929328678972
A-253,2746,3.706033536924258
LCLC-103H,9926054,2.81223402195442
Panc 04.03,9926054,1.9560696374821285
TE 441.T,6505803,-1.628255920679656
OV7,selumetinib-GDC-0941 (4-1 mol-mol),2.168494345054348
JURL-MK1,6505803,-3.009657758249373
KYSE-510,246676,4.677306022279273
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
CAL-54,100016,6.472919480601912
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
KM12,135411,0.6015632837543741
EHEB,54618771,1.2042140049426533
SNU-840,11167602,3.3324863600881756
Raji,135411,0.5014739051384897
M059K,9926054,1.7795727491270252
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
BT 172,9926054,1.8062475080252252
IGROV-1,10385095,1.0670946713416192
2004,12001922,1.169008288480047
HH [Human lymphoma],11455910,0.005551580985779
SNU-407,9926054,1.9660241476439948
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
JM-1,11455910,-0.0097968256607179
NCI-H1435,42642645,0.8169170251526645
MOLM-6,6505803,0.3209765108224145
OCI-AML-3,11455910,-0.2153245710553746
NCI-H2196,12001922,1.3300465529610377
EoL-1,10385095,0.4720665951427926
OPM-2,135928012,2.8826672527394956
OV-90,6505803,-3.2294324705329576
Namalwa,24753719,3.8228113675826063
HEC-251,selumetinib-GDC-0941 (4-1 mol-mol),3.2910402284708757
WM793,136227924,4.7819042035619255
U2OS,11396600,3.835959810142159
SNB-75,11167602,3.6380121611156007
HT-55,24753719,4.165074033971129
CHP-212,9926054,1.886787046066781
SNU-878,9926054,2.3591129664276194
JURL-MK1,42642645,-1.811177703351284
SYO-1,6505803,-0.5697677300157696
CHP-126,6505803,1.8994279506826215
CFPAC-1,100016,6.545938487461667
VCaP,10385095,1.1570117666550257
SCC-9,12001922,2.463166865850559
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
LS180,12001922,1.7594619366424422
HEC-265,3825829,3.481933010146602
YD-15,54618771,0.7976995145825885
T-47D,387447,-4.195503384100167
COR-L105,42642645,1.1549939076973508
HCC-56,2746,2.5868502665085615
MDA-MB-231,54649381,4.253092807097923
RKO,15953870,3.3462063589818034
GMS-10,54618771,2.907722210856396
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
MOLT-16,100016,4.920795787487072
TT2609-C02,4705,3.2623564948908106
SNU-503,387447,-3.900825733266281
NCI-H1395,12001922,2.192187193874862
J82,9926054,1.9182596726219543
Rh41,42642645,-0.1793892559248887
SNU-213,54649381,3.760371456180229
HEC-251,12001922,1.784757920551605
U-118MG,9926054,1.9994289810495935
Lu-65,387447,-3.75008165482626
NCI-H460,136227924,3.925006850615035
NCI-H1155,9927531,3.8709301895195023
HuT 78,24753719,4.53725590635391
Rh30,24753719,4.445119660878695
BICR 18,135423438,2.266029017324442
HuG1-N,9927531,4.775383733857977
BL-70,12001922,1.3949690705923978
MES-SA,9927531,4.955649444081026
JeKo-1,3825829,3.5162020408315384
SNU-213,387447,-4.101875903510779
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
HOS,135411,0.9561696617155332
CAL-54,11396600,3.3062490005536467
NCI-H526,54618771,1.0633322876543316
Mono-Mac-6,3825829,2.716373820316147
BT 112,2746,3.687274706255036
EPLC-272H,10385095,1.1702440891240469
U-251MG,387447,-4.0705106847416275
KMS-26,12001922,1.5310966537372677
ZR-75-30,11396600,3.757449742584293
MOLT-13,10385095,0.963304038916334
LN-18,3825829,3.5708308293865603
SNU-478,24753719,4.1429991016755245
EoL-1,6505803,-1.4779318620644195
DEL,15953870,2.6942637126545868
GCT,selumetinib-GDC-0941 (4-1 mol-mol),2.439679750854635
Ku812,9926054,1.5145588468111315
LS513,12001922,1.5608624208847215
SNU-216,9927531,4.928854217015946
NCI-H661,387447,-3.746079371333459
DND-41,136227924,1.87568318170164
BT 504,15953870,4.189590150947692
Rh18,15953870,3.1265714408321297
SNU-16,9887053,1.5180413133151411
Ri-1,136227924,2.363884089308993
HSC-4,387447,-4.060952426407354
Aska-SS,10385095,1.4450418871576047
COLO 201,54649381,4.697416619617796
CAL-62,15953870,3.04980821126728
2004,54649381,3.6030543138524584
8305C,24753719,4.566230945327615
OCI-M1,9926054,1.747333325747777
253J-BV,11396600,3.6309884615301953
KYSE-520,3825829,4.690634819321673
MDA-MB-453,100016,6.0730906594859215
MDA-MB-361,9927531,5.403888941869855
NCI-N87,10385095,0.9731458206829144
MDA-MB-435S,100016,6.42664314163943
SH-10-TC,4705,3.0238585653901655
SNU-475,246676,5.352165829175543
SU-DHL-8,54649381,3.664789254937442
KYSE-510,54649381,3.815475443460375
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
AsPC-1,12001922,2.2862775547931675
HCT 15,15953870,3.1728591873553924
SNU-C5,10385095,1.2057512834065311
SNU-1,15953870,1.9148670829656065
ChaGo-K-1,3825829,4.445461759620719
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
MDA-MB-231,9887053,6.322194712762026
UM-UC-3,12001922,2.3356736764660506
SEM,3825829,3.0657110006972026
K029AX,100016,6.8355789955685395
EPLC-272H,9926054,1.8633723849420136
MOTN-1,42642645,1.0241980992869986
A2780,4705,2.567744201920244
NCI-H1155,24753719,3.3116025060765955
Panc 05.04,9887053,5.31603140935116
WM793,11455910,1.0189470974054349
HCC38,11455910,0.8868705732454679
COLO 678,136227924,3.6500617296173288
PLC/PRF/5,4705,2.7931521546735243
JHUEM-3,4705,2.325459550435627
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
BT 330,2746,4.080308483434876
SKM-1,10385095,0.5930890296191716
TALL-1 [Human adult T-ALL],6505803,1.3130685662142687
PL-21,100016,4.334695208074886
Hs 729.T,387447,-4.698480487086246
SiMa,42642645,-0.2087499546994571
PaTu 8902,54618771,-1.3103145579416535
HOP-62,135928012,5.236707943844288
Rh30,135411,0.2201905263491922
42-MG-BA,10385095,1.3787421167269815
HT-55,9887053,3.900445579463886
MOLM-6,11396600,2.3493263787787244
NCI-H1339,54618771,2.498525802737919
HDQ-P1,6505803,-0.3319389932283364
Becker,246676,4.322247201161359
BT 504,9926054,1.7523750045888775
BT 340,136227331,4.417429547624524
DMS 114,54649381,4.452337791479875
BEN,BRD-K16130065,4.206876741952794
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
COLO 205,42642645,0.1499562425432145
NCI-H1915,12001922,2.4312833499087665
VMRC-RCZ,54618771,3.963095950994299
HCT 8,6505803,0.5074441333519764
BxPC-3,54649381,3.6406106092590007
MDST8,12001922,2.1068751805520423
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
TE-6,4705,1.909603555694431
G-401,135423438,1.541142645334712
NCI-H1435,10385095,2.199410869757901
MOTN-1,387447,-5.959152747851936
KMS-12-BM,24753719,3.8340594609092
COLO 668,9927531,4.694789725560254
KMS-20,135928012,3.091470628632976
NCI-H810,49836020,4.546134729481912
BC-3C,9927531,5.131139518306293
WSU-DLCL2,135928012,3.405156777163597
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
EB1,136227924,2.1314721571590876
ESS-1,54618771,1.2318880484657342
JM-1,4705,3.374089362448498
JHH-5,100016,5.964491744827364
KMS-26,11167602,0.2768125005658594
PLC/PRF/5,15953870,3.9476910695044767
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
8305C,10385095,1.3364399031185752
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
U266B1,4705,3.88133298077809
TCCSUP,9926054,2.5470676869748763
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
KCL-22,387447,-5.256093812270022
IM95,10385095,1.0460048441425125
UO-31,2746,3.591448305166117
KLE,54649381,3.9923802992632687
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
EoL-1,2746,-0.0046206936254649
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
HCC1171,10385095,1.858745136689112
RPMI-6666,387447,-5.002779109785374
NCI-H69,15953870,2.6587942768044477
SNU-878,100016,5.516104284834857
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
PE/CA-PJ49,387447,-5.239888509178112
MHH-NB-11,11455910,-0.4373414457289755
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
PC-14,3825829,3.604955593937337
COR-L95,135411,0.6709946332822974
TE-8,11167602,2.1649297116968484
BICR 22,9927531,5.395078942533075
SK-OV-3,42642645,1.640931292575566
CCF-STTG1,100016,6.985278157575169
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
KP-N-SI9s,136227924,1.797924144791439
RL,15953870,3.556693176710817
SK-CO-1,9926054,2.0008566323964576
OCI-Ly3,387447,-5.2004302941077105
BT 145,135411,-0.2321779622871452
LCLC-103H,387447,-4.181459599606492
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
KMS-20,54649381,1.58560475565201
253J,42642645,1.023207271262847
DU145,136227331,5.067250261949365
LOU-NH91,54649381,2.7277802519486514
CW-2,100016,4.445901991176778
42-MG-BA,15953870,4.077816944399742
BT-16,4705,1.941125757653359
SK-BR-3,54649381,3.8002658347162344
FTC-238,9887053,4.357525752063845
SNU-8,54649381,3.860275528998684
NCI-H2452,3825829,3.8827569930751937
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
MG-63,3825829,4.401803636096853
HCC-56,100016,6.404810900486153
OVCAR-4,54618771,1.8457330551632656
HCT 116,387447,-4.347041065225661
LAMA-84,54618771,0.5560134201720579
SK-N-BE(2),10385095,0.6921659768247342
NCI-H1435,54618771,-0.0103086846499203
Hs 822.T,9926054,3.800948674297046
LNCaP clone FGC,2746,2.220031738697338
Hs 688(A).T,54649381,4.09309336631427
HCT 8,10385095,2.576875256318049
HCC366,42642645,1.0809862733434576
AsPC-1,4705,5.582464580618905
Hs 888.T,387447,-2.1819696492095986
K-562,9926054,1.8612748023096723
SNU-1272,135423438,5.060183017948369
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
NCI-H2122,3825829,3.800201671004512
HCC95,24753719,4.535760675090215
SNU-182,9887053,3.800056711157262
BT 164,135411,0.3041276702407011
SNU-1,11396600,2.945712911704453
HCC1833,9927531,4.651328537031639
NCI-H69,44197249,3.785151870529891
TYK-nu,54618771,0.511557548457066
VCaP,9926054,1.7541172082533985
EFO-27,2746,3.149760082978987
HCC1806,136227924,2.6306602850580387
LOX-IMVI,387447,-3.914151602497852
BICR 22,100016,6.157225392196351
WM266-4,11455910,-0.4355783836702207
SIG-M5,15953870,3.775492786372982
SW1573,42642645,1.1024283721976142
BT 320,136227331,4.5584663350036605
NCI-H1395,11455910,1.7673103520073516
RPMI-7951,11167602,2.502155495655697
EM-2,9887053,2.8609234444384968
MEC-1,15953870,3.2315358904774407
NCI-H2029,54618771,1.4933886789628814
KMS-20,136227924,2.296093636743899
YKG-1,9927531,5.706988241233545
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
P3HR-1,10385095,0.8570193110669726
Hs 611.T,2746,3.500782789021053
SCaBER,54618771,2.268737587506627
SW1116,4705,0.6661703449380979
DOV13,136227924,2.864785745195549
LoVo,15953870,2.9352023189332703
BT 145,42642645,0.5547560462078965
ZR-75-30,15953870,3.4330522689171064
PK-59,136227924,3.43326158684526
OCI-Ly3,44197249,5.29194196273527
NALM-6,11167602,2.3296888483311577
J82,selumetinib-GDC-0941 (4-1 mol-mol),2.8384419330971147
K-562,54618771,1.1969173800987956
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
WSU-DLCL2,49836020,-5.951866834778445
COLO 800,42642645,1.4452162588291009
NCI-H2106,54618771,2.789728608480185
SK-N-BE(2),9926054,2.2939851330117413
HCC1833,3825829,4.543250520424916
Reh,11455910,3.330656455417661
L-540,2746,2.2201981774781383
Hs 729.T,24753719,4.079114648455497
WM1799,387447,-3.0411008125904453
Rh41,11455910,-0.4442712184273157
NCI-H1299,54618771,0.5506920644788533
SK-MEL-2,54618771,2.1400716929659045
EKVX,11455910,2.049892638783207
HCT 116,15953870,3.8070663955023263
NU-DHL-1,11396600,1.7686570539993816
SW1990,100016,6.759971253936254
LOX-IMVI,2746,2.55877549764083
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
NCI-H1755,11455910,1.1406081050587142
NCI-H1694,2746,1.1698970904386303
SKM-1,42642645,1.502866726077564
UM-UC-3,11396600,3.088705801401897
KMRC-2,11167602,4.424264905666824
BT 340,12001922,1.114254659213152
LAMA-84,6505803,-0.5453051583932805
SNU-8,387447,-4.803741501160462
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
TE 617.T,9887053,1.3952225168172891
YH-13,54618771,3.881155680896358
HCC1428,4705,3.7350108144218983
TE-15,11455910,-0.076849872958893
BT 416,11455910,-0.2427833720473563
SK-MM-2,12001922,1.570834379606124
OUMS-23,44487330,3.8218275981148144
SNU-C4,11167602,3.0209947329806437
BT 340,3825829,4.338825465008533
LS123,4705,2.777266406946489
HOP-62,136227924,3.3249367186884564
Hs 895.T,11167602,4.982461660939475
HEC-6,10385095,1.086644508305165
HEC-6,387447,-3.862170196634393
OCI-Ly10,135411,1.9759822389972583
COR-L279,135411,-1.9183680514972976
CAMA-1,11167602,4.874000698373902
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
GI-1,135928012,3.9782423311586257
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
BT-549,42642645,1.6219324424635808
NCI-H1435,2746,2.5897217485668222
SU-DHL-6,3825829,3.5283611337160155
Hs 766T,4705,3.67943819927122
OVTOKO,136227924,4.392974848141837
OCI-AML-2,73707440,3.915095713182096
TUHR10TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.6041094312427258
SW579,4705,1.9687725092896824
PK-45H,24753719,6.262848613391698
TCC-Pan2,9926054,2.315773971229038
NCI-H1341,9927531,3.217953728153189
Caov-3,49836020,-0.0609342715049496
DND-41,3825829,3.6379861092485486
LUDLU-1,100016,6.796390484470128
ONS-76,3825829,4.014711164490238
Calu-6,24753719,4.065149652165168
L-428,9926054,1.7396260856582195
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
PK-59,11396600,3.5699719356694573
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
HCT 8,54618771,0.896470905316868
EC-GI-10,3825829,5.039904674459976
DMS 273,9887053,1.8082863610482875
KE-97,11396600,3.2423162434671293
HEC-251,11396600,4.750561988154587
KYSE-30,11455910,0.7960710883386756
KMS-11,42642645,-1.6095881562241476
M-07e,12001922,1.0816677732760167
COLO 792,9926054,1.6988024802785178
GP2d,135411,-1.1735255015444224
Hs 729.T,54618771,1.7662519209313146
K-562,3825829,2.9396673791475587
TM-31,136227924,2.988827636595516
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
IPC-298,2746,3.067568930900854
Daoy,24753719,4.045268630777391
MHH-ES-1,54649381,3.4472293740768247
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
Lu-99,15953870,3.3150988417028473
SK-OV-3,3825829,4.139200001280225
Karpas-620,9887053,3.5468102907345016
FaDu,136227331,3.76397674876245
NCI-H2081,3825829,4.196645416863087
HCC1143,54649381,3.828405406955801
SU-DHL-1,9887053,2.0473441666614156
HuG1-N,selumetinib-GDC-0941 (4-1 mol-mol),-3.3555719378633375
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
EM-2,6505803,-0.543849671747512
KMS-12-BM,11167602,1.7675298654448677
SNU-216,6505803,0.9385001329114314
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
CAL-12T,42642645,0.0873482621348498
BICR 16,136227924,2.8848408076895393
NCI-H1650,9927531,5.159202312794284
SYO-1,3825829,4.067641020493478
SNU-216,11455910,0.3573804688779068
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
SYO-1,15953870,3.683656904301567
WM115,9926054,3.0880179510914454
SNU-C5,15953870,5.1211072982932215
OE21,135411,0.4173817790505238
HT-55,4705,2.5986536735617833
HuH-28,12001922,1.6625633047238413
BICR 31,42642645,1.5553576315566706
EFO-21,11167602,2.787371694479732
MDA-MB-468,9887053,4.887858795967984
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
RL95-2,24753719,4.206948488089824
RKO,6505803,-0.9276151073099124
B-CPAP,100016,6.506572981316216
HCC202,9926054,2.1190704993467917
NCI-H1105,4705,1.2739510490449024
DV-90,135411,-0.387089401482153
SK-BR-3,9887053,3.751749968465411
DAN-G,selumetinib-GDC-0941 (4-1 mol-mol),0.9464172392973902
JHUEM-3,10385095,1.0184545903744842
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
HL-60,6505803,0.5284927754579164
NCI-H1703,3825829,3.704251894257376
NCI-H838,3825829,4.268756112360613
NCI-H1435,selumetinib-GDC-0941 (4-1 mol-mol),1.0023239879000474
RL95-2,11455910,0.9076770125519352
DK-MG,11455910,0.6874488483397508
NCI-H1299,135411,1.0826020500388394
U2OS,54618771,2.9736494040757924
OAW28,54649381,3.786658613217657
Caov-3,9926054,2.84814467099178
GOS-3,136227924,2.1351760440562533
SW48,9887053,1.6385742110161594
EFM-192A,9927531,5.058042989735013
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
COLO 320,100016,4.196375737127383
IGR-37,9887053,4.927098264959097
TE-9,42642645,0.8130746606737675
OCI-Ly19,11455910,0.6096382769703742
NCI-N87,12001922,1.750767235665954
SNU-478,3825829,3.6170801565006694
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
JHOM-1,42642645,1.4690532950039623
C2BBe1,54618771,1.7187966275352082
FTC-238,6505803,0.5896695785026528
MOR/CPR,387447,-3.678397799489162
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
KYSE-510,387447,-4.55671268851583
K-562,12001922,1.1213264373636214
CGTH-W-1,387447,-4.0905797496158725
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
NCI-H1395,135411,0.822890110332085
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
SNU-626,49836020,-1.879821731308555
D283 Med,387447,-5.573112310264525
FTC-238,15953870,4.031807890382158
SK-MES-1,49836020,5.814503877703118
BHY,10385095,2.088020241498876
MKN7,selumetinib-GDC-0941 (4-1 mol-mol),2.574249068911848
U-251MG,135411,2.577728000044866
BICR 6,10385095,1.2855816104984523
JHH-5,135928012,4.941437261235863
BFTC-909,54618771,2.8225313881877545
TALL-1 [Human adult T-ALL],54649381,3.190527415255916
CAL-33,54618771,-0.7874087703723603
SW982,54618771,0.7299689874898085
SW1463,6505803,0.5252870082270547
NCI-H23,11396600,3.42598990187636
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
RCC10RGB,24753719,5.18895385781671
GP2d,2746,2.2157786787544023
HCC2935,136227924,3.4382607017764473
HMC-1-8,54618771,0.1355198199402433
CAL-148,54649381,3.5521322310531893
SNU-1076,10385095,2.120355301569047
YD-38,135411,0.5996233659487772
EN,9926054,1.746243630057145
MOLP-2,11396600,3.664107522761926
LK-2,3825829,3.986193817548812
CMK,3825829,3.5430422603894853
MOLT-3,10385095,0.6724792762753087
ST486,135928012,3.203233778229845
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
NCI-H1573,10385095,1.001955726752377
JHOC-5,136227924,3.178485175637893
WM88,10385095,0.3545398644716653
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
SUP-M2,246676,3.894144452123606
NCI-H838,10385095,1.1161561983941106
SNU-81,9887053,2.281153151762533
MSTO-211H,387447,-3.4382078488280063
SF126,135411,0.8161115161833692
T24,9926054,1.988465622132668
KMH-2,9887053,3.2360475812117757
JL-1,54618771,3.703254873905745
A-204,12001922,1.2747075164963704
Hs 611.T,54618771,-1.6189149218844685
MHH-ES-1,24753719,3.7932935338290954
BICR 56,42642645,0.6136572080042532
BICR 22,15953870,4.283514914534557
HCT 8,12001922,1.907771317922764
G-292 clone A141B1,3825829,4.397061617057086
SJSA-1,73707440,4.290448161515078
BL-70,49836020,4.386780315181427
SK-MEL-1,9927531,4.509159168037888
CAL-33,9926054,1.6426139792956471
SK-BR-3,54618771,0.9510207607432342
MOR/CPR,6505803,-2.446657793445472
769-P,387447,-4.283738237757274
MFE-296,15953870,3.156899619124077
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
IGR-39,387447,-4.44011322570149
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
TM-31,10385095,1.0519358784247812
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
TUHR4TKB,12001922,2.43438892522683
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
Hs 578T,54618771,1.0464366040522988
SUP-HD1,54618771,-0.1374288926012433
BT 498,246676,4.408890433497639
NCI-H1581,3825829,2.6084486445178916
LP-1,2746,1.409450400710279
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
22Rv1,100016,5.084356097831624
NCI-H650,12001922,2.829548148533841
SK-N-FI,136227924,2.3066593011882084
NCI-H2170,10385095,1.0758750418417444
Fu97,4705,3.9554938740337096
LoVo,135928012,4.12079355273469
BxPC-3,11455910,2.77826122800999
Hs 852.T,100016,3.86747930561629
Hep-G2,12001922,1.7010359951064702
HDLM-2,9926054,1.2404831446966105
T3M-10,44197249,3.528865337305728
HT-1376,6505803,-1.649820321739373
HCC1937,387447,-4.5219432345337145
BT-549,12001922,2.460799936977109
LUDLU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.599632203402907
SUP-T1,9926054,1.5313307080964844
NCI-H1869,11455910,2.924449694106302
SNU-489,12001922,2.3578854771996616
SCC-9,3825829,4.24505295528646
A2058,2746,3.220065264010931
JHH-5,4705,1.264083267323837
A-549,2746,4.106748757541722
LS123,24753719,4.285942546954198
SK-LMS-1,15953870,4.449149497882856
HCC1395,15953870,3.420071190653329
NCI-H747,selumetinib-GDC-0941 (4-1 mol-mol),-3.828774406071909
MV4-11,54649381,3.4578918757252963
NCI-H1944,9887053,4.982680527457183
KMS-11,15953870,2.629420884905892
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
U-937,9927531,3.434526864785126
RT-4,3825829,3.4258833117884064
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866
HCC2108,135423438,4.347791872690299
CGTH-W-1,10385095,-0.093106341441523
ALL-SIL,11396600,2.960335319566646
SNU-410,2746,4.749931599758568
EN,10385095,0.9687928929720704
A-375,42642645,0.983657975432455
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
RPMI-8402,12001922,1.505990013379826
NCI-H211,136227924,1.9167606171360705
U-251MG,11455910,1.7912494784014348
8505C,24753719,4.418317774206583
NCI-H1299,24753719,4.197116792706203
MOLP-2,11167602,3.580459987371732
AGS,54649381,3.9006769577431113
SNU-175,42642645,-0.9671913024447542
BT-16,15953870,3.691947391326344
TE-11,100016,3.880053912311749
YD-8,4705,3.8146154447521146
SH-4,2746,3.3582559523336024
T-47D,2746,3.323386211929572
HCC2279,selumetinib-GDC-0941 (4-1 mol-mol),1.829926030012146
Mel JuSo,54618771,-0.9101150768043303
HCC1195,9927531,5.131359962593503
KE-37,100016,3.280443906920473
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
LAMA-84,9887053,3.4512164241540297
TE-8,387447,-4.710099116774778
JIMT-1,54649381,3.9069207568617346
HEL,100016,4.260371486080393
Caov-3,selumetinib-GDC-0941 (4-1 mol-mol),3.787884726335324
TALL-1 [Human adult T-ALL],42642645,-0.4725549324705695
SYO-1,54618771,-0.0439888220829119
KG-1-C,11455910,4.990169857060823
M-07e,387447,-5.072568697910827
NCI-H1693,11396600,3.0020537778987286
COR-L105,135411,0.974173137304268
JURL-MK1,11167602,0.2204954688746393
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
JVM-2,6505803,-0.473368143486524
SUP-HD1,11396600,3.836607370981288
NCI-H1869,12001922,2.1512424663065692
GSU,15953870,3.5893208486831867
DB,136227331,5.354479486577142
AU565,9926054,0.9817648939808896
PL-21,11455910,0.5383649206422021
IGROV-1,246676,4.485924799339535
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
HCC1500,12001922,1.110118640671234
A2780,9887053,0.4462184617201571
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
SNU-216,11396600,3.905215698607568
SNU-478,selumetinib-GDC-0941 (4-1 mol-mol),-0.9905008638696244
KYSE-140,11455910,1.0441153824583205
NCI-H23,10385095,0.5302597946113806
NCI-H2081,387447,-5.408009728713125
COLO 320,135411,-1.5764846144025433
Mel JuSo,selumetinib-GDC-0941 (4-1 mol-mol),1.489805359284141
LCLC-103H,3825829,3.811795614479008
NOMO-1,4705,2.5023829157060926
NU-DUL-1,136227924,1.961051427269065
Hs 294T,selumetinib-GDC-0941 (4-1 mol-mol),1.293217302318029
CAL-33,387447,-4.14748450312445
LOX-IMVI,9926054,1.7031980960413209
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
PL-21,9926054,1.453737550570679
KNS-42,4705,5.099780843040584
HPAC,9926054,1.8309217170446392
PC-3,100016,6.704789318152335
KLE,15953870,2.3268887568767767
L-1236,100016,5.644363792904431
NCI-H1838,9926054,1.7507639405240023
MPP 89,135411,1.1169132674811386
KYSE-510,15953870,3.73241111430141
BT 271,15953870,3.910748784691976
HuP-T3,9927531,4.952379772704904
SW1710,3825829,4.3008452318398405
SaOS-2,11167602,3.026359974607451
HT-1197,10385095,1.8216995461668084
U-937,11167602,1.9406749416671407
COLO 684,11455910,-1.3406228718579627
U-BLC1,136227924,2.288895160726179
SK-N-FI,6505803,0.5825551569342805
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
KMRC-2,15953870,4.6713206769498585
Yamato-SS,9926054,1.8348633448645275
SIG-M5,100016,4.056618507771364
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
RERF-LC-A1,136227924,2.978723056085531
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
SU.86.86,12001922,2.2788646770176175
CW-2,12001922,1.0796441550434837
CAL-29,10385095,2.379885316927196
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
SK-LMS-1,6505803,0.606445374310417
JHOS-2,11396600,4.0221153186085905
IST-Mes1,49836020,4.276541253138442
Panc 08.13,54649381,3.362449847389926
SK-MEL-30,246676,4.409971807400667
SNU-C5,11396600,3.0577499527766316
COLO 205,9926054,1.7915651258593497
MKN74,136227331,4.503917554589063
LOX-IMVI,3825829,4.353482853449277
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
KMS-18,9887053,3.2129537527629064
EM-2,11396600,2.356094145041023
SET-2,135411,-1.5084865108910783
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
KYSE-150,selumetinib-GDC-0941 (4-1 mol-mol),2.603924706865474
SK-MEL-31,11455910,3.802034948643962
A-204,42642645,-2.945766112541093
NCI-H1092,387447,-4.501071900555183
KATO III,6505803,3.725568714877732
BT 232,15953870,4.315203211904352
NB4,11455910,0.3286835470988328
KMS-18,6505803,1.18095143270811
KYSE-510,54618771,0.5023256188939713
MDST8,2746,2.514425635914287
NCI-H929,10385095,0.7754305798230204
KMRC-20,54649381,3.798675470632658
NCI-H838,9926054,1.8305885270474245
BT 179,136227924,3.760107948072088
UACC-257,136227331,4.461620315172803
MDA-MB-361,15953870,3.3089377800270876
DMS 114,11396600,3.971117414652232
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
HD-MY-Z,136227331,3.950603619388181
NU-DUL-1,6505803,-0.4706315127513403
HOP-62,6505803,-0.0366684489798773
HCC95,10385095,0.8007390261026306
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
DB,4705,3.0475659193893296
HMC-1-8,9926054,1.7153047636867798
HCC78,24753719,4.491348672589333
THP-1,100016,3.892329450898836
NCI-H2170,42642645,1.1190711442550063
COLO 320,11396600,2.8347180367361235
BT 172,42642645,1.529037883589328
Kelly,387447,-5.885480978917412
RPMI-7951,10385095,1.3251666848544306
HCC1195,387447,-3.1780010134097405
Panc 10.05,6505803,-0.9946511088404476
Caki-2,12001922,3.0607512170721662
HCC44,42642645,-0.2201911730095828
Hs 888.Lu,9926054,2.118592716385535
EC-GI-10,42642645,1.0154278949979725
Hs 895.T,10385095,1.68656194127411
KMS-18,42642645,0.2098451338148192
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
Karpas-299,387447,-5.123448760897007
SUP-HD1,136227924,3.4836971225000735
NB4,24753719,3.7028003977883137
A-498,10385095,3.0502652475567347
HOP-62,42642645,-0.4674089233275948
NCI-H1155,9926054,2.490439813838108
FaDu,11167602,1.7467972789730146
HuG1-N,42642645,1.095697835234743
HuH-1,4705,4.381282786595648
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
DB,54618771,1.151207273522801
Kuramochi,12001922,2.291978450853829
U266B1,2746,1.1489280814220546
GI-1,54618771,0.7325470873707357
HEC-251,54649381,3.657596408740149
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
SHP-77,54618771,1.054053584588012
TOV-21G,42642645,1.539682345524948
OVSAHO,15953870,2.423404719212484
BT 164,9887053,4.205272246648629
JHUEM-2,9926054,1.5571026590008097
JIMT-1,15953870,3.7526391312242744
SK-BR-3,11455910,1.4950616471057503
NCI-H1838,54618771,1.6121528318079854
SYO-1,100016,3.831378840669671
A3/Kawakami,11167602,1.5696684185546212
MHH-ES-1,135411,0.2720416488721636
NCI-H889,135411,1.5633287457595502
NCI-H209,9887053,0.254400305901777
JM-1,54618771,-0.5043757930015165
SKM-1,15953870,2.3750866132882305
VMRC-RCW,246676,3.8050193333668463
SUP-T1,3825829,2.6482464739936984
TE-8,54618771,2.0990725036496123
EHEB,11396600,3.4241723821303314
EM-2,44197249,2.692484862904757
EBC-1,9887053,4.6942466583782325
AML-193,11167602,1.123439400433108
BICR 18,2746,3.306459207135074
SF539,9887053,4.243548054334724
SNU-46,9926054,2.489766142928295
YD-10B,54618771,-0.547775158029887
MV4-11,49836020,2.655795655295622
CML-T1,11455910,-0.3388293365451558
NCI-H292,9926054,1.8794077191249725
OAW28,135928012,4.847644989583831
SU.86.86,135423438,1.7276185076707382
GB-1,135423438,1.7622813158496486
BT 333,4705,3.363159057665455
WM983B,11396600,3.738380516099371
KMBC-2,49836020,0.1766293750985906
GI-1,9926054,1.7357819318992778
5637,selumetinib-GDC-0941 (4-1 mol-mol),0.4079577317339777
HuH-1,15953870,2.0117337044563244
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
HCC1171,selumetinib-GDC-0941 (4-1 mol-mol),-0.4155569356036221
G-402,2746,4.175584503802389
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
OS-RC-2,42642645,2.648365682479735
COR-L88,12001922,1.9272093199872875
A-172,12001922,2.209243740174037
TC-71,12001922,1.6128279763162578
MCAS,2746,3.159271623653468
KNS-81,11455910,2.3157999192593888
HPB-ALL,selumetinib-GDC-0941 (4-1 mol-mol),3.2361225802608593
PE/CA-PJ15,24753719,4.1461682769332615
SUP-B15,135411,0.3372093956296002
SK-N-MC,11396600,3.4054376977010485
SR,54649381,4.330559904068815
ES-2,135411,0.5422018773217715
AsPC-1,387447,-4.291846387154746
PL-21,135411,-0.0006930098223885
ONCO-DG-1,6505803,-0.2819077176711598
PC-14,6505803,-1.6585666949761726
UACC-62,12001922,2.5302650809484453
NCI-H1650,11455910,2.7994234029229372
JM-1,9927531,4.0230036766634125
RERF-LC-Ad1,54649381,3.845102321657733
MHH-ES-1,387447,-3.882318105798204
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
CAL-12T,135411,0.9593052130787368
TE-4,246676,4.790257687439562
DMS 273,9927531,4.953960158421894
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
NCI-H716,54618771,0.9147566577185032
MKN7,387447,-4.49178363939995
ECC12,42642645,1.3595920196025868
BT 333,135411,3.603414715380041
EFO-21,9927531,5.470218663007946
Hs 729.T,11455910,1.0467944276793937
KMS-11,9926054,1.1489638287123365
Peer,selumetinib-GDC-0941 (4-1 mol-mol),3.981609189515586
BT 428,387447,-4.747611518769308
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
LP-1,9926054,1.657631549896095
Hs 852.T,12001922,1.7611304783870956
Karpas-620,136227924,3.0310478312116467
Hep 3B2.1-7,136227924,5.40641673036814
HT-1376,15953870,5.904213661909733
PF-382,11455910,1.1839598995526908
Rh30,387447,-4.304641706039777
CAS-1,54649381,3.7802305789920343
CHP-212,11455910,-0.0664645017636666
Mino,44498493,4.4262129486717585
COLO 201,10385095,1.2644655705332717
SNU-213,12001922,1.7290947375839942
SK-N-FI,3825829,3.4012840568375884
OAW42,2746,4.654777781524689
BT 245,54618771,0.8318467537608688
HCC366,54618771,1.7092661743346285
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
UM-UC-1,11167602,3.102654436447589
CJM [Human melanoma],12001922,2.3763416544392024
G-361,135411,0.565114954213132
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
MEC-1,11455910,-0.0965490267087482
RKN,6505803,1.4092626649390017
HT-144,11455910,1.485095962050077
OCI-AML-2,135411,-2.217327064193932
ACHN,24753719,4.196398568680715
GI-1,3825829,4.185338449640786
NCI-H1395,3825829,4.5765318321652355
Aska-SS,3825829,4.613612651673856
ACC-MESO-1,24753719,6.460305862241897
SW1710,246676,4.96799578187702
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
NCI-H460,387447,-2.436463262555682
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
JL-1,10385095,3.307622791524891
BV-173,10385095,0.9438349957623432
CAL-148,9926054,1.1690943917504333
BT 231,11455910,0.2900866749520439
ST486,2746,0.9238009694882156
MOLT-16,387447,-5.383202908558775
HEC-1-A,11167602,2.1676131013886946
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
Hs 746.T,6505803,-0.4653374975150369
NCI-H716,11396600,4.406293438661701
BT 286,135411,0.4622735027269605
HeLa,2746,3.522514487554161
CAL-120,54618771,-0.541329282057163
NCI-H1341,9887053,3.9654519771940353
KP-4,6505803,-3.0608028116863464
SNU-503,4705,4.54925442873891
Hs 746.T,3825829,4.406834891425848
Ki-JK,10385095,0.8839794805977479
GaMG,9926054,2.873858460522757
Kasumi-1,136227924,1.874085610777816
647V,3825829,3.989173007910981
TE-4,6505803,-1.521875186657464
SNU-1105,42642645,1.010201184776654
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
KALS-1,136227331,4.320673828023345
SW1417,2746,3.073421161812704
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
DV-90,11455910,-0.2128562796551693
MOLP-8,54618771,0.2679151571300236
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
GSU,selumetinib-GDC-0941 (4-1 mol-mol),-0.0301350261262937
SaOS-2,387447,-3.480142635313653
Toledo,9926054,4.027631226191203
TE 441.T,135928012,2.9186612392594107
PE/CA-PJ41 (clone D2),42642645,1.5712136673163746
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
UM-UC-1,3825829,3.698642039908176
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
DMS 114,9927531,5.183306198807951
DMS 53,100016,7.1608088069035185
TE-11,15953870,3.737102436212784
IGROV-1,11455910,-0.2792640061206097
A-549,6505803,-0.295425809550202
Ri-1,11396600,2.305014362827753
HCC2108,10385095,1.3545455997149978
JL-1,9926054,1.8045722808491491
K-562,135928012,4.4390204871751004
MHH-CALL-4,9887053,1.5551059592614176
MDA-MB-453,2746,1.6853152695376463
L-1236,54649381,3.667085201827836
J82,2746,4.586638058567165
SF295,12001922,1.8411518312335016
PE/CA-PJ49,42642645,0.7462290895329329
L-540,136227924,2.3931383545900524
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
NCI-H1299,3825829,3.823746918774883
L-363,54618771,-0.4858237315579012
KCL-22,42642645,-0.9874483321155404
COLO 320,9927531,3.3062100750903594
Hs 294T,12001922,1.6072883850021913
HPAC,54618771,1.6074763393424083
RL,6505803,0.5926513253188753
NCI-H1563,11455910,-0.3468172057796411
HEC-1-A,9926054,1.9825174619243453
BICR 16,10385095,2.1459054309975523
SNU-387,15953870,5.251304817354926
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
HuG1-N,9887053,4.347498397599696
BT 239,6505803,-2.8170451599207733
NCI-H322,12001922,2.010845920065637
HCT 15,12001922,1.0584624734280177
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
MJ,2746,3.266657890633373
CA46,54618771,1.203400154931592
SK-OV-3,387447,-3.0618968905277164
ACC-MESO-1,136227924,3.807440016829928
NUGC-4,42642645,0.2656700210226594
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
EFO-21,135411,1.087124021621254
CAMA-1,15953870,2.399722591719849
HCC15,54649381,3.779002151510325
JeKo-1,136227924,2.4041415853814687
MHH-NB-11,10385095,0.6613180284209285
Li-7,11455910,1.362279388286256
NCI-H1355,3825829,2.696034849072001
K029AX,11396600,4.390484410073567
BT 239,12001922,0.6251306016836425
Ri-1,54649381,2.8324832014718155
KATO III,2746,3.141354246007229
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
NCI-H1694,42642645,0.7568707679884984
Hs 688(A).T,54618771,0.2687022491152004
NCI-H526,24753719,4.440370143489617
EoL-1,49836020,1.4161576765733714
OCI-AML-5,135411,0.2780762637388145
SK-MEL-24,11396600,3.3796631473976135
U266B1,135423438,1.4944799516316452
NCI-H1105,135928012,3.3305496903427843
HuT 78,11455910,0.0216709312460527
HEC-251,246676,4.542645339130495
23132/87,15953870,3.0044283960001956
Mel JuSo,387447,-3.9456129695878417
HSC-4,135411,-0.261300177061483
P12-Ichikawa,24753719,2.55959592126112
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
EM-2,387447,-6.139708254599935
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
KNS-81,135423438,1.6796399573672585
HEC-1-A,42642645,1.5415941085813123
SW1088,6505803,-0.5883716848555307
NCI-H2452,9927531,4.529523169776047
NCI-H69,3825829,3.674462034577914
NCI-H2126,11455910,1.7285212021483076
NCI-H2110,4705,2.9559067422385494
NALM-6,49836020,4.594148282336944
NCC-StC-K140,11396600,-1.2265429504727747
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
NMC-G1,9927531,6.6210082677754984
BT 504,11455910,0.316004589079872
CAL-85-1,54618771,1.8439388085147956
HOP-62,9887053,4.379241554178957
NCI-H650,54649381,3.8521604200989583
SK-N-DZ,2746,1.2350474359899652
MHH-CALL-3,9926054,1.9964305651779948
NCI-H2110,9927531,4.774812830583443
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
OCI-Ly19,100016,6.584850236816641
NCI-H2170,2746,3.369366607476525
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
IGR-37,4705,3.0869599188409658
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
G-401,135411,0.5966957307940325
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
PC-14,12001922,2.282227019704268
COV644,387447,-5.345033445718049
OCI-Ly3,24753719,3.800130789629197
RS4;11,54649381,3.17825296632297
Mino,11167602,5.227056331573394
CAL-51,136227924,2.079284078064279
MKN7,2746,3.491753391139794
SF295,42642645,1.0127855753280748
HEC-59,24753719,4.79630184603725
D283 Med,11167602,1.7563320025634743
BT 187,100016,7.76208292164505
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
SK-LMS-1,54618771,1.3800871170557885
Panc 03.27,15953870,3.638466820116044
CGTH-W-1,54649381,4.100273118487709
JJN-3,11396600,3.2077193233266375
KYSE-30,6505803,0.8895731520069545
T84,9926054,1.9260026490734707
YD-8,3825829,4.049048632362995
HEL 92.1.7,42642645,1.6144058148411065
HPAF-II,54649381,4.137901378476713
HeLa,42642645,1.2695095995750458
GB-1,387447,-4.774805703480107
WSU-DLCL2,12001922,1.210195158069358
A3/Kawakami,9887053,0.9849240365434958
TE-8,9926054,1.8785619758496184
NCI-H1793,4705,3.730029638704029
SNU-1,135411,-0.3253331966899897
NCI-H1568,3825829,3.749474944576795
OCI-Ly19,11396600,4.160001255842617
BT 359,387447,-4.840635080987452
TC-71,54618771,1.220599365734416
NCI-H446,100016,4.920277084242614
Pfeiffer,15953870,1.001650812958963
KNS-81,54649381,3.905570031258064
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
Lu-99,11396600,3.614830317436624
DMS 53,3825829,3.570356502937496
SW982,9926054,1.795372121114862
SNU-16,24753719,3.78652594456274
OCI-Ly19,42642645,-0.4805944031246006
SCC-4,9927531,4.977228114447549
PSN1,6505803,-2.1554317854287097
DK-MG,54618771,1.0774373419981456
SNU-423,2746,3.5801912517104695
5637,12001922,1.6765399674359167
PE/CA-PJ34 (clone C12),9887053,4.7354636419859935
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
Hs 895.T,6505803,1.07500421429109
BT 444,11167602,2.4668021270212086
TTC-709,136227924,1.406309539576174
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
Calu-6,2746,5.003270781401264
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
RERF-LC-Ad2,9887053,4.334988147698079
PE/CA-PJ41 (clone D2),12001922,2.6504343623639732
NCI-H1651,2746,3.195891738830615
BICR 56,12001922,3.230063291719707
Jurkat,10385095,1.1081293360903846
AML-193,9926054,0.8292500331421907
BT 112,54618771,1.3381626551406447
HMCB,24753719,4.311459213197197
DV-90,136227331,3.915454108317936
FTC-238,135411,0.7929413052980172
COLO 668,6505803,-1.9386091565051409
BT 428,3825829,4.221207301902304
NCI-H211,3825829,3.0298516582881683
SK-MM-2,54618771,0.349796062936111
HH [Human lymphoma],54618771,0.4732630552220457
ECC10,136227331,5.843658104512461
OAW42,54618771,1.2241554078015442
HGC-27,11396600,2.081101267240524
SW948,54618771,1.4567685239775812
OAW42,15953870,3.465465294716235
NCI-H1694,11396600,2.3248952404491976
Ishikawa (Heraklio) 02 ER-,11455910,1.4574745929250947
SF268,6505803,-0.4080835752334602
SCC-4,9926054,1.835519091908301
TF-1,10385095,0.9707611134468052
DK-MG,selumetinib-GDC-0941 (4-1 mol-mol),2.430443160394254
SW620,9887053,4.404308003440313
CA46,10385095,0.6992054873225039
KNS-42,10385095,2.5512346184474444
UO-31,54649381,3.540272349499179
HT-144,11167602,1.9204372739091764
BT-12,6505803,0.2176692391310213
MKN74,11455910,0.5314790476879293
TE-1,246676,4.450819178803798
NCI-H1092,11455910,0.2647471022018075
U266B1,9887053,5.563573564396111
JHH-2,135411,2.4352063043457424
SK-BR-3,49836020,6.022467534114696
NCI-H2228,136227924,2.998313400459559
HMCB,6505803,-1.40903466994972
MOLT-16,12001922,2.526617411225939
BT 179,44197249,4.949779647592256
HGC-27,136227331,3.820430594188932
CAL-12T,11396600,4.498308812674723
MOLP-8,135423438,1.7176055832456645
OPM-2,24753719,4.370940438199297
U-118MG,15953870,4.305894428504275
NCI-H2110,49836020,-1.7351781152481929
HCC1428,42642645,1.6889301708371032
DB,24753719,3.8531105532779697
RPMI-6666,selumetinib-GDC-0941 (4-1 mol-mol),0.4507229369642581
SNU-626,44494015,6.327875246768692
NCI-H889,15953870,3.183643420455648
G-401,9887053,1.7608751069117703
HuP-T4,387447,-3.3954092974628347
HOS,12001922,2.342454669820776
Malme-3M,15953870,3.897704451564179
NCI-H2196,15953870,4.97144966997748
G-292 clone A141B1,135411,0.4309838256030321
OE19,100016,6.21408400033578
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
OAW28,12001922,1.8847589611064504
YD-8,54618771,-1.0700457769979232
SW982,100016,3.947877721573723
LCLC-97TM1,4705,3.0319662392534057
HuH-6,12001922,1.1856032378119004
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
KYSE-520,54618771,1.6405254882986982
BT 231,54618771,0.7922646437361874
BT 422,12001922,1.171067799339474
Lu-99,9887053,1.3770005960501683
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
Mono-Mac-1,10385095,1.4007420160965849
Calu-1,11455910,4.249423837752583
NCI-H1563,15953870,2.9256289120910006
SK-MEL-24,9887053,4.0873392279106815
BT 145,54618771,1.0324414673710869
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
COLO 741,15953870,3.1919917550207484
HT115,3825829,3.3613521757850817
Fu97,6505803,-2.9243122575537552
JHH-2,11396600,2.878978251675123
RMG-I,387447,-2.787885618218071
TF-1,42642645,1.3277397143262784
SK-MEL-31,387447,-4.084845225301597
BT 333,42642645,1.8321879515004684
769-P,100016,6.594067506922387
TE-8,135411,1.1703242896089727
TE 617.T,387447,-4.6885019632323255
SU-DHL-1,10385095,0.4695713178913991
KYO-1,136227924,2.5889716651569614
OE21,12001922,1.590204471841314
KNS-81,12001922,2.4349681867915565
EC-GI-10,54618771,2.241833399474009
SK-UT-1,135411,0.7872586171820456
NCI-H1563,100016,6.550294719377214
SU-DHL-1,42642645,0.6641769458510169
ECC10,136227924,2.5549710603978366
EoL-1,136227331,3.409385468978638
SHP-77,12001922,1.6858386601267483
NCI-H1092,6505803,2.777743929422052
TE 617.T,135928012,3.262303401406854
SK-CO-1,10385095,1.4661007046294967
SNU-1077,6505803,4.592101417459953
OPM-2,9887053,1.8393709016316329
SNU-761,135423438,1.615583061665389
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
NCI-H2228,4705,2.420157544814273
BT 228,15953870,3.98907826196433
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
COLO 829,136227924,3.354215786550203
KNS-62,12001922,2.6065454467512543
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
HEC-151,11167602,1.902436852174608
SNU-719,24753719,4.605269118671092
U-251MG,11396600,2.977650858137137
SW620,11396600,3.2226280594878145
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
BT 112,9926054,1.759668872476805
PaTu 8988t,12001922,2.536714978511883
JHUEM-1,3825829,3.769100376137878
JHH-5,42642645,-0.1665302669321067
IA-LM,49836020,4.225846480888235
BT 444,136227331,4.190644654212499
EKVX,15953870,2.911948360276665
HCC15,42642645,-0.8684016042996798
BT 271,11455910,0.6743644259938443
HuH-28,9926054,2.302050382507772
BICR 22,6505803,-0.8504421983690468
697,135423438,1.9125323106681824
RL95-2,9926054,1.9942568161623715
A-549,54649381,4.103112658972653
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
L-1236,387447,-2.575058274330638
OAW28,387447,-4.631995500074297
PF-382,3825829,3.5943460783681207
FTC-238,2746,3.1491636542411605
LoVo,11396600,2.965288622606591
OVTOKO,54649381,3.746770857719419
A101D,10385095,2.1713752730464626
KALS-1,135423438,2.6558677077861783
HCC2279,24753719,6.029621521681119
Rh30,11396600,3.5985518110360997
NCI-H929,49836020,2.30560189930029
SIG-M5,10385095,0.6926293967264278
NCI-H1299,6505803,-0.2534280947368875
Panc 05.04,44197249,3.871427381075925
BT-16,6505803,-2.626677217469799
AML-193,9887053,2.7928557450616327
IMR-32,135411,-1.4785586518887983
HCC78,10385095,1.2930087557549492
L-540,100016,3.9234848652304097
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
BT 239,135411,2.0122298788080255
TCC-Pan2,2746,3.0854386111148333
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
KMBC-2,42642645,1.3462679167777547
SK-N-DZ,3825829,4.333813891986567
Fu97,12001922,2.497735102569248
Karpas-620,12001922,2.216302561014168
KE-97,9926054,0.8495096752282992
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
JHH-2,12001922,2.4936900412990974
WM88,9926054,1.794473369640358
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
Hs 746.T,54618771,0.5763857654673513
SHP-77,387447,-4.149209610569124
TE-10,135411,0.5425097856205735
PE/CA-PJ34 (clone C12),42642645,1.4632083376153606
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
DMS 454,135423438,1.477667151193616
BT 228,6505803,-0.8466206341020581
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
HSC-4,4705,3.95336427523857
NCI-H1944,11396600,2.88322672555981
NCI-H2452,136227331,4.192235498443636
HCC2218,136227924,2.978872567688762
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
IM95,54618771,0.6089600215622465
BICR 31,49836020,4.313223650735915
NCI-H1385,10385095,-0.3639074849589327
Peer,11455910,-0.1315414365833526
LXF 289,9926054,2.043368643335034
SNU-1105,9887053,4.4317236945417715
LK-2,24753719,4.196249511971625
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
OAW28,2746,2.637952220594215
NCI-H2196,246676,4.3795263450239466
HuG1-N,11455910,1.8248856097934676
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
BT 504,135411,2.214114198151371
NCI-H526,9926054,1.8580444014969677
MOR/CPR,selumetinib-GDC-0941 (4-1 mol-mol),2.600932232406458
YD-38,9887053,5.000290179411191
G-402,10385095,0.4806633165796566
HuP-T4,12001922,1.7614770356349254
HOS,42642645,1.4677031939688314
MDA-MB-361,3825829,4.3848572067869265
Hs 578Bst,9926054,3.786469361001098
PL-21,4705,2.342779269332656
SNU-C1,12001922,1.147228430008778
D283 Med,135928012,2.2283751237398906
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
DB,387447,-5.792279431299119
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
NCI-H2081,11396600,3.4950774921622174
MOLT-16,11455910,-0.4766797538258427
SUP-B15,3825829,3.9195732820356906
CAL-12T,136227924,2.605918242540546
NCI-H1793,49836020,4.8036601506688275
NCI-H647,9926054,1.878907234482811
KMS-18,54618771,-1.0350203667424809
L-540,136227331,3.8428800907354983
P31/FUJ,54649381,3.661627004097492
CCF-STTG1,2746,3.7135967128071385
COR-L95,10385095,1.3959867651371194
NCI-H1755,9926054,2.18101646942672
COLO 320,387447,-4.016679204390258
Caki-1,2746,3.5868220629550858
HH [Human lymphoma],11167602,3.579332325804806
NCI-H23,387447,-5.113380191941882
SNU-1066,54618771,0.6033249887552533
KNS-42,9887053,3.833885284196865
JeKo-1,2746,1.6598198436915612
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
NCI-H1435,9926054,1.8918877697265553
CJM [Human melanoma],4705,3.52697616396543
SK-MES-1,11455910,0.6501278721551685
SU-DHL-8,135928012,3.191791952572065
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
NCI-H1915,54618771,0.2887330377515757
COLO 829,10385095,0.8100752114980174
ECC10,387447,-5.050381669967023
CAS-1,10385095,2.6335228393539944
HT-55,9926054,1.864291830267701
NCI-H810,2746,1.0986608343124125
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
Pfeiffer,11167602,1.364593396360834
TE-15,15953870,1.748445900477018
KMS-12-BM,9887053,-0.448618862637891
BT 245,24753719,4.292609421440975
HT115,24753719,3.8979668457059873
NCI-H522,9926054,1.815484319665427
TE-5,9927531,4.466928464790859
EPLC-272H,2746,3.4040670746589523
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
SF295,54618771,1.9072877365394525
CAL-51,10385095,1.0305027810027567
HEL 92.1.7,9887053,3.657921116041027
SK-N-MC,3825829,3.2804443974154536
PE/CA-PJ49,4705,3.0123221957178017
OCI-AML-5,42642645,-0.9883986244862538
HPAC,10385095,1.6323615748888127
WM266-4,136227331,3.760867873542347
HCC366,11396600,4.932418286549936
DB,135423438,1.7960303918163716
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
SK-MEL-28,42642645,1.6429344569807516
Daudi,9887053,0.4273795924431001
HPB-ALL,135928012,3.139219958493933
HD-MY-Z,24753719,4.079912472521239
HT,selumetinib-GDC-0941 (4-1 mol-mol),2.035866243674196
HCC1395,9877608,6.36391605144629
Calu-3,9927531,4.58448758255864
SUP-M2,15953870,3.1737596382362727
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
MOTN-1,9887053,4.2528435844398516
ME-1 [Human leukemia],selumetinib-GDC-0941 (4-1 mol-mol),0.4788349760990721
HMC-1-8,3825829,4.024579961120436
MOLT-3,4705,3.045598390925212
HT,6505803,-0.8511885729054358
BL-70,24753719,3.6587703277512182
786-O,15953870,3.8327323616467903
T84,12001922,1.0984811418501697
GA-10,387447,-5.665927080543195
SW48,136227924,1.7122170056378203
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
SNU-387,24753719,6.078615403196679
BT 187,11455910,1.1160186893710065
ChaGo-K-1,6505803,0.7391022920837463
Li-7,9926054,2.073130645224697
TE-6,54618771,1.015505758549108
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
769-P,42642645,1.7065283332425516
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
Hs 839.T,136227924,4.248389123686858
BT 187,54649381,3.824215245652595
NUGC-3,54649381,3.869271637490854
SNU-466,9887053,5.021240159927006
NCI-H1944,54618771,0.5378192056232364
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
DOV13,selumetinib-GDC-0941 (4-1 mol-mol),3.389057426499923
G-401,387447,-4.890417311710873
RL95-2,selumetinib-GDC-0941 (4-1 mol-mol),-1.0392511344110156
NCI-H520,2746,2.5300013032729556
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
Panc 03.27,9927531,5.182143526242967
YD-38,10385095,1.2654205909097365
KNS-62,9927531,5.413841173671558
SNU-761,15953870,3.150731537463946
SK-LMS-1,3825829,4.897973293918553
LC-1/sq-SF,12001922,2.3429921369014832
GCT,11396600,3.3936538094375317
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
TCC-Pan2,11396600,4.21456785581041
OVCAR-5,387447,-3.970986913690591
HOS,11396600,2.933584432278509
HCC44,9926054,1.5614419320460398
TE 617.T,24753719,3.744070928960869
C2BBe1,49836020,4.36863555932656
SNU-1041,44487330,5.719023506973167
KYSE-510,24753719,4.343319490515707
SNU-423,9927531,5.196680575825113
Rh18,135411,2.3577273148044657
HT-1197,24753719,4.164524114468767
JHUEM-1,11167602,1.7927694326745718
JURL-MK1,11396600,3.824773747794518
Daudi,136227331,3.813653547789358
ECC12,selumetinib-GDC-0941 (4-1 mol-mol),2.781694050737888
Caki-2,9926054,1.76147282411668
BT 482,135411,3.2601698618862676
Rh41,387447,-4.665970148102917
SNU-601,387447,-4.768478216982885
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
NCI-H1184,11396600,3.277329955302312
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
TE-9,54618771,0.2399637036570816
BT 422,11167602,2.104960059691873
JVM-3,9887053,3.2272514449498937
SIG-M5,3825829,3.9959318617447823
SNU-719,9926054,1.5286214740335768
U-CH1,2746,3.3579143403808995
OPM-2,42642645,-0.4905470491794313
Hs 895.T,42642645,0.8006984761765567
SK-N-DZ,10385095,0.8733492382150887
SNU-C5,135423438,1.6231432447945644
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
NCI-H810,4705,3.09227910852851
KCL-22,136227924,2.6502010503693016
EB1,135411,-0.6581562133084127
NCI-H508,2746,2.9093324415745094
YD-38,387447,-4.020257287464525
MOR/CPR,11396600,4.52695838854887
BL-41,10385095,1.158422194070115
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
BICR 6,12001922,2.5376888747367645
Panc 08.13,15953870,2.4184523221557557
Hs 940.T,136227331,4.452644003789645
NCI-H2126,54618771,2.112004674949257
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
253J,10385095,0.938050191732742
NCI-H1694,3825829,3.875245119752738
NCI-H1341,42642645,-0.7286892026422629
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
NCI-H1573,11455910,2.1224271669039902
JVM-3,54618771,-1.0453450586020971
KMRC-20,100016,7.210629640241846
DK-MG,136227924,2.9692161266572707
NCI-H1623,135928012,3.849713333151309
B-CPAP,42642645,1.2545407873532517
TE-11,9926054,1.7898768600573436
ZR-75-30,9927531,5.796828878545894
EB1,11455910,-1.5299168268702652
Jurkat,246676,4.546018962680684
Kuramochi,54649381,4.16651970817049
SNB-75,54649381,3.9199916385094657
UM-UC-1,11455910,0.1775144921107808
OVK18,3825829,3.748252346458453
OAW28,11396600,3.5740319462685535
EM-2,135411,0.2841826240796504
COR-L47,9926054,1.681825446292649
NCI-H810,54618771,0.890127008742605
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
SUP-T1,136227924,2.470227214750311
L3.3,100016,6.042484334243821
TF-1,135411,0.5555016634489159
G-292 clone A141B1,387447,-4.01918580844713
SHP-77,100016,6.499498313563913
IGR-1,3825829,4.198555894712998
A2780,135423438,1.4521240670524396
SNU-478,9887053,4.093570297059847
HuG1-N,4705,3.1646359507228623
OVTOKO,54618771,1.1892418619446876
IGR-37,9926054,1.73801540894826
KE-39,11396600,3.848773124810753
SH-4,136227924,2.5718168505003693
A-253,3825829,4.7589083568435075
DMS 53,54618771,0.8665759166845977
COR-L88,15953870,3.9989290848472665
CL-11,11396600,3.643774231055674
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
JJN-3,136227924,1.2624051766932831
NCI-H929,12001922,1.6200785055416655
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
EBC-1,11455910,1.3767667984766183
SNU-1196,9926054,2.598124573780665
BT 172,9887053,4.1673439249802025
LS1034,selumetinib-GDC-0941 (4-1 mol-mol),-0.3273277386123449
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
BT 147,42642645,1.553666960946683
HEL 92.1.7,12001922,2.3204600249134035
JMSU-1,42642645,-0.2855975002109457
SU-DHL-8,10385095,0.5850869783930369
JVM-3,54649381,3.4114849841468535
ES-2,100016,6.579379467241575
MM1.S,136227924,2.5395832269167027
SNU-245,10385095,2.5153017104707263
MOLP-2,15953870,3.4088994133559543
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
SU-DHL-1,387447,-5.562438756444553
M-07e,6505803,0.1015429750426806
NCI-H520,135423438,3.6436020684370463
42-MG-BA,11396600,3.992983938802259
BT 239,10385095,0.554561661848966
BICR 6,2746,3.4354439873980143
SUP-T1,135928012,2.4845707468799687
NCI-H889,3825829,3.986915111100791
ES-2,24753719,4.95493894106221
BT 333,11396600,2.8942593651334567
Calu-6,9887053,4.375543852570706
BT 440,54649381,4.029218777918959
KMS-26,9887053,1.48109473328979
MHH-ES-1,15953870,2.7845064920938123
OCUM-1,135411,-1.243171699653697
RPMI-8226,42642645,1.1639668201351825
AML-193,2746,2.0410312997302698
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
PSN1,2746,4.086398996517882
HT-1080,9887053,3.510668052715185
NCI-H1299,136227924,3.5346618762414392
PE/CA-PJ41 (clone D2),3825829,4.527338573645581
MDA-MB-361,11455910,0.4388713413004988
A-549,15953870,4.749569227898693
NCI-H1623,387447,-3.670338978810225
8-MG-BA,2746,3.598296066021755
BT 359,9926054,3.2726911092773223
EBC-1,11396600,3.453174926041772
GSS,54618771,-0.6166501734641827
COR-L95,136227924,2.879022500990784
HCC1428,54618771,4.504577297987602
SNU-1079,24753719,1.4594897792984398
NUGC-4,135928012,3.892614955295735
BxPC-3,135411,0.8341107494370649
IGR-1,6505803,1.3637597658923408
A-549,9926054,1.8971220341716168
CML-T1,135411,-2.1332231058037796
TE-4,11167602,2.9393987233558807
AGS,12001922,1.7816493510804028
HMC-1-8,6505803,-1.2276193463288383
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
BT 428,11455910,0.0710771584645227
SUP-B15,387447,-5.756915751204593
NB1,10385095,0.6202993417039071
OCI-Ly10,42642645,2.2836882716745692
NCI-H1666,11167602,0.4125799351695397
SNB-75,4705,4.116486299784252
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
TE-15,6505803,-1.869936847714552
TOV-112D,54618771,0.882664692368087
MOTN-1,24753719,3.563807007676044
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
NCI-H2228,12001922,2.352395200171033
VMRC-RCW,12001922,1.8189287943078536
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
HCC2218,54649381,3.8304752709798464
BT 224,selumetinib-GDC-0941 (4-1 mol-mol),3.286346759744933
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
HL-60,2746,1.7934505084154275
LOU-NH91,54618771,2.8270991446030593
22Rv1,387447,-4.661943486979205
SW579,136227331,4.609326652979714
KYSE-30,11396600,3.6948052468539654
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
BT-12,11455910,1.8698034646141068
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
T98G,11455910,0.2544044244043033
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
NCI-H1755,49836020,-0.0301714782676706
NCI-H146,11455910,-0.4209962248823531
TOV-112D,136227331,4.785922428339521
SNU-216,12001922,1.864153419618113
SNU-761,11396600,3.454843575520041
BT 245,136227331,4.251360717375094
NCI-H1355,15953870,2.963536255593462
TOV-112D,3825829,3.913207568511401
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
JHH-1,100016,6.434861287132587
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
P3HR-1,15953870,3.2355314646730062
NCI-H196,135411,1.5759989708641096
HPAC,100016,6.325474069382135
NCI-H1355,54618771,0.7096344074223282
SF539,10385095,0.5044778211988786
NCI-H1092,9927531,3.406213307022425
NCI-H1755,54649381,4.3205155201520755
Hs 822.T,54649381,4.257367611648936
CAL-33,11455910,1.2995904735860209
SNU-1214,24753719,4.20428044650039
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
RS4;11,42642645,-1.252225955502167
ST486,54618771,-1.8169523642360077
NCI-H838,15953870,4.328717320267694
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
SNU-1033,136227924,2.5540912421490387
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
KE-39,24753719,4.8851025960405074
PF-382,12001922,1.3621804177433754
HCC-56,9926054,1.8387784948097223
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
TUHR4TKB,54649381,4.063472676566029
WM793,9887053,4.971798307876137
Raji,54618771,-0.1378575615243227
A-498,11455910,2.747308138802023
PF-382,9926054,1.6899693166343082
PK-1,24753719,4.344966881263849
NCI-H2106,135411,2.8433470854477596
GB-1,9887053,3.3603902850728593
Hs 895.T,3825829,5.866669500118176
IM95,3825829,4.016424882427798
Panc 03.27,10385095,1.0322111934041436
JHH-4,10385095,1.4023288225703123
WM266-4,135423438,3.754515663812223
Reh,15953870,3.040014290223745
NCI-H647,24753719,4.184864317200406
HCC1937,12001922,1.9857697092804127
OE21,49836020,4.665936469802933
JHUEM-2,54618771,-0.9670015993235072
LOX-IMVI,24753719,4.180599025033894
NCI-H2291,54618771,2.606874288662127
NCI-H1734,9926054,1.950289426848977
NCI-H2452,11455910,0.7111396076654327
SaOS-2,15953870,3.7774839542606617
SK-UT-1,136227924,4.460190875137593
HuT 78,3825829,4.013992283960839
DEL,100016,3.851368536137221
NUGC-4,9927531,4.1074548867853045
EJM,11396600,3.800195279839431
NCI-H2452,9926054,2.7849990975548726
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
FaDu,246676,4.360118966738819
HOP-92,11396600,3.514379135780385
HCC95,15953870,3.8908206740788542
MG-63,10385095,2.7143231062656197
NCI-H196,12001922,1.8660420195191385
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
MV4-11,9887053,2.1496957851451817
769-P,135411,0.1615714866920327
OCI-M1,24753719,3.8441601097778015
NCI-H2126,10385095,2.2244288571563846
HOP-92,3825829,4.4402375756937245
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
RCH-ACV,54618771,-1.6129004186602771
COLO 201,54618771,0.4783318937698353
T24,11455910,0.9790559747688146
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
42-MG-BA,54649381,3.8574334944856776
TCC-Pan2,6505803,-2.1340382600385035
SNU-489,9926054,2.706160270050288
RS4;11,12001922,1.7136327675679155
CML-T1,15953870,2.3626237456804025
OVCAR-8,10385095,0.9629487477547042
NCI-H520,9887053,3.988492309043506
BT-474,11396600,4.260974029786902
CJM [Human melanoma],42642645,1.268326391900268
HCC1143,6505803,-0.5233928936461414
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
HCC1195,3825829,5.245542141356405
RT-112,42642645,0.1170275675022441
Capan-2,9926054,1.7295951578081552
SNU-489,selumetinib-GDC-0941 (4-1 mol-mol),2.3199148187504592
ZR-75-1,2746,4.074441390340067
THP-1,15953870,3.2773850484347196
P31/FUJ,136227924,2.3905530687579497
OUMS-23,selumetinib-GDC-0941 (4-1 mol-mol),1.2093335289094016
NCI-H2291,selumetinib-GDC-0941 (4-1 mol-mol),-0.2991032125390215
TE-5,11396600,3.2450913131710957
Tm87-16,54649381,4.271271478303165
RL95-2,135411,-0.0466044319397537
KP-3,15953870,3.990399169996875
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
TCCSUP,42642645,1.035198778312657
AsPC-1,6505803,-1.959385905579291
JVM-3,24753719,3.3641173434244345
8305C,3825829,3.882801441279991
PC-14,9926054,2.1919524814380846
HCT 8,3825829,4.251510045569675
NCI-H2029,11167602,1.636861856546505
HCC1195,11167602,1.8207467609610304
HCC95,387447,-4.192216273294883
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
BICR 18,42642645,-0.6769886178089254
NCI-H647,42642645,0.6408660705553061
HCT 116,42642645,4.371361636720889
Hs 294T,6505803,0.4155965097555305
KP-4,135423438,2.950077613704309
NCI-H526,6505803,0.072926475224881
P31/FUJ,9887053,2.876589254443052
SK-CO-1,15953870,2.1343083972614725
TE-6,15953870,2.1094884303307797
G-292 clone A141B1,12001922,2.3866772179286655
NCI-H520,6505803,3.2437812579556864
ACC-MESO-1,3825829,5.620049570908759
SU-DHL-10,9926054,1.7621581525939023
NCI-H2452,10385095,2.425738192808243
HEC-108,387447,-5.079207916782074
CAL-51,12001922,2.008779489179369
HT115,44498493,5.950058621722862
23132/87,3825829,3.5434267062196443
CL-11,387447,-5.550386686338738
BT 131,9887053,1.3414102009699755
BT 139,135411,3.1054244698858566
NCI-H2122,11455910,1.0821419204732732
SNU-503,12001922,2.083143861009323
PLC/PRF/5,100016,6.529147023700783
MKN1,15953870,3.454153639130422
LN-18,136227924,2.6730717807576347
OCI-Ly19,12001922,1.747004755578139
SNU-1214,3825829,4.190729041400542
NCI-H1299,10385095,1.4970328026397637
2004,11396600,3.4880760696639417
GCT,9927531,4.599543435598106
MDA-MB-453,12001922,1.470906003655458
5637,15953870,2.099989810908487
RCH-ACV,15953870,2.2250377095938294
PK-1,3825829,5.213929131853521
GA-10,2746,0.7729221646050856
HMC-1-8,135411,0.5425233800739662
NCI-H196,15953870,6.198131940680453
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
NCI-H1155,135411,-0.7223828393172724
KO52,11455910,0.9067852842316652
MIA PaCa-2,42642645,0.3251150152649052
EC-GI-10,136227924,3.398194138185936
C2BBe1,15953870,2.230642532753978
NCI-H1944,135423438,6.01931856981719
KP-4,11396600,3.580302793635078
BHT-101,11396600,4.367853211267109
A2780,136227331,3.7351205807719863
SNU-16,12001922,1.0670712076162967
OVK18,135411,0.8544663692994154
NCI-H441,100016,5.015174861435744
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
GaMG,54618771,-0.7184169257406299
Granta-519,12001922,1.093482575381039
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
NCI-H2030,100016,6.672614959068411
KMS-12-BM,387447,-5.588552036556516
P-STS,54618771,0.5747646300183281
NH-6,9926054,1.9034563361062868
NCI-H522,6505803,-3.5272214952237344
COLO 699,135411,0.3565860364596762
SU-DHL-1,246676,5.693727803678488
RD,selumetinib-GDC-0941 (4-1 mol-mol),0.4291937329067764
HCC2108,54649381,3.8131747738004567
Capan-2,11396600,4.3940876054708005
Hs 936.T,9926054,1.615791858991988
MFE-296,135411,0.0308526868660611
MJ,42642645,-0.910764146609361
SUP-T1,15953870,2.607748333286253
COV362,4705,3.5601253805360975
KO52,2746,2.0900422497447906
HT-1080,6505803,0.5678766317067223
HCC4006,selumetinib-GDC-0941 (4-1 mol-mol),1.2371025715535526
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
NCI-H1563,11396600,3.5189077710115244
KMRC-2,11396600,3.609897485717139
HPAF-II,24753719,4.7373633717585975
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
NCI-H520,4705,3.58444135118044
KMS-28BM,11455910,0.2155476441980809
HEC-1-B,10385095,1.4850589250139663
BT-12,42642645,1.0277830150550853
SYO-1,11455910,1.1491108391479796
SNU-C5,selumetinib-GDC-0941 (4-1 mol-mol),1.7590235463431136
SK-UT-1,246676,5.689307282465742
Caov-3,15953870,3.3253234394392743
BT 232,6505803,-2.078004846595285
NCI-H747,54649381,3.8294363389634407
HCC202,387447,-5.727395432972954
U266B1,387447,-5.479400433027951
YAPC,3825829,4.484241364021175
786-O,54618771,1.0235126095922562
HSC-3,12001922,1.7016354189742475
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
TM-31,54618771,1.840176176931743
HCC1500,2746,2.6069735713089006
Hs 944.T,3825829,3.8037042594283506
TE-11,4705,1.37332661199947
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
U-BLC1,49836020,5.6845894274854585
BT 482,12001922,1.0867997269237288
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
SNU-503,9927531,6.946018069076572
JHH-5,11167602,1.5103149068209596
Ishikawa (Heraklio) 02 ER-,387447,-4.209171325852115
SNU-1077,15953870,3.3476247633777585
SU-DHL-1,9926054,1.6936537424309908
MM1.S,9887053,3.7557116412340568
NCI-H1694,54649381,3.7301303223794258
MKN74,24753719,4.72692215200023
Mel Ho,15953870,3.0413155551308297
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
NCI-H647,15953870,3.2923326421266235
HCC1500,387447,-5.435802195710178
NCI-H1650,135411,0.449785286643268
SK-ES-1,24753719,4.536634843325145
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
KMRC-20,54618771,1.1098897337437623
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
Calu-3,100016,7.471917827082483
Capan-1,9927531,5.621022347820903
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
HT-1376,49836020,5.287165459832521
MG-63,54618771,1.3665941956425405
Kuramochi,selumetinib-GDC-0941 (4-1 mol-mol),1.9620820620986936
ZR-75-1,24753719,3.331653955858336
Yamato-SS,387447,-3.3037694747965527
HCC1428,selumetinib-GDC-0941 (4-1 mol-mol),5.009115635429041
DAN-G,10385095,2.273453653362206
OCI-M1,3825829,4.266885937330685
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
WT2-iPS,54618771,5.206944426983613
Detroit 562,9926054,1.947776964101976
WM983B,2746,3.5652531947368495
Rh41,246676,5.784638860753491
PK-1,11455910,1.3401068508197878
23132/87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1204952013387844
KMRC-20,135411,1.924751982395428
NH-6,9927531,5.219237358239311
LN-18,6505803,-2.139737100228386
BT 228,11455910,0.8628346849534536
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
COV362,136227924,2.2847413829349947
BT 139,387447,-3.566401702341635
GSU,9926054,2.0753432463220065
WM88,15953870,4.011231604967574
MOLT-13,135411,-0.0386413131394998
Becker,24753719,4.281079864002637
Caov-3,2746,3.7712035722232304
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
NCI-H1694,24753719,4.146900765581546
SW948,11167602,-0.1815305116238505
SK-MEL-28,11455910,1.7343524639503471
DMS 273,11455910,0.4737958394902512
OE21,3825829,4.065896901751797
Ci-1,387447,-4.618323196916918
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331
EC-GI-10,11167602,1.549524194849354
EC-GI-10,10385095,2.518396307471165
SK-MEL-31,2746,3.1579151966275343
SNU-387,54618771,3.696671727532153
CAL-78,135928012,4.841154200407359
SNU-308,15953870,3.462040803535903
IGR-37,15953870,3.832718760347283
A-498,4705,4.1964696083385595
SNU-878,387447,-4.044315660463195
SNU-119,9927531,4.042335314323924
SK-MES-1,135423438,2.7133393164015027
SNU-213,24753719,4.370347771119096
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
BT 187,44197249,3.7545111944098006
Lu-99,135411,-1.9725841061331628
YKG-1,11167602,4.915993662125618
BT 131,42642645,0.7311054472104954
VM-CUB-1,24753719,4.506537888296173
BV-173,9926054,1.6102872074476016
NCI-H2141,42642645,0.5006578232699423
RPMI-6666,10385095,0.628840005049414
BC-3C,387447,-4.766294881634265
TE-10,10385095,1.858372873249832
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
NCI-H1792,9926054,2.787600202110533
NALM-6,9926054,1.499716705925791
AN3-CA,3825829,3.633283861365007
NCI-H526,15953870,3.664554614644739
NCI-H1944,4705,2.455781593710475
U-937,24753719,4.219333200465045
SNU-1196,136227924,2.95634276982207
OC 314,11455910,0.0768833443632768
HSC-4,12001922,2.169357927696289
TE-10,9926054,2.0362558072853827
NCI-H1395,387447,-2.916256020115362
HT-144,selumetinib-GDC-0941 (4-1 mol-mol),0.3357004293629391
BT 428,9927531,4.812195201637174
NCI-H2126,11396600,4.817248126603388
MDA-MB-435S,54649381,3.981466115909339
HCC827,3825829,3.776575449370697
TE-5,136227331,4.141551967030233
NCI-H1944,6505803,-2.861840554451695
JJN-3,10385095,0.9998368526729328
SK-MM-2,135411,-5.030603017749758
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
P12-Ichikawa,11396600,2.4412876679668165
NCI-H2141,54618771,0.6862443380441183
Namalwa,135423438,1.9520788575137753
TCCSUP,100016,6.5110410318476575
Fu97,11396600,5.862463296841975
SK-BR-3,9926054,1.6318008391907537
NCI-H841,42642645,-0.3721547208744662
AML-193,135928012,3.8560863444893982
KMH-2,42642645,0.908731492566517
Ri-1,24753719,2.417177193104349
HCC2279,10385095,2.674099948774722
NCI-H522,9887053,3.177768808520637
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
SK-MEL-1,12001922,1.2584341541482038
BT 422,selumetinib-GDC-0941 (4-1 mol-mol),3.332699583710218
A-673,15953870,2.6171812575314757
ST486,72199289,4.347318676727556
NUGC-4,136227924,2.1432448607030308
Ishikawa (Heraklio) 02 ER-,135411,1.0348224013117624
5637,135411,-0.2925000301353472
ChaGo-K-1,4705,3.918553629962962
SW1710,24753719,4.404471197340268
SK-MES-1,12001922,1.393136563934824
SF539,135928012,3.885367249068042
SNU-869,42642645,1.5853291921220307
SNU-668,12001922,1.906558105613108
UACC-257,10385095,1.15357102602932
Capan-1,42642645,1.1819071124577496
KG-1-C,42642645,0.8170428304086311
A-204,387447,-4.663999129907044
ONCO-DG-1,10385095,1.023258211832854
RPMI-8226,54649381,1.6645002770366162
T24,4705,3.5984863118556065
VM-CUB-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2001367648558769
SET-2,136227331,4.340141921453115
HSC-4,11167602,1.6360881716966182
RERF-LC-Ad2,11396600,4.594180065221676
TOV-112D,9926054,1.7834686388264986
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497
LoVo,2746,2.3133613771451524
SK-MEL-3,136227924,3.573502388362414
253J-BV,54618771,0.8699065308229518
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SNU-620,15953870,2.165511333781728
OV56,135411,0.4349768856678936
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
Hs 895.T,9887053,4.261540808405506
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
NCI-H1793,10385095,1.202499235212937
J82,9887053,4.480677110410891
DMS 114,10385095,1.113027996437857
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
OVTOKO,387447,-4.429835195174456
DLD-1,11455910,2.1228676329479397
SW579,135928012,4.371539050286041
SNU-1077,54618771,3.2500418975361347
NCI-H1373,135411,0.3964388730692773
P-STS,2746,1.4034499567898922
NCI-H520,11167602,5.235788711953261
HEC-1-A,15953870,3.31722931516423
CHP-126,387447,-4.015508892911081
KE-37,54618771,-2.6599690790186425
T98G,6505803,0.2412993690877728
SNU-C2A,387447,-5.308265988306766
BC-3C,9926054,1.793966289929591
LOX-IMVI,10385095,1.0613031288741694
GI-1,24753719,4.3958442293343305
NCI-H2444,387447,-4.127390002531985
Ku812,24753719,3.51384685300995
HuT 78,387447,-5.436092440743046
KMS-11,54649381,2.7121087044330108
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
HCC1143,24753719,5.247680835091332
Hs 934.T,12001922,1.4003272312150303
MG-63,11455910,1.9804853910986304
NU-DHL-1,9887053,0.6312128826435269
HGC-27,387447,-3.492607517948141
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
GSS,135411,0.6455113716410611
JHH-2,11455910,2.202317711271985
CAL-33,2746,4.008172318733893
MOLM-16,3825829,2.1444414384784714
BT 245,100016,6.42627295768896
KP-4,15953870,3.4462713281416697
GP2d,10385095,1.144770275016541
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
PE/CA-PJ15,9927531,4.562949408871821
DV-90,2746,1.1630599878188876
OVCAR-4,6505803,2.147472746643062
HCC1395,54649381,3.677425180977059
RPMI-6666,24753719,3.8145532012003938
EKVX,11167602,3.3348952564527865
Hs 611.T,49836020,3.6507368971801983
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
COV644,4705,3.798670959115779
COLO 678,12001922,1.6196462346044982
BT-549,136227924,3.266068806496957
AsPC-1,2746,3.619198032462304
CL-11,42642645,0.3839378627546586
KCL-22,10385095,1.1871398170066128
EM-2,3825829,2.7385006031441947
MOLM-6,42642645,-2.7335068677288223
HT,3825829,3.372297741097032
SK-N-SH,136227924,2.487245372945198
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
PC-14,387447,-3.812338595624124
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842
ALL-SIL,135411,-0.5620485907345016
FaDu,9887053,3.776402188409021
ECC12,136227924,3.114580380384796
NCI-H520,136227924,2.065702540466464
NCI-H1915,9926054,1.8603630934731663
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
LOX-IMVI,10385095,1.0613031288741694
NCI-H292,11396600,3.7365966834404225
Hs 822.T,135928012,3.7528660445554247
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
639V,10385095,1.9992924364223104
SK-CO-1,11455910,1.152685438196598
HCC15,11455910,-0.3399110905288865
TYK-nu,6505803,-1.946353341465887
Calu-6,10385095,1.5195799432137909
Granta-519,387447,-5.4996124066637435
LS1034,44197249,3.821880068474453
HOP-62,135411,0.996647312538749
Panc 02.03,136227924,3.0839082623333387
VCaP,387447,-5.173916633196666
U-118MG,11396600,3.770930746611021
SF295,11396600,4.282405011310363
C2BBe1,9927531,4.784416538426047
NCI-H446,6505803,2.330935427354621
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
SNU-1077,136227924,3.612132735883527
HSC-3,387447,-4.149874850312051
Hs 940.T,11396600,4.001977527096724
KP-N-YN,2746,2.243582059323954
JeKo-1,11455910,-0.102644590273409
NCI-H1092,10385095,0.6716651912361483
AML-193,12001922,1.1501522551679335
KMS-28BM,9926054,1.6939379684191658
TOV-112D,42642645,1.267916863659074
8505C,9926054,2.4332368789969734
Kelly,3825829,3.634714361432549
PSN1,4705,3.10830122261482
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
HuH-28,54649381,3.7524268374632905
FaDu,54618771,1.2079595597502673
JeKo-1,10385095,0.5289255976933436
DMS 53,12001922,1.2254114563506444
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
TE 441.T,54618771,1.354234974700439
Hs 683,9887053,4.217541093528145
SK-MES-1,9927531,5.425786603716899
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
BICR 31,4705,2.7587837218207194
MKN74,3825829,5.028254794750419
IM95,12001922,1.2578184387032223
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
BV-173,6505803,-0.0472737333369297
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
LS513,9887053,1.34916385503377
NUGC-4,54649381,3.636011655069359
HCC4006,54618771,1.138326772964569
EHEB,6505803,-0.4928001321157277
BT 131,24753719,4.828449358654909
H-STS,54618771,0.7523066402016166
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
SNU-5,11455910,3.529816425197799
COR-L51,9887053,-0.3697818987504753
NCI-H1184,135928012,3.766245125513684
HEY A8,2746,3.567367579370524
253J,54618771,1.0062396076481863
KMS-34,136227924,2.5847633588950147
SNU-1105,12001922,1.9089929942254595
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
KMS-12-BM,49836020,4.363885927749537
MJ,6505803,-0.8623373124046138
COLO 205,136227924,2.4867417586096416
SK-N-DZ,6505803,0.8525676742203174
NCI-H2052,136227924,3.050038230910341
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
SNU-C1,9927531,4.924275506690927
HLF,54618771,-0.5261928492303469
HCC1428,12001922,1.5869594218336285
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
WT2-iPS,3825829,5.596536511200843
GP2d,4705,2.380546540309972
BICR 16,3825829,4.594244337352527
JHOC-5,10385095,1.1914017073923984
ACC-MESO-1,100016,6.4652465436588775
THP-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.4555480818826622
NCI-H526,135411,0.2773825068651638
RKO,135411,0.3039750611139232
BT 482,54649381,4.176471526323477
BT-20,42642645,1.1875520352883364
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
SW1271,12001922,2.1604198968714754
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
HGC-27,4705,3.374202647698771
Hs 940.T,9926054,2.0266998753682324
JHUEM-3,9887053,4.4574978029578824
EHEB,9887053,2.923841050224105
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
MPP 89,12001922,2.15430006337516
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
HT-1080,11455910,0.1997315897525516
NCI-H1650,136227924,4.84526698521074
NCI-H1793,9887053,5.006557484212018
CAL-27,135411,0.5079952152843086
FTC-238,387447,-4.995253744226477
OCI-AML-5,11455910,0.2167444305252664
SK-N-BE(2),6505803,3.424835431725291
NCI-H292,387447,-4.003442188855186
CJM [Human melanoma],9926054,2.54173081148122
SF126,54618771,1.1174524755985609
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
KHM-1B,24753719,3.787412928700261
LS180,54649381,3.823257143411622
BT 172,54649381,3.878686800703052
WT2-iPS,135411,-1.7099745454404136
KNS-62,3825829,4.068857100955721
8505C,10385095,0.6196547026906353
DU145,11396600,3.556301760853191
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
NCI-H1838,15953870,3.7151983765883223
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
KMS-26,9927531,3.4485802259646703
B-CPAP,246676,4.303313026788405
SNU-761,42642645,0.1564251852447773
DU4475,11396600,2.471584986754413
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
BT 359,54649381,3.952446913755983
OVCAR-4,54649381,4.269013155401103
MOLM-13,10385095,0.2048351805935088
TUHR14TKB,9887053,4.05865278996367
23132/87,387447,-4.33404895580382
BT 147,11167602,1.7242539171723648
SU-DHL-8,4705,3.58469118843627
HCC1143,15953870,6.0969880807250085
EJM,2746,1.455612839065016
TUHR14TKB,11396600,3.8849450559075343
BT 286,4705,3.0604993750879834
HCC4006,2746,3.5545517621317586
NCI-H1299,136227924,3.5346618762414392
LNCaP clone FGC,49836020,4.788899602776088
BT-20,9927531,4.105614320548644
KYM-1,2746,1.273696140003964
NCI-H2106,9926054,3.0044250532123735
HLF,selumetinib-GDC-0941 (4-1 mol-mol),3.676368121214341
KMS-27,9927531,4.171626738694902
UO-31,24753719,4.2224866834082135
NU-DUL-1,135411,-0.380891714727419
SK-N-DZ,selumetinib-GDC-0941 (4-1 mol-mol),1.1652159438027232
786-O,2746,3.398389202890904
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
Namalwa,11455910,-0.4529585092669797
CA46,135411,0.0331424760277949
MES-SA,15953870,3.723952304334324
JHH-4,selumetinib-GDC-0941 (4-1 mol-mol),1.975979663923368
MEC-1,54618771,0.2642234138424628
CAMA-1,9877608,5.870182576067418
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
Hs 766T,10385095,2.0923812413059992
OE33,11455910,2.709307324033481
SNU-466,10385095,0.6686430469836288
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
CCF-STTG1,42642645,1.477320759489864
SNG-M,4705,3.157780900696135
OV7,9887053,6.197225137125892
SNU-1077,11396600,4.998092576249027
EFM-192A,3825829,4.263153967468734
A-673,11167602,2.442600782118551
GI-1,136227924,2.879759291125734
TT,selumetinib-GDC-0941 (4-1 mol-mol),2.303935736572117
HD-MY-Z,136227924,3.0737298330446103
Hep 3B2.1-7,3825829,4.187718301348179
JHH-2,42642645,1.1309941514618012
8-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),3.0365797378883843
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
KYSE-150,6505803,-1.1236376275824325
PE/CA-PJ15,4705,2.241412647888812
Ishikawa (Heraklio) 02 ER-,42642645,4.32459394836607
8-MG-BA,42642645,1.5513078414251742
SU.86.86,11167602,2.458587249616875
COLO 684,selumetinib-GDC-0941 (4-1 mol-mol),1.3698128792946012
TE-4,10385095,1.682137029626504
HMC-1-8,12001922,1.9270910115661624
KYSE-510,136227924,3.267869272747249
SET-2,3825829,4.044328892203194
Ci-1,2746,3.190931407467591
EFO-27,6505803,0.9411407576336728
HEC-1-A,24753719,4.9584766677320475
JM-1,9926054,1.6867956204893688
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
KPL-1,44494015,4.459934814858864
NCI-H2106,11455910,1.3355909303164284
CML-T1,12001922,1.44047939392769
RPMI-8402,6505803,1.0273996849455458
SNU-1041,54618771,3.2318145292931195
BT 239,3825829,4.303945684647588
BT 112,136227924,2.645928432247734
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
SNU-478,54649381,3.786745330607419
SF126,11167602,2.368623287420037
KP-N-YN,135411,0.4776606909582138
COR-L95,54618771,1.9587299059916856
NCI-H2170,12001922,2.2236692964109976
YKG-1,3825829,4.427024688096871
IMR-32,6505803,0.9080588170181416
DMS 53,4705,3.2924346460856015
RERF-LC-Ad1,10385095,3.535917584536634
NCI-H2141,12001922,1.037553574527669
HT,11396600,2.79137838927363
Namalwa,9926054,1.683884099727144
HL-60,selumetinib-GDC-0941 (4-1 mol-mol),-2.2086507819126213
J82,15953870,4.2180584413226825
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
YD-38,11455910,1.5894943212861383
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
CAL-85-1,100016,6.683113656599713
KALS-1,11396600,3.671510042060093
SK-MEL-3,12001922,1.3656226676364642
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
SW579,387447,-4.0289330288066845
TE-1,9926054,2.343374218225638
NCI-H520,136227331,4.183046250285636
NCI-H1105,11396600,3.854794582402416
NCI-H647,10385095,0.97952933951215
BT 504,2746,4.403785985788142
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
ECC10,54618771,0.89322852305294
SW1783,9927531,4.46381053918724
AN3-CA,6505803,-3.3327049528719312
OCI-AML-3,49836020,4.587745933093821
MeWo,10385095,0.7159237438593402
EC-GI-10,selumetinib-GDC-0941 (4-1 mol-mol),2.251648827392905
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
Detroit 562,135928012,3.717897986819555
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
BHY,387447,-4.368616082940834
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
NCI-H1581,10385095,0.301303893898011
COV434,4705,5.401407376455341
SNU-620,54649381,3.159685610143632
COLO 680N,12001922,2.002841282355022
NCI-H211,9887053,2.2407211579403294
MHH-CALL-3,9887053,2.306454802668345
MKN74,12001922,1.7190700710045448
SU.86.86,136227924,3.0459574781144014
KYSE-70,9926054,2.326174845830733
MCF-7,54649381,3.6941524068844367
KLE,11396600,3.656351561000123
SNU-1066,136227924,3.4679855479635644
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
SJSA-1,2746,5.233978868985217
MEC-1,11167602,1.5646333943840791
PLC/PRF/5,9926054,1.9278694567430317
Hs 888.T,100016,7.920695284419831
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
BT 416,9926054,1.8827513028201357
OE21,9927531,4.992848693668257
HCC1569,11396600,3.770118441175883
TE-5,135423438,3.0033799425211405
T98G,42642645,0.8480271641084243
SUP-T1,100016,6.229647258472745
SK-MEL-5,54649381,4.626873834001773
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
HCC1954,12001922,1.7774832322720509
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
GDM-1,9887053,3.2944436157994232
ALL-SIL,42642645,-2.33031271995146
HMCB,9926054,1.939305093595803
HT-1197,42642645,1.5402491011918673
SK-MM-2,135928012,3.5944087067361505
TE-1,2746,2.3035924875170997
U-937,387447,-5.24372520637314
NCI-H520,3825829,4.101892879518108
NCI-H526,11455910,1.2336462288733878
MKN1,11455910,-0.2869953117882883
SK-N-FI,15953870,3.818724091297744
COLO 680N,54649381,4.2156287323669135
SNU-8,15953870,4.687237129335348
SNU-46,246676,4.376439211619656
LCLC-97TM1,11396600,3.6456493290211425
HCC1143,49836020,2.702530837822698
BT 440,4705,3.213211271406504
JHOM-1,54618771,2.421101396642466
Yamato-SS,11396600,4.2294198024767145
U-937,12001922,2.0543148174696326
CHP-126,9887053,3.534144838518124
DBTRG-05MG,9926054,3.4438340523747955
IST-Mes1,2746,3.2096433183027604
B-CPAP,15953870,3.3315928326884756
LAMA-84,11455910,0.4620694061975223
AU565,49836020,5.742264990221176
HEC-251,100016,6.174926130166858
MHH-CALL-4,100016,6.461754156645112
NCI-H1155,15953870,3.200420673936154
RL,11167602,4.161997325292916
PE/CA-PJ49,11167602,3.7054194129551736
HCC78,135411,0.2956789390174362
WSU-DLCL2,6505803,-0.444395871025773
HEC-251,54618771,0.8830858807964597
KP-4,11167602,1.7428553982677493
Panc 04.03,11455910,2.454958233695195
PK-59,6505803,-0.3559678115713951
HEL,387447,-4.961191552031455
GSS,15953870,2.249610266987025
EB1,11167602,1.3482748147027377
MHH-ES-1,10385095,1.1490063468144698
PE/CA-PJ34 (clone C12),24753719,4.157355819781257
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
TE 617.T,49836020,3.775264114601375
OCI-AML-3,135423438,2.310750023126374
SK-N-BE(2),12001922,1.19170454638318
MDA-MB-361,9926054,1.9315814680305097
MM1.S,24753719,4.473744821146246
MOLT-3,3825829,2.711373482017621
SNU-182,12001922,1.1285522184772547
NCI-H1395,4705,3.4784735381586183
PANC-1,9887053,3.878433673694437
ESS-1,15953870,4.251182517456194
KCL-22,15953870,1.612215737425325
WM266-4,15953870,3.862940814981747
JVM-3,6505803,-1.4044558034159191
NCC-StC-K140,9927531,5.259562635251384
HT-1080,136227331,3.9777239464002223
KYSE-410,15953870,3.289472194998764
YD-10B,9887053,5.044840409033614
CML-T1,135928012,3.921778036516406
EN,12001922,2.2743015908551447
NCI-H2085,12001922,2.428895251313968
KMS-34,9887053,1.3441018332964594
EC-GI-10,2746,3.3454005249386243
T84,11167602,2.5996752416167492
NCI-H2081,2746,1.7876165118995768
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
VMRC-LCD,54618771,1.8324078419915515
HMC-1-8,selumetinib-GDC-0941 (4-1 mol-mol),-0.1007905970017958
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
MDA-MB-453,9887053,5.45770037243801
CAL-62,9927531,5.042893811802322
DAN-G,2746,3.5284338969271265
RMG-I,11396600,4.055852766131107
SK-LMS-1,10385095,1.8771783160907216
UM-UC-3,42642645,2.0272069869133627
OVCAR-4,2746,3.8556050114326506
OCI-AML-5,6505803,-0.3064133467102931
LP-1,10385095,1.2298439845363769
BFTC-905,3825829,4.518180163143889
OVCAR-8,54618771,0.8925254662704427
CHP-126,54618771,-1.2207824703172212
HCC2218,12001922,1.1879364076303054
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
OCI-Ly3,3825829,3.936732013816713
Hs 888.T,136227924,1.939793098771597
U-251MG,42642645,1.4189953167650486
SR,135411,-0.1612982630483475
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
LS123,11396600,3.4015234811291246
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
NCI-H2452,15953870,1.9726746369071917
HSC-4,10385095,0.4573663196580717
NCI-H1299,54649381,3.8627163696986098
CL-11,4705,3.0893529529673347
JHOC-5,54618771,0.913993677886488
BT 112,12001922,0.29456942425987
SNU-1272,3825829,5.135605064206703
PL-21,15953870,2.570096406228743
COR-L95,9887053,2.0711365362831193
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
SU-DHL-8,3825829,3.604833597953699
MKN74,42642645,1.392605787753803
LOX-IMVI,11455910,0.9161498134653596
JHH-2,24753719,4.644854006308001
SW1417,6505803,-1.211390297431511
DND-41,selumetinib-GDC-0941 (4-1 mol-mol),0.5695513725916952
EoL-1,3825829,1.62057734053031
KP-N-YN,9926054,3.360231389536055
MDA-MB-157,42642645,0.4106458170856017
AGS,387447,-4.541066993299316
697,100016,3.656696343596264
KMS-20,135423438,1.13023072719564
Capan-2,54649381,4.1976896993198825
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
Rh30,2746,3.242991400457772
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
Ku812,11396600,2.326776145026828
LN-229,3825829,4.282293100667686
ECC12,3825829,3.611755199721166
KM12,9927531,4.5473811141762965
ONS-76,15953870,3.841628876209717
Kelly,selumetinib-GDC-0941 (4-1 mol-mol),2.978588327990176
P31/FUJ,3825829,3.1586120375796516
KE-39,54649381,3.8116402123721578
PLC/PRF/5,2746,3.4483774015176447
LN-18,54618771,-0.903169975136804
SK-MEL-5,10385095,1.0393957169918682
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
RERF-LC-A1,49836020,4.4326562717782005
ChaGo-K-1,15953870,3.0294240657930955
TYK-nu,100016,5.6630271022409495
BT 286,9887053,1.2721711931799218
NCI-H292,15953870,3.631273190289841
HMCB,135411,0.3409472589453896
EFE-184,387447,-4.441660271733979
NCI-H716,2746,2.8210994981095556
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
BT 359,136227924,4.313964424354799
SW1783,4705,3.473081250569121
NCC-StC-K140,9887053,4.133862097193235
MEC-1,10385095,0.5052680490549927
Pfeiffer,3825829,2.830750153733547
NCI-H2029,10385095,1.1841713860109806
SaOS-2,24753719,4.762341084721446
OV7,12001922,1.836891134789565
RKO,54618771,2.3159310195777985
NCI-H841,11396600,2.6632446224517454
G-402,4705,2.98367942972675
WM88,11167602,2.5186858712876963
JIMT-1,135411,1.1222176810647364
SNU-1076,54649381,3.9203568036210585
KM12,2746,3.7112872132085686
NCI-H2052,54618771,-0.8339738497532683
DMS 79,136227924,2.929954381299975
SU-DHL-1,100016,4.0163007651424945
T3M-10,15953870,4.3032514614952415
P31/FUJ,24753719,3.279397605233023
JHH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.7984148033328824
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
NCI-H1944,136227331,3.877742239943195
NCI-H810,9926054,1.762118845212232
A-549,135411,0.6793431682717198
Mel Ho,11167602,5.1060633134996465
A-172,11455910,2.3992948402654095
NCI-H1573,42642645,-0.0700693476557949
Lu-65,2746,3.448286012693329
WM983B,24753719,6.015635762527396
NCI-H647,3825829,3.822021409695252
SNU-869,15953870,4.286370733846898
2004,11455910,0.701648674397756
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
LAMA-84,42642645,-1.66832071642959
Rh18,42642645,0.5414115073786433
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
NCI-H520,387447,-5.005937359447702
NCI-H1944,10385095,1.274017817809668
RT-4,387447,-3.0484703414890744
NU-DUL-1,10385095,0.7003289664231471
SCaBER,12001922,2.3387149490522794
HCC44,6505803,-2.265511821723746
SF268,selumetinib-GDC-0941 (4-1 mol-mol),2.7601032387039433
NCC-StC-K140,54618771,0.2055366704850876
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
KMS-11,6505803,-3.448917575969749
WT2-iPS,selumetinib-GDC-0941 (4-1 mol-mol),0.0160943327982104
COV362,42642645,1.4396512125308818
NCI-H2405,selumetinib-GDC-0941 (4-1 mol-mol),-1.6328323472989523
Daudi,9927531,3.2507934675389447
THP-1,12001922,1.4398536280556002
A-204,9926054,1.5825801354867326
SNU-216,135411,3.273149769706094
P12-Ichikawa,10385095,0.2155062736179899
Hs 888.Lu,42642645,0.8608866862202371
KP-N-SI9s,9887053,3.5959287403451627
SNU-475,136227924,3.0898415955820715
SNG-M,11396600,4.011470573491779
DMS 114,100016,6.89872652787532
CCF-STTG1,6505803,-1.8344087076537687
DMS 53,6505803,0.1213526787251841
EJM,49836020,4.362565190709962
MOLT-13,387447,-5.536082916597753
SK-N-BE(2),2746,1.332316139919228
LMSU,11396600,3.695024866246392
BT 440,49836020,4.914023334980662
SNU-46,136227924,3.2751090842747637
KE-37,246676,4.808811994794393
HT-1080,24753719,3.879973652696449
RERF-LC-A1,42642645,1.655315386787829
Sq-1,42642645,0.949856336835377
NCI-H28,49836020,4.481045778865963
SNU-1033,4705,2.6216736811916044
RL,49836020,3.855414326561088
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
769-P,selumetinib-GDC-0941 (4-1 mol-mol),2.2458256114397788
HCC1171,9927531,5.509897026708257
HEL 92.1.7,136227924,2.7818707499809188
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
HEC-59,6505803,0.8725276425647639
HEL 92.1.7,15953870,3.647004785229891
GSU,100016,6.3262103117900805
SHP-77,135411,1.0007237168198035
Sq-1,4705,2.78304746157314
MPP 89,3825829,4.279216794927578
COR-L95,2746,2.78697970441755
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
GI-1,11455910,0.5064796295845606
BICR 56,135411,1.5289881878958271
AM-38,6505803,-3.272255667195971
NB1,4705,2.5823945012160214
NCI-H1915,136227331,4.393848466029563
JHH-2,2746,3.041008676294123
LCLC-97TM1,24753719,4.6973214087473405
BT 147,2746,4.827192237439561
BT-12,54618771,-0.2566375632021986
KMS-11,387447,-5.808193712301717
KMH-2,3825829,2.5333469127311004
TE 441.T,11396600,2.898111820402536
HEC-6,3825829,4.0162682213789624
NCI-H2452,54649381,5.966732082850981
NCI-H2029,24753719,4.110032115019825
SNU-1196,10385095,1.3720330826166771
CML-T1,6505803,-0.3633146304142068
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
P12-Ichikawa,42642645,-1.022719521590982
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
COV434,54618771,-1.0404001935191405
GDM-1,54649381,1.706339667752085
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
BT 228,54618771,0.9979024036150752
Hs 940.T,6505803,3.2300274365907486
KMH-2,136227924,2.758064098306969
JHUEM-1,246676,4.366062260954229
KP-N-SI9s,selumetinib-GDC-0941 (4-1 mol-mol),1.114910325038949
SNU-668,3825829,4.10051277902364
SNU-C5,3825829,4.587262372250537
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
HCC78,3825829,4.020249687325182
COR-L51,4705,3.639553791730093
KMS-21-BM,3825829,2.831962906161111
WSU-DLCL2,54618771,1.0658572900197
Hs 944.T,136227331,3.8800196533098847
JVM-3,12001922,1.34806109687291
MDA-MB-468,11455910,1.0367745441510958
SW579,15953870,3.2887800937582634
COLO 680N,136227924,3.1124323049819003
M-07e,136227924,2.437184343955499
CAL-85-1,12001922,1.5620705993055266
BICR 16,selumetinib-GDC-0941 (4-1 mol-mol),2.023123629912069
IMR-32,15953870,3.6691189890833416
JJN-3,6505803,-0.5101554809068779
UM-UC-1,42642645,-0.0254538013223521
Ku812,73707440,4.534867519967767
Ku812,15953870,2.600365830737877
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
SF539,42642645,-0.0077042862761951
MCAS,54618771,1.3372810495752594
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
T98G,2746,4.022730778919953
OCI-AML-5,11396600,3.436150065828036
Becker,12001922,2.507016459914465
COV362,9927531,5.782280660469085
WSU-DLCL2,9927531,3.1454575318264495
HCC-56,6505803,2.324726755657099
JeKo-1,100016,6.219930850058466
NCI-H810,selumetinib-GDC-0941 (4-1 mol-mol),2.904538887533327
NB4,10385095,0.7773344099741176
HT115,11396600,3.748253613191512
NCI-H292,24753719,4.2962074219620225
EN,2746,3.955257118996246
HCC1833,11455910,1.7776428599570322
HCC95,11455910,1.9982111231876976
P31/FUJ,9926054,1.2698752833949425
SNU-478,6505803,-0.3330598781077968
HCC2279,9927531,4.656852539502924
BHY,54649381,3.621856124101286
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
COR-L105,2746,3.1035280268076217
OC 314,54618771,0.7264278872863676
Calu-3,54649381,3.883525654269074
ECC10,135423438,0.2657741812126756
WM115,15953870,3.7155207356015207
PC-14,135423438,1.1691167584744715
NCI-H322,15953870,3.7851761847252874
A3/Kawakami,10385095,0.4168450235753773
OVK18,2746,3.0954313714228316
KYSE-30,54618771,0.4265256767943792
Rh41,54618771,-0.2470499473038629
UM-UC-3,9887053,4.587427127075117
IGROV-1,135411,0.626702113064729
U-118MG,3825829,4.385253353393135
L-363,11396600,3.444833933433015
HuG1-N,54618771,1.617121666996059
SW1417,4705,3.4268309691018377
Rh41,24753719,3.827279335828554
Lu-65,54618771,-0.448084270947246
COV362,387447,-4.8197487164241535
U266B1,24753719,4.293400712044674
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
SU-DHL-1,54618771,0.3433661921186922
MHH-CALL-3,136227924,2.519521666896543
HT,15953870,2.4749463147960538
NCO2,42642645,-2.6055941527545228
LS411N,6505803,-0.6536233604701492
HuCC-T1,387447,-5.2749709044848885
BT 239,136227924,1.4188260158561712
TE-10,136227924,2.8479301717793435
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
DK-MG,4705,2.3650435397254492
NCI-H2009,10385095,0.2451756361843044
PE/CA-PJ49,3825829,3.9547991089939383
OAW28,54618771,1.1011370240470315
RMG-I,12001922,1.5218959719572809
Sq-1,11167602,2.104600718889136
GOS-3,135411,0.9391696009475228
Kasumi-2,11167602,2.198810465874189
HCC-56,12001922,2.256303460323792
TUHR10TKB,4705,2.6546560293729677
JHUEM-2,12001922,1.6985536593614663
NCI-H2170,3825829,4.040952890997883
IGR-39,10385095,1.5292077021390125
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
HOP-92,49836020,5.403656238129832
BT 139,10385095,0.5327849644676411
NCI-H2087,9927531,4.212541441573842
NCI-H1581,54618771,2.0706230217486468
NCI-H1694,135411,0.129417627550737
NCI-H2196,11396600,3.4925760347357
KYO-1,10385095,1.0303500905009049
D283 Med,24753719,3.1316348069328357
G-401,42642645,-0.5846467586678221
MSTO-211H,100016,4.243846732059744
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
NALM-6,10385095,0.98891927621668
MCAS,9926054,1.882674367902201
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
Panc 08.13,3825829,4.184576495388553
M-07e,15953870,2.2360986630595705
BT 444,15953870,4.3735457159428925
LK-2,136227924,2.893153940116167
ChaGo-K-1,2746,5.131732167485152
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
SW1417,10385095,1.3111570658719054
HEL,11455910,0.7002369428142345
HCC44,100016,5.500199899639815
T24,selumetinib-GDC-0941 (4-1 mol-mol),2.57595628877945
SET-2,100016,6.077577626399248
Mono-Mac-1,54618771,1.1455775902832934
NCI-H358,136227924,2.8821870791202873
HCC1588,42642645,0.6315909146869447
EFE-184,9926054,2.5194211419802723
WM115,135423438,3.926483426744841
OCI-Ly3,6505803,0.3462361722784563
TOV-112D,15953870,3.931137654728885
MHH-CALL-4,11396600,2.799931622192491
ESS-1,6505803,-2.0071033756271106
HEY A8,100016,6.30003295297675
Calu-1,24753719,4.36133444781149
TCCSUP,3825829,3.3137008216702686
P31/FUJ,49836020,4.674155414221834
RERF-LC-MS,135411,0.496828330774242
LN-18,42642645,1.0929858355498483
GB-1,BRD-K16130065,4.42493590422296
CJM [Human melanoma],3825829,3.9130484480721424
OAW42,11455910,0.9169740584979637
5637,42642645,0.3945656338119296
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
Raji,3825829,3.3082858479955557
NCI-H520,12001922,1.1311757401308036
F-36P,387447,-5.355947455324157
OAW42,4705,4.623217521868117
RT-4,12001922,1.7739058895208752
NCI-H1869,10385095,1.0868363203730835
KYO-1,2746,2.1757976930185854
Mino,387447,-5.275097956726417
TE 441.T,4705,3.429293976923017
SK-MEL-3,11396600,4.278325283702902
L-540,54618771,-0.836764308956379
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
MOLM-13,11455910,-0.3133362084586128
CAMA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.627092897381015
SNU-387,6505803,0.0715059334590081
SNU-423,15953870,5.451798235524798
A-549,24753719,4.621771717936227
FaDu,136227924,3.658135500280057
Mel Ho,54618771,0.7088013166832736
MFE-319,15953870,3.800473172062692
SK-N-MC,24753719,3.5641231091057652
HCC-56,9927531,5.667739973718857
JHH-4,42642645,0.9903566872426725
NCI-H226,15953870,3.9399123185822553
EN,54618771,2.591553593247422
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
AML-193,15953870,2.8318815624528706
Lu-65,136227924,3.620246561182502
YKG-1,9926054,2.005416681797869
MHH-CALL-3,135928012,3.1624768364718534
NCI-H2009,42642645,0.1491359953679814
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
CCF-STTG1,2746,3.7135967128071385
TE-11,42642645,0.7992732102499902
NCI-H2196,54618771,3.689475396494767
MOLP-8,100016,7.090961588333011
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
MDA-MB-468,11396600,4.2742989673627045
MHH-CALL-4,24753719,3.3862640639647457
CAL-51,135411,0.595745817277345
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
Ki-JK,24753719,2.999848182641454
BT 131,11396600,1.7130676585109468
639V,15953870,3.719384527051872
SNU-308,3825829,4.765268226018265
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
A-253,6505803,0.0619140769446045
BT 328,3825829,4.625111565622426
LUDLU-1,54618771,1.3669770958947776
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
NCI-H522,2746,2.8917767436803414
FU-OV-1,3825829,3.720797122696784
NCI-H647,12001922,1.9537768000320568
KCL-22,6505803,-0.612713471586346
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
NCI-H1869,9926054,1.781753958996035
A4/Fukuda,2746,1.0000278581130588
SK-N-SH,15953870,3.557399614154719
NCI-H2172,387447,-2.372723736293485
NCI-H1694,100016,6.457618599357896
ZR-75-1,12001922,1.7875378588976238
FU-OV-1,387447,-1.63105242136749
P31/FUJ,15953870,2.7000087530897776
OAW42,10385095,1.3430576612490104
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
HCC2935,4705,1.0369145434655835
BT 232,44197249,3.8584447662296
G-402,387447,-5.20484691496797
SK-N-BE(2),54649381,3.105685004258964
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
Daudi,11396600,1.6595042173405945
F-36P,10385095,0.4233873484016709
WT2-iPS,2746,4.7130481819205015
SW1573,4705,3.887877577681455
F-36P,15953870,2.011519160758859
8-MG-BA,54618771,3.7934452714384954
HT,9887053,3.665131868561722
T84,9927531,3.2336753080400933
NCI-H1666,3825829,3.808516897437362
HOP-62,10385095,0.93787190415745
NCI-H2228,135423438,0.7954817184322217
DU4475,2746,1.2992930311917237
HT-1080,100016,6.676268064255503
EJM,12001922,1.7275636633087754
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
GMS-10,24753719,4.855734491232824
SH-4,11396600,5.060968167282413
YD-8,136227924,3.733712180219105
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
COLO 741,11455910,3.212603536123838
AML-193,136227924,2.0129973822753735
2004,100016,6.70935199674954
U-937,2746,2.8216172923240825
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
UACC-257,12001922,1.3054642351261323
NCI-H2106,15953870,3.1937362331595325
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
NCI-H1666,136227924,2.19834773760599
SNB-75,135411,2.2305587957399067
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
HL-60,24753719,4.3122950153676065
TCC-Pan2,9887053,4.977817640542438
MG-63,2746,4.323476175039674
MEC-1,12001922,1.4964639294654882
KU-19-19,9926054,2.3371072555508445
HCC1438,11396600,3.772048320050974
TALL-1 [Human adult T-ALL],100016,4.020437007073488
COLO 684,54618771,1.417005870587021
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
SNB-75,54618771,2.061985596678881
HCC78,12001922,2.5599602602364877
HuH-6,15953870,3.0890536312720003
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
NCI-H1734,6505803,-1.047831457511852
BICR 56,selumetinib-GDC-0941 (4-1 mol-mol),-1.0561550719087085
PC-3,12001922,2.6852515889984474
SK-N-SH,42642645,-0.6199182133596995
HGC-27,135423438,0.8474032670168677
TE-6,136227924,2.9118612520968803
Hs 683,387447,-4.17962939881664
NCI-H520,42642645,0.4863260579261142
HCC1428,24753719,4.247513508462614
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
NCI-H1155,42642645,0.054815756453449
UACC-62,4705,3.53935768937283
K-562,4705,3.481256778033869
COR-L105,100016,7.1590039780101895
HOS,387447,-4.46883147654818
ACC-MESO-1,10385095,1.944189744357827
SNU-81,15953870,1.3050219745867302
BICR 31,11167602,4.451308398956488
CAL-148,42642645,-0.6512599349150872
DMS 114,24753719,4.208202347185018
SNU-620,selumetinib-GDC-0941 (4-1 mol-mol),-2.4786489689796554
YD-10B,6505803,-2.5898311798787774
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
SF295,135411,-0.4035877293475021
DU145,3825829,4.09288773137039
Hs 611.T,135928012,2.863158989308795
KYSE-450,246676,4.496442396396831
GOS-3,3825829,4.328758127334123
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
Mel JuSo,42642645,1.9740671997552055
MeWo,24753719,4.301435629078812
NCI-H2286,387447,-3.284313902252811
SF295,6505803,0.007344164780963
OCI-Ly3,135928012,2.659684883343282
Hs 766T,11396600,4.535282068757712
HEC-151,42642645,2.0154759097446875
RERF-LC-Ad2,24753719,4.674751178496499
NCI-H526,10385095,0.7237833055240664
PC-14,136227924,3.162840410264972
RERF-LC-A1,12001922,1.989956989154949
NCI-H1568,11455910,-0.0792581795853734
NCI-H146,9926054,1.7480459470636802
SW620,100016,5.873144490676751
U2OS,54649381,3.677688671313786
SNU-175,54649381,2.364761615724883
SW1417,136227924,2.767989145735224
ESS-1,42642645,1.3351553509560612
KYSE-140,136227924,3.3753020930843065
A-253,42642645,1.626631810712626
SNU-878,BRD-K16130065,4.3857850176988125
SF539,11167602,1.5763974980915605
CML-T1,11396600,3.3654395371867425
NCI-H1581,11396600,3.1540391346849015
NCI-H69,6505803,2.592784813804099
SUP-HD1,11455910,0.2376646387177033
DOV13,387447,-4.071843893807314
NCI-H2087,135423438,1.5480624083633234
Daoy,12001922,1.7754613307016656
NU-DHL-1,2746,0.9771874808438498
HuH-28,11396600,3.662277898501366
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
ECC12,9926054,2.4969836568853507
SNU-1105,selumetinib-GDC-0941 (4-1 mol-mol),2.42350207909939
BV-173,42642645,-1.5801319366470357
KNS-62,15953870,4.22682409118771
JJN-3,135423438,1.720470314756554
Hs 294T,10385095,0.86114024133981
TE-14,135411,0.5329688265157383
COLO 699,3825829,3.815051570276692
Rh41,selumetinib-GDC-0941 (4-1 mol-mol),-0.3258971504305004
COLO 800,387447,-4.888149681631436
NCI-H23,24753719,3.636573192136899
UACC-257,135928012,3.790943284106433
BICR 18,11455910,2.028324794320248
BT 187,135411,2.52542384478069
NCI-H1869,15953870,3.614398642782243
JeKo-1,15953870,2.808726897141004
HCC4006,15953870,3.500353230007888
OAW28,11455910,2.4986666790908583
HuH-28,10385095,2.5639170726190867
SNU-878,135411,0.5112505984821519
NCI-H1869,10385095,1.0868363203730835
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
GSS,24753719,2.4096224758736895
SNU-668,387447,-4.037818244884638
G-401,11396600,3.403558125152034
NCI-H650,135411,0.6442940550248003
MHH-CALL-4,49836020,-0.2445846673370129
Daudi,387447,-5.635352264179238
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
MV4-11,11167602,-2.091462426837002
K-562,6505803,-1.797722788015983
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
ACHN,387447,-3.5610238207006315
KM12,4705,2.9738555795227093
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
EC-GI-10,387447,-2.8425743189614354
SJSA-1,387447,-4.412192265380835
MHH-ES-1,49836020,5.438630069429388
BT 416,11167602,2.2298904272575686
BT 239,24753719,3.429710725233414
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
SiMa,3825829,2.3563594026539105
U266B1,6505803,-0.3564252706563441
HOP-62,24753719,5.014649450364504
SNU-407,387447,-4.858242945028756
MM1.S,9926054,1.5897504862532963
B-CPAP,6505803,1.185723298587951
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
HCT 15,135411,0.564526141932712
NCI-H810,11455910,-0.6368425988840776
DLD-1,42642645,1.381636603396627
NCI-H2228,11396600,3.725847437407865
SUP-T11,54618771,1.250827086156436
Calu-3,9926054,2.517272987008367
NOMO-1,136227924,2.5449106490851263
HCC1588,9887053,1.6056393273993497
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
DEL,54618771,0.826392883586264
KCL-22,246676,5.0117921419569935
A-673,135411,0.3370419809316401
NU-DHL-1,100016,6.7557445252971355
BT 333,54649381,4.356279912518799
NCI-H358,100016,4.0854531303861155
HuH-6,10385095,2.0589740741607496
SNU-886,11455910,-0.4283095081187237
A-375,12001922,1.740140875939179
PL-21,54618771,-1.4027013448904684
Granta-519,3825829,3.4773445434270243
BT 286,9927531,5.383522650777723
ONCO-DG-1,9926054,2.478958665773676
YD-10B,54649381,3.641118153675974
Karpas-299,135928012,3.0234494590511103
EBC-1,136227924,2.637152829802991
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
NCI-H1975,6505803,-1.9841603923716855
NCI-H2122,10385095,1.3305975818263436
Jurkat,12001922,1.661997127809645
NCI-H2405,135411,0.4706604189228246
TT2609-C02,54618771,3.852922772730834
OVSAHO,12001922,1.945556313823465
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
KP-4,24753719,4.448787857438118
HEC-6,100016,5.931518422248653
U-251MG,selumetinib-GDC-0941 (4-1 mol-mol),1.876710388033308
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
OVCAR-5,54649381,3.89481636296304
KNS-42,42642645,1.578808963757168
DAN-G,54618771,0.722967916386815
NCI-H1838,136227924,4.034071845409975
SR,4705,3.533585643751883
SK-BR-3,387447,-4.932591348822772
ONS-76,42642645,1.3507577274785498
KYSE-410,2746,3.332005025730893
SNU-1214,54649381,3.4023462512727516
HeLa,42642645,1.2695095995750458
TE-4,4705,1.41757349828419
THP-1,11396600,3.1299513207633365
BT 159,11455910,0.815831828499024
NCI-H1734,12001922,1.6351637212511063
EJM,9927531,5.060130602494636
L-428,136227924,2.9759698761374795
A-375,9926054,2.393426871996004
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
PE/CA-PJ41 (clone D2),2746,3.71543902732957
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
SHP-77,11455910,0.1077676986814373
DU145,54618771,3.337458824494602
BT 422,6505803,-0.9027311495147816
PC-14,54618771,1.2873092129984136
BHY,6505803,-1.0358392928215592
LCLC-97TM1,54618771,0.7707104681824843
Hs 294T,4705,3.364751346281281
KCL-22,73707440,5.760609737483316
NCI-H1793,54618771,0.9383287956329432
IGROV-1,135423438,0.764137689665023
HuH-1,42642645,1.549653619802018
SK-N-DZ,135411,1.0278880804758272
BT 248,11396600,1.9236183524788075
T24,15953870,4.174514529702368
OV-90,10385095,1.3192036587024902
SNU-1,11455910,-0.8370004146214793
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
G-402,12001922,2.1928241285845305
Hs 852.T,6505803,-1.3832996341384214
MDA-MB-415,6505803,-3.148015366392549
SK-LU-1,4705,2.465937162773369
NCI-H2444,selumetinib-GDC-0941 (4-1 mol-mol),3.5798793535857625
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
DMS 114,3825829,3.9512028605032863
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023
PSN1,135423438,3.9890178070104927
MFE-296,54649381,3.940238955854076
AGS,15953870,3.442784639619473
SK-N-MC,6505803,0.6222225816137853
SNU-119,42642645,1.209873965485747
SK-MEL-1,49836020,3.8417397632517143
L-540,12001922,2.498837980652074
CAL-33,3825829,3.756349374073515
HEY A8,15953870,5.549355940537034
PE/CA-PJ34 (clone C12),387447,-4.003769145095816
QGP-1,11455910,1.8508501526124652
EFO-27,9926054,1.857839666788878
LK-2,11455910,-0.0454664251663307
NH-6,135411,0.4610643788220936
T84,135423438,1.8548659324700536
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
HCC44,135423438,1.5851293275166212
JHUEM-1,42642645,1.3772977583210164
Calu-1,9927531,5.244935764908175
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
HGC-27,100016,3.78981980973908
8-MG-BA,136227924,3.3968176736472446
UACC-62,3825829,4.497200188370442
LXF 289,6505803,-2.367756082461904
BT 504,12001922,1.1383643597706272
KE-37,387447,-5.7137536763470305
Panc 05.04,54649381,4.8922376801040395
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
RS4;11,selumetinib-GDC-0941 (4-1 mol-mol),0.8544814441739125
Ku812,6505803,-1.520866948509506
SW1353,42642645,1.0358647954805058
HCT 116,11455910,1.427750976717415
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
HEC-108,135411,0.6194051184569405
Kasumi-2,12001922,1.274437651383908
EFO-21,4705,3.5117788930279037
DU145,42642645,1.4952043269742437
RD,136227924,2.2627633289805424
Hep 3B2.1-7,9926054,2.8753203525792026
HCC1438,54618771,1.468368103137055
UM-UC-3,4705,3.0900844559148632
GSS,42642645,0.9983353320399786
HEY A8,10385095,0.768983308384478
OCI-Ly10,9926054,1.7793271735454907
SK-N-DZ,136227924,0.9645463461515836
SK-N-DZ,135928012,0.4627844057418054
Ku812,54649381,2.9639483445767087
DV-90,136227924,1.3959750608222408
SNU-1272,54618771,3.136436186338116
Kasumi-2,54649381,3.5158481033233593
HSC-4,24753719,5.996217074466553
CAS-1,387447,-3.443278075124448
T84,3825829,3.9385604310519926
KATO III,9926054,1.9057208307143456
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
MV4-11,9927531,4.708512628737502
HPB-ALL,2746,1.2086783297242478
TE-14,15953870,3.387978036470922
BT 224,15953870,5.452698262733333
HuP-T3,9926054,1.9266750805140576
OCUM-1,6505803,-2.038766132244714
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
M059K,72199289,4.467934336193957
8505C,12001922,1.7305283965564249
PaTu 8988s,24753719,4.178289167008363
A2058,135411,0.6867578131570076
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
NCI-H1568,136227924,3.032081072579533
SK-BR-3,100016,6.79119351825136
HCC44,246676,5.33842573528245
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
LOU-NH91,3825829,4.327670981782257
PLC/PRF/5,9927531,3.33785239114395
SCC-9,54618771,0.4910288003516506
253J,6505803,-1.7434391894499837
HEC-6,selumetinib-GDC-0941 (4-1 mol-mol),2.6580781853062887
TUHR14TKB,54649381,4.174302915655764
SNU-C1,11396600,2.8735657781270003
GI-1,selumetinib-GDC-0941 (4-1 mol-mol),2.406121419892038
CAL-12T,54618771,2.0833735357091077
Hs 729.T,selumetinib-GDC-0941 (4-1 mol-mol),3.0623228913945684
SF539,136227924,2.8154987155907905
KMS-20,2746,0.7437630311682376
KNS-62,9926054,2.478814606658306
KYSE-450,135411,0.9240917820052414
MCF-7,246676,2.937501315455756
COLO 668,135411,0.2001897105148926
LS411N,49836020,4.501659667614969
Panc 05.04,9926054,1.8029787074876424
CAL-27,10385095,1.2295716682430473
Lu-65,24753719,4.200901719906933
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
SNU-182,387447,-4.724838289623096
K-562,11167602,1.4540526159902811
NCI-H1155,selumetinib-GDC-0941 (4-1 mol-mol),2.5268470929641964
DND-41,11396600,2.425122364939696
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
EFO-27,100016,6.711163327148508
A2780,42642645,-1.071178701221225
LUDLU-1,10385095,0.8860258407517785
MEC-1,2746,2.441084907474043
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
NCI-H226,387447,-3.7392555372048353
IMR-32,9887053,1.6349533965413043
HCC2279,54649381,3.654870231570339
Namalwa,135411,-0.3844815221234907
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
TF-1,246676,4.293619273323295
KNS-42,9927531,5.582016236081196
G-292 clone A141B1,6505803,0.1616313040376176
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
SW48,135411,0.1882785626851766
SNU-175,10385095,-0.1957909072596834
MFE-319,6505803,1.682030282534213
HT115,135411,1.0774780257680006
BT 159,9887053,6.199508129593037
Karpas-299,100016,4.52969889794102
VM-CUB-1,9887053,5.178897068414814
BT 145,11167602,0.8188247230307861
NCI-H1299,387447,-3.841089512214304
NCI-H1568,9887053,3.9549233487650666
GCT,9887053,3.454713669986264
BT 145,15953870,3.623445250122532
NCI-H2405,9926054,1.7306933863874645
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
HT-55,135411,1.069750925380365
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
ECC10,54649381,3.5357027767335616
Becker,15953870,5.473273860376091
SCC-25,387447,-4.090104079633871
DU145,2746,3.3697589984535528
HCC95,12001922,1.7724298271089127
EN,3825829,4.434799217842366
HCC1954,15953870,2.491271140323311
JHUEM-2,15953870,1.6685712254078513
SW1088,387447,-4.628126484221308
CGTH-W-1,12001922,2.0957786933952423
TE-8,136227924,2.7469773037217715
NCI-H2029,135411,0.8396262630738457
647V,4705,2.7300428943650044
LOX-IMVI,100016,4.319089113839007
OCUM-1,9927531,5.3600518663523244
DU145,4705,5.59514886378127
A-498,9926054,1.5026788619071982
BT 504,11167602,1.7922968046934435
PSN1,15953870,3.8792207123251927
ESS-1,100016,6.502595194480242
T24,3825829,4.086431045149668
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
SNU-761,54649381,4.531458815816955
WM266-4,11167602,1.5442126726614676
U-87MG ATCC,9887053,5.479975636502987
BICR 31,136227924,2.8140968842668923
RERF-LC-MS,387447,-4.351660250848144
M-07e,24753719,3.1748367378954025
C2BBe1,3825829,4.2866326738130205
HEC-1-A,9927531,4.872071430147468
OCI-AML-3,2746,0.9833779922081392
HeLa,3825829,3.5823199274172457
MDA-MB-435S,9926054,2.269822503715403
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
HEC-50B,246676,0.7337794677145143
BT 245,2746,2.160904338087323
IGR-39,12001922,1.9585403862048083
DU145,6505803,2.9308640693327126
Kasumi-2,100016,5.973936097539331
CFPAC-1,387447,-4.14278988535647
NCI-H2106,12001922,1.5707040733372517
YKG-1,24753719,4.608335607306647
EPLC-272H,42642645,0.4422522789708903
OPM-2,15953870,2.653227585048534
BT 232,11167602,3.700775508233816
CHP-212,6505803,-3.651985635286723
KU-19-19,54649381,3.8760376098429616
BT 482,10385095,1.2210220764323911
NCI-H1650,6505803,-1.2537158640702348
CL-11,11167602,1.668699813232642
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
SNU-407,54618771,0.7273608158174886
SET-2,42642645,1.5716650325889971
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
Calu-6,9926054,1.940861811750295
SNU-46,387447,-3.420653354066012
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
NCI-H660,136227331,5.940989847463471
MOLT-16,9926054,1.655760518642202
HCC1171,12001922,2.168243519217375
DEL,135423438,0.2559505435004567
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
U-937,4705,3.455929812371293
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
BL-70,4705,3.4398242170879723
HCC1954,135411,0.8668176742548241
NCI-H1734,9887053,4.497634637953186
NCI-H1755,selumetinib-GDC-0941 (4-1 mol-mol),0.8235666459967586
BT 131,12001922,1.1112525676649827
MIA PaCa-2,9927531,4.662028210048159
P-STS,3825829,4.084393375293328
SK-N-FI,100016,6.445734787344034
MFE-296,136227924,3.1639946768284672
EFO-27,387447,-3.111228692284437
DEL,9926054,1.477463428719593
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
NCI-H196,42642645,1.4168604332758885
BT 330,24753719,4.584303652526146
Kasumi-2,11396600,2.2579616248243495
BT 333,9926054,3.6254500020575366
BFTC-909,11455910,1.958059547603208
Hs 683,3825829,4.070799794805118
PLC/PRF/5,12001922,2.4212466115662368
HSC-4,42642645,1.8060847122685193
TT,6505803,-1.545669685670545
JHUEM-7,135411,0.5518757066941595
Yamato-SS,54618771,0.3737524907753581
BT-16,24753719,3.652590286088957
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
NCI-H2029,selumetinib-GDC-0941 (4-1 mol-mol),3.389084232117775
LP-1,49836020,4.554043159133258
OCI-AML-5,10385095,0.6242077157368962
IGR-39,135411,1.0355787110501846
GSS,135928012,4.989265033759339
NCI-H209,15953870,2.4365262020056195
SNU-878,6505803,-0.5234937095696075
Caki-2,136227924,3.8399348879900854
HEY A8,12001922,2.286291008326013
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
SF268,11396600,2.843144767793207
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
NCI-H209,54618771,0.4504113944457773
DMS 53,136227924,2.35473496791988
HCC1937,54618771,3.213475189198509
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
SUP-M2,3825829,2.0508944512759086
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
Kuramochi,9927531,6.027141313400392
BT 228,42642645,1.049898841414108
OC 314,387447,-4.868879366422279
F-36P,3825829,2.646240330618036
U-251MG,11167602,1.923404426526953
P-STS,6505803,1.2409378245961384
NCI-H1703,24753719,4.328584237137895
RCH-ACV,11455910,1.239951006790748
BT 333,selumetinib-GDC-0941 (4-1 mol-mol),3.256611594261358
SNU-878,15953870,1.988866876158544
JIMT-1,24753719,5.242052344798916
HMC-1-8,54649381,3.643687745183644
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
COLO 668,11455910,0.5026800479718163
OUMS-23,3825829,4.629767078806252
DV-90,6505803,-3.886582260565957
PSN1,135928012,5.378087256008376
Panc 02.03,54618771,1.0884531427161812
PaTu 8988s,136227924,2.43354349220747
SF126,12001922,2.065631030654864
SNU-489,11455910,3.799785050507332
HSC-2,246676,5.600888719484109
Caov-3,3825829,3.630817782117976
HLF,11455910,2.0760137944141355
TE-4,135928012,3.6544866498990505
HCC38,135928012,3.818186297448824
HuCC-T1,11167602,2.489104894066524
Sq-1,49836020,-1.2584721229421645
BT 286,11167602,0.1521684661712007
YAPC,10385095,1.3302689043535871
MOLT-13,9926054,1.5657094756283445
NCI-H1341,100016,3.8327529210726903
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
Mel Ho,54649381,3.712605181816169
BT 245,11396600,2.7099317658056927
OV56,100016,6.603582199202106
NCI-H1435,4705,4.767035431854917
JIMT-1,387447,-4.243631847469051
Namalwa,6505803,0.5277329545448584
Hs 611.T,10385095,0.6904393672995198
MKN74,42642645,1.392605787753803
LUDLU-1,9927531,4.97566245035899
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
KYSE-70,54618771,1.1170424016733127
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
Karpas-422,6505803,-0.6034425689167541
ECC10,11396600,2.3430961684425133
DMS 454,9887053,3.722472735116911
LoVo,11455910,2.8170443999319574
Hep-G2,387447,-2.9195151512018427
SCaBER,selumetinib-GDC-0941 (4-1 mol-mol),-0.4937512054243923
PC-14,2746,2.459398202696394
KP-3,9887053,4.887376712089991
DU145,11396600,3.556301760853191
GA-10,100016,3.803284916821312
HCC1937,11396600,3.939286660836918
MSTO-211H,12001922,2.4775669078904397
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
BFTC-909,9927531,5.31835549136936
KMS-27,3825829,3.2801020801317917
CAS-1,54618771,0.3007933924780016
MOLP-8,10385095,0.909191851453096
EKVX,10385095,1.522200885711341
SK-ES-1,11167602,2.2216524822610886
A3/Kawakami,4705,2.957663936707348
SF126,9926054,2.7905707570317686
NCI-H810,11167602,1.4687825393723717
BT 333,11167602,2.748002514213894
YD-10B,9926054,1.7388994338775816
HCC1171,136227924,3.688896594319452
HCC1937,11455910,2.342196786755475
BT 159,100016,7.101052412805122
CAL-148,selumetinib-GDC-0941 (4-1 mol-mol),1.314198336751646
KMS-34,6505803,0.7585459942154548
OCI-Ly19,24753719,3.7362509862240194
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
NCI-H1581,24753719,4.397195007836128
L-428,10385095,1.2929398683818265
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
RL,135928012,3.3748809385058007
NCI-H1694,9926054,1.45656685953477
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
NCI-H1693,24753719,4.303581161701555
C2BBe1,11396600,3.438018426982882
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
Peer,3825829,2.386744840341019
NCI-H2170,24753719,4.072230001387307
G-402,6505803,-2.2482825610741095
MM1.S,11455910,0.7825849388460823
IPC-298,9926054,2.387739594101664
Hs 888.T,54649381,4.173610166807138
SUIT-2,54649381,3.849827051138413
CGTH-W-1,11167602,0.1199165911910428
BICR 31,24753719,4.233476426959058
2004,10385095,0.7198089210343366
SUIT-2,54618771,1.0369427055295135
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
COLO 699,24753719,3.4559713951503475
SNU-620,12001922,1.5907870982375298
HOP-62,4705,3.552280933872326
TTC-709,54649381,3.8552287348177954
SK-N-DZ,11396600,2.4748866696759113
K-562,9927531,3.3022164605184763
HuT 78,42642645,0.2069800565131915
ACHN,selumetinib-GDC-0941 (4-1 mol-mol),3.1627804075909727
NCI-H1734,10385095,0.2874995552525176
COV362,24753719,4.739913484239243
OUMS-23,136227924,2.42742246798026
NCI-H1395,10385095,0.8966814857932361
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
CAL-85-1,10385095,0.8490063817191821
ES-2,12001922,1.915519006547152
CAL-51,24753719,3.9981702522006257
DU4475,42642645,0.4683189222062291
LN-229,387447,-4.183650302035926
BT 164,387447,-5.781244332556346
RERF-LC-Ad1,42642645,1.4403465890046834
NCI-H28,387447,-4.862213450727532
BV-173,135411,-0.2523143396300763
NCI-H841,136227924,2.950651455010232
HCC1195,136227924,3.859466477996048
Calu-6,54649381,4.446880992987996
PaTu 8902,4705,3.6244040622068256
SNU-601,3825829,3.988246973539955
HCC1954,42642645,1.573794878095148
Ki-JK,246676,5.098695936612285
NCI-H810,136227924,1.6901408020045232
MM1.S,15953870,5.481933437473156
HT-1080,44197249,3.898018081829295
NCI-H69,136227924,3.1937315471147443
HEC-6,11396600,6.108645448487235
D283 Med,9887053,1.695110985326941
JeKo-1,4705,3.398339905986335
HCC1500,9927531,5.051014893697188
KMS-34,387447,-5.192952496396707
CAL-85-1,9926054,1.875240534371988
MKN74,4705,5.009866699561135
HDLM-2,135411,0.5971288572289424
LOX-IMVI,24753719,4.180599025033894
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
SNU-1196,42642645,1.3951870406979174
NCI-H1092,4705,2.99261822421246
NCI-H28,9926054,1.6125728317603996
SK-MEL-3,9927531,5.047514354060135
L-363,10385095,0.7301179506909989
NCI-H2106,42642645,0.6485488182459481
RKN,10385095,1.0188882527918253
BHY,12001922,1.7297602625272912
GMS-10,42642645,1.3170615357914186
YD-15,54649381,3.7380840478684183
BT-16,10385095,1.306973954118471
UACC-257,135423438,1.9285683204106765
BT 112,6505803,0.1257905254161033
Rh41,49836020,4.456584836146854
PE/CA-PJ41 (clone D2),10385095,0.9808392410745812
NCI-H1373,24753719,4.8613532140843105
T98G,9926054,1.93846990860498
NU-DHL-1,10385095,-0.0540424655836512
KYSE-70,10385095,0.9665013844498838
HOS,11455910,0.0895853773471224
MIA PaCa-2,387447,-4.141831839994585
LNCaP clone FGC,136227924,2.6855023326383387
BFTC-909,42642645,1.561027146692027
COLO 678,54618771,1.45327687843265
SNU-1076,135411,0.3811171906499344
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
HT-1197,12001922,1.7997649435605243
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
KYSE-30,100016,6.190453384433256
HPAC,54649381,4.046091120445625
BFTC-905,11455910,3.497810765417644
IMR-32,136227924,2.2103917598606326
UO-31,135411,0.1204164278110409
DBTRG-05MG,selumetinib-GDC-0941 (4-1 mol-mol),1.9211216865971592
EM-2,12001922,1.7226595490551926
Mel Ho,10385095,1.46898666860575
BT 245,9926054,2.9422912383021393
MIA PaCa-2,54618771,1.4864580952045414
ECC10,42642645,-0.069366061650994
BT 422,15953870,4.148639041835956
L-428,15953870,2.0577398308557577
CW-2,135411,0.1393752481912831
KO52,136227924,2.4006650771153923
BFTC-909,6505803,-2.7076869289136147
SNU-81,387447,-4.728664972971387
IGR-37,9927531,5.0345741970674975
HCC15,24753719,5.171121417544096
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
SK-MEL-2,9927531,5.603550958927875
TOV-112D,9927531,5.049724327124321
HCC827,135411,0.5265450686257335
Kasumi-1,24753719,3.975004241105681
SF539,136227331,3.3252279599925085
NCI-H2228,136227331,3.956978031272767
KMRC-3,15953870,3.0428187012679664
REC-1,135411,0.3102978372083019
LOX-IMVI,42642645,1.0245315252626934
OV-90,2746,3.04639214002508
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
JHH-2,3825829,4.1176609225165475
Mino,136227924,1.7493984310197022
DEL,387447,-5.503324234976076
A-375,54649381,4.147503640092436
MKN74,135411,1.5838498923654774
A-204,136227331,3.914790015372966
RERF-LC-MS,136227924,4.560045704487339
KP-3,12001922,1.9624704543542888
NUGC-3,100016,7.160996607387645
HMCB,246676,5.779204987667754
253J-BV,12001922,2.108742341414822
ChaGo-K-1,10385095,0.7525502719591264
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
BL-70,54618771,0.7229646502566096
NCI-H1793,100016,7.252403961124031
HCC15,15953870,3.1000423449826275
RT-4,9926054,1.7601963161522494
LCLC-97TM1,6505803,0.2281876141434561
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
L-1236,246676,2.905629045644303
HCC1806,24753719,5.03925473475155
BT 139,44197249,5.019770619603963
LP-1,12001922,1.3926156457590702
NCI-H1341,4705,2.9971891882923485
NCI-H1373,selumetinib-GDC-0941 (4-1 mol-mol),2.438730896518944
HH [Human lymphoma],2746,1.0745261144361813
MeWo,387447,-4.704014450400971
SNU-1033,11396600,3.651423781511848
Peer,387447,-6.505406503605324
OVCAR-8,15953870,3.79030674312114
SCC-25,2746,2.621805832840377
GI-1,135411,0.8909303562676832
NCI-H441,387447,-3.062923203841212
CJM [Human melanoma],135411,0.466360245120922
ESS-1,44197249,5.299862122462015
BT 330,15953870,3.8560811614803696
P12-Ichikawa,6505803,0.5806976705214316
COLO 699,387447,-4.692177926035206
ESS-1,136227924,3.049003867547222
K-562,135423438,0.8826240773524879
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
KMRC-1,136227924,2.9529226708788734
G-401,12001922,1.3873374697674952
Hep-G2,4705,3.661377424610174
HPB-ALL,54618771,-0.7909644269662123
MOLT-16,selumetinib-GDC-0941 (4-1 mol-mol),2.290963052000247
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
DU145,9927531,4.922928089289864
NCI-H2141,11455910,0.8457435139245203
SNU-478,9926054,1.8304489551937344
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
LNCaP clone FGC,54618771,1.2210181091381391
SK-MEL-5,3825829,3.883151083406129
SW620,3825829,2.933456146999203
Panc 08.13,11396600,4.2902573182297665
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
Panc 03.27,6505803,-2.205442615727637
SaOS-2,4705,3.668938036329027
GA-10,11396600,1.0536432572837295
GA-10,135411,-0.6139581022042082
HCC2218,44197249,3.83159054202454
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
EFO-27,11396600,3.826824277303455
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
SCC-4,10385095,0.7698990433535621
NCI-H460,10385095,2.2920897819597896
639V,54618771,0.9699506907820744
Calu-3,3825829,3.815004048498393
AML-193,6505803,-1.7450029346129687
Becker,11396600,4.49881996506653
RPMI-8402,73707440,5.61171543505587
NCI-H1703,9926054,1.7378583933423122
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
WM793,2746,3.494212158504219
SK-N-SH,54618771,1.3194145394853296
RKN,11455910,3.815213247766997
JVM-2,135411,-2.059853197074913
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
NCI-H1944,136227924,3.273500409836235
UACC-257,387447,-4.282749815472462
NCI-H508,136227331,4.38758043299591
TE-1,135928012,4.974195679336153
IGROV-1,2746,2.8413672686351212
GP2d,9926054,2.6461987815751096
DBTRG-05MG,54618771,1.322739647725507
HPAF-II,136227924,3.1547615754637
SNU-C2A,135411,0.5328935224556473
KO52,9887053,3.73966963035621
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
HCT 116,10385095,2.270155964027336
BT 444,11396600,3.072900716227824
NCI-H28,12001922,2.2993326696025376
SW1088,11396600,6.290027933724405
SF539,387447,-5.002674810102925
BT 224,3825829,4.410970515832672
TE-6,11455910,0.2232951915413818
DK-MG,11396600,4.342648785841818
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
COV362,54618771,1.3077362978490088
BxPC-3,100016,6.453363473458683
NCI-H1568,11396600,3.496587037401377
GA-10,15953870,1.8595203133344016
AsPC-1,15953870,5.362858272792295
T24,246676,4.650292847742773
SNU-5,15953870,3.1202568025223973
YD-38,42642645,1.3600120162800655
SKM-1,3825829,2.28297195030611
HH [Human lymphoma],9926054,1.7922289040675246
JHH-1,2746,1.382928885813351
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
LS123,selumetinib-GDC-0941 (4-1 mol-mol),1.252033053606901
A-673,136227331,4.241984110268528
NCI-H1435,15953870,2.220740315960451
AsPC-1,4705,5.582464580618905
NCI-H1792,54618771,0.988608164360901
Rh41,135411,0.772588245722524
RCH-ACV,246676,4.239213024568716
SNU-1076,42642645,0.8215518491746978
SNU-1,10385095,0.3695201358363642
Panc 08.13,9926054,1.852191503455224
SIG-M5,135411,0.5082219987847001
CAL-27,12001922,2.212988544461775
CML-T1,136227924,1.8923919385229255
NCI-H1355,136227924,5.68794295830134
DU4475,135423438,2.3536121101855096
SNU-1105,54618771,1.067302549999792
EJM,42642645,0.830143723901443
KM12,387447,-3.335452954170261
MKN7,11455910,1.138632994153518
SK-MEL-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.2410221738936931
SNU-668,42642645,1.9415397683183333
TT,12001922,1.633077667192507
HLF,10385095,1.177724307805522
697,9926054,1.6701290934346382
BT 187,9926054,3.0457893099703197
LOX-IMVI,136227924,2.635687863612288
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
Mel JuSo,6505803,-1.4537757141410834
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
SNU-869,54618771,1.00410575890065
BT 231,4705,1.5996652236036175
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
Becker,387447,-3.92218262413233
SCC-25,11396600,2.765145835118827
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
HEC-151,100016,5.913951457428463
Malme-3M,42642645,0.4425865665727854
HT-1080,11396600,2.8023964018444176
OVCAR-5,4705,3.2119011926923378
OV-90,44197249,3.9758846471244658
SR,15953870,2.798848601304184
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
HCC202,3825829,4.305199233108946
OAW28,9926054,1.976123345191561
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
NUGC-4,6505803,-2.369150454841633
YD-15,6505803,-2.549779097055298
IGR-37,42642645,1.428808433640827
KNS-60,15953870,2.8294291239386973
VCaP,2746,1.3458949391757813
KMRC-2,42642645,1.3665066587462662
BT 145,10385095,1.0797698804435325
SNU-475,3825829,4.797866520227357
HCC2935,selumetinib-GDC-0941 (4-1 mol-mol),0.0464684942355828
SW1573,12001922,2.294011710402099
COLO 792,11396600,4.429975159558261
TYK-nu,4705,3.3824774754373
GA-10,9927531,2.891443375149746
IST-Mes1,136227924,2.313131576565863
SNU-1272,15953870,3.4362338657153835
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
HSC-2,135423438,4.318138286967173
SNB-75,9927531,5.402780165726325
HSC-3,24753719,4.387222706020441
PE/CA-PJ15,10385095,0.8645470546748426
RMG-I,42642645,0.9332465288359848
OVCAR-5,42642645,1.23376252738047
MOLT-13,11396600,2.919023807687231
NCI-H2444,54618771,3.319337103675071
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
Namalwa,12001922,1.9514258181134656
NCI-H1092,12001922,1.6370209009668415
HT-1376,135411,1.728406668868799
SNU-899,9926054,2.026075556253581
PE/CA-PJ49,12001922,2.488213828418306
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
OVK18,11455910,-0.0430501401536957
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
CA46,12001922,1.4868064190708767
MIA PaCa-2,11396600,3.289038329533777
EoL-1,9927531,2.893857253769426
MKN74,11455910,0.5314790476879293
SH-10-TC,135411,1.2931707023218102
NCI-H2342,54618771,3.373010202836016
MFE-296,9927531,4.364597960371392
SNU-761,2746,2.9250609675985917
BT 320,11396600,4.5560356349666
AML-193,135423438,1.545921076680538
KALS-1,136227924,3.4972882997363257
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
Ishikawa (Heraklio) 02 ER-,246676,3.9831360741159463
NCI-H1694,selumetinib-GDC-0941 (4-1 mol-mol),2.084938486650406
KNS-42,11455910,1.3943687177837636
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
HCC1428,15953870,3.611931761105117
RPMI-8402,9926054,1.3971414667672897
Panc 10.05,54618771,0.7242321681283157
NCI-H1105,387447,-5.033192332624926
OCI-AML-3,11396600,2.62511537736271
BICR 31,11455910,2.0785566961581186
BT 131,4705,3.217253929262008
NCI-H1184,54618771,1.2504018594222124
GI-1,387447,-4.677356768823175
EB1,387447,-5.6659241694602
MV4-11,11396600,-2.6796840852640966
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
TE-6,11167602,3.4392943140139676
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
OVCAR-4,15953870,5.208617547404722
KYO-1,9887053,1.6336541753344382
HCC2108,3825829,4.6343664994608496
TUHR14TKB,9927531,5.242660147082698
HSC-2,387447,-4.953605093013747
RPMI-8226,2746,1.5846721201375709
BT 482,136227924,3.374884803280594
OV-90,54618771,1.0119398680970997
T-47D,12001922,1.6846043239778687
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
VM-CUB-1,387447,-4.164150173008023
IGROV-1,6505803,-0.2382223795960626
HCC1806,selumetinib-GDC-0941 (4-1 mol-mol),2.757254827906479
NCI-H1299,54649381,3.8627163696986098
RERF-LC-A1,135423438,2.4770286699108857
K029AX,12001922,1.5980485037822982
SNU-407,24753719,4.181962435947778
SNU-449,10385095,1.0986031812390589
Kasumi-1,11396600,3.073022183075244
CJM [Human melanoma],11455910,2.204115994538186
BT 172,12001922,1.2096799911918574
MeWo,135423438,3.135774621295312
MDA-MB-415,9927531,4.701582574311918
NCI-H1693,4705,2.4450047758451054
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
F-36P,11396600,3.0952958144122724
BT 320,135411,3.5003751238841887
RS4;11,10385095,0.7199215311682879
697,6505803,0.3097004019947232
HOP-62,3825829,4.170218994796182
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
OVK18,54618771,0.5319615878172647
HEC-1-A,135423438,1.6269697099453948
BICR 16,6505803,-1.4833128134740765
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
SNU-8,6505803,0.4041272460627742
RL,136227924,2.481613482211788
A-673,10385095,1.0544598585596625
GB-1,12001922,1.814681447205165
AGS,selumetinib-GDC-0941 (4-1 mol-mol),0.9665370398813388
LN-18,15953870,3.17300319715774
HCC4006,10385095,0.8428128861435789
DK-MG,42642645,-0.3737863567948565
NCI-H1694,54618771,0.8096670876443307
COLO 741,387447,-4.718574604900297
YD-10B,135411,-1.5268264195984915
BT 286,11396600,2.040730461375106
SW1271,54618771,-0.1319273231055389
F-36P,9927531,3.277951098444252
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
SK-N-BE(2),11455910,1.253525820715845
SNU-C5,11167602,2.179649924577758
P12-Ichikawa,3825829,2.9732930390002115
Peer,54618771,-0.6256151799638473
UACC-257,44197249,4.011857037374671
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
NCI-H446,42642645,-0.3552480522557149
FaDu,3825829,3.9563875296606534
KALS-1,15953870,5.91178249332218
ECC10,9926054,1.849592705301639
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
SNU-449,9887053,4.621717664819675
BT 228,10385095,1.1315778331384152
OCI-Ly3,135411,-0.0515713337753011
Pfeiffer,11455910,-1.170722455400671
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
CAL-27,49836020,4.376742607272952
NCI-H2023,54618771,0.8725356592337147
HuH-1,2746,2.931726924620674
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
MeWo,12001922,1.2676364406892235
RL,9927531,3.353152417945259
CCF-STTG1,42642645,1.477320759489864
KYSE-510,135411,0.4893840258787899
NCI-H226,12001922,2.7625374376909204
U266B1,136227924,2.814695997301776
NCI-H520,12001922,1.1311757401308036
CAL-12T,100016,6.470654025405006
BT 320,54649381,5.331321773509753
RERF-LC-A1,135411,0.8558941149277943
K029AX,10385095,1.9655495624947168
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
NCI-H1869,3825829,5.0249554409349875
SNU-182,9927531,4.620682064232075
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
HCC1428,9926054,2.453077305759455
LS513,44197249,3.870902449293608
OV7,42642645,1.1741666480378357
Ri-1,9926054,1.5974379061435915
HEC-251,3825829,3.9592537531247447
OVCAR-8,49836020,4.475611867400311
L-363,136227924,2.122664399399679
WSU-DLCL2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2724910625039847
PE/CA-PJ49,11396600,3.5050583522874637
HuH-1,selumetinib-GDC-0941 (4-1 mol-mol),1.7373904451201925
COLO 684,387447,-4.885870256853943
SEM,9926054,1.3281424685311425
BC-3C,3825829,3.767472456252349
YD-38,54649381,3.807168630789832
NCI-H292,9877608,5.923265260718527
UM-UC-3,387447,-4.302592940998861
NCI-H1299,9887053,5.800538449025383
KMS-27,54618771,0.0520641396166809
KYSE-140,54618771,1.7180424995817132
THP-1,3825829,2.869521438526818
COLO 668,9887053,0.5697558093996736
LoVo,6505803,-0.2027234925460443
JVM-3,73707440,6.054081463346775
JHUEM-1,135423438,4.272448858092011
NCI-H2172,11455910,3.487096997214958
HCC2935,54649381,3.99675987919713
GA-10,44197249,1.2039962980914516
OC 314,4705,3.18423368229223
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
KYSE-140,9927531,4.387230999589902
COLO 201,100016,6.515418099212221
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
SK-N-MC,136227331,5.402807013617019
IGR-37,3825829,4.196749191205033
THP-1,11167602,1.2377873801120165
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SNU-685,54618771,0.6420391462722509
SBC-5,42642645,2.1700569257248734
OE33,9927531,5.791665708309609
Ci-1,24753719,3.143659983929841
SK-MEL-30,54618771,0.8383532620392692
BT 228,387447,-6.110792335484957
Li-7,135411,0.2842081014153288
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372
CAL-33,10385095,1.604664266221027
SCC-9,136227924,3.721677265331546
KALS-1,24753719,4.821139206280144
M059K,387447,-4.265106039582325
NCI-H196,11455910,1.326317749713535
CAL-29,3825829,4.4034541655200465
SNU-1077,54649381,3.672520779647441
CAL-54,11455910,0.6457231079325149
JHH-4,387447,-5.028867049277109
KP-4,42642645,-0.9361975871435074
JM-1,387447,-6.033292615187937
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
NB1,100016,5.984902151942781
NCI-H1299,10385095,1.4970328026397637
NCI-H1650,42642645,0.4971030861022595
NCO2,100016,5.1199760357582385
IGROV-1,9926054,1.8111808945519428
NCI-H1339,387447,-3.859692304272627
KMRC-1,15953870,4.40931040558564
Hs 746.T,49836020,5.866178883912361
SNB-75,387447,-3.3698482484414174
NCI-H1373,54618771,1.0971026728505908
LS513,11455910,1.3682876788708345
WM793,42642645,1.6343237729440876
NCI-H1339,100016,8.285361450373896
M-07e,54649381,3.683033880015157
8305C,44487330,3.754241958429516
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
COV362,15953870,3.4873308150756337
KNS-60,136227331,3.7348276766396986
NCI-H1563,54649381,3.839413575795704
M-07e,10385095,1.243871367579541
SK-MEL-31,3825829,4.309140682602916
SK-N-SH,44197249,1.2076436443184098
H-STS,42642645,0.4333051661235175
BT 159,387447,-4.167143042192471
CAL-51,12001922,2.008779489179369
SNU-1079,12001922,1.6663555364591485
IGR-1,135411,2.856911878718207
SET-2,9926054,1.6776501813643687
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
Panc 04.03,15953870,4.151399322633975
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
RCC10RGB,135423438,4.4299924289236055
HCT 116,54618771,0.4629468645075349
SK-MM-2,42642645,0.783579514884387
NCI-H838,100016,5.521581837907123
OCI-AML-5,11167602,2.461233339824551
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
Rh18,9887053,4.851800513495416
MM1.S,42642645,-0.2096887803746246
SNU-626,10385095,1.227927473052019
Hs 895.T,9927531,5.651415148698969
SNU-1033,42642645,0.3333795520512672
QGP-1,100016,6.909688760762285
NCI-H1915,42642645,1.0836693438603435
BT 359,54618771,0.98089237051643
L3.3,9926054,1.9335911906728165
LC-1/sq-SF,2746,4.189437324423252
SF539,54649381,3.7800507892247337
A4/Fukuda,42642645,-1.373677794386147
Mono-Mac-1,100016,3.734497226962008
SCaBER,9926054,1.794532433131724
2004,4705,2.464885912287897
MHH-ES-1,9926054,1.555405413320919
NCI-H1581,9887053,3.5134313318530292
LC-1/sq-SF,24753719,4.740792040152904
HeLa,6505803,-0.0506022751267441
CAL-85-1,9887053,5.170722740903703
RKN,54618771,1.93479648501244
NCI-H1573,387447,-3.108668295011592
WM983B,11455910,0.7348895690575076
BHT-101,54649381,3.844602881732007
LAMA-84,387447,-5.316930915584967
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
SW1088,54649381,4.869847377788056
OCI-M1,387447,-5.720282808963336
TALL-1 [Human adult T-ALL],135411,-1.8050557395732971
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
KYSE-180,12001922,1.7478221517465942
Granta-519,4705,3.4024179319436483
MKN7,4705,2.6628082775423865
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
MCAS,54649381,4.395413097110276
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
EPLC-272H,49836020,-3.920805882597204
A-375,100016,6.005492870785018
KMS-26,387447,-5.275247943312664
BT 428,100016,4.306836909333982
LS180,387447,-4.2321913932512185
697,135411,-1.7491404596935498
SK-N-FI,42642645,-0.8226595226163214
CAL-85-1,11455910,0.9235836598300894
WM983B,9927531,5.417064832255327
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
Calu-6,15953870,4.155729629052737
RERF-LC-A1,387447,-5.173995922750218
MOLM-6,15953870,2.4084672634067243
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
JHUEM-1,9927531,4.870867049217503
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
IMR-32,100016,6.43791059275997
COR-L95,11396600,3.695258257335492
LP-1,387447,-5.59779100304281
U-937,6505803,-1.2409770185958264
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
NU-DUL-1,9926054,1.630316493703293
KHM-1B,387447,-5.058175638788416
BT 340,42642645,1.6439050244423692
LS513,49836020,4.383197758831643
BT 340,11396600,2.9184379115774375
LNCaP clone FGC,10385095,0.9687144663796518
K029AX,54618771,0.9903222324801182
NCI-H716,42642645,-2.759309700895452
G-292 clone A141B1,24753719,4.492149342969766
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
BICR 6,387447,-3.615885256505799
D283 Med,9927531,3.2144716566788745
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
NCI-H1339,3825829,4.0280644624374435
SF539,135423438,0.8139499502196877
NCI-H2029,9927531,4.454841105841318
TE-11,10385095,0.8286852440686213
JHH-2,15953870,4.705970158963108
THP-1,136227924,2.5094113505430737
BICR 31,15953870,5.115358479555731
SNU-620,10385095,2.2803267979745834
CAL-33,9927531,3.2885061744461273
MOLM-6,12001922,2.526202288067833
NCI-H747,136227924,2.5739387589966265
LN-229,54618771,1.209787731976597
DBTRG-05MG,42642645,1.8121411980748523
HuH-1,11455910,4.282125665148122
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
GMS-10,136227924,3.0615637003217433
MPP 89,9927531,5.277486378374347
NCI-H2081,42642645,-0.9606541390632763
OPM-2,2746,0.9082445461467812
SNU-869,387447,-3.8515775210931698
TM-31,9926054,1.8520077619388624
DEL,136227924,2.1995562608544494
EFE-184,11455910,1.1766265020277265
GB-1,10385095,1.4774808310590557
NCI-H2029,11455910,1.1545705407069018
COLO 668,387447,-4.142312529937059
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
IGR-37,12001922,1.586614371978584
AGS,3825829,4.308029751739555
IGR-37,11396600,3.951317160447081
KMS-21-BM,9877608,6.031837359251096
PC-14,11396600,4.745127634228124
NCI-H1373,9887053,4.211056072047831
SK-MES-1,387447,-3.6691957408850784
Daoy,9927531,4.407816470136583
SH-4,6505803,0.0908209591031931
CCF-STTG1,10385095,1.287783842967002
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
SK-LMS-1,4705,3.2417588485362554
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
SNU-1,9887053,3.835998748008506
Mel Ho,42642645,3.927444187836091
NCI-H1693,42642645,-0.7227780466558612
OC 314,11396600,2.739817011792775
RPMI-8402,387447,-4.932828758424725
OVK18,12001922,1.622305970526486
SK-ES-1,135423438,0.9314581283921904
SK-MEL-3,6505803,3.3435678878510817
YD-15,11455910,1.434316032947977
U266B1,54649381,3.7659802161667897
NCI-H2172,10385095,4.224975285900289
Caki-1,387447,-3.293939883918682
MKN74,135411,1.5838498923654774
HCC2108,54618771,2.799542688239582
MSTO-211H,4705,2.457156821386339
GCT,6505803,2.0457782939841667
MOR/CPR,12001922,1.7459171888338627
U-BLC1,42642645,0.9878731363014036
NCI-H2291,42642645,5.2063520566373365
SW1271,135423438,1.1699634662635283
CAL-51,387447,-3.720200693098244
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
KMS-21-BM,9887053,0.9712553227644046
ECC10,11455910,0.1106794798283132
SK-MES-1,3825829,3.953427903272987
SK-MES-1,2746,3.092337082097677
BICR 22,135411,0.5903998872112299
FaDu,135411,0.6587259178311046
BT 328,54618771,1.300712581347958
EB1,10385095,0.173257887720905
SK-N-BE(2),42642645,0.3028879658971615
SNU-738,42642645,0.6328008864455844
KYSE-150,11167602,1.7294148916205108
BT-16,246676,5.246852938804325
MOLP-2,selumetinib-GDC-0941 (4-1 mol-mol),2.6485727489944555
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
OAW28,12001922,1.8847589611064504
HEC-1-A,10385095,1.0280280082495876
PSN1,11396600,2.760096793353625
MOR/CPR,100016,6.350482300205422
HEC-6,54618771,0.3851736338204913
EC-GI-10,100016,6.57909581265972
HuP-T3,136227924,2.888640375816574
CCF-STTG1,12001922,1.64779237690147
BT 422,9927531,5.2521428794559
SNU-886,3825829,4.2404054797227735
ESS-1,387447,-5.037795986549112
NCI-H889,12001922,1.089350417128607
EM-2,11167602,0.236246568519281
YD-38,11396600,4.074151932666014
SNU-61,11455910,1.387165489844305
HSC-4,15953870,4.269670192757531
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
SNU-668,54618771,1.3172714373164345
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
NCI-H2110,54618771,2.4596551535175504
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
SNU-620,6505803,-2.9616664465853115
OV56,9926054,1.8437049272321575
SYO-1,9926054,1.4051151618362918
RVH-421,42642645,1.5550331115385962
Toledo,42642645,0.91330720483632
JHH-2,100016,7.043022520962564
PF-382,135411,0.1083131735898056
SaOS-2,6505803,-1.001039194104569
ZR-75-30,10385095,1.0547762324766166
RPMI-8226,24753719,3.634689092662078
SNU-1033,54618771,0.4334411730243536
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
KE-39,54618771,0.8543301924142261
VMRC-RCW,3825829,4.961866396060198
UACC-62,11167602,1.57164687093679
KNS-62,136227331,4.203841276745653
SK-LU-1,9926054,2.124586219371247
LNCaP clone FGC,9926054,1.750086860049474
A-253,387447,-4.867076140693361
SCaBER,42642645,1.4863979782333092
SF295,54649381,4.030819741798211
OVCAR-4,10385095,1.0528960580780835
CFPAC-1,15953870,3.265940435383662
OVK18,15953870,3.927161984839069
RKN,246676,4.414592383854902
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
MOR/CPR,42642645,3.5417463336801993
Peer,54649381,1.9000116641198852
YD-10B,42642645,0.4904985527717032
PK-59,42642645,0.6067807783414038
KP-N-SI9s,6505803,-1.8312599777173428
NCI-H520,246676,5.04286293449012
G-401,6505803,-2.085126737120111
UACC-62,135411,1.4523343724998452
SNU-423,9926054,1.7894708985292902
COLO 320,42642645,0.3710616056965425
OE21,11167602,2.1998769764079884
BT 416,136227331,3.8203373209104425
Hs 822.T,selumetinib-GDC-0941 (4-1 mol-mol),4.199779090816491
K029AX,selumetinib-GDC-0941 (4-1 mol-mol),-0.0187548496270864
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
SNU-61,42642645,0.1547953205487765
A2780,2746,1.939184711313242
JHH-2,387447,-4.787575430218603
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
SNU-449,9926054,1.9385314164963827
ChaGo-K-1,24753719,4.520891779779164
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
LS123,3825829,4.218802108211374
NCI-H1385,135411,1.2025272146161323
SF268,11455910,0.3275538615735771
PaTu 8988s,3825829,4.7222594331906915
BL-70,9887053,3.905138852796042
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
ONCO-DG-1,15953870,3.1699819142685284
IM95,135411,0.8588440823688528
SNU-886,6505803,-0.0303295506780238
MOLP-8,9926054,1.7939353525170396
NCI-H1650,54618771,3.34176248194117
BHT-101,selumetinib-GDC-0941 (4-1 mol-mol),-0.4263486280129431
SNU-601,11455910,0.7913610206716569
TUHR4TKB,11455910,2.848253003917055
Karpas-299,24753719,3.062088598517528
DK-MG,2746,3.5429718490608924
KYSE-510,9926054,1.8672783124576204
M059K,24753719,5.106233937055326
CAL-33,4705,1.086643830288211
OCI-M1,42642645,1.7044851255097004
HeLa,387447,-3.452898150134073
U-251MG,9887053,6.109947828836403
Mono-Mac-1,11396600,1.2647728617805982
KE-97,73707440,4.317298801738101
Rh41,11396600,2.905636505661568
IGR-37,2746,2.835708308282215
SU-DHL-1,12001922,1.0574025128990867
COLO 668,9926054,1.8652250146590224
HT-55,15953870,4.245497365085987
HPAC,387447,-3.631275387941533
SW620,2746,3.8356655866874414
YH-13,42642645,0.7428971462414599
JHH-5,12001922,1.6282119819932437
SK-UT-1,6505803,-1.8087484782267416
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
IMR-32,9926054,1.7425604419011955
NCI-H1755,42642645,0.7197616735988079
Hs 852.T,54618771,3.3539274587451935
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
HCC2108,387447,-3.2029305155754657
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
NCI-H23,6505803,-3.94863940408712
22Rv1,11396600,4.6208981896393215
SNU-761,54618771,-1.251470969575028
BT 416,9887053,4.191771571129995
JM-1,100016,5.094244415703564
TE-15,136227924,4.530652264188515
NCI-H358,15953870,2.926331959373054
WSU-DLCL2,9926054,0.3298976492900614
Kasumi-2,136227924,1.9658135956042504
BT 498,135411,3.2287003420197458
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163
DMS 53,11455910,0.8364370230272622
BDCM,135423438,1.7676973941849825
G-292 clone A141B1,9926054,1.742102063355914
NCI-H23,135928012,3.728691936192156
HT-144,135411,1.9199895866475432
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
NCI-H2029,42642645,1.408235356423464
JVM-2,387447,-4.181286618206111
OPM-2,6505803,-0.5489645461029444
YAPC,24753719,5.0641073859888
HuG1-N,10385095,1.5611722738302254
NCI-H2052,selumetinib-GDC-0941 (4-1 mol-mol),-0.0438612547991499
MOLT-13,136227331,4.740160343609143
SNU-840,9926054,2.11865142604258
SNU-626,9887053,4.686885424922037
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
SNU-449,3825829,4.613153689576251
CAL-51,9926054,2.2227862000004577
BCP-1,9926054,1.6337686711618178
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
Daudi,15953870,2.3174310256528017
COLO 792,4705,2.7626450241642355
SaOS-2,54649381,4.670802712896813
Lu-99,9927531,4.1215148534256105
8305C,11396600,4.152403523001879
Jurkat,3825829,2.3868558059925893
OC 314,135411,-0.5665953856301359
SNU-8,100016,6.375529183181613
SF126,10385095,2.260425505483892
UO-31,3825829,3.487522924884045
OVSAHO,136227924,3.9451154225840783
639V,387447,-4.051480778623548
SU-DHL-1,136227924,2.1802521862386395
SNU-840,42642645,1.6993701582363216
BT-474,9926054,2.0382536553726207
SNU-61,135411,1.4786327368897634
T98G,12001922,2.433944283223996
KP-N-SI9s,387447,-4.963217301510693
HuNS1,10385095,0.4099305568454984
Ri-1,12001922,2.5045482624061552
KYSE-450,136227924,3.5350495950730645
MOLM-13,54618771,-0.6841479707721928
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
HuH-6,4705,2.6985150624088967
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
SW579,selumetinib-GDC-0941 (4-1 mol-mol),1.5749080758485403
OV-90,387447,-5.084476458725148
NCI-H2196,9927531,4.117400803944708
CCK-81,24753719,4.044065548587902
BT 248,11455910,-0.0312737668402554
JHOS-2,135411,1.1801501574551538
SNG-M,135411,0.6715227588852292
MKN74,9926054,2.8513802079001844
TUHR14TKB,2746,3.3342973091296506
LS180,136227924,2.415770069388299
BT-20,12001922,2.386959845886897
BICR 31,135411,1.1842135795155395
SJSA-1,54649381,3.982441007676095
SNU-201,3825829,6.229287802510879
Calu-3,387447,-5.236364464603389
Hs 766T,6505803,-1.244402871615241
JHH-1,135928012,5.070741808583206
U-251MG,10385095,1.5750585422416694
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
SNU-475,2746,3.808468111093762
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
Mino,6505803,-0.2823157410063563
DOV13,3825829,3.9863305108716576
DMS 454,11396600,3.1958001986957143
BT 482,42642645,1.3433588463104076
LoVo,9926054,1.9069881185353632
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
NCI-H211,54618771,-0.4464011185148343
TUHR4TKB,9927531,4.964100941716243
LN-229,136227924,2.284287102346984
IGROV-1,54618771,1.2456991772210466
KNS-42,3825829,4.587610357991776
MOLT-3,11167602,1.5637048458250953
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
EC-GI-10,24753719,4.306483835560299
SCC-4,54649381,4.139136572902244
BT 340,54649381,4.353295921585357
SK-CO-1,135411,-1.9906675184189948
Hs 839.T,selumetinib-GDC-0941 (4-1 mol-mol),3.521332428924413
253J,3825829,3.221638930373727
OCI-M1,100016,6.862784368685653
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
NCI-H650,100016,5.632760623979546
NU-DUL-1,135928012,5.108313721394688
TM-31,11396600,3.128698302220667
SK-OV-3,9926054,2.1800400954819716
WM115,3825829,3.803690072721518
RS4;11,15953870,2.528840759966754
Tm87-16,9926054,1.142722518421256
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
NCI-H226,42642645,2.111360183888469
CAL-51,387447,-3.720200693098244
HD-MY-Z,9926054,1.8885520747906608
LS1034,11167602,2.8357030175070284
SK-MEL-1,3825829,5.509515179723942
MJ,135423438,2.050663035644961
LOX-IMVI,136227924,2.635687863612288
BICR 56,3825829,4.587316881552045
SK-N-MC,100016,6.319948334432407
SNU-478,135411,-0.1626649384592883
NCI-H1155,135423438,2.3311426063926795
NCI-H1092,2746,3.1114505923007583
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
Daoy,10385095,0.8624226642696267
U-BLC1,12001922,1.5273545678847515
Ki-JK,11455910,1.8601225007707891
Calu-6,100016,6.484915939204548
T3M-10,12001922,1.8173241430888112
TCCSUP,6505803,-2.3370703799020323
Hs 578Bst,136227331,4.283595415699579
CAL-120,136227924,2.519967645750226
U-118MG,selumetinib-GDC-0941 (4-1 mol-mol),2.998678120294993
KMH-2,54618771,-0.6611868525273566
NCI-H1792,3825829,3.9348635220301897
NCI-H1573,15953870,3.452167403969455
PC-14,73707440,4.422438937843538
BL-70,100016,3.880189960258483
L-363,54649381,4.100847995729025
OCI-Ly19,9927531,5.466722325400782
KG-1-C,54618771,0.7082793216949752
SU-DHL-8,24753719,2.049224728384907
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
HCC1438,11455910,1.641191029153792
NCI-H460,136227924,3.925006850615035
KMM-1,15953870,3.1763795995616793
OUMS-23,42642645,1.5239240257973337
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
KMS-28BM,9887053,0.8852053566205
NCI-H1869,2746,3.565752906078767
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
SNU-C2A,3825829,3.7710879487261537
GA-10,42642645,-0.7001416286986243
BT 147,15953870,3.6818456875105032
NCI-H1435,12001922,1.0985655792068092
LXF 289,100016,7.121965810949268
Ci-1,136227924,2.861978373437932
TUHR14TKB,54618771,1.495898324291793
KMM-1,246676,5.888531841272029
NCI-H508,9926054,1.9520179071989003
JHOS-2,10385095,1.2172987811190692
ZR-75-1,11455910,1.4286794272371928
KYSE-450,9926054,1.8553044985655331
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
Capan-2,11455910,0.6528691404413365
HEC-1-A,11455910,0.0025723571677065
A-375,54618771,0.2489032260565352
Karpas-299,3825829,2.720706571865646
RPMI-8226,11455910,-0.3031686531040117
KMS-11,9927531,3.9884073246481058
RL,12001922,1.6000849168158475
MKN74,15953870,2.991843284853693
P-STS,10385095,1.1186168802515164
Rh18,49836020,4.886485383707075
HCC202,10385095,1.5376384579545057
8305C,6505803,0.0695536722094139
RT-112,11396600,5.757660560625734
Capan-2,9927531,4.988385726182681
HuH-1,100016,6.427674645277276
SNU-182,3825829,3.5426168864538337
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
BT 444,3825829,4.3965707332057455
RL,3825829,3.6483443065262207
JHH-4,15953870,3.088659431325142
COLO 741,49836020,-1.8257608892409716
RPMI-8226,selumetinib-GDC-0941 (4-1 mol-mol),1.6638240545531544
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
WM1799,12001922,1.878385543810775
Ri-1,100016,4.838113149785687
DND-41,100016,5.882204784714585
HCC2108,42642645,0.687631636914302
MKN45,246676,4.422534829782778
KYSE-520,12001922,1.798190063883957
A-204,100016,6.602223097366851
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
SK-MM-2,136227924,3.42367167276636
PaTu 8988s,100016,6.475282567189534
MOLP-8,9927531,5.438833274000949
HCC2218,3825829,3.8059808455027704
TE-15,49836020,0.684840592082847
U-BLC1,11455910,1.1815633788614182
SW1990,10385095,0.931801208429433
NCI-H2291,54649381,2.808620749955139
MOLT-16,3825829,3.065920601927999
SW1990,54618771,1.819696432191247
KYSE-410,4705,2.1516675380518953
KMBC-2,2746,3.623005517857566
ECC10,24753719,4.390592261959423
DEL,3825829,2.337223575756098
SF126,24753719,4.936829746635371
JHH-2,9926054,3.1999514592679508
IM95,387447,-4.566268472932552
Hs 729.T,49836020,4.229774154263897
P3HR-1,135411,1.6234361075230843
DV-90,9927531,4.273842148602971
MOTN-1,11455910,0.7749413706396605
PSN1,42642645,1.5705380703829117
SNU-423,44498493,4.431214994890045
NCI-H1651,6505803,-0.3819158515130707
Li-7,3825829,3.7804752985046446
EHEB,24753719,3.508920403296929
JHH-1,6505803,1.4428022461389338
GOS-3,49836020,5.837697611269413
SF126,135423438,1.5830794600000448
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109
HSC-4,135928012,4.241462346184107
SNU-8,9926054,2.0095672828148636
VMRC-RCZ,15953870,3.8209529749485056
KPL-1,54649381,3.5935561223347783
Calu-1,54649381,3.1839946229098777
HOS,9926054,1.8874056753100945
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
SNU-761,11167602,1.5600382089395972
DMS 454,12001922,1.2881940625035937
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
OE19,15953870,4.57347740783193
OAW28,9926054,1.976123345191561
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
KMRC-3,136227924,3.033903598858876
A-204,136227924,2.1384474587970113
HuT 78,10385095,0.3743213193570641
HuH-1,135411,0.5798294845374534
OCI-AML-2,136227924,1.951984345015637
KMRC-20,3825829,4.552870179452752
RPMI-7951,54618771,0.8844591471525661
KMS-28BM,2746,1.511503840028706
BHY,15953870,3.4632113224831627
NCI-H1341,11396600,2.1149833327737615
RERF-LC-MS,42642645,-0.4358765804877467
U-87MG ATCC,10385095,0.087665858719859
GP2d,12001922,1.4485741159981689
MDA-MB-361,136227924,3.324084435927791
SU-DHL-8,11396600,1.8138091107788987
CAL-148,100016,6.461133409351435
SR,11396600,3.1743105813803085
TT2609-C02,9926054,1.870565341301735
MOLM-6,387447,-5.265993179213733
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
Li-7,136227924,3.3307357238068818
LN-229,42642645,1.4413391591939335
M059K,3825829,4.125206062385853
Peer,24753719,1.725588631134334
BV-173,135423438,-1.0531729027332817
NH-6,selumetinib-GDC-0941 (4-1 mol-mol),1.9246197081776155
SW1088,135423438,1.6657015051140114
NUGC-3,10385095,1.1907439183905275
NCI-H526,11396600,3.7053245475874785
AML-193,4705,3.164558666224438
Panc 03.27,100016,6.730276002902577
MIA PaCa-2,10385095,0.818601661096134
CGTH-W-1,54618771,1.2189927241974945
NCI-H2228,49836020,2.091075397258879
CW-2,387447,-3.324957254647769
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
Lu-65,4705,2.2628868276979404
HCC1195,9887053,4.350415322844043
MM1.S,2746,1.322857724988492
HT-1197,6505803,0.6995636823670472
PE/CA-PJ15,9926054,1.7631963091393454
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
MFE-319,10385095,0.9790688990862756
SNU-213,54618771,0.1807958320323681
TYK-nu,12001922,1.6203487273598625
CML-T1,9887053,1.7753443459725933
SF539,135411,-0.8521595547181242
TT2609-C02,42642645,0.3775738852094479
SNU-1076,15953870,3.4251894458829493
Hs 940.T,10385095,3.184897938078862
SCC-25,135928012,3.793388901602888
UACC-812,42642645,2.375397400257474
COLO 668,54618771,1.2538028479070895
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
WM115,11455910,0.9860510612095932
CHP-126,10385095,1.0341421510776674
Aska-SS,42642645,-6.050659008742591
Lu-65,15953870,3.741719586955095
Hs 895.T,24753719,4.81444426124174
MOLP-8,2746,0.9128995235322724
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
A-204,135423438,-4.574115498517721
Pfeiffer,10385095,0.6381642015116235
MeWo,15953870,3.8021729272843103
BFTC-905,54618771,-0.6913922246342757
BT 239,54618771,0.6858691475419959
MFE-296,42642645,-0.6625957705717848
TYK-nu,9926054,1.6864170114704335
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
Yamato-SS,15953870,4.427525138705309
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
JK-1,10385095,0.9550049798539404
SNU-1066,24753719,4.394571548693749
DMS 53,9927531,3.323341915494568
NCI-H520,2746,2.5300013032729556
QGP-1,136227924,3.0535414774537424
LS123,387447,-4.364641769285444
DOV13,54649381,4.743925295066235
COV644,11396600,3.2739624799588505
HEC-251,10385095,1.0476635397176672
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
HCC44,135411,0.2427468590633975
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
SNU-1,24753719,3.752863299707876
KYSE-140,42642645,0.699404434989545
Raji,15953870,3.353900819495554
NCI-H2171,2746,1.1013983502046127
Granta-519,9887053,0.035640336798207
HuP-T4,42642645,-0.0145942410141439
HCC827,6505803,-1.7879054202576514
HEC-1-B,24753719,4.359915820911249
OUMS-23,11455910,4.2280456550760235
TTC-709,24753719,4.2386311491710895
Hs 683,11455910,0.4733989942514576
DU145,42642645,1.4952043269742437
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
SF539,15953870,3.263207389755282
CAL-51,3825829,3.9510679995615257
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
Panc 10.05,54649381,4.513418792570307
HT-144,4705,3.2699315895586127
ChaGo-K-1,9926054,1.8139091606673228
NCI-H460,15953870,5.00315267734786
RERF-LC-Ad2,15953870,4.58156365468759
JHH-1,54618771,0.3940537570432531
Hs 611.T,135411,0.3015901655387148
NCI-H1703,11167602,-0.8464886698666326
8-MG-BA,15953870,5.406448679548666
NCI-H2023,11455910,0.9302760696412364
SCaBER,9887053,4.852287058435708
NCI-H1975,selumetinib-GDC-0941 (4-1 mol-mol),-2.1756384403206326
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
SNU-46,selumetinib-GDC-0941 (4-1 mol-mol),1.1203054933058916
DU145,135411,0.7312573110789992
HT-1376,24753719,2.891583671664211
SNU-620,135411,0.942314783014924
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
NCI-H460,6505803,-0.4074860596498978
NCI-H889,387447,-4.287787824592524
BICR 18,15953870,3.230458098616477
BT 498,9926054,3.200560952387037
SNU-840,387447,-4.209865765178409
RCH-ACV,24753719,3.8377277120048863
NCI-H1395,42642645,1.8763678628327745
Granta-519,10385095,0.7144131323279258
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
COR-L51,135411,0.9587849168943487
BT 444,135411,3.2928959141546548
LAMA-84,135423438,-1.4093443238275885
A-673,2746,1.857945511282164
TE-5,135411,0.8893226940140384
COLO 678,11455910,2.071395728825759
HD-MY-Z,11455910,0.2534017769980389
SNU-1,2746,3.00506247553621
Mono-Mac-6,42642645,-4.551917002705417
Karpas-620,135411,2.554392993552881
SK-N-AS,135411,0.3173917962022085
PK-1,54618771,1.395529069214854
PaTu 8988s,2746,3.571987596167747
Hs 294T,54618771,1.144454520663973
RPMI-8402,54649381,2.4015230280117144
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
HCC1143,100016,7.122041956726765
TF-1,selumetinib-GDC-0941 (4-1 mol-mol),1.467323615098958
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
RPMI-7951,9927531,5.17840544344631
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608
KLE,10385095,2.1345695418673354
PF-382,15953870,2.669476849035499
SH-10-TC,42642645,1.5802745475369844
MOLT-16,136227924,1.8334417676190544
KMBC-2,54649381,3.86367738798119
HCC1195,selumetinib-GDC-0941 (4-1 mol-mol),2.113355514825289
NCI-H2023,135411,-0.1576567673592895
COLO 792,136227924,2.7402829929938908
TE-8,15953870,3.2704148792119687
KYSE-410,54649381,4.165413744231657
IGR-39,49836020,4.439074954514643
KMS-20,3825829,3.171752203706611
CAL-78,387447,-5.5558199430474655
NCI-H23,11455910,0.0561940780927377
HCC1143,3825829,3.893715702367038
GP2d,42642645,-0.7579191426845988
NCI-H1650,2746,3.978561009929137
BL-70,246676,4.317555715151855
SK-ES-1,49836020,6.460464214010888
KMRC-2,4705,3.2105980144700004
BT 164,6505803,-0.6124673991006063
MKN45,387447,-3.435571985138428
SNU-620,387447,-5.0191333966618705
SW1783,44197249,1.0547858460239052
SNU-1196,selumetinib-GDC-0941 (4-1 mol-mol),2.312847943895299
HLF,24753719,3.674130875270684
LS1034,49836020,4.406866434657065
SNU-601,selumetinib-GDC-0941 (4-1 mol-mol),-0.2622654032095929
A-204,9927531,4.116017775807866
8505C,selumetinib-GDC-0941 (4-1 mol-mol),0.125719667045265
Caki-2,54618771,1.2625964957313875
CAL-12T,10385095,1.410088866478716
SW1353,54649381,3.9754097874607313
SNU-1214,136227924,2.9720785133706213
NCI-H1563,42642645,0.4655471213496578
SK-MM-2,387447,-5.027849983221287
NALM-6,54618771,-1.340027714929621
MKN74,54618771,1.3558742291917982
NCI-H2172,3825829,4.682162679328668
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
NU-DUL-1,100016,4.060799847781438
FTC-238,12001922,1.7809236682407366
SNU-1272,10385095,3.7094210277095274
Panc 02.03,10385095,1.3097039910351371
SNU-216,49836020,4.392080781330326
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
TE 441.T,9926054,1.7722508105545176
NCI-H650,6505803,-0.3045816142319602
MCF-7,135411,0.2929807878774432
NCI-H1650,selumetinib-GDC-0941 (4-1 mol-mol),2.5973614834330965
647V,10385095,0.9897075230174724
SNU-407,2746,2.5870056952714777
JHOC-5,6505803,0.9816960895026916
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
HCC1833,100016,6.427561679501585
ZR-75-30,100016,8.126082181881081
HGC-27,136227924,2.541882907814414
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
F-36P,100016,3.924028764616067
KATO III,12001922,2.241398633273007
NCI-H1944,12001922,1.6688707308208333
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
KMS-34,10385095,0.6181489160442079
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
MDA-MB-468,24753719,4.129239306048558
DMS 273,2746,1.8465116882146249
NCI-H2126,387447,-2.90295787313441
FaDu,15953870,3.785092733257921
KYM-1,135423438,1.6984584998013297
VM-CUB-1,135411,0.410873885106146
786-O,12001922,2.335272184237166
KP-2,42642645,1.304815452253056
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
AMO1,3825829,2.5093886870909277
SNU-C1,135411,0.8975987859972445
YAPC,54618771,0.5686030675412354
SUIT-2,387447,-2.953323382165442
HEC-265,10385095,1.3618072308793756
COLO 201,3825829,3.950975363979348
HEC-59,11396600,4.681293728583163
MKN1,9927531,4.774967251580727
EC-GI-10,4705,0.5713397420594433
BICR 16,54649381,6.0952061079834206
NCI-H28,136227924,2.9733016664554155
SUIT-2,44197249,3.8764143883383224
IPC-298,10385095,1.5595446684536465
BDCM,selumetinib-GDC-0941 (4-1 mol-mol),0.2374601063606183
NCI-H446,4705,3.0322510190148795
BT-549,49836020,-1.94641857460656
PE/CA-PJ41 (clone D2),15953870,4.204773718329985
HSC-3,9926054,2.205728912393848
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
COLO 680N,100016,6.604594090356929
MOLP-8,24753719,3.861578571306771
SKM-1,100016,4.336407790429152
NCI-H841,3825829,3.7411567532610968
NCI-H2196,11167602,1.792156355999927
SW1271,9927531,4.558020454092029
JHUEM-7,136227924,2.4332957155572688
Daudi,135928012,2.6114481479622516
BT 440,54618771,0.7745514333639397
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
KYM-1,4705,3.22823778940345
OCI-Ly3,42642645,1.4139106264479906
NCI-H2228,54649381,5.765486109069033
NCI-H1915,6505803,-4.13754619223685
GB-1,24753719,4.75558309806726
NCC-StC-K140,136227924,1.8113931494957989
Kasumi-2,387447,-5.322857892005912
HCC1954,3825829,3.7573372341381934
GDM-1,135411,-0.0217449649407941
KATO III,24753719,4.4209901608966
HDQ-P1,136227924,3.063540067223108
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
NCI-H647,9887053,4.301851174224865
NCI-H660,6505803,2.5478241570945026
BT 333,10385095,1.869788440737833
MDA-MB-231,49836020,-4.061290256388782
CHP-126,135411,0.0104194256476736
SW982,387447,-3.067226815630322
OVCAR-8,135411,1.6905437732598307
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
GA-10,11455910,-1.5757849465302998
HD-MY-Z,9887053,4.281050579490845
CAL-51,135411,0.595745817277345
SNU-869,12001922,1.949952510058232
Daoy,11167602,1.994230067492168
SK-ES-1,4705,2.9772656086028
SNU-423,135411,0.8949713421437451
TE-4,387447,-4.748292449787346
BT 131,selumetinib-GDC-0941 (4-1 mol-mol),2.219067508706083
NCI-H1869,9927531,5.985290716685452
MCAS,100016,6.4909883414165135
MOLM-13,15953870,2.45012914744678
SNU-869,3825829,4.78550550976993
SNU-182,42642645,-0.5508687627250707
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
NCI-H322,11455910,0.5525831103614591
SaOS-2,10385095,0.9171223668306429
NCI-H2196,24753719,4.748637323499507
Granta-519,9927531,4.885085469625254
BT 248,15953870,3.6832035377423216
HCT 8,136227924,3.7452024891634785
BT 245,54649381,3.7292740708947094
KE-39,11455910,-0.1151631297895284
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
D283 Med,100016,3.728925578699804
NCI-H69,135411,0.7098007474261369
Karpas-299,54618771,-0.1406101617053584
REC-1,9927531,3.800278065681949
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
KHM-1B,42642645,-0.1657476945294937
DMS 454,54618771,0.8095302292114137
SW1353,387447,-4.17811329227342
NCI-H810,24753719,4.056303258094418
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
KMBC-2,135411,-0.2962045954833053
BT 179,42642645,1.6249746356985328
NCI-H1341,3825829,2.8809993915342487
CGTH-W-1,3825829,3.7767621594199343
SW982,2746,3.3231218148802144
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859
NCI-H2122,2746,3.68558209467045
OCI-AML-3,4705,3.3295764443297475
DMS 273,11396600,2.9821670224503025
BT 271,387447,-5.117114557710019
Kasumi-2,9926054,1.3771704127752784
VM-CUB-1,12001922,1.724133183134661
TC-71,136227924,2.205314859996721
Karpas-299,11455910,0.3767083594332863
SNU-685,11455910,0.9033032633285248
HCC1806,135411,0.4484407480021858
NCI-H1355,387447,-4.190539835326961
CMK,10385095,1.16038597640568
B-CPAP,24753719,4.549431908166172
ST486,3825829,3.4497279801035665
HuP-T4,24753719,4.326193689938818
Ci-1,135411,0.7532597736337989
SU-DHL-6,387447,-5.553627026103078
23132/87,9926054,1.8706773159839023
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
WM115,136227331,3.7917327546536983
IMR-32,42642645,-1.1438472820018184
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
MHH-CALL-3,54649381,4.297708916418872
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
NCI-H2286,11455910,3.2712794680477173
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
KYSE-140,54649381,3.121234531215916
MDST8,42642645,1.1052716804296012
L-428,11396600,3.243581020285636
KMS-21-BM,42642645,-0.0520859605675617
BT 330,135928012,3.687683575459301
CAL-33,135411,0.1292363385283667
A-253,49836020,4.493346426084629
PF-382,44197249,4.457184218022553
DU4475,10385095,0.476817246538896
U-87MG ATCC,9926054,2.857820648476152
T24,2746,3.727610415765059
KP-4,12001922,1.8310999373499832
TT,54618771,0.4529536382950971
SW48,11455910,-0.1633281652990052
HeLa,10385095,1.105005903985203
G-361,11396600,3.133964518585525
T24,24753719,4.567748064975528
KYSE-410,136227924,3.831866760516254
KMS-34,100016,4.459610626448404
MHH-CALL-3,selumetinib-GDC-0941 (4-1 mol-mol),3.01666713959806
SNU-1196,387447,-3.9072336100304144
HuP-T3,11455910,1.0919804440303738
SNU-761,12001922,1.5720197674498737
WM115,44197249,3.814304480361476
23132/87,9887053,4.635383576452631
BT 232,54618771,0.7442415190466014
OCI-M1,135411,0.469490466947555
NCI-H1650,9887053,4.69604494844116
769-P,24753719,4.182312209848352
ESS-1,24753719,4.181647881164435
DB,135411,0.4581770255714568
G-292 clone A141B1,136227924,3.074698527992838
NCI-H2196,11455910,0.991466046593156
WT2-iPS,100016,6.129452507999119
Hs 888.Lu,49836020,4.832752015410737
JeKo-1,9926054,1.771855949205148
MKN74,136227331,4.503917554589063
EJM,135411,0.4460244130907568
NCI-H2228,2746,2.5336872635274226
TE-6,246676,4.234974035576642
KMS-11,136227924,2.4847849493179406
EFO-27,136227331,4.702115323060179
NU-DUL-1,11167602,1.4420689285823494
HEC-59,10385095,1.2806197233190435
DAN-G,9926054,1.747482520890968
SK-HEP-1,42642645,1.5394057036271682
PK-59,15953870,6.175335011158435
BT 239,11396600,1.7772646645104542
NCO2,135411,-0.0942193787788768
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
G-402,3825829,3.9134997529232978
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
Pfeiffer,136227331,3.814394552258677
NCI-H1793,9927531,3.368036257397712
SNU-119,12001922,1.855369676663499
SBC-5,10385095,2.1758850118167077
Ci-1,12001922,1.1912082026612816
T3M-10,54618771,0.7014662357085544
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
NCI-H2405,100016,6.531050125500204
HSC-2,11455910,0.978871234646886
KU-19-19,10385095,1.1563887024661463
Panc 05.04,10385095,2.321131550463211
MG-63,11396600,3.547749871707555
VMRC-RCW,54618771,0.4533300000402974
SW48,6505803,-3.5264924347891897
L3.3,2746,3.431089753490113
AML-193,387447,-4.453165066909558
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
NCI-H2405,24753719,3.770423795130907
Aska-SS,49836020,4.404663805549638
IGROV-1,10385095,1.0670946713416192
OV7,11455910,1.3702614621166394
SW1353,12001922,1.980156657035459
LP-1,15953870,3.7751814331512374
RPMI-8402,246676,4.500897758755647
KMRC-3,387447,-5.0655754349548445
NCI-H446,136227924,3.5012378178100487
MKN74,4705,5.009866699561135
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
BHY,24753719,4.126050347648706
KMRC-1,9926054,1.768451409600443
SUP-T11,3825829,3.0652515569380383
SW1990,15953870,4.463395728130823
CHP-212,15953870,3.2458137168318983
SW1463,387447,-4.88012723681038
EFO-21,100016,8.032262329904976
OE21,11396600,3.3249407167750284
WM1799,9926054,2.0873998071095685
639V,54649381,3.800461890991362
SF268,136227331,3.2043124531473945
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
KG-1-C,12001922,1.7212105846516743
Ki-JK,49836020,-3.31096865556518
SNU-1066,54649381,3.6137078459556062
PSN1,selumetinib-GDC-0941 (4-1 mol-mol),0.7617880642657375
Hs 683,54649381,3.1065100499344034
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
KYO-1,135411,1.2652988502628082
SW48,3825829,3.1303188593692854
SK-OV-3,12001922,2.3689117655248197
EPLC-272H,15953870,2.2299099931124813
SNU-886,2746,2.8162256970394295
KATO III,9887053,4.203512060933646
HCC44,54618771,-0.1525308444748626
HOP-92,9927531,4.8467416959319625
RPMI-7951,100016,4.945357769827656
Mel JuSo,24753719,4.834599240822851
G-292 clone A141B1,54649381,4.470441213738355
KMS-21-BM,135928012,3.3009158839837003
NCI-H2170,4705,1.2718117604923076
BT 112,9887053,4.183653051540166
VMRC-RCW,9926054,3.031512586509183
OCI-Ly19,49836020,4.441664761754026
KMS-34,9926054,1.6315221733896668
NCI-H1666,387447,-4.709594884501651
TE 617.T,135411,1.06145621929179
Kelly,54649381,3.675135028481117
FTC-133,135411,0.6572104898559208
NCI-H660,135928012,3.227296461505481
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
PSN1,54618771,1.0833304445253575
YD-38,6505803,-1.6031716801172209
SNU-1076,24753719,4.547023810572654
697,11167602,1.3401738421970035
Hs 888.Lu,9887053,4.784740565169466
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
T-47D,42642645,1.554581075718231
Kasumi-1,11455910,3.359505919978685
DMS 53,9926054,1.7188884438075969
HMCB,135423438,4.419625220654583
NCI-H647,2746,3.2477313608093143
RT-4,54618771,0.6660630053371256
DLD-1,15953870,3.351188075983659
SBC-5,54649381,4.189343649803657
HMCB,42642645,1.005103914323319
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
NCI-H2171,10385095,0.5588950968794439
MDA-MB-453,15953870,2.92470748098227
NCI-H508,selumetinib-GDC-0941 (4-1 mol-mol),1.363383946626654
COR-L51,24753719,4.364015816260333
Hs 940.T,2746,3.6289293164152614
CAL-27,3825829,3.991008099989648
HCC1419,11396600,4.111721753411411
RS4;11,11455910,-0.9811499604134568
KMRC-3,42642645,1.137265407173895
LP-1,136227924,2.2350423658008416
SF268,9926054,1.8343424406702535
SNU-407,54649381,3.599307229784025
BT 482,4705,3.30831403068686
LXF 289,11455910,1.909862916296106
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
OAW42,24753719,4.028981617914578
Reh,136227924,1.9009503552795357
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
Sq-1,54618771,1.1991492698184876
SCC-9,9926054,1.898935947612019
BT 164,selumetinib-GDC-0941 (4-1 mol-mol),1.5214027789841535
NB4,387447,-5.192825481591231
Hs 888.T,49836020,6.084092385452033
SK-LU-1,10385095,2.41706615965267
MDA-MB-157,2746,2.873003215594031
JHH-1,136227924,2.990976056622349
HCC1438,selumetinib-GDC-0941 (4-1 mol-mol),1.8999757097381424
A-204,49836020,-1.292663609986573
BCP-1,54618771,1.535577379039456
MOLT-3,11396600,3.214493659676048
CCF-STTG1,6505803,-1.8344087076537687
RCH-ACV,3825829,3.3036400241390287
NB1,3825829,3.910744698915021
A3/Kawakami,100016,3.999978023882096
COV644,12001922,1.3972533599068502
VMRC-LCD,100016,6.5149453048399515
SNU-626,54649381,3.859528019524815
SNU-601,24753719,4.305423273046676
SNU-1041,10385095,2.492918478264542
RVH-421,9926054,1.6904251361057423
MOLM-6,54649381,3.7299287975397015
LCLC-97TM1,11455910,0.6647050862050086
ESS-1,2746,2.6118901158900423
NCI-H441,54618771,2.015817613413058
OS-RC-2,54618771,2.9628716823736334
TE-14,3825829,4.1158266662634
P3HR-1,387447,-4.2266406198382755
T-47D,10385095,1.8124181388020704
NCI-H2030,9926054,2.071654789099982
BT 333,136227331,5.5959520749391904
EFO-27,136227924,3.515702384882397
RPMI-8226,100016,4.270983790022636
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
L-363,100016,4.553463106890726
A-549,15953870,4.749569227898693
YD-8,11167602,2.315498397427602
MeWo,44197249,4.2230235993521354
BL-41,42642645,2.244713688819507
MKN74,2746,3.2220393473660973
NU-DHL-1,54649381,3.9562595650424375
BT 139,9887053,5.710056569748746
RPMI-7951,9887053,3.65793605994431
HGC-27,3825829,2.9189466522382426
BT 422,3825829,6.185924859715056
HT115,12001922,1.502442073433963
OPM-2,10385095,0.6586756349946576
SR,9927531,3.5947665035551113
SCaBER,2746,3.471134652471349
NCI-H1623,135411,0.3784026464220375
OVK18,136227924,2.593591625928113
SF295,9926054,3.0771086967152845
SIG-M5,12001922,1.6775946264082653
AN3-CA,54618771,2.457771155909442
SNU-761,4705,2.9442474881607676
SNU-216,136227924,2.452598137182288
COLO 678,9926054,1.8882856749448629
MHH-CALL-3,10385095,1.4473660892521885
Rh30,3825829,3.769723551386186
SUP-HD1,11167602,5.788315638654396
JHH-2,6505803,0.8669908144871188
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
Detroit 562,246676,5.339776238455787
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
P12-Ichikawa,54618771,-0.5432908489240523
NCI-H1693,11167602,1.7330490995258525
G-401,4705,3.1032512954578415
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
NCI-H2291,100016,7.4079580735543695
WSU-DLCL2,3825829,3.050363233988625
NCI-H522,135411,0.5669945497970937
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
LoVo,387447,-3.727342469020989
Mel Ho,24753719,4.678102855184008
SJSA-1,11396600,3.615139997245977
MFE-296,4705,3.3548297681801387
NCI-H292,54618771,0.019803014891406
MHH-CALL-3,11455910,1.7272986441128235
NCI-H520,9927531,5.647411307076465
PK-45H,387447,-3.2312634208020747
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
NALM-6,42642645,-1.52736651717228
NCI-H1650,15953870,3.116155128935324
SK-MEL-5,15953870,5.041877344086934
NCI-H2029,9926054,1.852947583651784
BT 139,9926054,3.0317650629280717
DMS 79,135411,0.3477956916291458
IM95,6505803,-4.184612620621751
BL-70,135411,-0.0441330068408555
TE-6,42642645,0.8060773495098279
Panc 03.27,12001922,2.2812198135528408
CAL-85-1,136227924,2.9828253747888067
OCI-AML-3,42642645,-0.8981598919505451
LC-1/sq-SF,54618771,0.7298922583446973
L-428,9887053,4.103347956927703
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142
NCI-H841,6505803,-2.206212090567919
RCH-ACV,136227331,3.661348982396994
HCC38,6505803,-2.5112247246736787
JHUEM-3,2746,2.584117066729092
SW48,24753719,4.052743892866938
YD-38,54618771,0.1066197400708346
KMRC-3,24753719,5.2495549155565655
TE 617.T,11455910,0.3917461009813664
JURL-MK1,15953870,2.4801829647100044
C2BBe1,11455910,0.6579710467185694
RVH-421,54618771,0.9846410856532696
KMS-18,54649381,1.601061681315784
MFE-296,2746,4.362260792624359
ONCO-DG-1,100016,7.582922943410799
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
WT2-iPS,11455910,0.3504555455596581
NCI-H647,54618771,1.14773606602027
Detroit 562,12001922,1.5956797725265548
EFE-184,9887053,5.886886468048456
MDA-MB-453,24753719,4.38597739181452
MCF-7,9927531,5.854182634805009
CAL-27,24753719,4.134679985346333
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
CAL-54,4705,3.029255173670364
KMRC-20,24753719,4.050847735561683
Ki-JK,selumetinib-GDC-0941 (4-1 mol-mol),1.348149232454661
LNCaP clone FGC,11396600,3.414051330907707
PSN1,387447,-4.805653422102418
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
MDST8,15953870,3.886262261351445
Ri-1,2746,1.8815592761229076
MOLM-13,11167602,-1.7638454235436123
A3/Kawakami,135411,-0.5963643141606774
OCUM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2423134599079573
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
KMRC-1,42642645,1.142476115564406
KE-39,136227331,5.536038659908766
MOR/CPR,10385095,1.3001404643624
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
HeLa,9926054,1.7615972318293558
MFE-319,11167602,3.3061519307992944
NCI-H1693,selumetinib-GDC-0941 (4-1 mol-mol),1.7777896818074843
BT 248,3825829,4.117903271720201
SCC-4,54618771,3.088112117698249
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
Calu-1,3825829,5.5688615901889404
NCI-H1573,selumetinib-GDC-0941 (4-1 mol-mol),-0.038011367109904
CAL-62,136227924,2.2921842664772996
IGROV-1,11396600,3.99372654279783
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
NCI-H1694,15953870,3.457553869731663
YD-10B,9927531,6.486218545334236
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
HDLM-2,387447,-5.200166229864254
VMRC-LCD,387447,-3.363086673945957
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
HCC4006,135423438,4.2746750258396835
Ishikawa (Heraklio) 02 ER-,15953870,3.735200947814725
Ri-1,135928012,2.2309450357468994
KP-2,54618771,1.1956106328766414
JM-1,9887053,1.8224498727300744
HSC-3,6505803,-2.979370598270903
LUDLU-1,15953870,2.499580662756335
HCC1438,15953870,3.5793238385969532
MDA-MB-231,15953870,3.57416352699914
HuT 78,4705,4.420154035532244
A2058,12001922,1.186720138213994
KMRC-20,9926054,2.16526453404653
KE-97,42642645,-0.322611531923453
DMS 53,42642645,0.4730460915240638
NU-DUL-1,12001922,1.11986016292645
LOX-IMVI,6505803,-1.7860593354464098
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
Hs 940.T,9887053,4.308955620937453
EFO-27,11167602,3.5204241483481686
F-36P,49836020,5.768901368593018
HCT 8,24753719,4.305781458021924
SW1990,9927531,5.3345214594202695
NCI-H889,6505803,4.205027761053593
NCI-H2052,100016,6.8923960055757805
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
SK-N-MC,42642645,-0.897402388843346
U-118MG,9927531,5.792159501722103
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
SNU-878,11167602,2.6489023898698005
Tm87-16,12001922,1.5767227781070154
TT2609-C02,6505803,-2.0944052734627565
Hs 766T,54649381,3.8734670913778584
Hs 294T,9927531,5.24007707651297
KMS-20,12001922,1.070822318900554
ACC-MESO-1,54649381,3.866115711509678
Ci-1,9927531,4.406404304601132
HD-MY-Z,135411,-0.4374721649112024
NCI-H1155,54618771,1.281458310238897
NCI-H2023,54649381,4.104345830438444
HuP-T4,6505803,-1.7764683089441893
KP-N-YN,10385095,1.8219052928535877
TE-11,11396600,4.3576491196249565
YKG-1,6505803,-0.4747915631752394
OV56,6505803,0.8040031173297286
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
SF268,10385095,0.0686798865721721
HLF,387447,-4.583804186450182
LUDLU-1,9926054,1.8617120828735427
SK-N-AS,42642645,0.9617810876109002
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
G-361,11455910,0.6100431250643066
SK-N-MC,9887053,3.9832399807302217
NCI-H650,54618771,-0.8168884104410387
KMS-20,100016,6.235059528000449
SNU-878,9887053,4.136884274334722
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
AU565,135411,0.1136824900578053
KHM-1B,54649381,3.5405814758079117
SKM-1,6505803,-1.0817481083509812
K-562,49836020,4.414855158615189
SW948,4705,1.720002028261835
Hs 888.T,10385095,1.428283638903242
SET-2,136227924,2.6175155289445646
BT 444,4705,3.933248870863524
PSN1,135411,0.4042509940293521
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
COLO 684,42642645,1.5629352638756593
Hep-G2,6505803,-2.5933743398692894
NCI-H358,387447,-4.514213154556116
SNU-503,9926054,1.9244850158263864
DoHH2,42642645,-0.8103673293209743
SK-HEP-1,11396600,5.84824704867975
JIMT-1,6505803,0.7397672871240382
RL95-2,15953870,3.1356469262440148
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
HCC1195,9926054,3.439884423988142
HCC1438,4705,3.126117336231009
SCaBER,387447,-5.1235737119075075
SNU-478,387447,-5.153660559577127
Ci-1,11396600,2.9258292979253744
P31/FUJ,387447,-5.269499156732966
SNU-C1,6505803,-1.67895267377521
RD,24753719,4.598359093575622
TF-1,11167602,1.5429843870165718
MSTO-211H,9887053,4.1066593545259975
NCI-H2009,135411,0.2253946709705592
Kuramochi,15953870,3.8328114376827664
YAPC,12001922,1.7591466639310227
SNG-M,9887053,5.628777742661128
LUDLU-1,42642645,1.3015152577682023
IGROV-1,9926054,1.8111808945519428
A4/Fukuda,10385095,0.4549399411675465
HCC4006,12001922,1.795162857544078
MHH-CALL-4,387447,-5.003000237478102
OVCAR-8,6505803,-0.7401549831867192
HCC827,387447,-3.9033844503372865
BT 440,135423438,-0.018963982293905
A-204,11455910,-0.408799298050112
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
TE-5,136227924,2.0128832307516715
HT-144,2746,3.166634323430978
NCI-H1155,136227924,2.9905910988633653
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
KLE,136227924,3.154327848580928
UM-UC-3,6505803,-0.1078533908221657
MFE-319,9927531,5.194887870380863
PE/CA-PJ49,24753719,4.080575528970359
J82,10385095,1.0430089520475925
BT 224,24753719,4.793475637464062
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
LS513,387447,-4.61499304218378
639V,136227924,2.8924456476929605
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
BT 271,11167602,2.00091705558841
HCT 15,9926054,1.8634175733293992
A-673,3825829,3.830298825271896
NCI-H1793,12001922,1.909029487819767
RMG-I,135928012,4.918968495586244
SBC-5,387447,-4.42204631831661
KMBC-2,9927531,4.40438479738659
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
UM-UC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.98446738693651
NCI-H226,136227924,3.4351319272724585
HCC366,54649381,3.8727324583962344
NCI-H1793,selumetinib-GDC-0941 (4-1 mol-mol),1.778228229757508
Hep-G2,2746,2.5421699123058383
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
SNU-1076,135928012,4.595771044017897
FU-OV-1,6505803,0.8019489696335256
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
SKM-1,135411,-0.1897153244847568
Caov-3,12001922,1.7507998466798642
Mino,12001922,1.9054218463923691
COR-L88,100016,6.409850176158066
EoL-1,44197249,1.1153126681709968
P12-Ichikawa,9927531,3.8027198390435792
NB4,100016,6.294523599868374
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
8505C,54649381,3.737800661679275
SNB-75,11396600,3.7273557083084583
LN-229,11396600,3.892523581558088
BT 416,100016,4.165407662771479
OAW42,135423438,3.883711298971531
FTC-238,9926054,1.7889944253526169
MHH-ES-1,54618771,0.4734030568205798
Panc 03.27,9926054,1.7808185952102251
CCF-STTG1,54618771,4.049347271840678
SW620,54618771,1.1689155284524844
Granta-519,42642645,-0.7384711962533689
K-562,2746,2.4328857060914797
SUP-T1,135411,-0.5274545577034621
42-MG-BA,12001922,1.6222598543057754
KPL-1,11396600,3.5604078040671796
Karpas-299,11396600,2.5931923649102804
Panc 05.04,54618771,3.033977458741074
QGP-1,387447,-4.654222362311648
U-118MG,24753719,4.187893090926533
COLO 699,9887053,4.433814630767489
TE-10,3825829,3.696857823853888
NCI-H196,9926054,2.525003076989932
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
SET-2,9887053,1.5615374832251925
NCI-H322,54618771,1.4640514819881318
BICR 31,3825829,4.543850483279072
DU4475,12001922,1.131589361146838
SNU-410,11396600,6.23981949111421
HEC-251,24753719,3.820812144153033
JHH-6,11455910,3.965766048623887
SK-LU-1,54649381,4.2563598308568285
Detroit 562,15953870,2.8919275833068383
NB1,24753719,3.9501485382605535
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
TF-1,15953870,3.4880790035911655
MCAS,387447,-5.167136486263057
KP-2,3825829,4.902227254577184
GCT,135411,0.5820345989724034
DU145,24753719,4.348475848084312
TTC-709,11455910,-0.0853911997786654
CL-11,6505803,0.4915645691833006
ECC12,387447,-3.9402767819579534
WSU-DLCL2,15953870,1.982675391197866
TE-15,387447,-4.257900705403723
KMS-11,11167602,1.9167472278241215
SW948,136227924,2.9576701343794145
SNU-840,135423438,2.360395222844115
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
U-118MG,135411,0.8832868137735985
BV-173,15953870,2.7755500748031214
KYSE-140,12001922,1.7474021837860103
BT 286,9926054,2.06315076189255
5637,9926054,2.1895240062195396
BHY,135423438,4.398718869974742
OAW42,9926054,1.8927643653266228
KNS-60,6505803,0.337360479400098
HT-1080,9926054,1.8253134121716592
HCC366,10385095,2.3646693511925214
BT 172,135928012,3.7160166805444144
EB1,54618771,-0.3915386993254522
BC-3C,11396600,2.927390282149192
MEC-1,42642645,-0.0766715948288204
NCI-H1666,4705,1.0065866231900624
MHH-CALL-4,15953870,2.9134788493888735
SK-BR-3,136227924,2.8779705448471975
SJSA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9428552640575236
WM88,387447,-5.090155290607234
SW579,135423438,-1.0918455211139204
MEC-1,3825829,3.885455376804437
OVK18,11396600,3.420105685661315
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
NCI-H716,135423438,0.7002351169719838
BT 179,3825829,4.737915054305949
BT 145,9887053,3.989506256456816
NCI-H526,136227924,1.9152739000663332
NCI-H1703,54618771,1.8200920979055903
SK-N-AS,24753719,3.666987280744212
EJM,54618771,0.5366367501744294
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
RERF-LC-A1,54618771,2.031168626063029
HCC2935,11167602,3.9237673358003766
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
HPB-ALL,11396600,3.1053872858307225
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
U266B1,selumetinib-GDC-0941 (4-1 mol-mol),1.5301935614482745
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
MSTO-211H,11396600,3.2938939565791765
SBC-5,3825829,3.3495967392740953
COV644,246676,1.7961225471603073
NCI-H2452,135423438,1.816833708086427
JHOS-2,387447,-4.113326131895584
647V,42642645,1.2844201929185752
SW48,54618771,0.2213541125267267
HD-MY-Z,4705,3.2851682687360735
SEM,49836020,0.2207243584754971
OE21,54618771,-0.7908986466721764
BICR 22,10385095,0.7738978245677988
HT-29,15953870,3.733691211537793
MOLT-16,9887053,1.5048223634292213
LS513,54649381,3.8510027136584672
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
HCC1438,54649381,3.7823792587140295
KATO III,15953870,3.722068069848937
AsPC-1,136227924,3.2025742465891938
CAL-29,135411,0.64036151747723
LOX-IMVI,3825829,4.353482853449277
GB-1,15953870,3.655638735246604
SNU-478,100016,6.124719500368946
BT 147,136227924,1.9245142249128984
BT 440,10385095,1.3562224236695042
CAL-120,selumetinib-GDC-0941 (4-1 mol-mol),2.9364136017139932
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
JHOC-5,42642645,4.060158288928526
SR,387447,-5.647600146635853
HLF,136227924,2.390310427445978
SUP-HD1,6505803,-0.2605550921206995
ChaGo-K-1,54618771,2.4705381408155183
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
COLO 678,2746,3.5639277993349254
NCI-H358,9927531,4.779825407302033
SUIT-2,11396600,4.33113824085374
COLO 320,2746,2.553177448203693
KU-19-19,387447,-3.0100561484626738
NCI-H2106,selumetinib-GDC-0941 (4-1 mol-mol),2.731448809919849
DoHH2,9887053,1.714398983692226
TYK-nu,246676,5.58650577200375
Hs 578T,135411,1.812912718027184
EFO-21,42642645,1.7452456088120063
ONS-76,12001922,1.7268373273866384
KM12,42642645,-2.1903261970009047
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
FU-OV-1,15953870,3.743404981829692
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
ECC10,15953870,2.466320220342026
NCI-H460,54618771,1.6853262233131374
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
AU565,54649381,3.996593912741648
NCI-H2085,9926054,3.027383511126382
OCI-Ly10,12001922,2.8378587565085303
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
TE-5,2746,3.896227334745537
KE-39,42642645,1.367345124375733
SNU-182,selumetinib-GDC-0941 (4-1 mol-mol),-0.56211795944893
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155
MDST8,6505803,-0.0816923181525763
G-401,15953870,2.2768915791068483
SNU-308,10385095,3.412893840135653
NCI-H1944,42642645,1.1185854297530742
5637,3825829,3.117967559735808
M059K,42642645,1.0881273985372937
SK-N-AS,10385095,0.6911222834259994
ZR-75-30,24753719,4.255400986755656
TE-14,10385095,2.0741734466244424
CAL-78,135411,0.8850515882288977
Caov-3,11455910,2.963871199363813
SNU-878,10385095,2.873231871472218
CAL-148,387447,-3.0177715013942077
SK-CO-1,24753719,4.51149350773187
HuNS1,24753719,3.3564356231301997
TE-10,9887053,4.821041196756578
PE/CA-PJ49,11455910,0.6367427486190916
HOP-62,9927531,4.3195662996069855
OVCAR-8,246676,4.456779412413474
CML-T1,54649381,3.615747973120369
KO52,9926054,1.7676529122170044
RERF-LC-Ad2,6505803,1.9541445598040723
RS4;11,11396600,2.516092176764727
NCI-H526,3825829,3.586382874927845
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
BT 359,2746,3.6241977126009206
NCI-H1838,100016,6.459213557236613
CAL-120,12001922,2.506463216518753
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
8-MG-BA,387447,-4.07403283121393
8-MG-BA,10385095,0.96743723287677
786-O,135411,0.7105187604245919
G-401,24753719,3.1602445998928186
NCI-H1623,136227924,2.959018127447204
Li-7,selumetinib-GDC-0941 (4-1 mol-mol),0.6490035918823776
Rh18,11396600,3.2185471746223975
U-937,54618771,0.4735715356031699
MHH-CALL-3,135411,1.4084915797372148
KHM-1B,11396600,1.492899305921399
GaMG,11455910,1.9778197277547145
NUGC-3,9887053,3.9156704737457937
GCT,100016,6.941224948418202
NALM-6,387447,-4.92458906639725
Ku812,10385095,1.0609410330256543
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
Rh41,6505803,-0.6098068443145847
BT 330,4705,1.8638133419743137
U266B1,100016,6.458228016262307
L-428,3825829,3.2750243139678687
SUIT-2,54649381,3.849827051138413
RERF-LC-A1,9887053,6.112452950263811
NCI-H1838,54649381,4.101374573262838
F-36P,6505803,-0.1070428944453584
HCT 15,9887053,4.107913600626708
SNU-449,387447,-3.8386512960067862
HCC4006,9887053,4.1786544973697834
MDA-MB-361,9887053,4.825915726937945
Hs 766T,9926054,1.7033769922015074
KNS-62,54649381,5.597475827307652
Hep-G2,9926054,1.3870503906392218
MDA-MB-157,9887053,3.277628039368057
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
SNU-46,54618771,3.9719869663653578
M-07e,2746,0.8814107880911471
NCI-H1651,selumetinib-GDC-0941 (4-1 mol-mol),2.159962931758626
SCC-4,11167602,2.493488675880142
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
NCI-H1155,387447,-4.981289728469468
OVSAHO,54618771,1.1645898575055549
DLD-1,11167602,2.7796925101079015
SW1710,42642645,1.7958841216286026
Hs 766T,12001922,1.6647134525244718
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
PLC/PRF/5,387447,-4.9533047793677145
JHUEM-3,11455910,0.589239225317042
MOLM-13,12001922,1.648284949914827
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
MOR/CPR,3825829,3.5070269686753295
NCI-H520,9887053,3.988492309043506
SK-HEP-1,15953870,5.227718988850451
KG-1-C,54649381,4.445020655449275
LOX-IMVI,387447,-3.914151602497852
SK-MEL-31,12001922,1.726443521834175
SNU-C5,9887053,4.898326937250418
SNU-216,100016,6.2010021575017085
L-428,135411,0.2810085573848619
PK-59,387447,-2.937224287200573
Ku812,135411,-0.2793980307615341
NCI-H1105,24753719,4.604645555885144
HCC1588,136227924,2.6333776491111585
COR-L105,387447,-4.5302496546864885
NCI-H1651,387447,-4.217126593199173
SNU-387,9926054,2.4528482629879655
SNU-668,9927531,6.94205854979306
SCC-4,42642645,1.2826749861631914
IGROV-1,135423438,0.764137689665023
SNU-16,100016,4.136425652163891
HEC-151,54649381,3.9974164574496824
Hs 683,24753719,4.249788601430605
NCI-H1944,2746,3.2082243372495354
NCI-H2405,42642645,1.2133151516298384
Pfeiffer,9926054,1.762205807051045
NCI-H522,54618771,1.252244709003548
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
BT-16,9926054,1.298876500503981
Sq-1,387447,-4.126122878848654
LS1034,9927531,5.052618610074112
MOLT-16,10385095,0.8199182110324024
OCI-Ly19,3825829,3.891484386811787
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
RPMI-8402,136227924,2.2526718879349694
HEC-265,100016,5.251492285111922
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
KMS-28BM,42642645,0.4810562236071797
COLO 792,15953870,2.985446840863719
CAL-29,12001922,1.8514601411629812
TE-4,12001922,2.092024675643085
GSS,6505803,-2.9961696629002956
MFE-319,54618771,1.5027851162197383
HuT 78,6505803,-1.3012174270497974
MOLT-16,15953870,2.7657988560466475
NCI-H2081,9887053,1.079075391336974
A-549,42642645,0.883993697279782
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
IGROV-1,387447,-3.9508602289798658
CAMA-1,24753719,4.725261490673885
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
NCI-H650,9887053,5.265762404515491
OVTOKO,15953870,3.670477375403871
MM1.S,12001922,1.2922454576478266
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
BT 422,136227331,4.344086098247262
OV56,11455910,2.728140912842352
253J,BRD-K16130065,4.180822895879859
MFE-296,9887053,2.859474662915646
A-172,2746,3.137938137682863
M059K,2746,3.2617211369125383
Detroit 562,100016,6.391000104824681
GB-1,9927531,4.312258679101311
KP-N-SI9s,100016,6.171993249574907
KYO-1,15953870,3.0541623789170043
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
HPB-ALL,136227924,2.35435467065409
NCI-H358,10385095,1.945629004610518
HCC4006,136227331,3.713774396347732
SNU-1033,135411,1.2023812389363322
DMS 273,54618771,0.8675837195237585
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
SNU-626,135411,0.9155402165079763
M-07e,9926054,1.1111810240373077
TUHR14TKB,135411,5.562092297196421
COLO 800,9926054,1.9844303127825855
NCI-H1734,54649381,3.101900971486818
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
TC-71,11396600,3.405164109661843
YD-10B,10385095,1.1055417407476955
SNU-182,135423438,0.1698643444011356
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
SEM,12001922,1.121071645665963
DMS 454,136227331,4.3527556098556275
GDM-1,10385095,1.3683176527917005
KNS-62,135411,1.9141681745352888
MOLP-2,9927531,5.358514182418203
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
22Rv1,42642645,0.9570274094225678
SW1783,9926054,2.85460969526429
JJN-3,11455910,0.8680436077837121
NUGC-4,100016,6.130178573368833
VMRC-RCZ,136227331,4.757387304339598
PaTu 8988t,135411,1.3050507330755643
MKN7,42642645,1.6270425394973294
MCF-7,136227924,2.325387172028071
HCC95,54618771,0.2896337021071054
Kelly,11396600,2.808288398090548
LCLC-97TM1,136227331,4.3740550996774745
SNU-423,54618771,0.8845738276291084
SU-DHL-10,10385095,0.7045701508639168
KP-N-SI9s,9926054,1.6199423536774489
TE-5,9887053,1.9044110594435215
Hep 3B2.1-7,387447,-4.1626491950883056
NCI-H508,42642645,1.2364811484710792
KYSE-510,9887053,4.757989021138123
OVSAHO,10385095,1.067864313486602
JIMT-1,9926054,3.6367846725262543
HH [Human lymphoma],6505803,-0.1440406835782353
SK-MEL-3,4705,2.152547921158096
SU-DHL-1,9927531,2.969590320438058
CCF-STTG1,9926054,1.9394922490252933
JVM-2,11455910,0.2677947916943763
AsPC-1,3825829,4.335500071907528
NCI-H2110,24753719,4.19042786016423
SNU-16,3825829,1.900115467014968
NCI-H292,135411,0.5538002090667975
OC 314,54649381,3.896975669662466
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
AsPC-1,136227924,3.2025742465891938
HT115,54618771,0.5275869701844733
KMRC-20,11396600,4.3348303945761835
M-07e,9927531,3.229988201288456
HCC2935,12001922,1.5756153207800547
OE33,42642645,0.9705663776809944
SF268,387447,-4.545774138199886
MOLM-13,44494015,-5.247330257185634
SCC-9,11455910,1.869884665357408
NOMO-1,54618771,-0.7336388686704796
SW579,9887053,4.045410712586741
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
SEM,9927531,4.847523560791686
A101D,54618771,1.2420685416826056
FTC-133,246676,4.92384525208296
MOLP-8,135928012,3.056644501758044
MFE-296,3825829,3.8780983849113304
BT 131,6505803,-1.6388820093496137
NCI-H2452,12001922,2.2907278374018296
NUGC-3,387447,-2.9848094100296283
CL-11,9926054,1.919128241871703
WM266-4,4705,3.3453038415665652
TE-8,11396600,3.483213709023348
KNS-42,9926054,3.077818601925372
MeWo,42642645,1.0047850984942823
TOV-112D,24753719,4.1939686401691265
CMK,54618771,0.9710170961013548
BT 232,11455910,0.0350412788633053
NCI-H2122,9926054,1.7352659466482192
CAL-27,4705,0.9855510405669268
Daudi,54618771,-0.114332288085178
SNU-16,11396600,2.12862636556111
NCI-H1793,9926054,5.214680491004607
Hs 578Bst,11396600,3.7098372009722262
Hs 688(A).T,selumetinib-GDC-0941 (4-1 mol-mol),3.4396417778201305
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
BT 239,11455910,0.8577205226551546
TOV-112D,11455910,-0.1683002015136989
NCI-H661,24753719,3.905315348750775
MFE-296,11455910,1.116173433967265
Hs 688(A).T,10385095,3.663662193175485
8505C,54618771,0.8247832120162748
A2780,136227924,2.141563547945887
Pfeiffer,24753719,3.8974563263323145
JHUEM-3,54618771,0.1338872502491787
MHH-NB-11,9887053,1.9249549417896823
HEY A8,3825829,4.289610893469285
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
JHH-2,4705,4.1476073277063445
Raji,9887053,4.170344123457071
HL-60,11455910,0.6593265039247426
NCI-H1105,selumetinib-GDC-0941 (4-1 mol-mol),2.7215813635503165
NCI-H2196,4705,3.044507714028595
EC-GI-10,15953870,4.126898467797981
PE/CA-PJ41 (clone D2),6505803,-0.4507500369158054
CHP-212,135423438,1.6303147778889178
Caki-1,246676,5.885712898696045
Hs 944.T,12001922,2.487929903867702
NCI-H1693,10385095,0.8246403113712971
SW1783,135411,2.3314592986122453
NCI-H510A,9927531,4.438228286684184
Lu-99,6505803,-2.9740342250772644
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
SU-DHL-8,6505803,-0.9881094595359692
HCC202,6505803,-1.9707463625548352
KMS-27,100016,3.811410813700335
CAL-62,6505803,1.4700941326099095
TE 617.T,6505803,-2.094273905964543
ZR-75-1,selumetinib-GDC-0941 (4-1 mol-mol),1.5981380020167046
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
HPAF-II,selumetinib-GDC-0941 (4-1 mol-mol),0.3156523393039555
CAL-51,136227924,2.079284078064279
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
SW1990,42642645,0.6858937551923172
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
OVISE,11396600,4.241731433198166
SNU-182,135411,0.9565637759009532
LOU-NH91,10385095,0.9698085069900604
SNU-182,10385095,1.0621508368080206
OCI-M1,10385095,0.871946369037786
TALL-1 [Human adult T-ALL],9926054,2.0252828062199257
MOTN-1,136227924,2.565430053126423
Tm87-16,49836020,-0.9947449056575012
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
TE-5,54618771,0.4798060513951584
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
BT-474,11455910,3.140407546934709
SNU-C5,54618771,0.8135546853425193
FaDu,6505803,-3.622954111449815
Hs 766T,387447,-4.257954012390404
OE19,387447,-3.827318756298702
Kelly,9887053,3.8225633523423426
DV-90,54618771,-0.717052278919437
OE33,54618771,0.6463967742027482
SNU-1077,12001922,2.14758213265239
HL-60,12001922,1.7224011403350483
KMS-27,54649381,3.6361143349419898
COR-L51,9926054,1.8572799108466955
HOP-92,11167602,2.8847454841740108
SNU-869,11455910,2.0379647800047813
ST486,135411,0.6201857418977628
SEM,4705,3.2789499070594816
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
OCI-M1,2746,2.0288899582402165
JHH-2,9927531,4.777538001331337
HCC2218,15953870,3.7305294656594623
NCI-H841,11455910,0.3569598695245802
SNU-685,9887053,4.451899337752592
PK-1,2746,4.301846105037093
HOS,15953870,4.017312311631895
SNU-1079,54618771,-1.146333378136814
HMCB,10385095,1.0131649772543003
BT 320,12001922,1.695610420399754
T24,10385095,0.9393437218263464
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
NCI-H1563,9927531,5.123884061924823
LCLC-97TM1,3825829,3.858617243526108
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
IGROV-1,42642645,0.3750175292659389
A2780,15953870,2.2934332620703457
AsPC-1,24753719,4.618559637878285
MEC-1,24753719,1.7642423252934831
TE-4,42642645,1.2583585475114674
HPB-ALL,42642645,0.7461764164223841
A2780,6505803,-1.803583295606165
A-204,11167602,-0.3115044738293965
HCC1588,24753719,3.2489503799535653
TUHR10TKB,136227331,3.9944328984652975
NCI-H838,135411,0.463513067046211
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
HuG1-N,11396600,3.640105128263337
Hs 936.T,135411,1.402977023446485
EBC-1,2746,2.5031802936730547
JVM-3,42642645,-0.6920767696882663
PK-1,6505803,-1.4956454507755823
KP-N-YN,15953870,1.7539818153514606
U-118MG,387447,-4.441850957306721
SIG-M5,2746,2.071797250841479
KP-4,387447,-4.423356409037355
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
HuH-1,387447,-3.398386483449346
MDA-MB-453,54649381,4.094182376460235
MOLP-2,73707440,4.42380771173
MKN7,24753719,4.312074399865491
RPMI-8402,54618771,-0.5360819718373795
IGROV-1,387447,-3.9508602289798658
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
Lu-65,42642645,0.9193657310014032
NCI-H1650,4705,4.261347716805476
PE/CA-PJ15,135411,0.500300489214103
SK-MEL-28,12001922,1.76503761159643
NCI-H2170,11455910,0.541639462195205
A-375,12001922,1.740140875939179
Rh18,54649381,3.810185302457492
EC-GI-10,6505803,0.7736206761478788
KYSE-140,135411,0.5977785665444979
HEC-265,54649381,3.709530634780814
WM266-4,9926054,1.9241350180859695
HDLM-2,136227924,3.1256787357030937
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
COLO 792,6505803,-2.4277417436087294
MDST8,10385095,1.2575537617816142
BT-16,3825829,3.95247016752169
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
TE 617.T,11167602,1.5922008252868003
SNU-719,12001922,1.3802679998627916
DND-41,15953870,1.7918574472508406
OE21,100016,6.577886119924336
HEC-1-B,136227924,3.6469104939920154
MOLT-3,49836020,4.359982480668932
JHUEM-7,9887053,4.4427477773471145
F-36P,42642645,0.6290792205748662
TM-31,42642645,1.4015294031884458
PK-59,9926054,1.7891376671835462
NCI-H1734,24753719,3.5136564159683092
HCC1588,387447,-4.599871608893709
JMSU-1,54649381,3.541592216317379
Calu-6,11455910,2.638834676965617
KMRC-3,10385095,1.720120305356793
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
CJM [Human melanoma],11167602,4.1800221593609415
LS513,9926054,1.5640640769912204
SNU-478,136227924,2.019778672481118
KMRC-2,2746,4.010185211314044
KMS-21-BM,12001922,1.228508044183715
TYK-nu,54649381,3.944136939252442
JHOC-5,54649381,3.8738786302787207
NCI-H209,42642645,-0.6980833637264824
HT-144,9926054,1.741901669011513
697,3825829,1.9181713017184043
BICR 16,9926054,1.5790536370066437
FaDu,11455910,0.0548486967941132
Namalwa,15953870,2.955206613456957
MES-SA,1474550,4.456267363828356
NCI-H841,54618771,1.7073628985349325
COLO 678,9927531,4.922936078042476
NALM-6,3825829,2.8788217125669098
HCT 116,selumetinib-GDC-0941 (4-1 mol-mol),2.1704161349367506
NCC-StC-K140,387447,-5.096585910130737
NCI-H2110,136227924,4.625762146403413
KMS-21-BM,136227924,2.0166655260293487
BT-12,136227924,2.3126118312621404
NCI-H1651,12001922,2.451603657914699
CAL-51,9877608,5.917079709597661
NCI-H1339,10385095,0.8150638105924319
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
TE-5,100016,6.463093527046919
MFE-319,24753719,4.037071783419627
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
VCaP,135423438,2.0671137172311305
NCI-H211,54649381,3.6427990077539114
Aska-SS,15953870,4.084404755513187
EoL-1,135928012,1.9970775215699643
F-36P,136227924,2.476842028434826
HEC-1-A,136227924,3.4085098693584603
SNU-61,136227924,2.341371828887226
G-292 clone A141B1,4705,3.730177058269135
COLO 684,9927531,4.094715698749933
8505C,136227924,3.0385484032115215
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
SNU-1079,11167602,4.298137640910785
JHUEM-2,246676,4.384067932362518
Lu-99,10385095,0.9808054093296624
Calu-3,9887053,3.752154569977795
HT-1197,135411,2.585993011625538
NCI-H2081,54618771,1.045855982244366
L-363,6505803,-2.0442344992040837
Panc 03.27,49836020,2.722888568283256
A2780,3825829,2.5427924978442467
Hs 746.T,10385095,0.9219781932462268
SaOS-2,12001922,2.1147367002170494
SJSA-1,6505803,0.5726906025627778
SNU-C4,9926054,1.7359691760271532
YH-13,9926054,1.834128888426512
H-STS,135411,0.6360583946211977
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
KP-2,24753719,4.333444273795511
IGR-39,3825829,4.436221317871402
TUHR14TKB,11455910,2.317206369851234
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
HDLM-2,54618771,0.2228052898730796
TE 441.T,9927531,5.546705362793043
Yamato-SS,3825829,4.4362543849943386
TE-9,6505803,-0.9474092806204982
CGTH-W-1,24753719,4.548095547879149
DBTRG-05MG,10385095,1.8263505725845104
CAMA-1,246676,1.5036012634543992
OVTOKO,selumetinib-GDC-0941 (4-1 mol-mol),2.323282098150216
BT 416,4705,1.1449833696295684
BT 440,100016,6.480442369798277
MOR/CPR,135411,0.2954116440661934
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
SNU-423,42642645,1.572075409923546
SK-N-DZ,9927531,3.3336857807362392
KNS-62,136227924,3.1878911405001236
COV362,9926054,1.902525685415388
KMS-12-BM,100016,3.5545657198194873
K029AX,1474550,4.799069569373645
BT-16,135411,1.0884775858358793
UO-31,10385095,0.6553455151296144
UO-31,11167602,1.0241794251111431
PK-59,11455910,1.1021180024981292
CHP-212,100016,6.525746829388361
OAW28,11396600,3.5740319462685535
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
RMG-I,3825829,4.5159653646465
KMH-2,100016,3.8705403745512017
TE-14,4705,1.5857323028822543
RPMI-7951,15953870,2.308533676595083
OCI-Ly10,49836020,3.5902164250425503
MDA-MB-468,selumetinib-GDC-0941 (4-1 mol-mol),2.2484170521033437
DND-41,49836020,1.1250375058635431
HEC-59,11455910,1.03172730185298
Hs 822.T,42642645,1.3634528576845386
KYSE-410,135423438,1.615361831673466
NCI-N87,387447,-5.408237770865747
LUDLU-1,136227331,4.9346482061859875
SNU-119,54649381,3.4431248050255636
Hs 895.T,15953870,6.142432886345069
AN3-CA,2746,4.007834108220286
NALM-6,54649381,2.5978988949513755
LS1034,12001922,1.270152916891487
LN-18,9927531,5.697950654725697
RCC10RGB,11167602,3.5267453541831695
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
T3M-10,387447,-4.202484944995307
NCI-H292,42642645,0.8145779285410705
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
T84,387447,-4.62773918346918
HEC-251,387447,-4.620878411620167
BT 145,selumetinib-GDC-0941 (4-1 mol-mol),0.1649490649734122
MDA-MB-231,10385095,1.360021419508986
OVCAR-8,selumetinib-GDC-0941 (4-1 mol-mol),3.698487260127977
NCI-H1666,54649381,4.013134936588192
FTC-133,2746,3.487652314498242
NOMO-1,136227331,3.913043208951298
SNU-601,54649381,3.789984807471819
LS513,42642645,0.4754964526295666
SW1710,11396600,4.154390829572998
NCI-H520,9927531,5.647411307076465
NOMO-1,10385095,1.0593467546243338
KATO III,10385095,1.4582736988543066
UACC-62,11396600,2.1673340141549886
WSU-DLCL2,24753719,3.632100272535821
TTC-709,3825829,4.017884696288738
EKVX,42642645,0.8481237259878417
BT-12,12001922,2.3224284461489395
COLO 680N,54618771,3.898900204814355
NCI-H716,136227924,3.096712149885638
IGR-39,136227924,2.6355333557661167
SH-4,387447,-5.078249181251653
BT 271,42642645,0.5365941533997074
Ci-1,54618771,0.8239917117342518
SW1353,135928012,3.769648949542413
LS180,10385095,1.937933801431244
647V,49836020,-1.4541135312501283
HCC1428,2746,2.7120939724972444
NCI-H460,15953870,5.00315267734786
DV-90,15953870,2.2434234211534063
BT 159,135411,3.005851333343464
NCI-H1155,246676,5.962550205332117
LP-1,42642645,0.4780260401875633
CJM [Human melanoma],6505803,0.8455714648191155
DU4475,135411,0.3729257477431006
JHUEM-2,10385095,1.0298503293450711
JHOC-5,9926054,1.8776072884950488
HCC1833,15953870,3.819356802324763
SNG-M,11455910,-0.2567139520485192
HOS,4705,3.554341392933483
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
NH-6,6505803,1.7515572770987142
SW1271,6505803,0.8186340021888412
HCC2218,9927531,0.7764965952119703
CAL-51,4705,2.903463840875761
KP-2,4705,3.822790950107379
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
TE-8,9927531,4.6696791278322625
SU-DHL-1,135928012,2.7237506411412427
EB1,135423438,1.4973113179323292
CA46,11455910,-0.2967360934235351
NCI-H2126,selumetinib-GDC-0941 (4-1 mol-mol),2.896687453534691
A101D,2746,3.2076862054046877
DEL,11455910,-0.2144903394891009
PC-3,3825829,4.265576621901599
BICR 6,11396600,3.532608369106794
OAW42,100016,6.607597097790758
SNU-407,3825829,3.6953347896705018
SF268,15953870,2.91526819045527
DAN-G,387447,-4.716826651858295
YD-15,100016,6.01418803247364
SNU-886,15953870,3.508651864027871
HT-1080,54618771,1.2813621768338197
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
NCI-H441,10385095,1.8039460773304927
UO-31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0895128254081629
SK-UT-1,387447,-4.561746078529997
HCC38,9887053,4.311133990466573
Karpas-422,135411,0.9481856703320688
JIMT-1,54618771,0.8201229283888136
NCO2,6505803,-0.6279815858005762
SNU-387,9927531,5.201038765097566
Toledo,15953870,3.8490087943820153
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
KNS-62,selumetinib-GDC-0941 (4-1 mol-mol),0.6177155702395645
SNB-75,12001922,1.6941643210659978
NCI-H841,selumetinib-GDC-0941 (4-1 mol-mol),1.7546401329299928
KYSE-450,24753719,4.912608563377894
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
PaTu 8902,42642645,2.254917267204718
HL-60,11396600,3.4352516220498215
CCF-STTG1,4705,3.7462462996550534
KM12,11396600,3.711398908201269
NCI-H1666,100016,7.086863626956854
UACC-257,54618771,0.929112305561946
MDA-MB-157,54618771,3.1146330047846877
SNU-761,11455910,-0.2070657020305296
BICR 6,15953870,3.8791129935832105
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
SNU-685,2746,3.0176644885418056
KYO-1,136227331,5.147481927043426
SK-N-FI,12001922,1.039022687514272
PF-382,24753719,2.156979591404902
SNU-201,9926054,3.435558365800804
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937
HCC2935,54618771,0.7337310107674532
MV4-11,100016,3.584878230644963
NCI-H2106,6505803,-2.4996848836853176
RPMI-6666,49836020,4.712616665171358
NCI-H1184,12001922,1.2105425311897628
QGP-1,15953870,3.7113072323773215
KYSE-70,3825829,3.6022414485207452
BICR 18,136227924,3.2249717702756486
BT 416,54649381,4.305934242917029
BICR 31,2746,4.041774334142006
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
Namalwa,2746,1.3872498592399898
HCC2935,387447,-4.47223994721058
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
KMS-34,4705,2.7646110447825647
HCC4006,11455910,0.2919573550060502
KYM-1,10385095,1.1469809702882436
SNU-886,24753719,3.844666745133929
NCI-H1373,11396600,3.5940766248042495
SET-2,2746,0.8916395455775363
DB,2746,2.552003566153149
A2058,selumetinib-GDC-0941 (4-1 mol-mol),0.6721412852797596
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
SNU-1077,246676,5.4377451130468435
L-540,3825829,2.5088900528466276
BFTC-909,11167602,2.8757137848929006
SNU-308,9926054,1.9749915644839853
Tm87-16,15953870,4.170797887331466
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
KYSE-450,11455910,0.6287655004796859
VMRC-LCD,135411,0.8215868838845786
C2BBe1,136227924,2.0906474270390656
HT-1376,2746,3.1690827101181736
UO-31,12001922,1.347761210452065
IGR-1,10385095,0.5872322378486591
Hs 822.T,24753719,4.3035414740623175
JHH-2,10385095,3.4516856743936866
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
TTC-709,42642645,-0.8563424771463005
NCI-H647,136227924,2.9483035397305164
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
DU4475,9926054,1.608890542810364
BT 248,54618771,0.8718785044821341
F-36P,4705,3.5916410235221914
OCI-Ly10,6505803,-1.8295734917413131
NCI-H2081,9926054,1.7325996665522785
NCI-H841,135411,2.040579244401937
SW948,11455910,0.6774609071475187
LS123,9926054,2.1967740903619934
Ki-JK,54649381,3.07886798337774
HEC-265,54618771,0.9168316740799288
A3/Kawakami,135423438,3.073341155380334
KMS-18,selumetinib-GDC-0941 (4-1 mol-mol),2.1372948898179462
HPAC,6505803,-1.845067175670312
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
OCI-AML-3,9927531,5.116735976562035
NMC-G1,9887053,4.251932400181619
JHH-4,24753719,4.1634800672109
SR,9887053,3.8022269814123897
WM115,10385095,0.3137764342063494
CAL-33,11396600,3.937699926815987
KHM-1B,9926054,1.3720275885206477
NCI-H1650,9926054,2.506807917571585
SNU-5,9887053,3.851795874872679
MCF-7,9926054,1.7310317924725227
22Rv1,246676,2.324287060158596
HPB-ALL,135411,0.2834820212610211
BT 271,9887053,1.773788162506692
JHUEM-7,54618771,2.242796216513649
TC-71,11455910,0.3179864486303165
Kelly,24753719,3.0223005039038213
SK-BR-3,15953870,2.675794235884171
RD,12001922,1.5093657959670652
J82,42642645,0.9682340642698132
Mono-Mac-1,42642645,-3.779947759429327
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
BHY,9926054,1.5277493877995152
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
ONCO-DG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.679099331983427
LUDLU-1,135928012,3.746067589786416
Karpas-299,9887053,3.87802464159633
MDA-MB-231,3825829,4.38601405631558
KMS-21-BM,11396600,-4.473822501630397
SNU-C1,10385095,1.2964940411522758
Reh,387447,-5.186409218900029
SUP-B15,24753719,3.508993666231369
L3.3,387447,-2.8513357804813553
YAPC,9887053,4.707664045043398
T-47D,selumetinib-GDC-0941 (4-1 mol-mol),3.2531063352612697
CAL-12T,6505803,0.5711509755258141
SK-MEL-30,387447,-3.0048080700008652
NCI-H1155,3825829,2.76644844422124
KYM-1,100016,6.934049900113359
786-O,42642645,1.60546841861654
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
BT 482,2746,5.533000175403538
GaMG,15953870,5.298249892931744
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
MPP 89,135928012,5.580608070348792
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
SNU-899,11396600,4.052340052261649
SK-MEL-5,135411,0.7753321282520284
SK-LMS-1,2746,4.054624823156548
TT,3825829,3.422506408557165
EB1,135928012,4.675406076244616
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
OVCAR-4,42642645,1.662574887747125
LN-229,selumetinib-GDC-0941 (4-1 mol-mol),1.343707265826647
JL-1,136227924,2.288232757655929
KALS-1,12001922,2.543795195369394
KNS-60,selumetinib-GDC-0941 (4-1 mol-mol),3.6071015552128873
JMSU-1,136227924,3.0914793862161747
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
NU-DUL-1,24753719,2.364592509391835
TE-5,3825829,4.035326307550199
OCI-M1,9887053,4.165081662028765
MV4-11,6505803,-4.621529690475533
TM-31,24753719,3.823866411765544
RS4;11,387447,-6.035204694133913
MDA-MB-468,42642645,0.7385012772526104
OE33,136227924,2.987067512543954
MOLT-3,15953870,3.4506694125982507
SNU-C2A,42642645,0.6667239374307586
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
TOV-112D,135411,0.0535331732396644
COLO 829,11455910,1.5093587467864735
KYSE-150,54649381,3.933212474608364
KMM-1,12001922,3.486102815406781
LS411N,54618771,1.0517408544895162
SK-MEL-2,12001922,1.5880296179795197
BT 245,246676,4.341306530425761
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
ONS-76,10385095,1.1655527010487017
ZR-75-30,3825829,4.339303276674152
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
KMS-18,11455910,-0.1916352786292855
CHP-126,42642645,-0.1140311691110747
RD,246676,6.440301876830501
SW1116,42642645,0.6467991915782154
A2058,136227924,2.613575897416718
SNU-119,15953870,2.479349019849552
SK-MEL-30,10385095,2.651721039374687
HuH-28,135411,1.2887103853728936
SNU-869,9926054,1.9894355639340104
Mono-Mac-1,136227331,4.247854438913471
KYSE-410,3825829,3.948132670947577
647V,2746,2.8879721375680214
DMS 454,selumetinib-GDC-0941 (4-1 mol-mol),0.8231378505894382
8505C,3825829,3.612321028126496
HCC1937,54649381,3.7499578403334697
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
AN3-CA,42642645,-0.9169147434440384
LK-2,42642645,1.2949651539095814
L-540,42642645,0.5354939909338379
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
COLO 320,15953870,3.6185551767903217
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
TC-71,24753719,4.206568050184285
MDA-MB-453,10385095,0.8735195901829151
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
MeWo,135411,0.5311387868220993
SUP-B15,49836020,5.289684304949365
GCT,11455910,0.2932583767108606
KMS-18,10385095,1.016735810068119
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
AML-193,9927531,3.384669993922374
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
Lu-65,11167602,5.906692389190635
PC-3,136227331,4.235931729378205
LS1034,11455910,0.6573376137938117
A-549,54618771,0.0374822867627876
MKN74,387447,-3.1334283259497067
CL-11,136227924,2.4405671689998027
MOLM-16,9887053,4.925358695937147
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
SR,11455910,-0.2292707717843843
NCI-H1568,4705,2.022283964907955
CGTH-W-1,6505803,-0.523636813552918
NCI-H1395,11396600,4.124168749082167
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
TUHR4TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.368524394039708
NCI-H2122,387447,-3.461359838367798
KMRC-1,387447,-4.945508167403058
KE-97,12001922,1.6686384685596831
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
KU-19-19,136227924,3.1447471190609217
SK-MM-2,2746,0.987120657113426
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
COLO 829,24753719,4.2760116652127484
SNU-685,12001922,2.111628386314526
KG-1-C,387447,-3.7385331211233814
Peer,42642645,-1.753928980443725
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
EFE-184,135423438,1.8647999692760415
Karpas-422,9887053,3.894192278074615
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
SNU-16,4705,2.028758835255635
AGS,54618771,0.8602025015707093
SK-LMS-1,9926054,2.9005897081408833
KATO III,11167602,2.032256481829287
OV7,9926054,1.9278544510999935
JURL-MK1,9927531,3.9851065784934945
AsPC-1,3825829,4.335500071907528
A3/Kawakami,9926054,1.6582602288279693
LS513,9927531,6.189167828595346
SNU-869,10385095,2.393805938113789
HT-144,3825829,4.172611648517566
SW579,49836020,3.73786460957764
Hs 683,1474550,4.474380523645793
CA46,3825829,3.8503527939376583
KMRC-2,387447,-4.643727787787694
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
SNU-201,387447,-3.8008865458092704
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
SYO-1,11396600,4.152528244885972
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
MKN1,54649381,3.7289863950529183
SK-ES-1,42642645,-1.0856176696515418
K-562,11396600,3.7562155275673415
HT115,9927531,5.770411786358663
SK-MEL-1,11455910,2.3970626759922418
KMBC-2,9926054,2.0094384239747294
G-292 clone A141B1,42642645,0.5756128447375837
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
HCC1954,11396600,4.077392960060392
TCCSUP,9887053,4.648275902812988
Peer,135928012,2.9370952209387493
T24,6505803,1.3138000670292382
HCT 15,11167602,1.5955189866784438
Granta-519,136227924,1.3333863896282263
COV434,11455910,1.492860778557748
Kasumi-1,135423438,-3.561696471128374
8505C,6505803,0.879841655503536
YH-13,387447,-4.910282103327875
Rh41,44487330,3.7374076612716647
A-549,11455910,0.2975953497649719
SK-N-FI,387447,-4.810371690465329
SW1353,24753719,5.958124958528096
HPAF-II,387447,-4.322714280662329
HT-144,100016,6.638904024373049
NCI-H2009,3825829,4.333180881174198
KALS-1,9926054,2.3431755062482487
Calu-3,135423438,2.2441987111134254
JHH-4,54618771,-0.357256318884579
SNU-449,4705,3.898593282840832
5637,6505803,-0.9891177489911248
HuH-1,10385095,3.172607785650955
HDLM-2,6505803,-0.3959336559510797
JM-1,15953870,2.1778700018066144
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
MFE-296,11396600,3.78613722040272
SNU-216,11167602,2.868305973285908
G-401,2746,2.560873344661061
KYSE-140,24753719,4.654807821882373
HCC1833,49836020,-1.119955366422227
OCI-M1,9927531,4.777784518044042
NCI-H28,11396600,3.4580715977014185
TT,24753719,4.601878873576192
HCT 15,2746,3.234164073098613
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
LS123,11455910,1.1940798457620236
EHEB,10385095,1.253390881214325
NB4,54618771,-1.2377399281525494
JHUEM-1,9926054,1.7870789981263362
PL-21,11396600,2.4757103369664084
LOU-NH91,42642645,0.5799169530603235
KMS-11,3825829,3.133557788363501
Hs 895.T,54618771,2.243323536930484
L-540,10385095,1.0338327990377625
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
U-118MG,54618771,1.5788983669789174
DB,10385095,0.676257442329155
NCI-H647,4705,2.403903221755703
SW1271,11167602,2.369450835450289
MOLT-3,54618771,-0.579298933394039
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
Kasumi-2,3825829,3.3479634665685167
LS411N,54649381,4.0879656113234315
SH-4,100016,6.480724052638794
A-204,2746,2.3964881328568315
OE21,42642645,1.345400530545778
SU-DHL-10,6505803,-0.3491248670962715
D283 Med,11455910,0.6480749902472364
NCI-H211,24753719,2.286443941284737
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344
KE-97,54649381,3.7494217326143695
SNU-601,42642645,1.3384360720933155
OPM-2,135423438,0.9866001177758746
A-172,135411,1.0587291590197103
SK-MEL-24,2746,3.4655100940792254
SF268,2746,2.880766016506668
LXF 289,24753719,4.56569970094865
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
Hs 944.T,42642645,1.0852506694496618
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856
HT-1376,9926054,2.913590047827676
NCI-H211,12001922,1.0188162274778227
BT 416,24753719,4.37847280119279
Mel Ho,387447,-4.779763298514976
LS1034,4705,2.791572248963506
OVSAHO,9926054,2.353589005438
SW982,10385095,1.6655541993822662
NCI-H1838,selumetinib-GDC-0941 (4-1 mol-mol),2.2361071015638445
CAL-33,15953870,3.314654639488514
SUP-T1,42642645,0.578403770532887
KMS-21-BM,135411,0.2992289409183569
COLO 684,11396600,2.8933753280460186
Reh,3825829,3.29627995354149
NCI-H647,11455910,1.3155768042278373
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
COR-L95,24753719,4.203119149122614
MOLP-2,24753719,4.994343973462867
Pfeiffer,6505803,0.5055759259934013
SNU-840,12001922,2.303082920964414
HEL,44197249,3.8651368484410056
Namalwa,246676,4.721429897591315
BT 112,44197249,1.805481072961874
SNU-182,9926054,1.7680094082282705
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
Rh41,9887053,4.599820051939316
JHUEM-7,3825829,4.01020461765645
WM115,9887053,3.7520086754622657
SU-DHL-4,387447,-5.192122565315846
BT 228,44197249,3.53843395082337
OVCAR-4,9926054,2.3051007827251095
Peer,15953870,1.9053581287506025
8305C,9926054,1.435515250555218
SNU-1,9927531,3.402077148066899
NCI-H28,11167602,1.9666975973252852
NCI-H2126,3825829,3.1927623956611613
HLF,4705,3.4184924882313372
SF539,24753719,4.7612365798691405
OCI-M1,136227924,3.580987744477365
EFO-27,10385095,0.896347771716858
HT-29,12001922,1.8500213919295192
JURL-MK1,135411,-2.0249855203886864
PE/CA-PJ49,6505803,-1.5018082269654205
OCI-AML-5,2746,1.486809354456374
NCI-H660,54649381,3.8665982420735783
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
MDA-MB-435S,12001922,1.7511679166396186
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
HCC4006,387447,-4.636611751321072
COLO 201,9926054,1.9430022433891496
NCI-H929,15953870,2.0316293430847594
HEC-151,15953870,3.67347109220223
Hs 888.T,9926054,3.017509441424242
IM95,24753719,4.235944018708707
KNS-62,42642645,2.833369116797052
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
NCI-H1341,15953870,3.412053631451967
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
SNU-840,selumetinib-GDC-0941 (4-1 mol-mol),1.257752895410429
NCI-H460,9926054,2.081701465030928
NCO2,10385095,0.8572094806219551
SK-N-AS,9887053,3.99593782577667
OVCAR-5,9887053,4.057540401732184
OVTOKO,10385095,1.0137593094154838
RPMI-8402,49836020,4.366358527241826
22Rv1,136227924,2.1207718843699
EM-2,9926054,0.5147420382885298
HuP-T3,12001922,2.3367896101102907
HCT 15,selumetinib-GDC-0941 (4-1 mol-mol),0.3162595465665505
SNU-46,11396600,4.157992682582123
KYSE-180,10385095,1.0867111286980162
KMS-20,24753719,3.26753514652521
OC 314,10385095,0.8203105692397765
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
Sq-1,selumetinib-GDC-0941 (4-1 mol-mol),2.237150148829387
HCC827,100016,4.431453048958875
U-BLC1,2746,2.5365215352469175
J82,3825829,4.439679228787519
EBC-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.174699743525061
SU.86.86,9926054,1.8736072532544432
Hs 611.T,42642645,0.1847495299149886
RKO,10385095,1.2981289243482117
Becker,135411,0.5687348881548171
BT 504,54618771,0.7999313784166654
MG-63,24753719,3.9781774427737617
GA-10,136227331,3.9402947188121793
HCC2279,12001922,2.191746757262951
ECC12,10385095,1.0249086857981329
MDA-MB-361,10385095,1.4298673211779267
JJN-3,42642645,0.9046996734779484
OV7,6505803,-2.17823489191902
RERF-LC-MS,54618771,0.9955970244631366
VMRC-LCD,42642645,-0.9727939003733428
PC-3,11396600,3.5715694520968
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
HLF,42642645,1.4809107386287856
Karpas-620,9926054,3.72255119036043
HSC-2,11396600,2.2102241778250757
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
SK-CO-1,6505803,-2.970063061644963
HEY A8,6505803,-1.5335181028470497
IGROV-1,135411,0.626702113064729
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
TE-4,11455910,0.4087808216227429
TT2609-C02,9887053,3.0659349545534944
KP-3,11455910,1.1515388808863225
GDM-1,387447,-4.245826264151859
SNU-869,9927531,5.42388661469149
A-375,10385095,1.3116334013128008
JM-1,135423438,1.5495237102322077
SNU-1196,9887053,4.6958512305359275
JHUEM-7,11455910,0.2186713515547739
SCC-4,11455910,0.5911512823156414
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
BICR 56,10385095,1.0617029264490752
Capan-2,54618771,-0.253287331081348
UACC-257,136227924,2.920939130155667
HCC1143,54618771,1.714955024233068
HCT 15,4705,3.822514103379746
SU-DHL-8,44197249,3.8620801311135926
NCI-H28,15953870,2.9779306311553237
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
SaOS-2,3825829,3.573326366415088
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
RVH-421,11455910,0.1784528957020075
SK-N-AS,9927531,4.866192814831014
NCI-H1792,387447,-3.3999997001728164
CHP-126,2746,1.549661784493303
TALL-1 [Human adult T-ALL],9927531,3.369458546084366
NCI-H2085,15953870,1.4600750836060117
DU145,54649381,3.1734563726622302
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
RERF-LC-A1,9926054,2.5963235420247965
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
UACC-257,2746,2.6143707562443135
JMSU-1,24753719,3.722529133671782
COLO 684,10385095,-0.5620331148053794
BT 482,6505803,-0.931790010731935
KMS-26,9926054,0.2958792952736858
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
RERF-LC-A1,11455910,0.7727825040667291
Daoy,44197249,5.067852360381338
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
DV-90,42642645,-0.0423219252429465
BT 330,11455910,-0.0355958099114693
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
COV362,3825829,5.079753144498528
NCI-H226,4705,3.419610218683655
UACC-62,2746,3.149907742936544
HEC-59,54618771,1.4246899684638197
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
A4/Fukuda,15953870,2.701018205920996
MV4-11,135411,-2.1889774549712326
RD,15953870,2.7054500984185834
Namalwa,3825829,3.564454365962588
LS411N,136227924,3.1900427132689724
ECC10,100016,5.627610035010204
IPC-298,9887053,4.3044553185981576
AN3-CA,135411,1.991464550187558
NALM-6,11455910,-0.1269393441174446
OCUM-1,11455910,0.0490190969024124
MSTO-211H,6505803,-0.0669493563910609
GaMG,2746,4.055581358402891
CGTH-W-1,100016,5.226111530095554
NCI-H1755,10385095,1.965568648376492
P31/FUJ,12001922,1.6134382673725098
CAL-85-1,136227331,4.603192424436066
DU145,9926054,1.942219630113699
SNU-8,42642645,1.5422938580488428
HCC2108,12001922,1.7040984021547378
G-402,selumetinib-GDC-0941 (4-1 mol-mol),1.3603902664341745
JM-1,6505803,0.12933264701109
RL95-2,11167602,5.300847360137522
CFPAC-1,42642645,1.8117399529317957
BT 231,15953870,3.368838744296408
EoL-1,4705,0.6699610598370959
SK-MEL-31,selumetinib-GDC-0941 (4-1 mol-mol),3.550007018724769
BT 164,11455910,0.017477073320278
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
MHH-CALL-4,2746,0.6611792988086074
LN-229,15953870,4.06823800158454
RERF-LC-A1,54649381,3.742824120436759
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
SNU-216,135928012,4.770569050642353
NCI-H661,2746,2.7828270451310786
KNS-42,24753719,5.430301045770774
HCT 15,100016,6.694419225032017
SNU-601,9926054,1.5128291451092608
Capan-2,136227924,3.162135891621308
NCI-H727,54649381,3.660865770056845
TE-6,135423438,1.6945535495060131
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
SUP-T1,6505803,-0.1872119927245122
BT 145,9927531,3.3032194302925557
MKN1,11167602,3.133021795040565
GA-10,11167602,1.4173414439490166
NCI-H1944,11455910,-0.1007611933414571
VCaP,15953870,4.748638555281071
KPL-1,42642645,1.6320283481891475
SW1353,9926054,2.273911586274605
SK-N-AS,54618771,1.0154959522530718
SNU-201,54618771,1.5381558224082674
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
MOLT-16,73707440,4.869509830184637
Hs 944.T,10385095,1.1433247729283496
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
ACC-MESO-1,12001922,2.4993315613358926
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
NCI-H2029,3825829,4.089852502230857
Rh30,9926054,2.2159405572329143
HEC-251,136227924,4.831338089277502
NCI-H1563,135423438,1.6420520323004266
HEL 92.1.7,135411,-1.68256943822166
HMC-1-8,136227924,3.367197210687835
MFE-319,135411,0.9500150248105194
OC 314,12001922,1.7088552211181505
HCC2218,11396600,2.588416382808436
KP-2,selumetinib-GDC-0941 (4-1 mol-mol),0.2413129500799869
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
KYSE-140,3825829,2.9293009002814183
HOP-62,11396600,3.498863261816077
HCC1588,3825829,4.334507307500312
SK-MEL-28,387447,-4.492461513664045
KMS-18,24753719,4.574822340106183
HOP-92,12001922,1.8638170251241897
NCI-H69,54618771,1.222543289082317
WSU-DLCL2,11455910,-0.3356389260792345
OPM-2,54618771,0.7318105179081044
BT 416,11396600,2.2118594965797147
SK-HEP-1,10385095,2.0924930980552148
RKO,24753719,3.882573791668401
JK-1,12001922,1.9016571467301675
YD-10B,11455910,1.0221520098708106
SNU-878,11455910,0.0025920112250637
L-1236,selumetinib-GDC-0941 (4-1 mol-mol),3.573145022328455
Daoy,135423438,2.308652476959376
DAN-G,4705,3.464155926779532
TE-14,2746,3.3749666856765304
DV-90,49836020,4.269422045712615
SNU-C4,387447,-4.407066299539727
OVSAHO,135928012,5.51852063281485
OE21,10385095,0.8074841582682157
LC-1/sq-SF,9926054,1.8795702077099137
HuCC-T1,9887053,3.659423085311097
OVCAR-8,54649381,4.475174069888557
LS1034,6505803,0.7621506671828905
Ri-1,9927531,3.385054072969868
Mino,11396600,2.601097362695862
NCI-H727,136227924,3.2179651731130585
BT 224,6505803,-2.453220276677442
HEC-1-B,3825829,3.929583177217195
NCI-H1792,100016,5.097619126157972
Caki-2,selumetinib-GDC-0941 (4-1 mol-mol),1.5536102429563667
OVCAR-5,24753719,4.714899424984898
SNU-398,135411,0.0973005288991104
PANC-1,3825829,4.298668056806913
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
Hs 766T,136227924,2.630952750368734
NCI-H1734,3825829,3.666820646997727
HCC2218,2746,2.1275689170875847
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
BICR 22,2746,3.5358057095338404
SNU-878,54618771,0.5665140825302253
SNU-601,11396600,4.148994335946169
NCI-H1693,100016,7.64063251702684
WM266-4,10385095,0.1508976066416572
HCT 116,12001922,1.8176446516770517
BT-20,11455910,1.5364398716433951
DMS 273,100016,5.677769516399485
DMS 454,9927531,4.138491843589823
NUGC-3,24753719,4.191075133336168
Hs 934.T,11167602,3.4668382200412453
TE-5,selumetinib-GDC-0941 (4-1 mol-mol),0.92004648470689
NCI-H2405,387447,-3.9137761631398726
NCI-H2228,11167602,2.310217161878112
22Rv1,3825829,3.949096095919817
SUP-T11,11455910,1.655670582891713
M059K,54618771,3.2179449616328775
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
SUP-T11,135928012,3.2224056142960307
NCI-H1666,2746,2.9810334185845617
BICR 18,10385095,1.2849545463227945
Hs 294T,136227924,2.369017342053728
SK-N-AS,11455910,1.0183707360563456
SNU-1066,12001922,2.2419521569123533
HuH-1,54618771,1.0275459281807533
HCT 15,10385095,0.6903357262692433
U-BLC1,11396600,3.266285635126102
HCC1419,selumetinib-GDC-0941 (4-1 mol-mol),1.9715069787616553
DND-41,6505803,0.5178331109157311
SF268,42642645,1.2191888086502212
SEM,2746,-0.0565030951113346
SK-MM-2,9926054,1.3112248924199803
HPAF-II,54618771,2.4967516753926216
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
SW948,11396600,3.556168564723583
KE-39,9927531,6.019185228760376
COV434,10385095,0.8854468588798045
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
SW1271,11396600,3.626770708484224
NCI-H358,54618771,2.9972263013300955
BT 179,54618771,0.9924128093703488
CMK,9926054,1.7941257572629667
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
TUHR10TKB,10385095,1.4872547202456603
RCH-ACV,42642645,-0.768591236038087
KYSE-410,135411,3.024507508048007
Reh,11396600,3.042988610167451
HT-29,387447,-4.251420049982416
LOU-NH91,12001922,2.55699926148122
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
A2058,42642645,1.281653765848877
SNU-61,10385095,2.7560205308704044
NCI-H1793,3825829,4.844788610718404
NCI-H196,49836020,1.0558785681395022
NALM-6,9927531,3.382690661986343
OCI-Ly19,6505803,0.7102258486981511
SNU-1214,42642645,1.0103419328558412
SNU-1077,387447,-4.3711527711694185
RERF-LC-MS,246676,4.480243243269967
HMC-1-8,10385095,1.010587069715564
SK-MEL-2,44197249,4.981669333138379
COLO 668,42642645,1.189885438354287
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
JHH-1,42642645,1.431802024363481
Karpas-422,136227924,2.027369566350396
L-428,selumetinib-GDC-0941 (4-1 mol-mol),3.762194755166614
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
U-BLC1,9927531,5.132450103816796
NCI-H2452,387447,-3.2957708741809975
JURL-MK1,9887053,2.159199966082003
253J-BV,15953870,2.236902482707788
MDA-MB-415,9926054,2.772494701182559
UO-31,100016,6.129898752942045
HCT 15,9927531,3.5842922899079173
G-402,9926054,1.7683002714551472
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
NCI-H2122,136227924,3.797810316623325
T3M-10,9927531,5.241044178261577
NCI-H23,42642645,-0.8027344471004203
KU-19-19,135411,0.3258457054887789
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
SNU-626,387447,-5.09988133415992
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
CML-T1,42642645,-1.8637300463446456
SW1088,4705,3.635040472252734
SJSA-1,54618771,0.8793199356074002
LP-1,3825829,3.7177263710946216
HT115,136227924,1.4968152830691424
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
SF539,6505803,-2.26727491960267
OE33,10385095,1.0575455043550728
BT 328,6505803,-1.1568571975604598
OV56,4705,5.529436174824006
GSU,12001922,1.8359998676097016
SNU-1076,12001922,1.9318813306683311
AsPC-1,10385095,2.76496705920137
NCI-H2009,54618771,-0.2233577251443086
MeWo,selumetinib-GDC-0941 (4-1 mol-mol),-0.6155502943571556
TE-6,136227331,4.078918341903366
BT 328,15953870,4.378443753461669
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
EFM-192A,54618771,1.407035681084211
EB1,136227331,3.874508283981952
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
GSS,10385095,0.9297454334410128
NCI-H1573,9927531,4.21902889327973
SNU-5,9927531,5.646839183086857
T84,54649381,2.840070311411164
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
NCI-H841,9927531,4.161760245261401
BT 444,54618771,3.3386759439235267
HCC202,selumetinib-GDC-0941 (4-1 mol-mol),2.1279074309941413
TE-8,135423438,0.3747901099487811
Ku812,9887053,2.4680731307119785
MHH-CALL-4,135928012,3.5215147296897493
BICR 6,11455910,1.839661874011414
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
LOU-NH91,15953870,3.547895487506012
RERF-LC-Ad2,3825829,4.845421431972124
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
BT 440,9926054,3.075570735220903
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
TC-71,135411,0.5578602362268543
NCI-H2106,3825829,2.970625540922889
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
BT 164,136227924,2.714674644422482
J82,54618771,2.0781543911386264
BT 359,100016,6.547217450499836
CW-2,11396600,4.1428337021020445
KYSE-520,387447,-4.690909195498477
NCI-H1944,135411,0.3737869123491996
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
NCI-H2029,11396600,2.8760485463291334
OCI-AML-2,9926054,1.545607447345451
KMS-34,11167602,1.5003618620555597
SK-HEP-1,3825829,4.395950359013269
LS1034,9926054,1.864667676562072
SaOS-2,9926054,1.5065280757428428
COR-L105,24753719,4.356648297258706
HuH-1,9926054,1.861851059546876
NCI-H2029,100016,6.638892611020326
22Rv1,12001922,1.6666261119310717
MOLP-8,4705,2.7848528520877727
NCI-H1869,100016,6.8338343579730285
SJSA-1,135411,0.2006630846998789
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
COLO 680N,135928012,4.231608649066135
SJSA-1,136227924,3.1619398784526176
5637,10385095,0.6643188027202117
SNU-878,44494015,4.4618367491886435
Mono-Mac-6,12001922,0.9964691314606112
HT-29,10385095,2.6878759136665824
HCC366,15953870,3.52918691824825
ES-2,246676,5.247336749197189
MCF-7,24753719,4.58802126050849
SK-N-SH,3825829,3.7303621997936887
Peer,73707440,4.301856504216986
JIMT-1,100016,6.5721980857327935
BICR 16,12001922,2.3492773600567407
NCI-H146,10385095,0.6869778017915235
COR-L88,42642645,1.256716950136764
SK-MEL-31,10385095,1.516996693340104
Mel Ho,3825829,4.138358857760196
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
HOP-92,4705,3.0147714927694387
SNU-685,387447,-4.589974699181374
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
SNU-899,selumetinib-GDC-0941 (4-1 mol-mol),0.9114020833269496
KCL-22,11167602,4.15023513027457
NCI-H446,11167602,1.6852750871191335
TYK-nu,10385095,0.5187167095917287
LAMA-84,12001922,1.4970261634490571
Lu-99,24753719,4.116519547594059
QGP-1,11167602,-0.8392847004817447
SNU-668,9926054,1.9494933006011008
SU-DHL-10,9887053,3.511052221678749
HDQ-P1,135411,1.7891042828082189
SUP-M2,11455910,-0.9872443510940216
NCI-H2087,135411,0.426798075107719
HeLa,9926054,1.7615972318293558
Ki-JK,135928012,1.311699583938011
TE 441.T,2746,2.0767838467856654
K-562,100016,4.034095210213227
TT2609-C02,24753719,4.8060720980706195
LS123,100016,6.571994849278421
TC-71,9926054,1.5758673536433587
JHH-5,135423438,3.9719572001946344
ONS-76,136227924,2.542073211711186
NCI-H1341,selumetinib-GDC-0941 (4-1 mol-mol),0.3827497304694547
TTC-709,15953870,3.8418974591012702
SK-MEL-24,42642645,1.1554645249405937
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
HCC1195,6505803,0.0153756164057107
KMS-21-BM,100016,3.297202365361246
JHUEM-1,387447,-5.311102118487854
TYK-nu,9927531,4.342224808335168
SNU-410,54649381,4.343480855108173
G-401,10385095,0.8697787767816428
NALM-6,136227924,1.937403591420271
IGR-37,54618771,0.3967957480696406
CA46,100016,3.773189878640827
KE-37,11167602,1.8775363642517875
GSS,54649381,3.288447109658824
MHH-NB-11,9927531,4.251740517213762
K-562,9887053,4.062685534067952
LoVo,54618771,0.7060685526757626
NCI-H522,11455910,0.4156799864056491
OVCAR-5,135423438,1.1993513830056843
OCI-Ly19,246676,6.051875422677845
KNS-62,2746,3.88205889014037
COV434,387447,-4.207097800652725
NCI-H446,54618771,-1.076941007220397
JHUEM-2,44197249,3.765464693875827
BC-3C,15953870,3.424334340589905
SU-DHL-1,15953870,1.992339234699044
SNU-899,10385095,1.2944139738105107
DMS 454,136227924,3.2899111891910424
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694
SNU-398,9926054,1.6383550213348652
EFE-184,54649381,5.984882925298918
EHEB,3825829,3.7186558518100705
BT 172,9927531,4.926572000473132
JHUEM-2,24753719,2.2917062172444203
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
OS-RC-2,136227924,4.587923384885118
NOMO-1,24753719,4.496099764979975
Calu-3,136227924,3.506459850502243
JHOS-2,135928012,4.296949674752725
COLO 829,387447,-4.676049256603897
Aska-SS,11455910,2.343634234167196
Calu-1,387447,-4.037106995788473
KYSE-180,54618771,0.8276624799970426
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
BICR 56,9926054,1.8423418764912696
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
WT2-iPS,15953870,4.2540296217839675
SK-UT-1,15953870,4.0206121025368216
BT 159,6505803,-0.0386292738928562
ECC12,12001922,2.3355483527198553
NCI-H1568,2746,2.7741418395417163
SK-N-BE(2),4705,3.5810026533743793
SNU-410,10385095,2.9494153659427145
BT 224,10385095,1.2514270685942803
NCI-H2030,54618771,3.292263250244386
NCI-H2141,9926054,1.978492871362738
HCC1806,3825829,3.3289554178034892
Karpas-422,42642645,0.4716956796226118
NCI-H1373,42642645,1.5961504357094825
KHM-1B,246676,1.870399937828377
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
AU565,3825829,3.6732705699214105
TE-8,54649381,4.202710576026855
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
Kasumi-2,9927531,4.453654232617923
CL-11,9887053,3.631104673767545
HT-29,54618771,-0.2374080700541868
LP-1,4705,3.1959395550133247
TE 441.T,135423438,2.5250342402764816
MOTN-1,135411,0.3380928655099081
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
KNS-62,387447,-3.782010179894299
NB1,6505803,-2.349165224527604
NU-DHL-1,9926054,1.5745053582273782
SNU-16,11455910,0.0764254411475756
BEN,54649381,3.777732124891488
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
DND-41,11455910,1.0422963026529204
BT 422,387447,-4.782614721120528
NCI-H196,54618771,3.538687286650074
EoL-1,54618771,-1.3490437314976569
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
253J,136227924,2.473625062581448
SK-ES-1,54618771,0.5955874337790977
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
FTC-238,42642645,1.0569874100246637
HuP-T4,100016,6.7159168289197915
A-172,3825829,4.199429686647249
TF-1,2746,2.294459830990238
MDST8,135411,0.5541309628089411
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
NCI-H446,9926054,1.7959327761623658
MG-63,135411,0.9071792658080758
Fu97,15953870,2.3980248292757413
TCCSUP,11167602,2.834914441950803
KMS-12-BM,136227924,1.841540408480291
TE-4,136227924,2.9171247501964945
KMRC-3,11396600,3.674088989428189
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
MM1.S,100016,6.180279624553647
NCI-H1563,4705,2.6238012803038124
253J,387447,-4.05650325842698
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
BICR 31,10385095,1.3759128494100044
NCC-StC-K140,100016,6.431860837963816
LC-1/sq-SF,135928012,4.446645449974171
M059K,6505803,0.7247359369416212
647V,12001922,1.1754525923132018
KMS-12-BM,2746,1.2802142564618226
SK-MEL-24,selumetinib-GDC-0941 (4-1 mol-mol),-1.728607730118346
U-937,15953870,3.089994488970631
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
LNCaP clone FGC,135411,1.269325429429485
SUP-T1,10385095,1.0302013641160523
SNU-466,9926054,2.420216987024882
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
HEC-1-B,135411,1.0191037484894645
AsPC-1,9926054,1.8957621767397328
639V,24753719,4.6896933942293835
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
NU-DHL-1,135411,-1.8300926299415428
MKN74,54618771,1.3558742291917982
H-STS,6505803,0.5486553702983976
MES-SA,135411,0.5980889893340017
SK-LMS-1,9927531,4.694028683387814
JK-1,6505803,-1.233807201849435
Mono-Mac-1,2746,1.2768381662660928
BT 172,6505803,-5.169287072935626
SNU-869,100016,6.487538118719535
NCI-H446,135411,0.7203649832526413
BV-173,136227924,2.1412277594985816
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
NCI-H1568,387447,-3.95080818095812
OE33,15953870,4.191063320508706
A101D,24753719,4.3282257905645185
GB-1,3825829,3.883651774392407
RPMI-7951,24753719,4.344653463611892
DMS 454,24753719,4.1661343014864824
HLF,2746,3.261638353143838
OE33,9926054,1.932041644306032
SK-N-BE(2),3825829,4.244883460233288
BICR 22,49836020,2.6142262300183305
HSC-2,44197249,4.328447137528811
KALS-1,3825829,4.265035068794827
SCC-9,2746,3.644005246156997
HCC78,11455910,2.0518993583639182
SNU-869,2746,3.873911314544542
OPM-2,9927531,3.0625153090482757
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
OE21,24753719,4.068797621390331
PC-3,42642645,2.645412809064484
FTC-238,24753719,4.029317045060616
A4/Fukuda,9927531,3.7257201794253776
SNU-503,10385095,1.5497117451451905
JeKo-1,24753719,3.5760839503149873
SNU-668,6505803,-2.4015311663396535
Kasumi-2,15953870,2.7617758274096404
TYK-nu,11455910,0.7161463243688381
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
HT-1197,136227924,5.329383648142769
COR-L105,136227924,2.729950058152846
OCI-AML-2,15953870,2.239575214756103
SNU-1,135928012,3.614097093070296
Hs 611.T,387447,-5.303952237268001
TOV-112D,12001922,2.3118172054107204
KP-4,54649381,3.8790856388273776
M-07e,135411,-1.7602949579736598
SW1271,42642645,0.8738549597199083
BT-12,9926054,1.4917142795883798
U-937,135423438,1.73395278295497
Namalwa,9887053,0.2875319408170879
SNU-601,4705,3.2115549185604757
HCC1833,387447,-2.8576374016585593
MOLM-13,9926054,0.378361077880871
AMO1,9887053,1.7121168320787905
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
Fu97,selumetinib-GDC-0941 (4-1 mol-mol),0.7041233813460074
HT-1376,54618771,1.723140489486428
BICR 56,6505803,-0.5151519512858532
SNU-81,135411,1.0381613293566891
Mono-Mac-1,9887053,1.5534992217620511
SEM,135411,-1.7060706905647656
CAL-120,11455910,1.9217151174360485
G-402,54618771,0.638636579266015
SNU-719,6505803,-1.6348433064714072
MeWo,3825829,4.108018780277727
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
L-363,9926054,1.3998682481230786
HuCC-T1,9927531,3.6522633748640487
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
SK-ES-1,3825829,3.289343770769238
DMS 454,11455910,1.2938635688773483
NCI-H322,6505803,-2.5278966657136577
NCI-H1915,135928012,5.1117655836564495
SK-MEL-3,15953870,4.253247791185363
MCAS,6505803,-1.4160035963714128
SK-N-SH,12001922,1.092658851526272
MOLT-16,54618771,-1.933148337810649
NCI-H524,10385095,0.2578965254075426
U-251MG,54649381,3.945596663005612
SNU-46,11455910,2.77319640879208
DoHH2,3825829,3.0359754331983133
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
Granta-519,135928012,3.1328015926823065
TE-5,6505803,0.1996396814401048
SNU-61,387447,-3.847354855280633
NCI-H716,3825829,4.114621834253342
THP-1,10385095,1.0442319132291376
HuP-T3,42642645,1.566786855324099
GSS,9887053,2.681738072239393
NCI-N87,15953870,2.623738434863841
Lu-65,9927531,5.027796470849251
BT 172,387447,-4.18391678163882
BICR 18,9887053,5.188480245029785
WM266-4,9887053,3.738007767323414
SK-MES-1,9887053,4.31219154209573
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
HeLa,54618771,0.9271666044907572
GSS,49836020,4.0402801556040036
HuP-T3,135411,0.8125735513868637
Mino,135423438,1.6490290727182615
MKN45,54649381,4.1252850750146335
Caki-1,136227924,3.8203162456228417
NCI-H2141,9927531,4.975438094968349
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
OUMS-23,24753719,4.226902193250076
253J,11167602,1.8529047716124176
ONS-76,6505803,1.3937943977095182
NCI-H1341,9926054,1.7553356281022332
VM-CUB-1,54618771,0.9006396829235269
KMS-20,9926054,1.4765400556600523
OAW28,135928012,4.847644989583831
CCF-STTG1,4705,3.7462462996550534
AML-193,135411,-1.734836163391053
SNU-1033,2746,3.071869125008986
SK-LMS-1,12001922,2.30628088963523
KMS-26,54649381,3.671421086556771
HuCC-T1,3825829,4.502676773817668
KNS-81,4705,2.5413050318058596
GCT,54649381,4.1474523373658
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
KMS-20,246676,4.441835225578849
MOLM-6,54618771,-1.125250361131471
SCC-9,135411,1.0456929507985402
A3/Kawakami,246676,3.7408216321489256
HT-144,135423438,3.7063212476270144
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
OCI-Ly19,9926054,1.6873576988098775
MOTN-1,135423438,1.8734384638779549
SW1710,54649381,5.669775749905543
NALM-6,100016,5.173644166821544
SK-MEL-5,24753719,4.331970921396319
NCI-H446,11396600,2.9015736046433607
CJM [Human melanoma],135928012,3.798099885550923
HDQ-P1,9926054,2.660031643800519
COR-L279,54618771,0.9541573251908244
BT 416,9927531,5.009885250018842
KNS-42,54618771,1.5414231722108478
SCaBER,1474550,4.666221767361497
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
NCI-H2087,136227331,3.603331893484652
SNU-201,136227924,3.0451171975506903
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
LS411N,9926054,1.9376785020428349
LS411N,135411,0.7383506227122603
BT-16,100016,4.275534033025709
A-253,24753719,4.312803034067271
NCI-H2009,11396600,4.054693544346837
KYSE-150,2746,3.6554538134101255
SUP-T11,9887053,1.8662970056119592
HCC1195,135411,0.9539520168507292
Ki-JK,12001922,1.1780807000269764
JHUEM-1,11396600,2.4949940260593872
MHH-ES-1,12001922,1.634757567044827
PLC/PRF/5,6505803,-1.356651808905463
TE-15,24753719,4.009686025079942
CAL-120,3825829,4.610316765925481
KYSE-180,6505803,-2.0087833017185264
BT-20,15953870,3.8375641504894342
UACC-257,11396600,3.5466245418165743
TCCSUP,12001922,1.8065976043630063
OVCAR-8,2746,3.926071578453057
CAMA-1,54649381,3.78312342409281
PSN1,9927531,4.910271279543014
Fu97,10385095,1.9014860285103132
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
SKM-1,9926054,1.2950133266657913
NCI-H2110,2746,2.5947990205927405
KNS-62,10385095,1.9317410054344168
DK-MG,12001922,1.7441661846351604
SKM-1,24753719,3.966974937988049
NCI-H1792,15953870,3.2826402380553468
MDA-MB-468,136227924,1.762243520931147
23132/87,54649381,3.752337851485564
RL95-2,136227924,2.901366933043705
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
MCAS,3825829,3.968162894586803
VMRC-RCW,135411,1.150318374941082
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
MFE-296,9926054,1.7629319837489352
HCT 8,9927531,4.796707314113722
U-CH1,15953870,1.806945811485401
TT,9927531,4.594242153757871
THP-1,54649381,4.147021468214167
CAL-54,54618771,-0.0146618789918735
HuNS1,135928012,3.4065980849923103
KM12,6505803,-1.021765760780758
NCI-H1385,11455910,-0.7459134175942048
VMRC-LCD,9887053,6.217580915821706
WM115,387447,-5.543981096917634
KMRC-2,12001922,2.386008364335044
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
GB-1,11167602,1.6517342289553878
NCI-H69,9887053,3.2617901667838782
BT-20,135411,0.3232772298643774
Capan-2,135411,0.5883316255104998
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
786-O,9926054,1.9189583630988831
SW1088,3825829,4.145475011870724
Hs 729.T,136227924,2.3598946894515014
KP-3,54649381,3.7166707762390385
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
HEL,9887053,3.0781159437380974
SW1573,10385095,0.5068001344623563
SK-ES-1,54649381,3.551129721812885
MDA-MB-468,387447,-5.19264236927867
L-363,selumetinib-GDC-0941 (4-1 mol-mol),2.240470367275986
UM-UC-1,10385095,0.7230126678224916
MM1.S,11396600,2.9620457472616533
BT-20,10385095,0.9284855433615824
TE-9,11396600,5.486103652826923
A-172,387447,-5.178249544709319
Capan-1,2746,3.367877422922766
SNU-1033,15953870,4.135823998081224
SNU-216,4705,1.5383436923122542
MDA-MB-231,54618771,1.2900163685753538
SH-10-TC,15953870,3.972353196131568
Hs 746.T,24753719,4.48003826242694
P31/FUJ,42642645,-1.1469220315427042
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
SF539,9926054,1.722417855539817
PK-1,15953870,4.487454213572285
Karpas-422,3825829,3.984444104401659
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
HCC44,3825829,2.6027380790203067
YD-8,6505803,-0.4521993512764767
HT,54618771,1.085769963879092
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
CAL-29,387447,-4.708812340471032
JeKo-1,11396600,2.6042135230770325
NCI-H929,11455910,1.7265755247991157
KE-39,12001922,1.538248730222034
MOLM-13,24753719,4.086009941734247
Hs 578T,6505803,0.7930921136576904
SNU-216,9926054,1.7628487898715297
HT,136227924,2.3517784191427613
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
TT,42642645,1.1320125986692542
BT 359,136227331,5.057853288307873
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
OAW42,9887053,3.1515627670394992
G-361,3825829,3.749266387661412
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
TT2609-C02,3825829,5.396663174071034
NCI-H650,15953870,3.6823638828245047
CAL-78,10385095,2.2250842594628035
Caov-3,387447,-2.7716071179837756
SK-N-BE(2),11396600,3.067666885131691
Kasumi-1,6505803,0.4376823954906434
Hs 944.T,9926054,2.091458056725466
WM88,9927531,4.19876481787408
IA-LM,15953870,4.160803294534019
NCI-H322,2746,3.8367481879313305
SK-OV-3,9887053,4.42879128381072
COLO 800,11167602,4.238548502616999
LAMA-84,135411,-0.2868161476420337
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
G-401,136227924,2.3105932180874365
CAL-54,42642645,1.0108936596015914
SIG-M5,11167602,1.4551156840002482
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
CAL-54,6505803,2.0649330507339183
BT 504,10385095,1.155084659325028
LMSU,9927531,5.404187778104352
OCI-AML-2,11455910,0.2624387958343751
COLO 800,1474550,4.435098521871389
IM95,72199289,4.342442192219408
KMS-28BM,6505803,0.5045053527572001
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
Toledo,12001922,1.1974462394008087
KMS-34,135928012,5.757372056901117
F-36P,12001922,1.376865879976315
HOS,100016,6.425173790511516
NCI-N87,54649381,3.6397596564561487
HCC78,100016,6.366939598030235
SNU-182,44197249,1.4167257489318792
ECC10,2746,0.8272304201141983
U-BLC1,15953870,3.155905606159002
BICR 6,3825829,4.133608325124951
BICR 18,24753719,3.9463687451027254
EM-2,24753719,2.7416621660310767
RS4;11,54618771,-1.3838955198533192
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
Hs 936.T,100016,5.806135174623166
OV56,2746,5.269655177673237
TCCSUP,54618771,0.6448534643306117
RPMI-8226,11396600,2.661670578170676
A-375,24753719,4.237865986535525
P3HR-1,15953870,3.2355314646730062
SIG-M5,54618771,-0.4946927468469176
TE-5,12001922,1.0300845417541995
KMS-20,9887053,4.355785993783173
NCI-H1184,54649381,3.6701043575171
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
NCI-H211,11455910,-0.4390844400246115
SNU-1214,100016,6.334633199659308
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
EFO-27,12001922,2.6878207164132517
Hep-G2,42642645,0.7845833845237471
TE-14,54649381,3.7440272990463774
AU565,9927531,4.912755977802547
HEL,3825829,3.033394475732853
GA-10,6505803,-0.6934451176376895
SNU-478,11396600,3.7061070175674904
DB,100016,4.066938426663746
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916
SNU-308,42642645,2.1176694587678617
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
GA-10,49836020,3.868484173874789
SUP-HD1,24753719,1.8237157201858607
8505C,42642645,1.2769089704754422
LoVo,49836020,1.6927786584323
Mono-Mac-1,15953870,2.971889199477423
DV-90,3825829,3.8506563799851183
OV7,387447,-5.14418700956558
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
MV4-11,387447,-5.316131182189997
BT 340,11455910,0.6869107925797121
TUHR10TKB,135411,3.535905617803136
Hs 611.T,3825829,3.8788340383084767
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
SW948,15953870,3.980690301912255
Reh,100016,6.483959173055827
BT 239,387447,-4.078416605108376
Toledo,9887053,2.6975601873648007
NCI-H1703,10385095,0.811634941740761
EB1,9887053,-0.1865767026593925
BT 245,387447,-4.390125196959702
SNU-626,11455910,1.8288059017639848
RERF-LC-Ad2,54618771,1.6045253072760792
FU-OV-1,42642645,1.0692746742635495
SF295,387447,-4.188925622132866
HCC1428,10385095,1.0242844092900787
HT-1197,387447,-4.89553325968602
HT115,15953870,3.427136718543439
SNU-398,11396600,3.339240330685363
SNU-119,9887053,3.651062425326841
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
NCI-H929,24753719,4.216810454357832
NCI-H2087,11167602,0.4948017667702105
Panc 03.27,42642645,1.34765843522779
NCI-H322,4705,1.051415284541447
NCI-H1435,3825829,3.757708324218467
T-47D,11396600,3.840733614966456
SU-DHL-8,9926054,1.545172236486763
Capan-2,10385095,1.6516866773102918
KE-39,9927531,6.019185228760376
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
MOLP-8,3825829,4.0673932001437
SNU-1,9926054,1.7218155896190992
NCI-H1666,15953870,2.9335806337145125
KMS-28BM,136227924,3.12099798130619
769-P,44197249,3.6464986083356528
HCC1419,12001922,1.662639892930276
MOTN-1,9927531,4.434768269129304
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
NCI-H211,135423438,1.3338851322165923
Kasumi-2,54618771,-0.6876381814105375
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
MFE-319,12001922,2.352010536331228
VM-CUB-1,100016,6.234028822794693
NCI-H2081,12001922,1.0080325544819035
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
C2BBe1,2746,3.6409486434648706
TTC-709,54618771,0.1325833030612315
HCC1500,54618771,1.4039271563223086
MFE-296,11167602,2.816070749987398
KMS-20,10385095,0.7360105255887816
HCC1588,9926054,1.7105432403142011
CAL-29,9927531,5.397915625533194
DoHH2,10385095,0.4781545014335026
LN-18,135411,0.338333708295224
AsPC-1,54618771,1.0442216511349782
WM1799,54649381,4.351863275722702
LCLC-103H,15953870,3.949183325485151
BICR 6,54618771,1.779612133300688
EBC-1,6505803,-3.073804899709993
TM-31,15953870,5.060894845865505
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
CAS-1,42642645,0.9621896854586698
MDST8,387447,-2.914953377887094
VCaP,54618771,1.0243470535164156
GB-1,73707440,4.5407422473928785
Rh30,6505803,0.7803145928661782
KE-37,44494015,-5.121109783937924
TC-71,9927531,4.177938465440418
AsPC-1,24753719,4.618559637878285
COLO 800,selumetinib-GDC-0941 (4-1 mol-mol),-0.6648524830772472
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
LMSU,3825829,5.912113214968355
NB1,246676,5.4793915839717515
NCI-H1355,135423438,1.8845070459109623
RS4;11,6505803,0.6734811242477595
SNU-626,9926054,2.31791428562488
KP-N-YN,24753719,5.28590811634551
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
Toledo,11455910,1.8011509430224568
SNU-449,1474550,4.524224948734458
NCI-H2110,15953870,3.912079483220952
UM-UC-3,9926054,2.187616038354346
HMCB,15953870,5.102048815758539
A-172,selumetinib-GDC-0941 (4-1 mol-mol),2.629230075004273
COR-L105,15953870,3.0827686267342957
BICR 22,24753719,4.1427183131543615
IPC-298,11455910,1.6404749147186584
SF268,3825829,3.5843948020059946
JK-1,135928012,3.5891358381438097
BT 216,54649381,3.975515503342643
SUP-T11,2746,2.7508028515684457
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
BT 216,4705,2.9949115895470704
Hs 852.T,42642645,0.335936240257902
JHUEM-7,24753719,4.234902187840303
KE-97,135411,-0.9723935899887912
22Rv1,15953870,4.619261904609794
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
JM-1,42642645,-0.9084434189288264
GDM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.4015630537734989
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
WT2-iPS,24753719,4.2236416503462415
JHOC-5,15953870,3.597901574238352
LoVo,3825829,3.571391318080427
Daudi,135423438,1.6157885595086947
Panc 04.03,9927531,5.313421559596226
NCI-H2009,12001922,2.0619007134450524
P3HR-1,24753719,4.729434793185607
Panc 02.03,387447,-4.21908064053878
NCI-H2342,selumetinib-GDC-0941 (4-1 mol-mol),3.1490507666269307
GCT,2746,3.501463189612396
HCC827,11167602,3.770310113048885
NCI-H2228,10385095,1.4041117697661651
SK-MEL-31,54618771,1.4879835427229802
Lu-65,6505803,-2.14133792645673
SK-MES-1,11167602,2.859403378030726
BT-12,135411,3.453461574094156
OCI-M1,12001922,2.3228381013236223
JURL-MK1,12001922,1.7331639695945016
DEL,12001922,1.5135537208579573
CML-T1,24753719,1.910679313408318
SW1088,10385095,1.7671822687646943
PE/CA-PJ15,42642645,1.5086089624743753
GaMG,10385095,3.009741881830446
SNU-16,387447,-5.631511136929922
DMS 114,9926054,1.677325946401266
IMR-32,135928012,1.2971235582262872
Hs 888.T,12001922,1.021632859800399
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
UACC-62,136227924,3.255935919058072
MIA PaCa-2,24753719,4.169307227992716
LCLC-97TM1,15953870,3.316413299321368
SK-N-BE(2),387447,-4.073733263223272
JJN-3,54618771,-0.9152585642725306
DLD-1,54618771,1.295500773429104
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
BT 286,54649381,3.967150181655946
KMS-27,9887053,2.6639337999908728
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
MKN7,11167602,1.88082569725068
K-562,10385095,0.5975872383647969
PL-21,9887053,4.195389959181903
PK-1,9927531,5.928994406522703
MOLT-3,44197249,1.5407168506925764
BT 139,11396600,2.700615833267889
BT 228,12001922,1.1334431152108806
BC-3C,11455910,1.805675194715763
HuG1-N,9926054,1.9171272639265269
HLF,135928012,4.119494005429506
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
EFM-192A,12001922,1.7606311950703983
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
SF126,42642645,1.117023388016572
COLO 320,54618771,1.0088130808392026
KNS-42,11396600,3.114434674778827
NCI-H446,9927531,3.935868593657491
COLO 699,selumetinib-GDC-0941 (4-1 mol-mol),0.865445033104183
NMC-G1,54618771,1.359129875373881
SNU-601,6505803,1.2450249306670702
JHUEM-3,9926054,2.0122307954459004
Mel JuSo,10385095,1.6841415744753898
SK-MEL-24,11455910,1.6031217504483102
NCI-H1105,135411,-1.4582997520163694
HuH-6,11167602,1.354506813263299
HT-29,54649381,3.9589627161660457
KMS-12-BM,10385095,1.107401404691538
NCI-H2291,387447,-4.246266535655531
BT 159,9926054,3.0118614770860286
EFO-27,44197249,3.884486906001317
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
RERF-LC-Ad1,136227924,3.427007002266959
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
NCI-H1838,387447,-3.46882608720269
A-375,100016,6.005492870785018
NCI-H1944,24753719,5.3103553125067355
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
SK-N-BE(2),24753719,4.532912367616784
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
JHUEM-1,54618771,0.4332987252464321
KATO III,42642645,-3.0573686796463813
LS123,54618771,1.1296400370948565
BT 320,9926054,4.941319925063275
MDA-MB-361,2746,1.2909021690228906
TUHR4TKB,15953870,3.352305834177315
NH-6,12001922,1.0934826663678348
WM115,12001922,1.1273981641266086
MIA PaCa-2,9887053,3.4042551427681103
MKN45,54618771,1.1504604366979514
BT 232,136227331,4.34663354921091
CFPAC-1,54618771,0.7086931491389132
Li-7,6505803,-1.5573674441888958
SaOS-2,100016,6.565789067704999
DMS 79,11396600,3.318439325862458
GI-1,10385095,0.7394831533440679
COLO 205,54649381,4.066436435817581
COLO 668,136227924,2.7222662640570356
KYSE-410,6505803,-1.395116732641888
KMS-28BM,11396600,2.8366519547889357
GSS,11455910,-0.448056775545068
BL-70,135928012,5.132992638925211
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
SU.86.86,135928012,5.11300850407066
HCC2218,10385095,0.9355515453003532
KNS-62,4705,4.3663723212199885
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
ME-1 [Human leukemia],11396600,3.0194011260213824
MOLM-6,10385095,1.035160122785837
SW1783,42642645,1.5180122548711477
SUIT-2,15953870,4.979127052854588
CJM [Human melanoma],15953870,3.932090712742591
SW48,135928012,3.696922095661256
SNU-182,100016,8.076902029611453
SiMa,135411,0.268951203437838
BT 328,42642645,1.526904383487112
8305C,42642645,0.8836120030501967
NCI-H1341,2746,1.640350418119998
BFTC-909,15953870,3.192835350037467
HCC1195,42642645,0.8072417550099853
NCI-H1568,135411,0.4069452326541798
COV644,49836020,0.1306983764226103
BT 330,54649381,3.7606030780580255
TE 617.T,11396600,3.161779711193339
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
NCI-H1734,11396600,3.6622911845899817
BT 245,11455910,0.6053339220870597
WM266-4,selumetinib-GDC-0941 (4-1 mol-mol),-1.002003549431085
Hs 688(A).T,11167602,4.095254333798956
KMRC-20,42642645,1.4773611251579275
A-549,24753719,4.621771717936227
KE-39,387447,-3.456484721663708
MOLP-8,11455910,0.4759456923848041
SNU-423,387447,-5.098598596433983
HEC-108,44197249,3.927114018352238
L-540,135411,-1.1479703822839216
KHM-1B,12001922,1.027456865676835
SW982,136227924,1.7454954285641082
COR-L95,11455910,1.0154509596480157
SNG-M,387447,-5.063296412264481
SU.86.86,387447,-4.86143019650036
NCI-H1666,11396600,3.2365396547508674
COLO 829,135928012,4.039885780801421
T84,135411,0.2084979580325832
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
TE-1,42642645,1.1761474457077226
OCI-Ly10,selumetinib-GDC-0941 (4-1 mol-mol),1.0181444461611715
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
SNU-1214,11455910,3.3877834337363124
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
TT,15953870,2.769388424875048
VMRC-RCZ,selumetinib-GDC-0941 (4-1 mol-mol),2.964733367482892
GDM-1,11396600,3.1168819453439895
A-172,9926054,1.9975239370798743
JHH-5,selumetinib-GDC-0941 (4-1 mol-mol),1.0650507170556407
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
FaDu,2746,3.60931245556166
OE19,42642645,1.539856086152574
LNCaP clone FGC,6505803,-1.5170131166658098
BT 224,9927531,6.091778203420535
ChaGo-K-1,12001922,1.4825695444436542
KYSE-410,11396600,3.754375595740645
TCCSUP,135411,0.4235399042489139
WM793,54618771,0.892561932009902
HOS,9887053,4.3326514968831855
SNU-175,100016,4.815284438481943
WM266-4,3825829,3.733906693023344
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
P3HR-1,11396600,3.8940986796449946
ACC-MESO-1,11455910,1.4227308564953651
OCI-Ly19,2746,2.185882112946918
Peer,135411,0.3019102733369013
LC-1F,11167602,-1.348931537750626
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
SNU-886,11167602,1.491891520160987
HuH-6,387447,-4.605349328210036
Tm87-16,selumetinib-GDC-0941 (4-1 mol-mol),0.1421801276665628
MES-SA,11455910,-0.2253675731239214
G-292 clone A141B1,selumetinib-GDC-0941 (4-1 mol-mol),0.4997156895846377
SNU-182,11396600,3.6909913141994584
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
SNU-182,54649381,3.879088047764719
BT 359,10385095,1.5328383331083568
HOP-92,2746,3.1946789045133217
TTC-709,2746,3.375818132682937
253J,246676,2.022290784770066
YD-10B,246676,3.4440336602109465
NCI-H1395,9927531,4.9557176619227015
A-375,42642645,0.983657975432455
SNU-201,42642645,0.8167686700637609
NCI-H69,387447,-5.1563546840556365
SNU-1033,10385095,1.019137651596638
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
Mono-Mac-1,136227924,2.2269797620359864
COLO 800,11396600,4.874134738718471
MOLP-2,387447,-5.842652633488704
NCI-H2170,135411,0.3769061151725236
HuNS1,42642645,0.896475462112374
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
MDA-MB-361,12001922,1.723033233476721
Hs 729.T,11167602,2.295672190190323
KMS-20,11455910,0.7957422642794928
DU145,9927531,4.922928089289864
SHP-77,10385095,1.0239488478640744
NCI-H1838,11396600,3.9087571666656222
OV56,15953870,4.470481384670773
MOLM-13,11396600,-0.7885098330267027
SNU-1033,49836020,1.7840304926095434
ZR-75-30,42642645,1.7100035384306749
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
Rh30,136227331,4.257101028878693
Fu97,9926054,1.5136567302830126
NCI-H69,selumetinib-GDC-0941 (4-1 mol-mol),3.077666934797567
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
GDM-1,15953870,2.7975295366317687
NCI-H23,12001922,2.196064826389766
TE-9,136227924,3.0742454984310825
TC-71,4705,3.1245427089592757
SIG-M5,11455910,0.7552766623437589
U2OS,9887053,4.3533937260829365
CCK-81,9887053,1.9409202265954744
MCAS,15953870,3.8672859313011614
SNU-1105,54649381,3.7925423825338456
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
HCC1833,54649381,3.732114486371366
KYSE-520,10385095,1.041852724573902
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
BICR 6,136227924,2.7894508880651485
EPLC-272H,387447,-4.291401323549034
SK-MES-1,42642645,1.0695406416711744
RVH-421,9887053,4.396295495300365
NH-6,24753719,3.897266044321257
RERF-LC-Ad1,54618771,3.6047591405088673
Hs 944.T,54618771,2.424765430874906
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
CHP-126,selumetinib-GDC-0941 (4-1 mol-mol),3.8559663060343
NCI-H460,9926054,2.081701465030928
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
SEM,54649381,3.0580730250658283
HCC202,54618771,2.3790685785467964
MOLP-8,387447,-5.214034261316855
Rh30,42642645,0.94638035992519
COLO 680N,387447,-3.7706744630491618
HT-144,15953870,3.79465450208216
SH-4,54618771,-1.4714653388751002
LS1034,136227924,1.69162800732405
OC 314,6505803,-0.2710007878606607
ME-1 [Human leukemia],9926054,1.888180715398536
SK-N-BE(2),selumetinib-GDC-0941 (4-1 mol-mol),-2.409093744965772
Hs 611.T,136227924,1.5120677878583844
Mel Ho,12001922,1.5992196834604604
COLO 829,11396600,3.5925898800882856
HCC1500,3825829,4.205963950909598
COV434,42642645,0.2113005358449795
HOP-92,10385095,1.1427882638896885
SUP-T11,10385095,2.0290179128287007
BHT-101,24753719,4.428246432741456
DMS 53,135411,0.30854806218738
NCI-H2228,selumetinib-GDC-0941 (4-1 mol-mol),1.1807966887528696
BDCM,11455910,-1.5577309500226444
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
EKVX,54618771,-0.0209843896322389
Li-7,15953870,2.7402951348819946
NCI-H28,135411,0.613490774381534
SNU-C4,11455910,3.771721357690206
OCI-AML-3,6505803,-0.781782964907092
SNU-1196,135928012,3.7192216074356046
NCI-H1155,10385095,-0.1024121821965068
NCI-H2196,9887053,4.217849754910272
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
KNS-60,12001922,1.7752108355109042
CMK,135411,0.4300734844204335
Hs 944.T,135411,-0.2984448992190572
SU.86.86,54649381,3.821783472776988
DAN-G,42642645,1.0588328555031938
COLO 829,3825829,4.745961595796288
HCC1171,42642645,1.0412077746096458
ONS-76,9887053,4.335145594020597
RERF-LC-MS,24753719,5.208830602571573
F-36P,54618771,0.2911241423131909
SNU-478,15953870,2.4993704602608755
IGR-1,9927531,6.184289140362073
COR-L105,11455910,0.425998653780944
SW982,6505803,-2.367469745570856
Panc 05.04,selumetinib-GDC-0941 (4-1 mol-mol),0.8434992349336349
CAL-62,11455910,1.9126970012437423
SK-UT-1,3825829,4.314395004241866
BT 498,4705,4.208148450276773
P12-Ichikawa,387447,-5.072899992001716
BT 147,11455910,0.0190221125535866
GaMG,42642645,0.9111711588298268
COLO 320,6505803,1.3976396139000618
RERF-LC-Ad2,100016,6.703705933143471
Panc 08.13,11167602,3.0281577588813966
AN3-CA,387447,-4.801616318597083
ST486,9927531,3.885019702146961
A101D,12001922,1.1628121240924432
BT 504,6505803,-4.714346364333315
SNU-423,136227924,3.242018782370702
SNU-1,4705,2.948044298069726
LOX-IMVI,15953870,3.5036673786727683
H-STS,387447,-5.130568890460207
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
Hs 852.T,selumetinib-GDC-0941 (4-1 mol-mol),1.139310291685008
EFO-21,12001922,3.0957899735002594
TT2609-C02,2746,4.994680494565545
SNU-182,15953870,2.49352124035998
G-401,11455910,1.3171347053017213
Hs 944.T,54649381,4.02018420291038
OVCAR-5,10385095,1.4205658100211482
Detroit 562,selumetinib-GDC-0941 (4-1 mol-mol),2.228637480790017
SK-MEL-5,12001922,2.0688607607777856
SK-N-MC,387447,-5.540748245044049
NCI-H2087,11455910,0.3125785540763442
HCC1500,10385095,0.8648832931247582
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
COLO 684,15953870,3.489074911155315
KYSE-450,12001922,2.3081029542586027
NCI-H716,12001922,1.6497991543254995
NCI-H1915,11455910,3.6924393637334703
NCI-H2286,15953870,4.641288343919363
BCP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.866380650613888
DAN-G,135411,0.8712875376691122
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
SNU-601,135411,0.5368882215365072
NCI-H2110,9887053,6.172725359065793
NCI-H2171,136227924,2.167829841056951
PK-59,135411,1.4779223783785622
U-937,9926054,1.4281376565753103
JHH-4,9926054,1.9011355280949385
BL-70,15953870,1.7010227279184564
BT 224,387447,-5.013635333417285
BT 179,9926054,2.969670240545962
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
BICR 56,4705,0.1068986630843261
NCI-H1568,54618771,0.8004506686595156
KMS-11,4705,3.23194213568903
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
H-STS,9927531,5.457961831541725
LoVo,135411,-0.4629764704945864
Calu-1,12001922,2.3923423899296683
NCI-H838,136227924,3.210993191129446
MFE-296,387447,-3.740057154514259
KP-4,10385095,0.8824730127283659
NUGC-4,15953870,2.7215900423818105
GCT,49836020,-4.509787849566978
MDA-MB-231,11455910,1.414181949063077
VMRC-LCD,9926054,1.8620502952585032
MFE-319,11455910,1.7600877604233616
SNU-668,11455910,1.1110208427049713
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
MSTO-211H,54649381,3.373909346349482
EHEB,54649381,3.7669466213883425
OVCAR-4,387447,-4.470800325537222
RPMI-7951,136227924,2.219680452566263
WM793,12001922,1.7029195893812905
TE-14,6505803,-1.7378811047388565
LOX-IMVI,54649381,4.093748298589484
MOLT-3,100016,3.7727587478901734
SCC-4,11396600,3.496408170179274
OCI-M1,11396600,3.110541819968075
Panc 08.13,42642645,-0.3813102882031995
HEC-108,9926054,2.177226179063823
TE-14,9926054,1.5943832140078456
J82,136227924,3.3108045260668564
Hs 940.T,54649381,3.757935265051222
JHOS-2,9887053,4.1176028230220165
TE-14,12001922,2.3151035394403916
KNS-60,9927531,4.453206768801637
JHH-1,9926054,1.7588254192067414
Hs 940.T,11167602,2.6924993673578688
SUP-M2,135928012,4.129772048663489
SK-OV-3,10385095,3.0219456492917485
Hs 294T,3825829,4.166435560821025
8505C,135411,0.5303076400869938
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
NCI-H2052,42642645,1.128029637646911
HPB-ALL,100016,7.357554409535215
U-118MG,6505803,-0.4944359132104617
P3HR-1,9887053,5.508801361813419
GP2d,54618771,1.3284936518837778
KMBC-2,12001922,2.090180788791515
786-O,6505803,0.1704415236348838
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
HCC1419,54618771,0.889402864117146
CA46,42642645,0.1424242949920916
LNCaP clone FGC,387447,-4.3744425710670685
HuP-T4,2746,3.1090463727506257
COR-L51,9927531,4.484495617917877
COLO 205,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404403717614667
KE-39,10385095,1.3052459079941114
BT-549,2746,3.8188337512891137
SF126,54649381,4.012473358933059
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
SW1990,4705,4.395682074596428
IMR-32,54618771,0.9755251255632068
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
Hs 578T,11167602,4.417478222776911
RCH-ACV,10385095,1.3487937317088552
HCC1438,2746,3.591868126146154
G-401,54618771,0.8582285882331511
COLO 829,6505803,-0.4572347239935848
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
SNU-840,10385095,2.2002748270654533
SNU-899,387447,-3.8358448890255574
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
NCI-H522,15953870,3.615553645162116
HCC1195,10385095,1.8165824213163204
SNU-685,136227924,3.487679457544809
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
G-402,135411,0.5795909115428128
OC 314,136227331,3.341110019421027
HCC1937,selumetinib-GDC-0941 (4-1 mol-mol),1.9717867215396572
HCC366,6505803,3.392526655908561
HEY A8,387447,-2.90923104242764
EPLC-272H,54618771,2.195123762717199
NCI-H2405,3825829,3.8680211633087622
TT2609-C02,selumetinib-GDC-0941 (4-1 mol-mol),0.2335990554024833
BT 359,11455910,0.3970564809620578
A-549,136227924,3.1395144761786486
SK-UT-1,2746,4.836098417840603
SH-4,49836020,4.187960947372796
T3M-10,135411,1.3173622864197252
NCI-H522,42642645,1.4297074042386375
HCC1395,136227924,3.3223803208690135
REC-1,42642645,2.0902609204351537
SUP-T11,42642645,-0.4427499325757069
MOLP-2,135928012,4.454279798802394
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
HPB-ALL,9926054,1.8714976527379283
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
NCI-H1650,10385095,1.420214094943267
L-428,2746,2.35147790863918
253J-BV,9927531,5.275278966830564
NCI-H2110,10385095,0.9459448618339928
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
MG-63,12001922,2.5146591169115484
HT-1080,3825829,4.150137867445533
NCI-H1734,54618771,0.2470181202194854
TE 441.T,1474550,4.431040328467024
EBC-1,9926054,1.6543051302548544
BT 422,4705,3.053482831247426
MPP 89,100016,6.902779011713528
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
RL,10385095,0.7021691282485717
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
LN-229,24753719,4.985619188567169
MOLM-13,135411,-0.7080955458923358
NCI-H28,11455910,-0.4430310622826519
BT 159,54649381,3.7375765593376578
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
MIA PaCa-2,3825829,4.074033438975014
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
KYO-1,9926054,1.8377950360183533
NCI-H358,11396600,3.567926614566842
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
LAMA-84,54649381,3.792958398004688
Hs 895.T,387447,-3.4359646297069952
BT 444,12001922,1.0083929080196758
Lu-65,3825829,3.880703687258769
NCI-H1869,24753719,5.307545419394006
NCI-H2228,54618771,2.218595953642778
TE-4,24753719,4.832981500993744
Daoy,54649381,3.687679725973642
SK-N-AS,49836020,4.951261339623108
RL,11455910,-0.0595035434135363
ECC10,9927531,3.415986585333862
U-BLC1,387447,-5.23576089371183
NCI-H2171,9927531,3.1501077196413783
CAL-29,15953870,3.29426671118957
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
ChaGo-K-1,11455910,-0.3769194241823518
GI-1,11167602,4.291743377924148
SNU-489,44197249,3.748714143321332
RERF-LC-MS,3825829,3.876424055067748
YD-38,12001922,1.852128176270752
BT 172,15953870,4.109968279365587
COR-L51,6505803,-0.8323566824264805
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
LoVo,12001922,1.64420677630862
NCI-H841,387447,-4.277551504303055
SCC-25,136227924,2.958495944269512
SNU-61,4705,2.600761934037586
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
NCI-H1915,2746,2.498380618372834
DEL,9887053,1.6339504982962685
A3/Kawakami,12001922,1.8297841659404463
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
BT 239,9926054,3.266360841464617
SNU-685,135411,0.6727032140605086
RKO,100016,5.817852214634293
TE 617.T,42642645,0.6329124315380535
KNS-62,11455910,1.837200886780492
NCI-H1944,selumetinib-GDC-0941 (4-1 mol-mol),0.8132454381958738
NCI-H2081,11167602,4.408206719858069
MEC-1,49836020,4.363121412189612
HDQ-P1,54618771,4.6079698372057605
SNG-M,42642645,1.950756468674996
SNU-620,49836020,5.484424750861699
Ishikawa (Heraklio) 02 ER-,3825829,3.6769006859587465
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
NCI-H1155,100016,6.5684025185087505
HuT 78,54649381,3.65840256094047
KG-1-C,11396600,4.230481509625587
A-673,12001922,0.9671300191794728
PF-382,54649381,2.3884242532831768
SNU-869,44197249,3.827925368069944
BT 416,54618771,0.7344198776151593
SH-10-TC,11455910,0.8075465879192946
EFO-27,3825829,4.213579429540561
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
HEL 92.1.7,9926054,1.77080435305732
Karpas-422,24753719,4.137089222307065
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
KM12,135423438,-1.274556391505103
NCI-H1694,11167602,2.150711211230678
HD-MY-Z,12001922,1.622677629407643
MPP 89,24753719,4.361684711095618
KP-N-SI9s,4705,2.458330533365605
EFO-21,3825829,4.276313572796431
YKG-1,42642645,0.5403714198289554
YD-10B,100016,5.941622042216757
KMRC-2,136227924,3.1141635996197183
HL-60,9926054,1.793392077078212
RVH-421,15953870,3.74601226953608
TE-4,135423438,2.180179409506435
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
IGR-37,10385095,1.6634682367301483
BT 504,9887053,2.369836256466927
NCI-N87,136227924,3.040461203265333
NCI-H2170,selumetinib-GDC-0941 (4-1 mol-mol),2.2424418004959654
EFE-184,11167602,4.805641466870204
NCI-H2286,100016,5.552985583261177
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
NCI-H460,54649381,4.173104904963283
BHY,49836020,5.6544174202433855
RKN,54649381,4.194319964969153
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
SUP-B15,135423438,2.052738806118931
A-549,10385095,1.3823205412091923
NCI-H322,9927531,5.259442104255536
SNU-668,11396600,4.182067548365165
LS1034,42642645,1.366573745689878
DAN-G,11455910,0.9235983275094882
HEC-151,3825829,3.2794548774754384
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
RPMI-8226,54618771,0.103524211569064
SNU-C4,selumetinib-GDC-0941 (4-1 mol-mol),1.401600163987786
DMS 53,10385095,0.6872712876062782
LNCaP clone FGC,12001922,2.092576995336353
ACHN,54618771,1.0716775131315517
Kuramochi,10385095,1.4788010869499648
SUP-B15,11167602,3.88002295585875
HCC15,10385095,2.335943691067567
639V,6505803,-0.4780888890381856
P12-Ichikawa,135411,-2.008624258854393
Lu-65,9926054,1.7186862089776234
NB1,42642645,0.1388412940461961
DLD-1,135423438,2.617658821195633
SK-LMS-1,387447,-4.300147473198931
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
DEL,11396600,2.9496069557825155
CCK-81,100016,4.4296308435579554
LNCaP clone FGC,9887053,1.6596295171491997
DMS 454,387447,-3.969323906722437
NALM-6,9887053,0.8515780040261804
MDA-MB-468,9926054,1.8087827398846443
LCLC-97TM1,135411,0.5874500365845237
KMS-27,387447,-5.343247809144446
CA46,246676,4.699933053014099
P31/FUJ,6505803,0.2535639265329721
SNU-620,54618771,0.0782224190169237
BT 422,11455910,1.0713128287987654
QGP-1,12001922,2.017880593277471
MOTN-1,12001922,0.9449576697980564
Ci-1,15953870,4.141393899020612
SH-10-TC,6505803,1.0685090299796742
Karpas-620,135423438,1.2661543285400736
SNU-8,12001922,1.7857478253759511
HD-MY-Z,11396600,3.2182854001324768
HuH-6,2746,2.1362629951594396
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
HOS,10385095,0.7815307414607308
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
KCL-22,11455910,1.070847957925647
NCI-H2030,10385095,2.209603603161303
VM-CUB-1,3825829,3.4897644348510317
TE-5,15953870,3.394659860942286
SW1116,54618771,-0.9904180488449444
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
GB-1,11396600,3.609932395636561
HCT 15,387447,-4.228339468672935
BT 428,15953870,3.768281629986435
SW1353,10385095,1.4015944143459336
SH-4,9926054,1.7270263084889954
NCI-H1184,4705,5.16871662983158
RPMI-8226,10385095,1.042981164600271
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
Hs 294T,135411,0.8280706413341736
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
Pfeiffer,100016,6.236222400968574
KYO-1,9927531,4.747865514161547
Tm87-16,24753719,4.184606573495666
P31/FUJ,54618771,-0.1557090961755644
NOMO-1,135411,-0.3073928829727976
BT-16,54649381,3.742687902763147
SNU-216,135423438,1.816422149531831
PLC/PRF/5,11455910,0.2914890015755099
HT-1080,9927531,5.0886456677015595
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
MeWo,9927531,4.558706173548934
HCC1419,9927531,5.21935192048334
TOV-21G,3825829,4.413336870923344
SW620,9926054,2.9151394622237823
UM-UC-1,135928012,4.823279700608146
U-251MG,54618771,1.0937916825211575
SNU-719,136227924,2.577096412948206
NUGC-3,12001922,1.850764543497205
PLC/PRF/5,135411,0.9422586029913752
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
SK-N-FI,selumetinib-GDC-0941 (4-1 mol-mol),0.5932957788770222
IM95,49836020,4.204800354439791
NCI-H1573,100016,4.561614919470221
HCC1588,54618771,0.4261259622820442
U-937,42642645,-0.3195086212920157
BT 444,9927531,5.530041138420047
LMSU,24753719,4.829555677738913
HCC1143,387447,-2.8902460626215216
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
MDA-MB-361,54618771,0.6906132618662956
GaMG,4705,3.2307282924763845
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
LS180,54618771,0.643112685351952
BT 231,54649381,3.7104884016936106
UACC-62,24753719,4.34536967174679
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
OE19,6505803,-3.540605672493051
BICR 16,135411,1.19487258513412
RVH-421,10385095,1.0938130776874428
RPMI-7951,3825829,3.4221940030653903
J82,135411,0.7792742532925491
IMR-32,387447,-5.0534644538912445
VM-CUB-1,54649381,3.700102898114625
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
NALM-6,246676,4.335918622435807
HCC44,387447,-3.8254624603474254
KE-97,136227924,2.279256150432482
LXF 289,387447,-4.093727880786265
SU-DHL-10,136227924,2.6642941314249327
CAL-85-1,6505803,0.4315173316533146
NCI-H1341,10385095,0.443628618091825
A-549,6505803,-0.295425809550202
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
HCC38,136227924,2.8991930932960983
COV434,selumetinib-GDC-0941 (4-1 mol-mol),1.0563079487833569
FU-OV-1,54649381,4.3760479468817675
SNU-119,9926054,2.3608984923700036
SCC-4,387447,-3.782373095512828
HSC-3,135411,0.4070318982819898
RERF-LC-Ad2,42642645,1.4647501272846788
SNU-119,135411,0.3740085311650424
Ri-1,4705,2.754354482473573
COLO 800,2746,2.915316687123913
CJM [Human melanoma],10385095,1.0314241373580202
OVSAHO,24753719,5.057101087958629
VMRC-RCZ,246676,4.509007401048671
U-CH1,4705,-0.5183454701294119
SNU-1196,54649381,3.975836868806459
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
PL-21,42642645,0.164390071210332
BT 328,11455910,1.1431162062454217
NCI-H2452,42642645,0.8357005775142816
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
NCI-H661,54649381,3.920223147571483
RS4;11,2746,2.038871596243954
AU565,24753719,4.632017214490639
NCI-H1299,9926054,1.7323284970245385
HEC-151,4705,2.9357366805195735
T-47D,11455910,1.56267041367126
KYSE-520,44197249,3.810576603167388
BT 216,15953870,3.7296482598538985
Mono-Mac-1,4705,2.1526940159262593
BT 147,9927531,5.037418148394567
NCI-H647,387447,-3.8631001490746217
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
TE-14,11167602,2.7334128910951514
KCL-22,9887053,3.9978900663500134
CJM [Human melanoma],2746,4.510121301862787
U-87MG ATCC,selumetinib-GDC-0941 (4-1 mol-mol),3.2770460011243308
CCF-STTG1,54618771,4.049347271840678
EFO-27,15953870,3.8448280803188233
EB1,9927531,2.850216647233053
IM95,246676,4.3722455515816
MOLM-6,11167602,1.1493810873642791
GA-10,9887053,-0.6474807816546203
WM115,11167602,1.5239005360441813
SK-N-MC,9926054,1.7404893912673354
NUGC-4,10385095,2.5267185642809498
HEL 92.1.7,4705,5.773447886671419
SU.86.86,11396600,3.58919118666286
Ku812,387447,-5.271865105209625
SK-N-SH,135411,0.5127151955242248
G-402,15953870,3.3708479683482127
SU-DHL-10,11396600,3.7742694309184297
JeKo-1,135411,-0.2186773636403685
TE-11,387447,-3.740267791095687
SJSA-1,11167602,3.0869867358954126
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
SW48,12001922,1.4259296039497584
COLO 684,12001922,1.769732075873958
MHH-CALL-4,42642645,0.2381641586834445
NMC-G1,42642645,1.1047489593795097
647V,9926054,1.756736719694015
ONS-76,100016,6.019166856387977
DU4475,100016,3.3182611876021157
NCI-H292,12001922,1.805770236255338
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
23132/87,42642645,1.5096172894282742
LNCaP clone FGC,24753719,4.279348645230378
DMS 454,135411,1.3482988813424366
CAL-29,136227924,2.032112399542908
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
JJN-3,100016,3.8434142095984303
MHH-CALL-4,135411,-0.3032175747249798
KE-97,9927531,3.606406667936729
HCC1833,42642645,0.6311898861195337
TM-31,3825829,4.133532029245381
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
RPMI-7951,12001922,1.647334289946116
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
SCaBER,135411,0.6647927526664434
Daudi,6505803,0.7229387165377155
SNU-1214,10385095,1.848528700998056
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
HSC-2,9887053,4.321078963559144
YD-15,9926054,1.8520578861045605
NCI-H520,15953870,3.2948576647285797
KE-39,42642645,1.367345124375733
RPMI-8226,136227924,2.992898649350054
Ku812,3825829,2.937255635905749
BT 145,3825829,3.9482825322373207
NCI-H2405,54649381,3.948261108676486
CCK-81,6505803,-1.799603519174377
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
Caki-2,15953870,4.38220553723398
WT2-iPS,387447,-4.901498068427168
BT 333,2746,4.493584993819337
YD-15,135411,0.2349376716896317
LOX-IMVI,2746,2.55877549764083
SNU-C1,15953870,1.8406144078242743
Rh41,54649381,3.170640992570448
HD-MY-Z,3825829,3.737933206647403
PLC/PRF/5,24753719,3.8725658441506368
MOLM-13,387447,-5.119095777855545
COLO 320,54649381,3.5963454362826655
HEC-265,387447,-3.846846491409912
COV362,selumetinib-GDC-0941 (4-1 mol-mol),2.9953812620195066
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
SK-N-SH,9887053,3.900914446127006
SNU-738,9887053,4.4132262532624225
T-47D,15953870,3.585837264475181
OCI-AML-2,24753719,3.4649014261279234
NB4,6505803,-1.6595544122287686
SU-DHL-10,42642645,0.0278873392733708
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
NCI-H1435,54649381,3.021017554973611
SW1271,54649381,4.56488530045006
UO-31,11396600,1.978530758998764
NCI-H1092,42642645,1.4285528009484267
DU145,387447,-4.445676725008602
Hs 766T,selumetinib-GDC-0941 (4-1 mol-mol),-2.707404573640349
BHY,11455910,2.7739554462043112
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
DLD-1,12001922,2.3163646379177467
WM88,54618771,1.141068520778182
SNU-61,54618771,-0.470226071786205
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
COLO 668,15953870,3.220146246948608
NCI-H1341,11455910,-0.2175400116786661
OCI-M1,11455910,0.9199836560966144
NCI-H520,54618771,1.0653077757718592
HPAC,24753719,4.331008763420313
Peer,6505803,-0.1877996402044426
ES-2,11396600,4.145090695204245
SNU-C4,11396600,4.202175701473822
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
SW48,9926054,0.5681768331785455
Karpas-620,9927531,5.121600131108068
HuH-1,24753719,4.403946384068282
HL-60,135411,0.5408462955215471
EHEB,15953870,4.2659113550785595
MOLM-6,100016,5.4880920806856865
LMSU,54618771,1.0017714306772694
NCI-H650,10385095,0.8249157569073927
U-CH1,10385095,3.2714624879482956
OAW28,54618771,1.1011370240470315
KYO-1,3825829,3.433797829467159
LOU-NH91,9926054,3.1176474597994908
P-STS,42642645,1.6272766190810968
HT-144,10385095,0.494228786741112
D283 Med,135411,-1.9342059509823124
Capan-2,6505803,-2.2561135668737533
DND-41,246676,4.979248741445813
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
RS4;11,9887053,0.6146521058585034
HSC-2,42642645,1.2156806046884086
NCI-H292,10385095,1.2562128411100733
NCI-H1395,54618771,3.4411900765558125
Hs 729.T,42642645,1.2008667584313113
CAL-54,24753719,3.5155753888160306
GI-1,42642645,0.0493777134295064
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
KM12,selumetinib-GDC-0941 (4-1 mol-mol),1.4045070472454428
TTC-709,387447,-4.251430137664213
DB,12001922,1.303791599828212
UACC-62,9927531,5.07743176976165
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
HSC-2,6505803,-0.2270434612108878
Hs 683,9926054,1.7064216062537565
KMBC-2,135928012,4.465224778976871
SK-MEL-24,6505803,-0.5263584853555022
GaMG,54649381,4.99519529579039
SK-N-BE(2),54618771,0.9594673871894048
Aska-SS,12001922,1.1901080826215733
NCI-H2452,100016,6.6405878618594985
Panc 04.03,387447,-4.060832381569581
SCC-9,4705,2.492131143046821
NCI-H1568,49836020,3.1231470101883336
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
HT-1197,136227331,4.1686832896523685
GDM-1,6505803,0.9886277472188528
A2780,54649381,3.634529154077109
JHH-1,10385095,0.9212963748686652
OPM-2,136227331,3.7431952210756014
HCC1500,136227924,2.675203690625814
HCC78,54649381,3.843915825706377
CAL-85-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1820592337314743
COLO 699,42642645,-0.6777391963563282
NCI-H1623,3825829,4.488518875119825
HT115,selumetinib-GDC-0941 (4-1 mol-mol),-0.4177192932655061
HCC1588,9927531,4.588881343798492
Namalwa,42642645,0.3352240740036911
OPM-2,11396600,1.8817984525619431
KO52,24753719,3.780928273062828
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
FTC-238,1474550,4.530529785630255
P31/FUJ,10385095,1.5135865779060806
DK-MG,10385095,0.8287186184930233
LS180,15953870,3.325208983942858
TYK-nu,135423438,1.6233801732572664
IST-Mes1,54618771,0.8929247318821524
MCF-7,11167602,4.300198069535502
Hs 578T,2746,2.072712678704015
JHH-6,9926054,3.460826847853425
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
MOLM-6,9926054,1.5702726782081282
U-251MG,6505803,-1.162158161162463
AGS,73707440,4.5504628850403
HCC366,selumetinib-GDC-0941 (4-1 mol-mol),2.581638032416284
PaTu 8988s,11167602,2.4534499550927653
BT 340,4705,3.3902514957212153
SK-N-SH,4705,2.8516151129930396
HCC1438,387447,-4.10465763962439
KYSE-140,11396600,4.836880334492914
MeWo,4705,3.307515593807436
BEN,12001922,1.810873556180342
FTC-238,54618771,3.2424899672946195
LC-1/sq-SF,3825829,4.5694969922835575
NCI-H292,6505803,0.1482155149138876
NCI-H2228,6505803,-0.5994588294177822
TE-6,54649381,3.679610172362025
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
RL,42642645,1.6098852469160734
NU-DUL-1,54618771,-1.656554068738758
OC 314,42642645,1.2636835014330388
A-673,44197249,4.247235211402652
SNU-216,54618771,-0.3617470583099299
EoL-1,135423438,-6.8618615828632565
JURL-MK1,387447,-4.856144413566707
HCC1438,6505803,-2.462970464658383
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
NCI-H2029,15953870,3.761607551225198
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
TE-4,54649381,3.7788411517778857
REC-1,9926054,3.5400616992055847
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
HEC-251,135411,0.7382049801010451
DOV13,9887053,4.563762217016214
VCaP,12001922,1.8729698384574696
KM12,10385095,1.303034363246703
HH [Human lymphoma],42642645,0.5702542724747921
A4/Fukuda,135411,0.1560078623072997
RPMI-8402,135411,-0.7281276056296015
NCI-H1092,3825829,4.014845832677727
786-O,136227924,4.54082640186513
NCI-H1838,3825829,3.396831243995627
Peer,9887053,2.6845860305518143
WM1799,4705,4.447302669477667
DBTRG-05MG,6505803,0.4569026356625297
HT-29,3825829,4.297956362425155
769-P,54649381,4.118767736311135
LS1034,135411,0.4135275119713904
NCI-H2085,54618771,-1.2353665657353068
NCI-H2444,10385095,2.9742620314108255
A-204,3825829,3.618000173873014
Toledo,3825829,3.8389416699526406
Ki-JK,9926054,1.4842884582556586
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
OC 314,15953870,3.232051295893418
HCC1143,11455910,1.411815978618001
HEC-6,12001922,1.662165040421573
SNU-899,12001922,1.9314520594740976
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
SK-UT-1,54618771,2.629062811355061
NCI-H1184,9926054,1.8119934997453773
KG-1-C,11167602,3.59062870021396
Hs 578Bst,9927531,5.122326242765859
YAPC,387447,-2.999100837413036
BT 271,6505803,-3.278165748164475
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
TUHR4TKB,42642645,1.4945058715703836
PC-3,24753719,4.295930498728442
NCI-H322,42642645,1.601350136235903
GA-10,136227924,1.4612725021832749
A2058,4705,3.593116670395646
SNU-C2A,136227924,3.0438027551295352
NCC-StC-K140,2746,2.399339405510586
BT 147,9926054,1.807277739033318
KYM-1,9887053,1.216029311283058
LOX-IMVI,9926054,1.7031980960413209
HCC2218,11455910,0.1685104412294276
NCI-H1792,selumetinib-GDC-0941 (4-1 mol-mol),1.680387740806623
MOLT-16,6505803,0.4764435531440419
MDA-MB-453,4705,2.8938913201458583
HEC-151,6505803,0.2052514279790806
TALL-1 [Human adult T-ALL],54618771,-0.8815186258752705
SiMa,9927531,3.724506882989752
YAPC,6505803,-0.1975849276423945
LN-18,12001922,1.755848808589523
IPC-298,12001922,1.753462100248321
HEC-1-B,11396600,5.535370939543194
HPB-ALL,54649381,3.474237619141925
CHP-126,11396600,3.667072533638785
JJN-3,54649381,3.2764391948302234
LOU-NH91,2746,5.002248002286792
CAL-78,selumetinib-GDC-0941 (4-1 mol-mol),2.58322288214442
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
8505C,15953870,3.4286601292332204
MPP 89,11396600,3.423222859590498
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
NCI-H747,100016,6.898929440027426
RKO,4705,3.750134101835121
KYSE-30,11167602,2.2363334961957784
YD-15,12001922,1.9828330012379096
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249
Lu-99,11455910,-0.2189814587074641
NCI-H2342,387447,-3.5069057887821615
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
Kasumi-2,49836020,6.151495097204233
KYSE-150,11396600,3.904935557523132
HT-1080,42642645,1.2173198333359505
SNU-5,42642645,-4.423152797825905
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
FTC-238,136227924,2.431059366258334
Kasumi-1,9926054,1.808732421420859
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
SBC-5,9887053,2.384081187432928
SNU-16,6505803,-5.221093931145045
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
BT-549,100016,6.139281322747303
IST-Mes1,12001922,2.6228240364869113
Rh41,135928012,3.196093656971978
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
GOS-3,387447,-4.946086426612472
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
NCI-H1105,9887053,1.5126154607737237
HL-60,387447,-5.09727748897219
COV362,2746,5.138153782003929
CAL-51,24753719,3.9981702522006257
HuP-T3,6505803,1.3238670991795596
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
NCI-N87,3825829,3.9513849877108207
COR-L51,11396600,3.4123493157330027
P-STS,selumetinib-GDC-0941 (4-1 mol-mol),4.834100084681968
MDA-MB-231,42642645,1.9473218978821516
NCI-H2126,42642645,1.0081247936014384
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
FTC-238,selumetinib-GDC-0941 (4-1 mol-mol),2.3347122521245396
MDST8,3825829,4.752817875520721
SW579,10385095,0.7098346172725386
DEL,42642645,0.0897143780892457
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
K-562,11455910,-0.068399521398108
NCI-H1341,6505803,-3.3380388018759772
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
VMRC-RCW,100016,5.733604538717687
SK-N-FI,11396600,3.485816734238302
HCC1500,246676,4.424448695399937
HCC15,11167602,2.587200682435675
NCI-H211,49836020,0.8643825091547783
BT 164,3825829,4.193878990701187
Capan-1,9926054,1.8783300658857656
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
OV7,11167602,2.335895680675998
GaMG,11167602,2.454786240978928
T-47D,54649381,3.812726890517992
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
HEC-59,9926054,2.31296864465942
GA-10,3825829,3.574861174929505
HCC38,387447,-5.636972664828067
42-MG-BA,3825829,3.5600424884124253
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
Pfeiffer,11396600,1.1420767199469808
Li-7,42642645,-0.9200367848225984
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
L-428,4705,3.188037531722373
CAL-51,54618771,0.0049145289548569
DMS 273,12001922,1.9670879212293255
A4/Fukuda,100016,4.8831896191852096
CAL-120,15953870,2.7073956497060165
TE 441.T,135411,0.5500346816082857
UO-31,42642645,0.2224739112071816
OVCAR-8,42642645,2.832345644908765
DV-90,387447,-4.999921691302061
SNU-668,54649381,3.6743640167823495
EoL-1,11396600,0.6541827154317742
Peer,12001922,1.2941302378827375
NCI-H1373,54649381,4.169120473191437
TALL-1 [Human adult T-ALL],selumetinib-GDC-0941 (4-1 mol-mol),0.2604149322081276
CAL-51,135928012,4.192641653546412
COV434,15953870,2.9333779977451138
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
NCI-H838,9887053,4.227029711619212
NCI-H522,135423438,2.202740699610144
DV-90,135423438,2.6619709505145637
HCC-56,54618771,1.0985960691001735
NCI-H510A,135411,0.832028903162037
Calu-3,12001922,1.0112232356892157
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
KU-19-19,73707440,5.592820593626321
KP-3,10385095,2.538896937216095
NCI-H2023,9926054,1.8656368845898197
JMSU-1,11396600,3.5882148906168254
BT 147,135928012,4.035578037937673
KYM-1,24753719,4.923463214660134
MDA-MB-231,selumetinib-GDC-0941 (4-1 mol-mol),2.1561447118873383
NCI-H520,6505803,3.2437812579556864
MOLP-2,3825829,4.253993017976943
Hs 688(A).T,9926054,3.3187342382489255
MOLP-8,6505803,0.6382990348001342
HuP-T4,11455910,2.9391845361778532
OV7,49836020,5.356073606057271
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
SK-MEL-5,2746,2.5702716912932337
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
VMRC-RCZ,44197249,3.9297847689455945
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
KYSE-70,12001922,1.7900886800743383
TM-31,387447,-4.661908457469729
SaOS-2,42642645,-0.01972406793895
NCI-H69,11455910,1.576050849827518
Panc 05.04,2746,3.125163927586484
SNU-201,12001922,1.797232844479541
MDA-MB-157,49836020,-4.4611089332084335
Granta-519,54618771,-0.1786557603441652
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
M059K,9887053,4.408394472763761
Ci-1,9887053,3.57755003859598
5637,54618771,0.8259357118151949
KYSE-150,11455910,1.1327678102936536
SNU-C5,136227331,4.384397979730017
AGS,136227924,3.766909782373439
SK-N-MC,135928012,3.5327380828942383
NCI-H1838,10385095,1.4314827828981946
JHH-5,136227331,4.11271540989167
Mel JuSo,11167602,6.074489946927437
SCaBER,100016,6.423492154596734
NCI-H1563,11167602,1.8845981628245831
NCI-H2087,100016,6.366125554898137
BT 248,6505803,-0.8385222866943476
CFPAC-1,12001922,1.889915230102209
A-673,49836020,4.096681472773702
SU-DHL-10,387447,-4.734051132640442
JJN-3,24753719,4.0858319271855175
KP-2,12001922,1.8054118649529691
NCI-H716,135411,1.2360299541171125
JK-1,2746,0.8600907908975023
Caov-3,11396600,3.9486242065815738
COLO 684,9926054,1.5779304975312065
HCT 8,135411,2.427882515224821
JJN-3,11167602,2.3976970643938436
SK-N-AS,15953870,3.313993154958585
LS1034,10385095,2.0322534617013623
A-253,135411,-0.1066885622478781
DMS 454,2746,1.9739977196857323
NCI-H1355,135411,1.9591460125401896
HEC-151,12001922,2.1072309594101086
COV434,54649381,3.656684100673021
NCI-H526,12001922,1.6327761705977564
YAPC,9926054,1.8358643335634888
COLO 829,9926054,1.880005790170633
BICR 31,387447,-3.4745770631768553
NCI-H524,11455910,0.6737102909376176
RPMI-6666,54618771,0.781806189170932
NCI-H2081,136227924,2.7498424735477913
TE-6,9926054,1.628264374651606
OCI-Ly10,9887053,4.327942194300294
Mono-Mac-1,9926054,3.1061890381784187
BT 231,9926054,1.8669465776815437
COLO 699,136227924,2.9902058739506385
Kasumi-1,3825829,3.964411216921587
OE21,136227924,2.0991161235844404
NCI-H1581,15953870,2.1898739803127847
SW1417,54618771,0.6384319893864374
Rh30,54649381,3.846703886529124
RMG-I,135411,-0.205961012414646
Hs 683,135411,0.700670072035792
OPM-2,136227924,1.7425170628423947
HEC-50B,3825829,4.4690100390651315
NCI-H747,15953870,2.641660850974131
WM266-4,11396600,1.7325332738125347
BT 416,6505803,-2.5410330503454173
TE-8,selumetinib-GDC-0941 (4-1 mol-mol),2.5154311677987575
BT-474,12001922,1.0320072484034275
DMS 273,15953870,3.8128904638275216
MOLM-13,49836020,-0.1965532240483963
KNS-60,135411,0.1268551704824933
HPB-ALL,15953870,3.213347861069202
42-MG-BA,11455910,2.2214845082540813
G-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.129609857983409
NCO2,11167602,0.0770809640123331
LAMA-84,73707440,4.880808269322907
BT 498,135423438,1.8216974125096568
MKN74,3825829,5.028254794750419
HEC-50B,387447,-4.014166780016221
SK-LMS-1,24753719,4.4754402870161485
23132/87,54618771,0.9253043807120772
MDST8,54618771,1.2096098448968695
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
HD-MY-Z,2746,3.1927944542914393
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
THP-1,6505803,-1.3271534570910488
SF268,135928012,5.414212013148948
TE-5,9926054,1.840497993611495
MDA-MB-435S,2746,3.2936917461422426
COLO 678,10385095,1.3568398033930142
HCT 15,6505803,0.2162599595018707
NCI-H2286,54649381,4.382793176488884
SUIT-2,54618771,1.0369427055295135
MDA-MB-157,387447,-4.079240132125457
NCI-H524,135411,0.0002618658292431
NCI-H1869,42642645,1.3954170409757802
BT 139,54618771,0.6654274606551459
PC-3,9926054,2.02880432108919
8305C,136227924,2.5381850582467913
SW579,12001922,1.0574135381368388
L-363,387447,-5.107294671134819
KATO III,11455910,0.859891525831657
BT 440,387447,-4.343909187687206
RERF-LC-A1,100016,6.9126876628990885
IGR-37,135411,0.8646527835114131
COR-L88,10385095,2.957735311196338
Peer,49836020,4.240424721025454
LS123,6505803,-0.3996553163472341
SK-MEL-5,42642645,1.5986422400461986
KP-2,9927531,5.1844073401368735
Calu-6,136227331,4.4599645259954555
Fu97,42642645,-0.3851605479153562
Ci-1,11455910,-0.0933169767027184
RVH-421,135411,3.7772915057140417
WM1799,136227924,5.317137472440357
Hs 746.T,9926054,1.836274642391939
8-MG-BA,135411,0.9057354016298808
NALM-6,15953870,1.870535972849895
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
SK-LU-1,387447,-2.872984091497821
RMG-I,10385095,1.4066751823682933
786-O,11396600,5.6652705596340045
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
SNB-75,42642645,0.3157572030530078
KYSE-450,11167602,4.298081277499996
TCCSUP,136227924,3.28330337763218
EFO-21,2746,3.739979027331037
MG-63,387447,-4.9134398622205016
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
JHH-5,6505803,-2.587639781058575
OCI-Ly3,12001922,1.6508032602531697
TTC-709,135411,0.6439502308609487
NCI-H661,136227924,2.7818959309662183
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
SNU-1214,54618771,-0.4857643216446591
HSC-2,24753719,3.8368377039493726
COR-L88,11455910,2.1470995526848258
NCI-H508,10385095,3.2185483792292
BT 330,12001922,1.1352898980242132
NCI-H1694,12001922,1.1685906275250846
DMS 454,3825829,3.400298652301806
SW1463,15953870,3.283482316204368
KMRC-3,54649381,3.5688325798930496
NCI-H1155,12001922,1.6775408668542555
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
NCI-H226,11455910,1.847807065010321
HT115,42642645,-0.1582848188368927
WSU-DLCL2,10385095,-0.5858040483296952
KE-97,6505803,-0.1313893221516437
SHP-77,selumetinib-GDC-0941 (4-1 mol-mol),3.697439866327475
L3.3,12001922,2.4292832661010557
TE-9,387447,-3.833842626139411
SW1463,9887053,1.032433665952219
HMC-1-8,15953870,3.5706847273661473
A-498,12001922,2.3665933531109564
42-MG-BA,54618771,0.7266363256889177
RL95-2,10385095,1.1225720295363144
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
CHP-126,15953870,2.60090482772569
MKN74,15953870,2.991843284853693
SEM,11455910,-0.3463344343386808
H-STS,11455910,0.6438795438543947
L-363,11455910,-0.1325866927171838
SW579,11455910,0.492813014431951
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
COV644,10385095,1.9854494861644112
TF-1,12001922,1.8993436560310355
JHH-1,135411,1.3082315883521831
SK-HEP-1,9926054,1.934364320328667
NCI-H650,selumetinib-GDC-0941 (4-1 mol-mol),1.2489714260088474
COLO 678,42642645,0.7925243593257668
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
KYSE-70,6505803,-1.025033993677824
SNU-61,54649381,3.9147762798202863
NCI-H1703,15953870,3.950055362058786
SUP-T11,44197249,4.2195322273667495
KMS-18,3825829,3.6703354163107065
F-36P,135411,0.818269408267781
EKVX,selumetinib-GDC-0941 (4-1 mol-mol),0.6299385991814179
SNU-878,selumetinib-GDC-0941 (4-1 mol-mol),0.5330473997899833
CJM [Human melanoma],100016,5.681499096329984
P3HR-1,2746,2.544135667971718
JURL-MK1,54618771,0.584482701420473
EKVX,12001922,1.6934203245661452
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
NCI-H2170,100016,6.477443817994488
NU-DUL-1,9927531,4.217714200280878
NCI-H2122,54618771,0.6219971058133998
SW1990,24753719,4.9557561363455624
GCT,4705,3.1348509657034036
BT 328,136227331,5.061934875267611
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
C2BBe1,135928012,3.5937325383146423
OVCAR-8,11167602,4.778235565433844
HT-55,10385095,1.4002254501907747
NCI-H929,54649381,3.9072363732080535
MOLP-2,9926054,1.6077834745045567
SNU-503,100016,6.601678520618542
SW1271,4705,3.86061099620112
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
HeLa,15953870,4.982907578745
TF-1,24753719,4.143029120811382
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
A-204,selumetinib-GDC-0941 (4-1 mol-mol),0.2553877558733737
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
IGR-39,15953870,4.63111831131581
KYSE-510,42642645,1.5790175631495278
A-253,selumetinib-GDC-0941 (4-1 mol-mol),2.2204781544732284
HCC1833,11396600,5.135041940263416
NCI-H520,73707440,4.350001287035215
NCI-H1869,42642645,1.3954170409757802
Hs 578T,42642645,1.0573459465672317
NCI-H661,9887053,5.171148908960024
HCC1937,15953870,3.9021464568616873
SUP-B15,12001922,1.6539905429285855
SW1088,136227331,5.532811982625497
HuP-T3,4705,2.7233440783632608
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
KYSE-140,6505803,1.6434747535859726
KMS-26,24753719,3.990171932388741
TE-6,11396600,3.777010025535689
TE-15,42642645,0.6450047304037199
NCI-H2052,387447,-3.1060771474636777
HT115,9926054,3.740593425047279
SNU-182,11167602,1.968372521302316
AML-193,100016,3.9854178308912074
SUP-HD1,49836020,4.390823916389519
KE-37,6505803,-0.078936185166994
BT 340,9927531,6.379921104021661
HL-60,42642645,0.1466674928670009
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
HCC1500,11455910,0.2448151005088887
OUMS-23,54618771,-0.8110473327008938
Caki-1,15953870,5.076007888885171
SU-DHL-8,42642645,-0.3624539461280198
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
JHUEM-3,24753719,4.082083068058561
BHY,54618771,-0.7807984758131394
HPB-ALL,6505803,2.1919107783283573
EoL-1,136227924,1.175653355009707
CAL-148,9887053,2.998977555870275
Hs 944.T,4705,3.126834538989372
EN,15953870,5.95263323852266
TE-4,9927531,4.138970102101572
NCI-H2196,9926054,1.658766361497933
SNU-1196,15953870,4.14320775106977
SK-N-AS,3825829,4.113120296702569
5637,54649381,2.7096996689808512
NCI-H1184,135411,0.1843383199757329
8-MG-BA,49836020,-4.019161217996327
BT 428,9926054,1.9432227600739695
TUHR4TKB,387447,-4.527588170208976
SIG-M5,9926054,1.755465184389032
KMS-18,15953870,2.7681626625677596
SET-2,15953870,2.8793590754908926
BT 440,11396600,2.3245110777445728
OCI-AML-5,54618771,0.4264677614075425
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
NCI-H1694,136227924,2.5297757130143887
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
CAL-54,selumetinib-GDC-0941 (4-1 mol-mol),0.8998815087239347
BT-12,11396600,3.9879207117312943
NCI-H1944,15953870,2.9936445779539382
T84,136227924,2.5199027398538707
HCC78,9926054,2.494370122209171
BC-3C,54618771,1.3234339265863326
KALS-1,42642645,1.6177449386823612
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
DB,9927531,3.16097275010185
HCT 8,9926054,1.7590637787808916
BT 416,15953870,2.7613678891160314
BEN,54618771,1.4690006980639003
Hs 729.T,135423438,2.291077671494273
SK-MEL-3,24753719,4.863122553951076
OCI-AML-2,100016,4.069849166636085
NCI-H1869,54618771,2.934235316942264
SUIT-2,387447,-2.953323382165442
BT 147,54649381,3.834593327085589
KMRC-20,12001922,1.7493187520827975
SW1353,6505803,0.3759495055091644
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
RERF-LC-Ad2,12001922,1.5702211119337048
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
SNU-81,44197249,-2.185783961489413
OVCAR-5,9927531,5.160514110518488
T24,135411,0.6229547867082265
NCI-H446,9887053,3.964503090884374
HuCC-T1,135928012,5.203582273263356
MDST8,9926054,1.8075400364112937
SF126,11396600,4.209455624849945
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
LCLC-103H,54618771,0.2983505798341654
Panc 08.13,387447,-4.668296268436948
BT-474,54649381,0.0597394528158466
HCC827,9926054,1.8610804670039272
A-253,10385095,0.7860799600541231
DB,3825829,1.8965329067227965
RT-112,54649381,3.7935691664289313
JHUEM-7,44498493,4.377210363637701
BICR 56,9927531,5.497555124114839
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
GP2d,3825829,4.454546832416788
NCI-H2122,42642645,1.7218128407798157
NCI-H23,54618771,-0.0460259250887816
NCI-H2170,387447,-4.4846588227416015
A-673,135423438,2.29660224903782
LUDLU-1,12001922,2.641025858331752
BT-12,9887053,4.24890737152825
H-STS,135928012,3.8653043239054976
SNU-308,9877608,6.965514964870985
BICR 18,9927531,5.5562254884624895
NCI-H841,24753719,4.206007237159814
BT 498,136227924,4.389685115045935
NCI-H727,9887053,6.41036176282966
MDA-MB-453,9927531,3.885109165752666
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
CAMA-1,54618771,-0.4577950074396519
RT-112,6505803,-1.2171367776544837
ChaGo-K-1,136227331,4.028131370047934
SNU-668,10385095,1.1222457232110925
A-673,6505803,0.2745970276233078
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
HDQ-P1,42642645,1.0231770902785078
HMCB,9887053,4.4985851609275995
KYSE-70,387447,-2.8804562370412765
Calu-3,11167602,2.8347339607086117
KMS-28BM,54618771,-1.095324315742339
SJSA-1,100016,7.674645652371816
DK-MG,9926054,2.480223353364803
HT-1376,12001922,2.205490030105262
NCI-H1838,49836020,4.844484842212348
Malme-3M,4705,3.370041144877098
BT 286,49836020,4.709879888093613
HMC-1-8,246676,4.4072237241276975
HT-144,9927531,5.124270234210206
SK-N-AS,4705,3.5227875242438103
SW948,6505803,-1.4287073835677784
NCI-H1573,135423438,5.2743221635386215
HT,54649381,3.4803131540197314
KYO-1,4705,2.8597279175992925
A-549,135411,0.6793431682717198
SW982,49836020,1.3794416609441722
IPC-298,100016,6.58023685235314
BT-20,11167602,1.9201106442116993
HCC1954,selumetinib-GDC-0941 (4-1 mol-mol),0.8258284821582321
EKVX,135411,1.7911476649648603
TYK-nu,3825829,3.888821650440236
TE-10,12001922,1.824670772718327
NCI-H1435,387447,-2.781534152709602
Hs 766T,100016,6.453782329995662
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
RKN,3825829,4.2934517576030276
SYO-1,24753719,4.366499494987805
EJM,136227924,2.8681258655198367
NCI-H1581,11167602,0.5039767071361789
C2BBe1,4705,2.8323844421338324
RS4;11,4705,2.710513990501979
KO52,11396600,3.051627581840025
CAL-51,6505803,-1.1525670311484852
LK-2,12001922,1.7404177209632283
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
P-STS,11455910,1.4406039312157646
SNU-685,24753719,4.490553777063157
LOX-IMVI,54618771,-0.8031507578309087
RT-112,387447,-5.139519889786105
OCI-Ly3,4705,3.087724315846988
COLO 201,135411,1.5397106447998985
HEC-59,387447,-4.738073441707704
SCC-25,6505803,-1.2912802856416608
MOLP-2,54618771,0.3344993744663657
SNU-81,42642645,1.3921275935464503
RCH-ACV,12001922,2.443580413607848
KYSE-510,4705,3.5266968051066856
BT-20,3825829,4.258781729160101
SK-N-DZ,15953870,3.730825930330099
BT 416,3825829,4.074757546233149
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
Hs 746.T,4705,3.427191561764603
CAL-62,10385095,1.4296656928583205
HGC-27,10385095,0.038631327360896
WT2-iPS,9926054,1.80219025961501
NCI-H1694,4705,3.5318874612096924
JHUEM-3,12001922,2.298963124090484
ALL-SIL,11167602,0.1759872916057691
CAL-33,6505803,1.0338529577109443
Daoy,selumetinib-GDC-0941 (4-1 mol-mol),2.0496212726424914
PE/CA-PJ49,2746,2.1917494925150653
LUDLU-1,387447,-4.026567803175827
SiMa,15953870,2.5278230402131823
Karpas-299,135411,-0.7769699158402811
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
NU-DHL-1,4705,3.159533609841756
Hs 936.T,2746,2.6919045473185284
253J,15953870,2.521482102759506
HEC-151,387447,-4.537682357362599
MOLT-13,11455910,1.8534554613452228
MDA-MB-468,135411,0.7723473923799312
NCI-N87,11396600,3.282772907192936
U266B1,11396600,3.5687128062577447
SNU-503,15953870,4.207490485876693
OC 314,9927531,4.337134005776663
ChaGo-K-1,11167602,1.7675321969112785
MOLM-6,9887053,2.62554936792193
BFTC-905,136227924,2.194418567728585
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
SK-ES-1,2746,2.7060210922441463
RL,2746,2.394974113272841
PK-1,10385095,1.3878392375696291
HL-60,9887053,3.801897516030589
GI-1,15953870,3.684136128627106
BxPC-3,24753719,4.274594841538204
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984
NCI-H1975,11455910,0.0232313677765091
OCI-AML-5,4705,4.476386157060081
OPM-2,100016,3.804278037815123
SNU-387,2746,4.374506555334325
23132/87,6505803,-2.824747584715181
EM-2,100016,3.5566389909433913
UACC-257,9927531,4.918712273550195
Ku812,11167602,0.0017995666708742
NCI-H1623,10385095,1.1256497169747182
PK-45H,42642645,0.8630305118145222
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
GSU,54618771,1.7980525914601972
BT 286,15953870,3.897211275702576
SNU-466,11396600,3.3990634673304707
TT,9926054,1.79906613528668
NCI-H2009,15953870,4.632669867834425
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
OAW28,11455910,2.4986666790908583
SW1353,11455910,2.4581078683414765
KYSE-410,387447,-4.701677943314103
SNU-1041,12001922,3.1545507221855824
KCL-22,54618771,-0.0982742970998633
Hs 839.T,54618771,1.980967408775539
HT-144,54618771,1.2488424909624232
A4/Fukuda,136227924,1.9204852137512072
NCI-H650,136227924,4.852289363773007
SNU-407,42642645,0.5877764105118765
JHUEM-1,136227924,2.224041693066133
KNS-81,387447,-5.029666843511057
A-549,3825829,4.248968416167453
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
LXF 289,3825829,3.6707575370566534
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
SNU-899,54618771,0.9144402364445118
BT 239,42642645,0.8810059710632603
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
IPC-298,54618771,-0.94588727453768
NUGC-4,11167602,1.8627836788845913
NCI-H1184,2746,1.0703875331333406
HCC44,11396600,3.8855375571171846
SW1088,selumetinib-GDC-0941 (4-1 mol-mol),3.0866822201862374
F-36P,11455910,-0.4221924181382917
M-07e,4705,3.81547426285279
A-253,135423438,3.929129844415613
NCI-H2030,54649381,4.795397326449117
HEC-151,24753719,4.229390718265724
SUP-M2,10385095,0.380584113735729
BT 444,6505803,-3.5785929274286694
SCC-25,100016,6.900174579464034
Tm87-16,11455910,1.895109547469087
MDA-MB-361,135423438,1.6675255620633262
SK-N-AS,12001922,1.350346132693266
HT115,9887053,5.574595809036319
COV434,135928012,4.274977578707457
8505C,11396600,3.6355990729160306
SNU-81,6505803,-0.5044882096333503
SNU-1041,54649381,4.319213604857619
Tm87-16,135411,0.8115019086172083
SU-DHL-4,3825829,3.5418228654380552
HCC15,387447,-3.5284625014182556
BICR 6,selumetinib-GDC-0941 (4-1 mol-mol),1.9156863537341864
Hs 895.T,136227331,4.438273380824898
MOLP-2,6505803,0.8225151705149113
K-562,42642645,-0.9952706094252596
VCaP,49836020,3.7297112197262337
JHOC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1101820766966832
CAL-62,9926054,1.583748031587333
SUP-T1,2746,1.6864160186054145
NCI-H2196,2746,3.7981769416630193
EHEB,100016,6.596024177667571
KP-N-YN,72199289,5.448053701160584
Granta-519,135411,0.2246473977843227
JHUEM-2,42642645,-1.8281765677467343
CMK,42642645,-0.1938312677510439
NCI-H2286,54618771,-1.3554512222972157
DB,42642645,1.6455219695098513
ONCO-DG-1,387447,-5.0603866439730645
MHH-NB-11,6505803,-0.1977325958086978
RKO,11455910,0.1271196393609195
SJSA-1,12001922,2.0399976948628713
GB-1,54649381,3.730276018258369
NCI-H69,11396600,3.636933869724233
SUIT-2,136227924,3.4861054974924133
TF-1,136227924,2.8858592548660766
SNU-410,24753719,4.971492186165212
BICR 22,4705,3.4365696424802477
MOLM-13,9887053,0.5396890830211841
SNU-620,3825829,3.357590535124467
KYSE-150,135411,0.7173808146680508
IST-Mes1,387447,-3.626604128124616
MKN74,54649381,4.134428711266374
MOLT-3,9927531,3.2112573350362372
NMC-G1,136227924,2.469359539544405
Capan-1,4705,2.4129084207631943
NCI-H1869,9926054,1.781753958996035
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
EBC-1,15953870,3.77003348875912
SUP-T11,9927531,4.66163575559017
LN-229,12001922,1.6113217280657364
KMS-18,2746,2.154567509155723
RERF-LC-A1,6505803,-1.6574767095757488
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
HuH-6,135928012,3.3984292164338776
Mono-Mac-1,24753719,5.146647018593083
HuP-T3,10385095,0.7178899916931367
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
ST486,4705,3.1106371129539325
OVK18,10385095,0.3993250675244317
HCT 8,2746,2.9621933110100103
IGR-1,136227924,2.467918205864833
KYSE-70,2746,2.8005709054024224
HuH-6,42642645,0.2881824801123396
RT-112,135411,0.3349380881439004
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
SH-10-TC,100016,6.555483038363527
JHUEM-2,136227924,1.8669676160402808
NCI-H2087,54649381,3.78622153080566
Yamato-SS,11455910,2.3027203497268327
C2BBe1,9887053,3.162544320437423
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
SK-MEL-24,10385095,1.8433665427575583
COR-L88,selumetinib-GDC-0941 (4-1 mol-mol),4.210918027029114
MDA-MB-361,11167602,2.1507003029997023
NU-DHL-1,246676,5.479524719053534
A-673,54618771,0.7910545462175201
DMS 114,selumetinib-GDC-0941 (4-1 mol-mol),1.847196257351989
HCC1588,selumetinib-GDC-0941 (4-1 mol-mol),-0.6693543343840518
Hs 578T,10385095,1.132741293219766
SK-ES-1,15953870,3.307195328695077
IST-Mes1,9926054,1.778703370274458
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
OE21,6505803,-1.9429365414296416
CMK,6505803,0.4799814546857159
SNU-5,54649381,3.5344175609316317
DAN-G,11167602,4.211033544620549
2004,3825829,3.728455631882035
EKVX,54649381,3.606283930249216
U266B1,9926054,1.2913740580373996
TE-6,10385095,3.1103566350783476
YKG-1,15953870,4.202012318992034
Daoy,387447,-4.774375996411498
NCI-H1792,136227331,4.237356132647452
LS180,9926054,2.059729849775666
PLC/PRF/5,54618771,1.111508720136614
KMRC-3,2746,3.925965159660651
BICR 31,54618771,0.3365869204450262
Calu-3,42642645,1.181413072164068
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
YD-10B,136227924,2.2440881554064105
COLO 829,42642645,0.997265190485505
JHOM-1,6505803,1.4741173976655575
SNU-620,100016,4.241219903285237
SNU-1076,387447,-5.005799892348099
PE/CA-PJ49,135411,0.8247523784493911
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
Jurkat,387447,-4.540227626984221
KE-39,2746,3.4287978126101337
Detroit 562,3825829,3.1187620167948835
LCLC-103H,54649381,3.974778393100258
NCI-H727,12001922,1.7281936629666887
HD-MY-Z,135423438,3.7471437497344713
YH-13,12001922,2.42245560318508
SK-N-SH,9926054,1.7311235151913027
A-172,54618771,1.0559368295396556
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
PaTu 8988t,6505803,-0.6279165545759258
COV644,15953870,3.6176563913660593
NCI-H1734,49836020,-1.214582633360451
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
A-673,11455910,-0.0977898825280259
UM-UC-1,9926054,1.7733389617998403
SNU-668,135411,0.4490653024374822
LAMA-84,9926054,1.7519699359088703
BFTC-909,100016,5.8134150302243865
HCC1954,54618771,-0.9668163478355224
NCI-H2052,9887053,4.392057354492596
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
OVCAR-5,12001922,1.786035165789309
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
SK-N-MC,4705,3.836161182771402
NCO2,3825829,2.543330928254624
NCI-H810,9887053,2.1477266667835
NCI-H1581,6505803,1.0030627815723745
8-MG-BA,9926054,2.058364924251872
COLO 668,4705,2.9161430559961588
IPC-298,selumetinib-GDC-0941 (4-1 mol-mol),-1.1184200059628775
SNU-886,9927531,4.416743823533711
SNU-1079,42642645,-0.042181798323702
NCI-H1373,246676,4.432877121602685
SNU-475,42642645,1.5559414568856846
Mono-Mac-6,9887053,4.308148878666837
NCI-H1355,10385095,1.6952620298374113
G-402,11455910,-0.05437779259868
JURL-MK1,11455910,-0.1674344407672636
KALS-1,2746,4.252891034132703
RCC10RGB,54649381,5.891551456540707
OCI-M1,1474550,4.415420788056462
U-BLC1,3825829,4.042251798693961
YD-15,10385095,1.276053613139171
NCI-H1623,12001922,2.89915315578861
Calu-6,135411,1.0942308451180898
Hep 3B2.1-7,6505803,-0.5491843508320539
NCI-H1184,11455910,0.4610574255043957
SK-ES-1,10385095,1.064305584268687
U-CH1,54618771,1.7714870299819865
BHT-101,135411,0.7491967095680389
NCI-H2110,3825829,4.046505267673778
P-STS,135423438,4.306983999338839
Capan-1,9887053,5.359399529574409
NCC-StC-K140,135411,1.3954893339930086
BT-12,387447,-3.627542544355518
DoHH2,6505803,-1.0222007356583789
SU-DHL-10,2746,2.3013930855347877
U2OS,selumetinib-GDC-0941 (4-1 mol-mol),1.8236240565324096
SET-2,6505803,0.5122894661821437
DND-41,54649381,3.4205733607604296
NCI-H661,3825829,3.711058317012711
CJM [Human melanoma],9927531,5.046484804612069
KMH-2,11455910,1.2516447842889498
TT,44498493,4.3272605262528625
EPLC-272H,selumetinib-GDC-0941 (4-1 mol-mol),-0.4942695564653549
BT 428,10385095,1.1753953127951546
EFM-192A,135411,0.6424955990845105
P31/FUJ,246676,3.344572915959865
Calu-6,11396600,3.718739877278185
CAL-12T,selumetinib-GDC-0941 (4-1 mol-mol),2.008414160334409
SUP-T1,4705,3.362457199926275
NCI-H2023,selumetinib-GDC-0941 (4-1 mol-mol),2.6884050561180253
Daudi,135411,0.411387979123234
NCI-H661,4705,2.5155315968978127
WM1799,42642645,1.3095003844965978
U-251MG,2746,3.594174971863172
BT 164,11396600,2.523887599451015
BT 416,135411,-0.0921802672256165
PC-14,4705,-3.029150478382576
JMSU-1,9926054,1.0458929376132455
BT 139,12001922,1.0025758835184926
Panc 02.03,135411,0.8368106867561712
A101D,9926054,1.713643305346107
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
DND-41,135411,-0.6731421760620027
HD-MY-Z,11167602,1.6882998388727035
PC-14,11167602,2.3645338141956924
P31/FUJ,100016,5.4217002529902185
SNU-398,10385095,0.96314398435141
CL-11,3825829,4.893328203109737
HCC1937,42642645,1.5295356677480636
697,9887053,-0.6225700871540578
EFO-27,42642645,1.7670896576814532
OCI-AML-2,387447,-4.763924709512359
SNU-C5,4705,2.835396064750649
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
NCI-H929,54618771,0.737310556758401
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
KYSE-70,135411,1.9014599224142343
RCH-ACV,11396600,2.874378489903408
NCI-H1339,2746,3.2710965804253633
MHH-NB-11,135411,0.0713240924225988
SNU-1,136227924,2.7041604085298205
SNU-466,54649381,3.750485969746157
SCC-25,54618771,-1.4085770807185976
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073
COV362,11455910,3.2611382384479186
Caov-3,10385095,2.182007820321694
TE-15,135411,-0.3374771976719254
COLO 699,12001922,1.7359152895313996
EB1,2746,1.806357780632162
HCT 8,selumetinib-GDC-0941 (4-1 mol-mol),2.0495496026415307
786-O,387447,-5.18068466057743
BT 228,136227924,3.2498510190278314
NCI-H1373,9926054,1.8231885221159896
NCI-H747,10385095,0.9147538624065388
RS4;11,135423438,1.0348635952337828
HuP-T4,135411,1.8399982070270944
Daoy,11396600,3.83670374909926
SF539,54618771,0.9520052550930058
JJN-3,3825829,3.9030635471634545
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
HCC202,136227924,3.1235993915196723
HCC2218,135411,2.314880593616264
BT 228,4705,2.9776742374727436
DU4475,4705,3.033607783661443
HuG1-N,100016,5.877444193140431
Hs 839.T,4705,4.001099763666499
NCI-H446,54649381,2.9476776718021127
G-292 clone A141B1,54618771,3.663374867416664
FU-OV-1,12001922,2.2107336164209586
NCI-H1703,9887053,3.75002048253337
Hs 746.T,11396600,2.998642785885706
GB-1,11455910,1.6376110278947926
TE-8,42642645,-0.0771383199104552
KNS-81,9927531,4.88247851361275
HEY A8,135411,0.1536787451418257
NCI-H841,4705,3.1864652961877917
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965
NCI-H196,11396600,4.033022120096851
TOV-112D,100016,6.758334848108728
BT 179,9887053,4.437751151594675
SK-MEL-1,9926054,2.8910201246716403
IMR-32,10385095,0.2389491055401895
COV434,12001922,0.9034122906742452
SF126,3825829,3.863713516821995
CL-11,136227331,4.347611231682629
EFO-21,15953870,4.263003578382981
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803
KYSE-150,100016,4.009775484830176
SW1990,246676,4.838396695986544
FTC-133,9887053,4.335569761437092
LP-1,11455910,0.2365094775897044
NCI-H2087,136227924,2.807670387816286
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
NCI-H1694,387447,-4.18072363765643
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
LS1034,15953870,3.761005514085335
NCI-H2452,4705,3.641149380662554
CL-11,10385095,1.583542969141602
KYSE-30,4705,4.659105063071051
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
ACHN,3825829,4.659816427062884
23132/87,100016,5.572734576179291
Hs 294T,387447,-5.521880807879572
HCC2108,136227924,3.562843531024723
SUP-T11,24753719,3.652693276768125
DV-90,11396600,2.8019083313135553
SH-10-TC,11167602,1.8651287635055684
HCT 8,42642645,1.5382218025423078
EB1,42642645,-0.3146100978873946
MDA-MB-453,42642645,1.5292302084545462
COLO 792,selumetinib-GDC-0941 (4-1 mol-mol),-1.2874205422493403
SiMa,selumetinib-GDC-0941 (4-1 mol-mol),0.1893088365447134
J82,11455910,0.4504251564245444
TALL-1 [Human adult T-ALL],15953870,2.413112355248274
SNU-119,54618771,1.6343524810724477
NCI-H1869,11167602,4.37189538269334
OCI-AML-3,3825829,3.7401641430818855
NCI-H2081,6505803,1.279924414831301
CCK-81,136227924,2.050553135971544
KMS-34,3825829,2.0862161275490267
ST486,6505803,1.144321831733621
TM-31,selumetinib-GDC-0941 (4-1 mol-mol),1.793600027043238
SF539,12001922,1.3704910391128322
SNU-478,246676,4.356671197134432
CML-T1,387447,-5.712019248069361
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
TF-1,6505803,0.7719508977741311
MDA-MB-468,100016,5.725845417349072
HEC-1-A,12001922,1.309343358015594
CAL-148,12001922,1.568846875992219
SW982,11455910,2.7333702343206547
SBC-5,135411,0.301348299555382
BT-20,72199289,4.513177041132638
MES-SA,selumetinib-GDC-0941 (4-1 mol-mol),2.335158862320408
HCC1500,11396600,2.707080690171913
KYM-1,11455910,1.0218934269529627
NCI-H2085,11396600,4.2540905152728845
SNU-1,49836020,4.400146563188995
PaTu 8988s,135423438,2.605491208286135
NCI-H358,135411,0.2490624917851207
MDA-MB-231,9926054,2.3849554736036613
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
PC-14,10385095,2.2928310628241455
SU.86.86,11455910,1.5020597787375292
BT 328,100016,6.778172011931934
SNU-626,42642645,1.2892729471191988
YD-38,100016,6.21667674155364
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
Sq-1,9926054,2.1337916564135906
HDQ-P1,10385095,2.7310210144681544
KMS-21-BM,11455910,-0.3641448488710944
OCI-Ly19,135411,0.0546672918295754
NCI-H2291,12001922,1.7217797400823511
WT2-iPS,6505803,-3.1225934149726156
BT 422,11396600,2.1657946593546384
Granta-519,2746,3.996696473436098
IMR-32,9927531,3.188320479836116
RMG-I,54649381,4.124547068967285
NCI-H211,42642645,0.3801251971348386
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
L-363,2746,2.0484035065398007
RS4;11,135928012,5.374249825470637
RCH-ACV,100016,4.052738843081589
A-204,54618771,0.0789139316749608
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
BT 245,12001922,1.1359321871248116
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
JM-1,2746,0.8560843341026924
GMS-10,12001922,1.9625907793466444
EFO-21,11455910,1.6034546526861042
NUGC-4,387447,-3.8888180796870904
CL-11,54618771,0.9971438816591957
NCI-H747,11396600,2.4515221760153603
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
NCI-H2087,42642645,0.4197072186190315
AML-193,24753719,3.879406334074648
CA46,9887053,1.048475441216289
LK-2,9926054,1.788707651887683
SK-MEL-24,9926054,2.7611591641517323
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
BT 245,3825829,4.258245820597346
BT-474,2746,-1.392865413318883
BT 164,2746,3.0448887101441793
Panc 03.27,2746,4.351064714114301
TALL-1 [Human adult T-ALL],10385095,1.4053466186378143
TE-1,54649381,4.275384635285066
TE-11,9887053,4.145437887777616
WSU-DLCL2,100016,5.8333868406138585
SNU-407,136227924,2.9703344519672785
OPM-2,11455910,0.7503761469114726
UM-UC-3,135423438,2.517852030384128
COLO 668,100016,7.809114037996309
MDA-MB-157,15953870,0.7968689532543627
SU-DHL-10,100016,5.73425222116556
Kelly,136227924,2.280835674454857
SNU-1079,387447,-4.985394780237214
SH-10-TC,10385095,3.3084843138225715
KE-37,73707440,6.056087509809561
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
NCI-H1693,9887053,3.8803607374777647
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
SiMa,387447,-5.072335241886544
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
NCI-H747,6505803,-2.758197562665133
NCI-H2052,9926054,2.624833706657142
SIG-M5,11396600,3.2448183238044255
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
THP-1,2746,1.8092224588916963
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
NCI-H1694,246676,4.827487057089954
WM793,24753719,4.8266947199238786
D283 Med,54618771,1.215604089870786
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
JHUEM-7,2746,3.3298840403754153
Daudi,9926054,1.7776420054693636
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
KMS-12-BM,9926054,1.301975129823355
FTC-133,3825829,4.910712910753543
A-375,10385095,1.3116334013128008
SW1353,3825829,4.392940799001886
COLO 800,10385095,0.8108166811299345
HLF,12001922,1.53308514436757
G-402,100016,6.451749665500501
A-549,136227924,3.1395144761786486
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
SEM,54618771,-1.6874791122177024
TCCSUP,246676,4.500819346374967
HSC-3,54618771,0.6642536113718133
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
P12-Ichikawa,9887053,1.6830974367658518
A-549,3825829,4.248968416167453
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
CAL-51,54618771,0.0049145289548569
8-MG-BA,6505803,0.3942705554258823
RT-4,6505803,-1.736360108528808
HOP-92,15953870,3.6997396384954766
EB1,44197249,1.2829816598898034
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
KYSE-150,9926054,2.2758457773041645
SW579,6505803,-3.37113602004837
AsPC-1,15953870,5.362858272792295
A-375,387447,-3.5908810872536066
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
WM266-4,387447,-4.452356579438182
JL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.640014576160969
SNU-C5,2746,3.0959467324138346
YKG-1,10385095,1.6490747273170454
MeWo,9926054,1.733945316459816
KYM-1,9926054,1.655871413890737
Pfeiffer,44197249,4.144182283744155
NH-6,3825829,4.035845884222022
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
OVK18,9887053,2.4279874684604095
BT 328,9926054,3.720062864226824
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
WM115,6505803,-4.475953396274594
MHH-NB-11,12001922,1.7736071524509158
Mino,54618771,0.6228570132231963
SK-MM-2,9887053,1.5121136123168657
NH-6,11455910,0.8097778679046014
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
BICR 6,9887053,4.363373895151885
NCI-H1341,135928012,4.190789793662479
HD-MY-Z,100016,6.5820470291511555
22Rv1,54649381,3.789617434409942
GDM-1,24753719,4.26675838017338
MCAS,42642645,1.6659127430061134
IGROV-1,3825829,4.144093606877803
SW1783,15953870,3.727401815787135
COLO 792,135928012,4.783566860921962
NCI-H358,12001922,1.9143271550848175
HCC1143,2746,1.9419289545652112
COLO 668,10385095,1.0235931260248912
AML-193,10385095,0.4941953706733294
GP2d,100016,6.428285689025714
Hs 683,12001922,1.3488364585339865
BT 320,42642645,3.0201339489728563
PK-45H,54618771,1.4553505750064293
Kuramochi,11396600,4.221456275944083
NCI-H841,2746,3.2973731643311193
NCO2,54618771,-0.1705151191723565
KMS-34,2746,1.024640964168084
EB1,15953870,2.2959529842546553
697,135928012,1.9728705970693543
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
TF-1,9926054,1.8165915475907757
NCI-H1666,6505803,-3.0985953637534354
NCI-H1651,42642645,1.410499641477735
D283 Med,3825829,1.8555624568055975
HT-29,136227924,3.5079295938152706
U2OS,15953870,2.266535732781899
WM115,100016,7.477930972064711
ChaGo-K-1,387447,-4.0313743226417875
A-498,54618771,1.1394352833671273
Rh30,10385095,1.4974792753109163
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
SCC-9,42642645,1.380036396261508
HH [Human lymphoma],49836020,3.7105679750249663
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
VMRC-LCD,2746,2.492181384222375
Lu-99,selumetinib-GDC-0941 (4-1 mol-mol),1.1181366334842004
IGR-39,42642645,1.2453764155814513
OE19,12001922,2.766905676958334
BT 147,10385095,0.6839896048308689
MEC-1,136227924,1.9415739350117864
HDQ-P1,15953870,3.8219035476758454
KMS-20,11396600,3.251276500206743
AsPC-1,42642645,1.2436203489585118
RL95-2,42642645,0.3115668042401481
VCaP,135411,2.126266451987344
CAL-85-1,4705,1.851642821697695
MOLM-6,24753719,3.7913017933628095
BT-474,54618771,0.7682511511531626
8505C,100016,6.577733697234268
G-402,42642645,-1.785938170541929
NCI-H1703,11455910,0.7967317937160228
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
JHOM-1,9926054,2.608228459897926
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
JHH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.61874119121482
MKN74,10385095,1.1692289790304908
HCC1395,42642645,0.5743147089668765
Ishikawa (Heraklio) 02 ER-,54649381,3.9004704347279566
JM-1,11396600,1.6173586604508372
JHUEM-3,387447,-4.484924580522653
BT 216,100016,6.740671439747835
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
H-STS,3825829,3.5499806421209854
Namalwa,11167602,1.8297854280338213
K029AX,3825829,4.309349709293952
COR-L95,4705,3.007858501345706
MOLT-3,9926054,1.73923619089024
ST486,9926054,1.8361941441765457
SH-10-TC,3825829,4.654240703208267
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
SNU-840,54618771,2.041373861449483
OCI-Ly3,100016,3.877117461004623
MDA-MB-435S,387447,-3.674674260016233
Hs 839.T,100016,7.045878686884313
K029AX,2746,3.0884726506960805
SK-UT-1,42642645,1.4382792591793798
BT 231,12001922,1.144949639789655
SNU-1,12001922,1.5910157015509323
BT 145,136227924,2.723434550490864
KNS-60,54649381,4.137511600942839
LK-2,11396600,3.577744596051322
OE33,135411,0.1035302974867378
HCC827,42642645,0.3755947438756838
Raji,387447,-4.438252130288484
KYSE-520,selumetinib-GDC-0941 (4-1 mol-mol),2.0690481757247037
L3.3,10385095,1.3503663642800654
A101D,15953870,4.36968614015201
NCI-H2106,387447,-4.111316448725346
AsPC-1,12001922,2.2862775547931675
OE19,selumetinib-GDC-0941 (4-1 mol-mol),2.914512652837311
UACC-62,selumetinib-GDC-0941 (4-1 mol-mol),-0.701178032611257
MPP 89,10385095,1.2849764052084127
CGTH-W-1,49836020,5.717814266829885
SNB-75,24753719,5.895430313636729
Ku812,49836020,4.574644913995472
TE-15,3825829,1.985318153826467
A-375,54649381,4.147503640092436
WT2-iPS,9887053,4.31038957379926
TYK-nu,49836020,4.345378886251337
JIMT-1,136227924,4.112902711551938
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
NCI-H2405,10385095,1.0090200859882867
LK-2,100016,5.670732740144693
OCI-Ly10,11455910,3.348747046731681
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
CL-11,135928012,3.70085356729294
BT 428,54649381,3.993232750237313
OVK18,9926054,1.8068809708246223
LS1034,24753719,3.5681552526361835
P3HR-1,135411,1.6234361075230843
HCT 8,387447,-3.504931745607726
MKN74,9926054,2.8513802079001844
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
PC-3,9927531,5.366538449676758
BFTC-909,3825829,4.25128930140834
SEM,9887053,1.384456155351722
TT,10385095,1.3981899222512604
Kelly,100016,6.527674974645037
NCI-H929,135411,0.3622558435964065
HSC-2,selumetinib-GDC-0941 (4-1 mol-mol),0.8174688254253049
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
PE/CA-PJ15,12001922,2.3409617701087577
CW-2,10385095,1.8686327254160755
HCT 116,135411,0.7931773181846494
MOLP-8,12001922,1.340541943266141
Rh18,4705,2.954039930023468
KMS-27,15953870,3.4686718283353453
OCI-Ly10,11167602,4.287131576849384
NCI-H1869,11167602,4.37189538269334
JeKo-1,6505803,0.6415741653854196
TC-71,15953870,4.21580973131526
SNU-668,selumetinib-GDC-0941 (4-1 mol-mol),1.744810645163071
NCI-H2087,387447,-4.957755773164931
EN,42642645,1.106336268841167
Calu-3,10385095,1.1090887882860962
EFM-192A,11396600,3.5001558011372045
SNU-398,12001922,2.646653462881348
NCI-H1666,136227331,3.5475542812047873
BT 139,136227924,3.476406727957654
HPB-ALL,11455910,0.3446196457259795
OAW42,42642645,1.4127058185888346
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
SCaBER,15953870,4.696881670083947
EoL-1,44498493,4.3086517306828656
K029AX,11455910,1.0219454107172774
HOP-62,11455910,0.5971366632673413
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
OVISE,54649381,4.33420809644373
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
TT,54649381,3.649988252021252
HEC-108,3825829,3.356859835270974
SHP-77,3825829,3.723718373622183
LoVo,136227924,4.6796674015936075
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
U-251MG,135928012,4.8118176150029335
SUP-T1,9887053,3.808477169767825
A3/Kawakami,42642645,0.9558867808126186
KMH-2,54649381,3.605505301942369
A2058,3825829,3.8218747284239263
PC-14,42642645,-0.2758248149200779
HuT 78,9926054,1.4431118641564118
NCI-H2081,24753719,4.037731991107883
COLO 741,selumetinib-GDC-0941 (4-1 mol-mol),3.828549424884254
FU-OV-1,10385095,1.480245925499038
KLE,42642645,1.516537245777594
RCH-ACV,9887053,2.2719455234781796
BICR 22,136227924,2.105383482893856
HCC44,136227924,2.988750330313465
DMS 114,11455910,0.636471074405143
TE 441.T,12001922,1.15774914966468
MFE-296,6505803,0.2108940318796544
CGTH-W-1,136227924,3.107802787848976
SCC-25,4705,0.8659317696448142
MKN7,12001922,1.9513764938821991
BT 139,6505803,-5.215267056081471
BICR 6,49836020,4.408429630205201
WM266-4,9927531,4.893127770626654
NCI-H2009,100016,6.24887408197215
T98G,387447,-4.912504065747704
EPLC-272H,6505803,-1.0769896118510445
HCC1428,11455910,0.3865695172976586
CAL-27,136227924,2.2169431722835324
Hs 895.T,selumetinib-GDC-0941 (4-1 mol-mol),2.3327892844393374
Rh41,3825829,3.489118142839909
BICR 18,12001922,1.8873096145571064
GSU,6505803,-1.4354147992291242
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
OC 314,136227924,3.246361398875885
MG-63,9926054,3.1754047574180815
LK-2,9927531,4.895223263990893
KP-4,9887053,1.9086083825489089
T84,6505803,-1.9695494266623712
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
NCI-H1385,9887053,3.383761295869436
HOP-92,54649381,4.061578826366214
TALL-1 [Human adult T-ALL],11396600,2.6371175707819887
OVK18,100016,6.632788488948234
Sq-1,6505803,1.095913417774702
JHUEM-3,42642645,0.9251279637473327
SCC-25,49836020,1.4878182873068626
T3M-10,42642645,1.3462145184322023
NCI-H2023,10385095,1.104290975738384
JHH-5,10385095,1.1597118706977676
NCI-H1838,135411,0.6293145208507315
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
SK-N-SH,387447,-5.520573584965203
RT-112,3825829,3.832651959029471
SUP-B15,15953870,3.76821036280456
A-549,11455910,0.2975953497649719
NCI-H1703,100016,6.215140096774371
786-O,selumetinib-GDC-0941 (4-1 mol-mol),2.324696492331355
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
COR-L95,246676,4.317733637680926
MOLT-13,selumetinib-GDC-0941 (4-1 mol-mol),0.648080768379065
WM88,135411,0.6500628188796147
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
TT,135411,0.6927819279965229
KE-37,12001922,1.5844157987654472
HOS,24753719,4.020757044996551
PK-59,10385095,1.2934299374128844
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
RS4;11,24753719,2.416843380239875
Capan-2,387447,-3.903817015655035
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
Hs 888.T,54618771,0.4236563431262232
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
BT 422,135423438,1.9130848394222184
RPMI-8402,42642645,-1.09919815686106
RVH-421,11396600,3.585263708085467
COV362,1474550,5.351656960676299
HT-1080,387447,-4.863880966614431
ME-1 [Human leukemia],387447,-4.584474272658371
BV-173,selumetinib-GDC-0941 (4-1 mol-mol),0.1025224911363418
MOR/CPR,54618771,0.4872515527398967
BT 164,12001922,1.0133510944912951
Panc 10.05,2746,4.189917582449672
Kuramochi,135928012,3.662358137180501
TOV-112D,11396600,3.358650381716018
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
UACC-62,15953870,4.492610824919291
NCI-H2141,10385095,0.6174596155985671
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
BHY,11396600,4.25848737272748
PC-3,6505803,3.983075773464378
SNU-1272,12001922,1.7945381645240002
TE-14,246676,5.320033654623924
KM12,15953870,3.30890578184041
OCI-AML-3,387447,-5.358475874635664
SU-DHL-8,12001922,2.6247237101289347
KMRC-20,387447,-3.930757262228924
NCI-H146,2746,0.8652413173737366
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
SNU-C4,15953870,4.108929076198745
HOP-92,100016,6.879559613863246
EJM,15953870,3.026448270110203
HuCC-T1,11455910,0.6774191240252393
NCI-H1693,12001922,1.0581291526802166
SNU-61,9926054,1.8929452670989917
BT 245,42642645,1.337897041981839
HCT 116,9887053,4.426298234499757
G-361,4705,3.3559681127377936
HMC-1-8,42642645,0.7775949139543654
SNU-620,11455910,2.08443042552151
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
639V,135411,0.4460265301140604
SUP-M2,135423438,1.6419066239176594
B-CPAP,135411,1.7170212116885226
NCI-H1339,42642645,1.6149753620501943
HGC-27,24753719,4.105970639778359
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
UACC-62,387447,-3.992140795211211
UACC-812,9926054,1.7122964049751828
GMS-10,selumetinib-GDC-0941 (4-1 mol-mol),1.7760805254050829
BT 159,136227924,3.541986211057949
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
HCC4006,100016,6.421907923076987
SKM-1,387447,-5.418764341651642
M-07e,100016,5.065678373530031
UACC-257,9926054,1.800588068202944
BxPC-3,9926054,1.7603137158224154
Calu-6,12001922,1.6912385474214862
NCI-H196,9927531,5.55374615852481
SCC-25,11455910,2.801880341049824
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
EB1,11396600,2.2409379442223134
KNS-81,42642645,-0.7087685108256111
ZR-75-1,54618771,1.401899107302776
SF539,246676,6.084250396214504
DU145,9926054,1.942219630113699
DLD-1,9926054,3.0182242883731516
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
HDLM-2,9887053,5.158038800358598
OPM-2,3825829,3.9075204590636226
ACHN,135411,0.7671981803470546
SK-N-MC,12001922,1.2507009578708026
MDA-MB-468,15953870,3.865823864544771
UACC-62,42642645,1.5811261834751351
NCI-H2342,42642645,1.1443849504605337
Hs 729.T,136227331,4.519931514074803
T98G,15953870,3.9159504449413687
Granta-519,6505803,0.3707466177802866
KYM-1,387447,-4.681354724572535
KMH-2,135411,0.0392364050134285
U-BLC1,9926054,1.6248687315541563
SNU-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1369641916187444
OE21,11455910,0.3483153837156987
MOLT-3,11455910,-0.1695088627496582
SW579,136227924,2.120211379000796
KYO-1,24753719,6.215004432138207
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
DB,15953870,2.862938424574366
SNU-C2A,12001922,1.6949887555097172
Becker,42642645,-0.0222198712525443
AN3-CA,9926054,1.8039265956503063
TE-1,10385095,1.326067613707214
OAW28,42642645,0.9360886571737812
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
SNU-C5,12001922,1.701335550737109
BT 231,100016,7.4946101776766385
Hs 729.T,9887053,4.1823572731531815
SYO-1,387447,-4.243562399567123
CAL-54,10385095,1.4205494165748902
Jurkat,136227924,2.4803602069258712
RT-112,15953870,3.6960986003593534
SNU-719,3825829,4.72361363258027
NCI-H1869,24753719,5.307545419394006
BT 131,15953870,3.962391526699234
BT 224,54618771,1.0609387834532893
TE-10,selumetinib-GDC-0941 (4-1 mol-mol),2.2597459184044593
VMRC-LCD,11455910,1.1166938549694674
Hs 294T,11455910,1.2626812839087918
BT 172,4705,2.221362713741292
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
DMS 114,135423438,1.5631091750684547
NU-DHL-1,12001922,1.2463642245780415
NCI-H929,100016,3.8135603062591
MPP 89,6505803,-0.6536237493754191
SNU-601,12001922,1.843539423316627
KO52,6505803,1.22031024799857
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
P12-Ichikawa,54649381,3.4055305380327874
Kelly,42642645,-0.2963666375904175
HuNS1,49836020,4.176817793282971
GP2d,24753719,3.999563090079058
NCI-H2023,12001922,1.8411418343828656
PSN1,24753719,4.290295429710992
ACHN,42642645,1.231857985064801
697,15953870,2.1386985405405805
Li-7,24753719,4.307945424099166
ONCO-DG-1,42642645,1.5247529918562113
SNU-213,136227924,3.1812992174761696
BT 248,135411,2.4646623802818577
NCI-H211,9926054,1.5085991120248008
NCI-H1975,73707440,4.623007313356143
NCI-H1734,9877608,5.725584045619203
BT 228,54649381,3.7325588856509753
M-07e,135928012,3.338942058081814
BT 416,44197249,4.552326885312017
PE/CA-PJ49,10385095,0.7863644844399451
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
SNU-1196,135411,0.5416388688787949
BT 440,42642645,0.1106109031973179
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
KCL-22,44197249,3.853332375191376
SK-MEL-5,9926054,2.75949424585879
BT 164,10385095,0.5505711348294146
SHP-77,15953870,3.4824943826779293
Mono-Mac-1,11455910,1.2371744705316827
HOP-62,387447,-3.823160514435493
NCI-H1105,10385095,0.6230711413041305
NCI-H1299,54618771,0.5506920644788533
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
U-937,54649381,3.694795206320444
Rh18,11455910,-0.2112753889424844
HEC-1-A,2746,3.527816775331282
SUP-B15,4705,3.3539496545861542
RKN,11396600,3.670395083293249
HOP-92,54618771,0.6588876018328178
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
NCI-H1563,136227331,3.8731399869875167
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
RD,135411,1.87304149468884
NB4,15953870,2.2741900948939087
Calu-3,246676,5.532559634665407
A2058,54618771,1.1536818044190116
NCI-H2342,10385095,1.222992790887497
SUP-HD1,9887053,2.785927680398398
NU-DHL-1,6505803,0.0102011938996583
PaTu 8988s,10385095,1.7438856573412385
IGR-1,2746,1.8985150610888328
HEC-108,15953870,3.7106591750651736
LMSU,11455910,2.490355648913592
RD,2746,3.2035817097570334
TE-14,42642645,1.3983104503701576
BT 416,42642645,1.3900431170994498
KYSE-30,135411,0.5399611674911847
Capan-1,54618771,1.2966911040963736
HuH-6,54618771,-1.3988584380495144
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
DEL,10385095,0.3320635123477122
SUP-B15,11396600,3.1558477769861892
DMS 114,42642645,0.7286893931518599
BT 131,9927531,5.2651806903181235
SNU-216,1474550,4.311507267346721
IM95,135928012,5.232224723877496
SEM,135423438,-3.9763751688577527
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
TOV-112D,6505803,2.1658799335254644
GI-1,9927531,5.508249375264951
NCC-StC-K140,10385095,0.7190988924751318
LCLC-97TM1,42642645,0.0997949580151915
SHP-77,9926054,1.3761087450643723
BT 216,9926054,2.3183160666654783
SNU-449,11167602,2.762483283064935
ST486,15953870,3.034939497181702
DAN-G,12001922,2.711917953072317
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
LUDLU-1,54649381,3.0876024568236984
VMRC-RCW,2746,4.068142110971067
NCI-H1341,12001922,0.9751112763461602
RS4;11,49836020,6.257665529441248
HSC-2,2746,4.285336510819298
HEL 92.1.7,11455910,0.3548529299693889
NCI-H1092,9887053,3.38988914418067
BT 145,4705,0.7034961776372417
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
OS-RC-2,54649381,3.8835191161813616
EKVX,9927531,4.418248493855361
HeLa,6505803,-0.0506022751267441
COLO 792,24753719,4.174759207225883
Hs 746.T,100016,6.2249168538435
MDA-MB-415,3825829,4.214267927648232
KP-N-YN,54618771,4.352699986589353
HPB-ALL,3825829,3.5728119173488673
BT 145,11455910,-0.1698312216802191
T84,24753719,4.006529455935125
PaTu 8902,2746,3.932313359375791
TE 617.T,136227924,1.63601430884803
DU145,54649381,3.1734563726622302
NCI-H2126,2746,2.4286105170144587
Kasumi-1,54618771,-0.5933473150200181
BT 232,9926054,2.340014679513304
MDA-MB-453,246676,1.942789144720036
SW579,3825829,3.988317098773548
Karpas-299,73707440,5.429383065350182
GSU,135411,2.7616580473048797
SNU-899,135411,0.7865219058030622
MeWo,11167602,1.655491206149829
BT 248,9927531,4.7076279917818225
MDA-MB-157,6505803,-0.678815881739905
Ki-JK,135411,-1.899619880733145
SW1783,11396600,4.918648417758992
HuT 78,54618771,-0.2261201753145263
JMSU-1,12001922,1.6202499949058322
NCI-H2081,10385095,0.3312851708861742
RT-4,135928012,3.02526945611553
DU145,9887053,4.180295079477411
A-673,9927531,4.216692000672551
U-118MG,136227924,3.3662867602003006
SNG-M,10385095,0.7800412283889386
KE-37,9887053,1.1178591550502972
OV7,15953870,4.174779124734957
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
BT 159,42642645,1.411719864949474
SK-MEL-3,11455910,1.2991192016646154
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
Hs 888.Lu,selumetinib-GDC-0941 (4-1 mol-mol),2.177806274579951
CAS-1,9887053,4.885726815898828
AN3-CA,10385095,0.1159584530929505
NCI-H841,12001922,1.8135403714576053
Aska-SS,136227924,2.71481465035111
SU-DHL-8,15953870,2.075415300828017
CA46,9927531,3.0223750820915978
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
MV4-11,54618771,-0.7918947949340449
Kasumi-1,12001922,2.0778099505178895
LNCaP clone FGC,3825829,3.9808343636151657
IM95,100016,6.474511795509729
MDA-MB-453,136227924,2.410345496671846
U-251MG,135423438,1.776157398246975
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
HCT 15,24753719,1.6813989750926222
NCO2,54649381,3.617596248249218
KYM-1,9927531,4.58392682790106
TE-4,54618771,0.5260278074732754
SK-MEL-28,10385095,3.2557901504831306
PE/CA-PJ34 (clone C12),15953870,4.1853998040231595
SNU-719,42642645,0.6837630111624428
Jurkat,15953870,2.2676688783124006
NCI-H650,135928012,4.623737326026262
HCC1806,42642645,1.5327925102613396
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
AML-193,42642645,-0.7623602768387703
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
BHT-101,3825829,4.548638095735274
HCC-56,54649381,3.100341079122986
KMRC-3,12001922,1.5999011614935867
HCC2279,6505803,3.133680214684758
Karpas-620,4705,3.7367070326716982
NCI-H28,6505803,-3.2149479697747534
DEL,11167602,1.5971782344142085
MHH-CALL-3,100016,3.61949081353442
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
HCC2218,100016,5.089450081937329
T24,387447,-4.275411351069935
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
P3HR-1,9887053,5.508801361813419
B-CPAP,54649381,3.6438923395842298
SNU-878,9927531,4.662529833906493
OUMS-23,54649381,3.7617226310775274
NCI-H2052,15953870,3.5516512941802407
HCC4006,9926054,1.7314546414063618
NCI-H1568,10385095,0.5241849666466598
CAL-85-1,2746,3.013278075815884
NCI-H508,54618771,1.4622256000794474
LAMA-84,100016,4.28644111913654
SNU-685,6505803,1.7815345104431104
MHH-NB-11,selumetinib-GDC-0941 (4-1 mol-mol),0.4891965075201672
Capan-1,11396600,3.9695297031649384
KYSE-180,15953870,2.8572759517399677
TC-71,387447,-4.777747319829986
OVK18,42642645,1.1271394615930117
KNS-62,54618771,0.989715202363148
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
CAL-12T,3825829,4.342907222048062
HCC1500,135411,2.801194317933856
DU145,9887053,4.180295079477411
OVTOKO,3825829,4.288227697588643
NCI-H716,11455910,0.5118733249267832
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
Hs 822.T,11455910,5.717819116017218
MES-SA,42642645,0.9027980803504554
BICR 31,6505803,0.2507928346620714
Kuramochi,6505803,3.382467599706822
HuH-28,49836020,4.5831032591173635
KE-97,54618771,-0.8035636826323382
TE-15,10385095,0.8889950613802687
U266B1,11167602,2.309921698105226
DMS 53,136227331,3.826104197881878
NCI-H810,6505803,1.3479141255635732
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
SW579,54618771,0.7719470301120797
253J-BV,42642645,1.6241896866167245
HCC2935,42642645,1.3801855341736522
SU-DHL-8,136227924,2.244700910858823
LP-1,100016,3.986438392754067
BICR 18,4705,4.076520014659249
JHOM-1,2746,3.154925992332872
NCI-H1573,6505803,-1.6898584234465963
SNU-C4,4705,2.69481257913417
SKM-1,2746,1.6032420730880204
KLE,135411,0.8012767106548482
Hs 888.Lu,136227924,2.7652519196534304
RCC10RGB,42642645,2.104174802814935
NU-DHL-1,11455910,-0.2130419418137634
NCI-H1651,9926054,1.9046490097522224
HT-55,11396600,3.0966663667884595
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
HT-1376,9887053,4.3872381433248755
MES-SA,9887053,4.198062941905947
TUHR4TKB,3825829,5.610276843292909
Hs 940.T,selumetinib-GDC-0941 (4-1 mol-mol),2.512556445742238
NCI-H322,24753719,4.204705082811736
BT 147,135411,1.560610875622162
TTC-709,135928012,3.664410481857117
NCI-H650,387447,-3.978675784221828
FaDu,387447,-3.210195407148332
NCI-H2170,136227331,4.269339943775955
CCF-STTG1,136227924,3.7108552267199504
G-401,135928012,4.758772301459146
A4/Fukuda,11396600,-8.215434514364686
MC116,15953870,2.391701161946214
Kasumi-2,11455910,-0.3707966959989963
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
TUHR4TKB,135411,0.8130706267140292
OVCAR-4,selumetinib-GDC-0941 (4-1 mol-mol),3.050941054620586
Kuramochi,24753719,4.390928067478378
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
VCaP,9927531,5.412919809162458
Granta-519,11396600,3.399615682634249
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
BT 482,11396600,2.553396780600671
LS513,3825829,4.33606609263949
KMRC-20,136227924,3.298573049161518
NCI-H460,3825829,4.446795399525052
JHUEM-3,9927531,4.734556698770441
JM-1,10385095,0.4126425157623973
786-O,246676,6.023561482429134
NB1,15953870,3.294494795471297
GA-10,10385095,-0.1867233293810926
WM983B,387447,-4.220808963695924
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
SCC-9,387447,-4.584813930042193
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
JJN-3,387447,-5.415643494119011
NCI-H1573,3825829,4.743319064477553
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416
SNU-387,selumetinib-GDC-0941 (4-1 mol-mol),1.4136760504697403
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
IGROV-1,15953870,2.712793598656007
IGR-1,42642645,0.9674588121559116
KP-3,9926054,1.9542215923866435
SNB-75,10385095,1.6720674409271052
BT 179,10385095,1.0109187966932571
Karpas-620,11167602,2.9384748402816947
DBTRG-05MG,54649381,4.320788110352735
SK-ES-1,11455910,-0.125480247265252
RD,6505803,-1.3634143694838363
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
SK-MEL-5,54618771,0.7093345512366925
Panc 08.13,selumetinib-GDC-0941 (4-1 mol-mol),0.8396472898062124
Caov-3,6505803,-1.4448132497594957
SF126,15953870,3.823506138019864
Panc 04.03,42642645,1.6619965718360328
Ki-JK,54618771,0.0695093081370742
BDCM,10385095,0.3905687055307765
ALL-SIL,135928012,2.5698772014589992
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
MG-63,9927531,4.972527766781062
NCI-H2030,136227924,3.923759704530775
KMBC-2,387447,-4.640187394922598
UM-UC-3,100016,5.625806405184742
UACC-812,11396600,4.679415745859403
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
HCC4006,42642645,1.2051299453172293
KG-1-C,135411,3.732362207839629
PaTu 8988s,9927531,5.1297297992623605
SNU-46,100016,6.6556000707540095
CAL-33,selumetinib-GDC-0941 (4-1 mol-mol),-0.2245005212599697
AsPC-1,54618771,1.0442216511349782
OUMS-23,10385095,2.9007183392939626
Rh30,15953870,3.023446559735349
TF-1,9927531,3.351583098746858
SNU-C1,2746,1.4154378520046618
YD-8,9927531,5.007831795650313
KYSE-70,11455910,0.6771697782379181
UO-31,387447,-3.857163529066561
KO52,42642645,-0.8739064396706098
RERF-LC-A1,10385095,0.5926472650541055
NB1,11455910,-0.1636183381201439
SW1417,3825829,4.339003489780433
TE-5,4705,3.380562740986189
HuP-T4,10385095,2.091530291453941
MOLT-3,2746,1.7836701533013988
OV7,24753719,4.262942269756317
TE-15,100016,6.263488161224716
PE/CA-PJ41 (clone D2),135411,0.8293994588997935
U266B1,42642645,1.5152146433336
Hs 294T,9926054,1.7844528476619044
TCCSUP,15953870,3.2845347165405623
BT 145,24753719,3.4612678536097814
MIA PaCa-2,2746,3.119583352790748
SNU-601,100016,6.491707225104745
SCaBER,136227924,3.000538162090115
NCI-H2172,11396600,4.171717068415809
HCC44,selumetinib-GDC-0941 (4-1 mol-mol),-1.5745455752339166
JHUEM-1,135411,0.7795801140018243
MFE-319,387447,-4.92293484170829
NCI-H1105,12001922,2.062719953351038
HCC15,135423438,2.37991378319322
B-CPAP,54618771,-0.888157328254987
SK-MEL-3,10385095,0.9651343435449692
AsPC-1,387447,-4.291846387154746
KMH-2,10385095,1.3020469045256973
BT 172,11455910,0.4137780640071803
JHH-5,11455910,0.7201597489902917
IGROV-1,11396600,3.99372654279783
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
NCI-H292,54649381,3.811841265663476
BT 440,135411,2.759705487632876
TE-11,11455910,1.33460610412381
MOTN-1,6505803,1.224860499211516
NCI-H889,2746,2.2836430328377997
ST486,11396600,2.643350967918509
RT-112,10385095,1.0115398078561386
KATO III,9927531,6.301212923475331
YD-15,42642645,0.8105684027384998
SKM-1,136227924,2.5339244468963407
EM-2,9927531,3.4413075859413556
HCC2218,4705,1.2825749224447869
KYM-1,49836020,-6.165786834710826
T3M-10,selumetinib-GDC-0941 (4-1 mol-mol),0.2338392597437749
Hs 683,135928012,3.6982239425483887
Calu-3,135411,0.6982940048451036
HSC-2,3825829,3.3302379686310344
OV7,9927531,3.7573149322821937
ZR-75-30,12001922,2.1670064084186302
CML-T1,100016,5.302267949835527
OCI-AML-3,135411,-1.6750420830550048
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
PC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.4972652387658174
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
HCC1438,9927531,4.9957520851932955
BT 286,246676,1.6855048913308266
SNG-M,6505803,0.0045720591705094
SUP-B15,42642645,-1.183748529103249
U-251MG,9926054,2.2647834350690483
NCI-H2110,12001922,2.34278570300224
P12-Ichikawa,11167602,1.8664895449187011
COLO 792,42642645,-1.1249431466829507
HMCB,12001922,1.7530973363803413
TE 617.T,12001922,1.7952011808857071
L3.3,15953870,4.520919895902943
Calu-6,3825829,3.5082679305648763
SUP-T11,387447,-3.8487936913403873
NCI-H508,6505803,-2.7126843112816927
Caov-3,24753719,4.572893640685599
Panc 08.13,4705,3.2768687691723395
Malme-3M,10385095,1.6346329465288842
L-540,4705,2.669607218607157
JHH-5,9887053,1.6626496078904724
SW1271,11455910,0.4702460968788743
G-402,9887053,1.369469696515782
SNU-449,9927531,4.924705078398161
PK-45H,12001922,2.2755811658276315
Ishikawa (Heraklio) 02 ER-,6505803,-0.7712031048650526
MOLP-2,4705,2.8444901068578687
EFE-184,54618771,1.5466528492822589
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
ECC12,135411,0.6818589697711982
